US20150098928A9 - Isoxazoline insecticides - Google Patents

Isoxazoline insecticides Download PDF

Info

Publication number
US20150098928A9
US20150098928A9 US14/148,410 US201414148410A US2015098928A9 US 20150098928 A9 US20150098928 A9 US 20150098928A9 US 201414148410 A US201414148410 A US 201414148410A US 2015098928 A9 US2015098928 A9 US 2015098928A9
Authority
US
United States
Prior art keywords
alkyl
independently selected
substituents independently
optionally substituted
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US14/148,410
Other versions
US9095138B2 (en
US20140127165A1 (en
Inventor
George Philip Lahm
Ty Wagerle
Ming Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39930577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20150098928(A9) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Priority to US14/148,410 priority Critical patent/US9095138B2/en
Assigned to E.I. DU PONT DE NEMOURS AND COMPANY reassignment E.I. DU PONT DE NEMOURS AND COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WAGERLE, TY, XU, MING, LAHM, GEORGE PHILIP
Publication of US20140127165A1 publication Critical patent/US20140127165A1/en
Publication of US20150098928A9 publication Critical patent/US20150098928A9/en
Application granted granted Critical
Publication of US9095138B2 publication Critical patent/US9095138B2/en
Assigned to CORTEVA AGRISCIENCE LLC reassignment CORTEVA AGRISCIENCE LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: E.I. DU PONT DE NEMOURS AND COMPANY
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/78—1,3-Thiazoles; Hydrogenated 1,3-thiazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N53/00—Biocides, pest repellants or attractants, or plant growth regulators containing cyclopropane carboxylic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/26—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds
    • A01N57/28—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-nitrogen bonds containing acyclic or cycloaliphatic radicals
    • A01N63/02—
    • A01N63/04—
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A01N63/23—B. thuringiensis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/30—Microbial fungi; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/40—Viruses, e.g. bacteriophages
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • This invention relates to certain isoxazolines, their N-oxides, salts and compositions suitable for agronomic, nonagronomic and animal health uses, methods of their use for controlling invertebrate pests such as arthropods in both agronomic and nonagronomic environments, and for treatment of parasite infections in animals or infestations in the general environment.
  • invertebrate pests The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer.
  • the control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, turf, wood products, and public health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different sites of action.
  • PCT Patent Publication WO 05/085216 discloses isoxazoline derivatives of Formula i as insecticides
  • each of A 1 , A 2 and A 3 are independently C or N; G is a benzene ring; W is O or S; and X is halogen or C 1 -C 6 haloalkyl.
  • This invention is directed to compounds of Formula 1 including all geometric and stereoisomers, N-oxides, and salts thereof, and compositions containing them and their use for controlling invertebrate pests:
  • This invention also provides a composition comprising a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents.
  • this invention also provides a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent.
  • This invention further provides a spray composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, or the composition described above, and a propellant.
  • This invention also provides a bait composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, or the compositions described in the embodiments above, one or more food materials, optionally an attractant, and optionally a humectant.
  • This invention further provides a trap device for controlling an invertebrate pest comprising said bait composition and a housing adapted to receive said bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to said bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • This invention provides a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein).
  • This invention also relates to such method wherein the invertebrate pest or its environment is contacted with a composition comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent.
  • This invention also provides a method for protecting a seed from an invertebrate pest comprising contacting the seed with a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein). This invention also relates to the treated seed.
  • This invention further provides a method for protecting an animal from an invertebrate parasitic pest comprising administering to the animal a parasiticidally effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein).
  • This invention further provides a method for treating, preventing, inhibiting and/or killing ecto- and/or endoparasites comprising administering to and/or on the animal a parasiticidally effective amount of a compound of Formula 1 (e.g., as a composition described herein).
  • This invention also relates to such method wherein a parasiticidally effective amount of a compound of Formula 1 (e.g., as a composition described herein) is administered to the environment (e.g., a stall or blanket) in which an animal resides.
  • a parasiticidally effective amount of a compound of Formula 1 e.g., as a composition described herein
  • the environment e.g., a stall or blanket
  • the terms “comprises,” “comprising,” “includes,” “including,” “has,” “having,” “contains” or “containing,” or any other variation thereof, are intended to cover a non-exclusive inclusion.
  • a composition, a mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus.
  • “or” refers to an inclusive or and not to an exclusive or. For example, a condition A or B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present).
  • the term “invertebrate pest” includes arthropods, gastropods and nematodes of economic importance as pests.
  • arthropod includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans.
  • gastropod includes snails, slugs and other Stylommatophora.
  • nematode includes all of the helminths, such as roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda).
  • invertebrate pest control means inhibition of invertebrate pest development (including mortality, feeding reduction, and/or mating disruption), and related expressions are defined analogously.
  • agronomic refers to the production of field crops such as for food and fiber and includes the growth of corn, soybeans and other legumes, rice, cereal (e.g., wheat, oats, barley, rye, rice, maize), leafy vegetables (e.g., lettuce, cabbage, and other cole crops), fruiting vegetables (e.g., tomatoes, pepper, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, tree fruits (e.g., pome, stone and citrus), small fruit (berries, cherries) and other specialty crops (e.g., canola, sunflower, olives).
  • wheat e.g., wheat, oats, barley, rye, rice, maize
  • leafy vegetables e.g., lettuce, cabbage, and other cole crops
  • fruiting vegetables e.g., tomatoes, pepper, eggplant, crucifers and cucurbits
  • potatoes e.g., sweet potatoes, grapes, cotton, tree fruits (e.g.
  • nonagronomic refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • horticultural crops e.g., greenhouse, nursery or ornamental plants not grown in a field
  • turf e.g., sod farm, pasture, golf course, lawn, sports field, etc.
  • wood products e.g., stored product, agro-forestry and vegetation management
  • public health i.e. human
  • animal health e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife
  • nonagronomic refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • horticultural crops e.g., greenhouse, nursery or ornamental plants not grown in a field
  • turf e.g., sod farm, pasture, golf course, lawn, sports field, etc.
  • wood products e.g., stored product, agro-forestry and vegetation management
  • public health i.e. human
  • animal health e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife
  • Nonagronomic applications include protecting an animal from an invertebrate parasitic pest by administering a parasiticidally effective (i.e. biologically effective) amount of a compound of the invention, typically in the form of a composition formulated for veterinary use, to the animal to be protected.
  • a parasiticidally effective (i.e. biologically effective) amount of a compound of the invention typically in the form of a composition formulated for veterinary use, to the animal to be protected.
  • parasiticidal i.e. biologically effective
  • Parasiticidal refers to observable effects on an invertebrate parasite pest to provide protection of an animal from the pest. Parasiticidal effects typically relate to diminishing the occurrence or activity of the target invertebrate parasitic pest.
  • Such effects on the pest include necrosis, death, retarded growth, diminished mobility or lessened ability to remain on or in the host animal, reduced feeding and inhibition of reproduction.
  • These effects on invertebrate parasite pests provide control (including prevention, reduction or elimination) of parasitic infestation or infection of the animal.
  • a parasite “infestation” refers to the presence of parasites in numbers that pose a risk to humans or animals.
  • the infestation can be in the environment (e.g., in human or animal housing, bedding, and surrounding property or structures), on agricultural crops or other types of plants, or on the skin or fur of an animal.
  • the term infestation is also intended to be synonymous with the term “infection” as that term is generally understood in the art, unless otherwise stated.
  • radical “SO 2 ” means sulfonyl
  • CN means cyano
  • NO 2 means nitro
  • alkyl used either alone or in compound words such as “alkylthio” or “haloalkyl” includes straight-chain or branched alkyl, such as, methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl or hexyl isomers.
  • Alkenyl includes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers.
  • Alkenyl also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl.
  • Alkynyl includes straight-chain or branched alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers.
  • Alkynyl can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl.
  • Alkylene denotes a straight-chain or branched alkanediyl. Examples of “alkylene” include CH 2 , CH 2 CH 2 , CH(CH 3 ), CH 2 CH 2 CH 2 , CH 2 CH(CH 3 ) and the different butylene isomers.
  • Alkoxy includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers.
  • Alkylthio includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers.
  • Alkylsulfinyl includes both enantiomers of an alkylsulfinyl group.
  • alkylsulfinyl examples include CH 3 S( ⁇ O)—, CH 3 CH 2 S( ⁇ O)—, CH 3 CH 2 CH 2 S( ⁇ O)—, (CH 3 ) 2 CHS( ⁇ O)— and the different butylsulfinyl, pentylsulfinyl and hexylsulfinyl isomers.
  • alkylsulfonyl examples include CH 3 SO 2 —, CH 3 CH 2 SO 2 —, CH 3 CH 2 CH 2 SO 2 —, (CH 3 ) 2 CHSO 2 —, and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers.
  • Cycloalkyl includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
  • alkylcycloalkyl denotes alkyl substitution on a cycloalkyl moiety and includes, for example, ethylcyclopropyl, i-propylcyclobutyl, 3-methylcyclopentyl and 4-methylcyclohexyl.
  • cycloalkylalkyl denotes cycloalkyl substitution on an alkyl moiety. Examples of “cycloalkylalkyl” include cyclopropylmethyl, cyclopentylethyl, and other cycloalkyl moieties bonded to straight-chain or branched alkyl groups.
  • halogen either alone or in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” or “alkyl substituted with halogen” include F 3 C—, ClCH 2 —, CF 3 CH 2 — and CF 3 CCl 2 —.
  • haloalkoxy and haloalkylthio are defined analogously to the term “haloalkyl”.
  • haloalkoxy include CF 3 O—, CCl 3 CH 2 O—, HCF 2 CH 2 CH 2 O— and CF 3 CH 2 O—.
  • haloalkylthio include CCl 3 S—, CF 3 S—, CCl 3 CH 2 S— and ClCH 2 CH 2 CH 2 S—.
  • haloalkylsulfinyl include CF 3 S( ⁇ O)—, CCl 3 S( ⁇ O)—, CF 3 CH 2 S( ⁇ O)— and CF 3 CF 2 S( ⁇ O)—.
  • haloalkylsulfonyl include CF 3 SO 2 —, CCl 3 SO 2 —, CF 3 CH 2 SO 2 — and CF 3 CF 2 SO 2 —.
  • Alkylcarbonyl denotes a straight-chain or branched alkyl moieties bonded to a C( ⁇ O) moiety.
  • alkylcarbonyl include CH 3 C( ⁇ O)—, CH 3 CH 2 CH 2 C( ⁇ O)— and (CH 3 ) 2 CHC( ⁇ O)—.
  • alkoxycarbonyl include CH 3 C( ⁇ O)—, CH 3 CH 2 OC( ⁇ O)—, CH 3 CH 2 CH 2 C( ⁇ O)—, (CH 3 ) 2 CHOC( ⁇ O)— and the different butoxy- or pentoxycarbonyl isomers.
  • C i -C j The total number of carbon atoms in a substituent group is indicated by the “C i -C j ” prefix where i and j are numbers from 1 to 18.
  • C 1 -C 4 alkylsulfonyl designates methylsulfonyl through butylsulfonyl.
  • said substituents are independently selected from the group of defined substituents, e.g., (R 3 ) m or (R 4 ) n , m is 0, 1, 2, 3, 4 or 5 and n is 0, 1, 2, 3 or 4.
  • the (R 3 ) m substituents can also be attached to the two available carbon atoms of the —CH ⁇ CH—S— moiety (e.g., —C(R 3 ) ⁇ CH—S—, —CH ⁇ C(R 3 )—S— or —C(R 3 ) ⁇ C(R 3 )—S—.
  • a group contains a substituent which can be hydrogen, for example R 3 or R 4 , then when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted.
  • variable group When a variable group is shown to be optionally attached to a position, for example (R 3 ) m wherein m may be 0, then hydrogen may be at the position even if not recited in the variable group definition.
  • hydrogen atoms When one or more positions on a group are said to be “not substituted” or “unsubstituted”, then hydrogen atoms are attached to take up any free valency.
  • the orientation of the Y 1 —Y 2 —Y 3 substitutents is as depicted in Q-A. For example, when Y 1 —Y 2 —Y 3 is —CH ⁇ CH—S—, then Y 1 is CH, Y 2 is CH and Y 3 is S.
  • a substituent to a structure is represented by a wavy line bisecting the bond joining the substituent to the remainder of the structure.
  • a benzyl substituent can be represented as
  • a “ring” or “ring system” as a component of Formula 1 is carbocyclic or heterocyclic.
  • the term “ring system” denotes two or more fused rings.
  • the term “bicyclic ring system” denotes a ring system consisting of two fused rings, in which either ring can be saturated, partially unsaturated, or fully unsaturated unless otherwise indicated.
  • the term “ring member” refers to an atom or other moiety (e.g., C( ⁇ O), C( ⁇ S), S( ⁇ O) or SO 2 ) forming the backbone of a ring or ring system.
  • carbocyclic ring or “carbocyclic ring system” denote a ring or ring system wherein the atoms forming the ring backbone are selected only from carbon. Unless otherwise indicated, a carbocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated carbocyclic ring satisfies Hückel's rule, then said ring is also called an “aromatic ring”. “Saturated carbocyclic” refers to a ring having a backbone consisting of carbon atoms linked to one another by single bonds; unless otherwise specified, the remaining carbon valences are occupied by hydrogen atoms.
  • heterocyclic ring denotes a ring or ring system in which at least one atom forming the ring backbone is not carbon, e.g., nitrogen, oxygen or sulfur. Typically a heterocyclic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. Unless otherwise indicated, a heterocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated heterocyclic ring satisfies Hückel's rule, then said ring is also called a “heteroaromatic ring” or “aromatic heterocyclic ring”. Unless otherwise indicated, heterocyclic rings and ring systems can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.
  • Aromatic indicates that each of the ring atoms is essentially in the same plane and has a p-orbital perpendicular to the ring plane, and in which (4n+2) ⁇ electrons, where n is a positive integer, are associated with the ring to comply with Hückel's rule.
  • aromatic ring system denotes a carbocyclic or heterocyclic ring system in which at least one ring of the ring system is aromatic.
  • aromatic carbocyclic ring system denotes a carbocyclic ring system in which at least one ring of the ring system is aromatic.
  • aromatic heterocyclic ring system denotes a heterocyclic ring system in which at least one ring of the ring system is aromatic.
  • nonaromatic ring system denotes a carbocyclic or heterocyclic ring system that may be fully saturated, as well as partially or fully unsaturated, provided that none of the rings in the ring system are aromatic.
  • nonaromatic carbocyclic ring system denotes a carbocyclic ring in which no ring in the ring system is aromatic.
  • nonaromatic heterocyclic ring system denotes a heterocyclic ring system in which no ring in the ring system is aromatic.
  • an optionally substituted group may have a substituent at each substitutable position of the group, and each substitution is independent of the other.
  • An optionally substituted group also may have no substituents. Therefore the phrase “optionally substituted with one or more substituents” means that the number of substituents may vary from zero up to the number of available positions for substitution. Similarly the phrase “optionally substituted with 1-5 substituents” means that the number of substituents may vary from zero up to the number of available position but not exceeding 5.
  • Q 1 is a 3- to 10-membered ring or 7- or 10-membered bicyclic ring system containing as ring members from 2 to 10 carbon atoms and from 0 to 5 heteroatoms selected from the group consisting of carbon, sulfur and nitrogen atoms, of which up to two of the carbon or sulfur atoms are present as C( ⁇ O), S( ⁇ O) or SO 2 , said ring or ring system optionally substituted with one or more substituents independently selected from R 2 . Therefore the ring or bicyclic ring system of Q 1 may be saturated, partially saturated or fully unsaturated (including aromatic if Hückel's rule is satisfied). Furthermore the ring or bicyclic ring system may contain only carbon atoms as ring members (i.e.
  • the ring members of Q 1 may include up to 5 heteroatoms selected from C, S and N as ring members.
  • the possible number of heteroatoms is limited by the number of ring members in the ring or ring system. Up to two of the carbon or sulfur atom ring members (including combinations thereof) may be present as C( ⁇ O), S( ⁇ O) or SO 2 (including combinations thereof).
  • A is a 6-membered aromatic ring containing carbon atoms and 0-3 nitrogen atoms as ring members, said ring optionally substituted with 1-5 substituents independently selected from R 2 .
  • these rings optionally substituted by 1 to 5 substituents include the rings A-1 through A-14 illustrated in Exhibit 1 wherein R v is any substituent as defined in the Summary of the Invention for A (i.e. R 2 ) and r is an integer from 0 to 5, limited by the number of available positions on each A group.
  • Q 1 When Q 1 is a nitrogen-containing heterocyclic ring or ring system, it may be attached to the remainder of Formula 1 though any available carbon or nitrogen ring atom, unless otherwise described.
  • Q 1 can be (among others) phenyl optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention.
  • An example of phenyl optionally substituted with one to five substituents is the ring illustrated as U-1 in Exhibit 1, wherein R v is R 2 as defined in the Summary of the Invention for Q 1 and r is an integer from 0 to 5.
  • Q 1 can be (among others) a 5- or 6-membered heterocyclic ring, which may be saturated or unsaturated, optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention.
  • Examples of a 5- or 6-membered aromatice unsaturated heterocyclic ring optionally substituted with one or more substituents include the rings U-2 through U-61 illustrated in Exhibit 2 wherein R v is any substituent as defined in the Summary of the Invention for Q 1 (i.e. R 2 ) and r is an integer from 0 to 4, limited by the number of available positions on each U group.
  • U-29, U-30, U-36, U-37, U-38, U-39, U-40, U-41, U-42 and U-43 have only one available position, for these U groups r is limited to the integers 0 or 1, and r being 0 means that the U group is unsubstituted and a hydrogen is present at the position indicated by (R V ) r .
  • Q 1 is a 5- or 6-membered saturated or non-aromatic unsaturated heterocyclic ring optionally substituted with one or more substituents selected from the group of substituents as defined in the Summary of Invention for Q 1
  • one or two carbon ring members of the heterocycle can optionally be in the oxidized form of a carbonyl moiety.
  • Examples of a 5- or 6-membered saturated or non-aromatic unsaturated heterocyclic ring include the rings G-1 through G-35 as illustrated in Exhibit 3. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula 1 through any available carbon or nitrogen of the G group by replacement of a hydrogen atom. The optional substituents corresponding to R v can be attached to any available carbon or nitrogen by replacing a hydrogen atom.
  • r is typically an integer from 0 to 4, limited by the number of available positions on each G group.
  • Q 1 comprises a ring selected from G-28 through G-35
  • G 2 is selected from O, S or N.
  • G 2 is N, the nitrogen atom can complete its valence by substitution with either H or the substituents corresponding to R v as defined in the Summary of Invention for Q 1 (i.e. R 2 ).
  • Q 1 can be (among others) an 8-, 9- or 10-membered fused bicyclic ring system optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention (i.e. R 2 ).
  • Examples of 8-, 9- or 10-membered fused bicyclic ring system optionally substituted with from one or more substituents include the rings U-81 through U-123 illustrated in Exhibit 4 wherein R v is any substituent as defined in the Summary of the Invention for Q 1 (i.e. R 2 ), and r is typically an integer from 0 to 4.
  • R v groups are shown in the structures U-1 through U-123, it is noted that they do not need to be present since they are optional substituents. Note that when R v is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or R v . Note that when the attachment point between (R v ) r and the U group is illustrated as floating, (R v ) r can be attached to any available carbon atom or nitrogen atom of the U group. Note that when the attachment point on the U group is illustrated as floating, the U group can be attached to the remainder of Formula 1 through any available carbon or nitrogen of the U group by replacement of a hydrogen atom. Note that some U groups can only be substituted with less than 4 R v groups (e.g., U-2 through U-5, U-7 through U-48, and U-52 through U-61).
  • Compounds of this invention can exist as one or more stereoisomers.
  • the various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers.
  • one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers.
  • the compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers or as an optically active form.
  • Formula 1′ two possible enantiomers of Formula 1 are depicted as Formula 1′ and Formula 1′′ involving the isoxazoline chiral center identified with an asterisk (*). Analogously, other chiral centers are possible at, for example, R 5 .
  • Formula 1′ often has the (S) configuration at the chiral carbon and Formula 1′′ often has the (R) configuration at the chiral carbon (e.g., when Q is phenyl and R 1 is trifluoromethyl).
  • This invention comprises racemic mixtures, for example, equal amounts of the enantiomers of Formulae 1′ and 1′′.
  • this invention includes compounds that are enriched compared to the racemic mixture in an enantiomer of Formula 1. Also included are the essentially pure enantiomers of compounds of Formula 1, for example, Formula 1′ and Formula 1′′.
  • enantiomeric excess which is defined as (2x ⁇ 1) ⁇ 100%, where x is the mole fraction of the dominant enantiomer in the mixture (e.g., an ee of 20% corresponds to a 60:40 ratio of enantiomers).
  • compositions of this invention have at least a 50% enantiomeric excess; more preferably at least a 75% enantiomeric excess; still more preferably at least a 90% enantiomeric excess; and the most preferably at least a 94% enantiomeric excess of the more active isomer.
  • enantiomerically pure embodiments of the more active isomer are enantiomerically pure embodiments of the more active isomer.
  • Compounds of Formula 1 can comprise additional chiral centers.
  • substituents and other molecular constituents such as R 5 may themselves contain chiral centers.
  • This invention comprises racemic mixtures as well as enriched and essentially pure stereoconfigurations at these additional chiral centers.
  • Compounds of this invention can exist as one or more conformational isomers due to restricted rotation about the amide bond linking Q-A to Z 1 and Q-B to Z 2 .
  • This invention comprises mixtures of conformational isomers.
  • this invention includes compounds that are enriched in one conformer relative to others.
  • Compounds of this invention may exist as one or more crystalline polymorphs.
  • This invention comprises both individual polymorphs and mixtures of polymorphs, including mixtures enriched in one polymorph relative to others.
  • nitrogen-containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides.
  • nitrogen containing heterocycles which can form N-oxides.
  • tertiary amines can form N-oxides.
  • N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethyldioxirane.
  • MCPBA peroxy acids
  • alkyl hydroperoxides such as t-butyl hydroperoxide
  • sodium perborate sodium perborate
  • dioxiranes such as dimethyldioxirane
  • salts of the compounds of Formula 1 are useful for control of invertebrate pests (i.e. are agriculturally suitable).
  • the salts of the compounds of Formula 1 include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids.
  • salts also include those formed with organic or inorganic bases such as pyridine, triethylamine or ammonia, or amides, hydrides, hydroxides or carbonates of sodium, potassium, lithium, calcium, magnesium or barium.
  • organic or inorganic bases such as pyridine, triethylamine or ammonia, or amides, hydrides, hydroxides or carbonates of sodium, potassium, lithium, calcium, magnesium or barium.
  • a compound containing a carboxylic acid group i.e. CO 2 H
  • the carboxylic acid group is converted to its salt derivative, also known as a carboxylate salt.
  • a sodium salt derivative is formed (i.e. CO 2 ⁇ Na ⁇ ).
  • the present invention comprises compounds selected from Formula 1, N-oxides and agriculturally suitable salts thereof.
  • Embodiments of the present invention as described in the Summary of the Invention include (where Formula 1 as used in the following Embodiments includes N-oxides and salts thereof):
  • R 11 is H
  • R 12 is H or C 1 -C 3 alkyl
  • R 13 is H or C 1 -C 3 alkyl
  • R 14 is C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl or C 4 -C 7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is H, halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, CN or NO 2 ; and Y 4 is CH.
  • R 12 is H
  • R 13 is H or CH 3 ;
  • R 14 is cyclopropyl or methylcyclopropyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 15 is H
  • R 35 is H or halogen.
  • R 5 is H; or C 1 -C 6 alkyl substituted with one or more substituents independently selected from R 22 ;
  • R 6 is C 1 -C 6 alkyl or C 3 -C 7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R 33 .
  • R 22 and R 33 are independently selected from the group consisting of halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, CN, NO 2 , CO 2 R 37 , C( ⁇ O)NR 37 R 38 and Q 1 .
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • L 1 is C 2 -C 6 alkylene optionally substituted with halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • L 1 is C 2 -C 6 alkylene optionally substituted with one or more halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • Embodiments of this invention can be combined in any manner, and the descriptions of variables in the embodiments pertain not only to the compounds of Formula 1 but also to the starting compounds and intermediate compounds useful for preparing the compounds of Formula 1.
  • embodiments of this invention including Embodiments 1-27 above as well as any other embodiments described herein, and any combination thereof, pertain to the compositions and methods of the present invention.
  • Q is Q-A
  • Z 1 is Z 1 -1;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN; and
  • R 1 is C 1 -C 3 haloalkyl.
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-A
  • Z 1 is Z 1 -1;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN; and
  • R 1 is C 1 -C 3 haloalkyl.
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • R 5 is H; or C 1 -C 6 alkyl substituted with one or more substituents independently selected from R 22 ;
  • R 6 is C 1 -C 6 alkyl or C 3 -C 7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R 33 .
  • R 5 is H; or C 1 -C 6 alkyl substituted with one or more substituents independently selected from R 22 ;
  • R 6 is C 1 -C 6 alkyl or C 3 -C 7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R 33 .
  • R 5 is H; or C 1 -C 6 alkyl substituted with one or more substituents independently selected from R 22 ;
  • R 6 is C 1 -C 6 alkyl or C 3 -C 7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R 33 .
  • R 5 is H; or C 1 -C 6 alkyl substituted with one or more substituents independently selected from R 22 ;
  • R 6 is C 1 -C 6 alkyl or C 3 -C 7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R 33 .
  • R 22 and R 33 are independently selected from the group consisting of halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, CN, NO 2 , CO 2 R 37 , C( ⁇ O)NR 37 R 38 and Q 1 .
  • R 22 and R 33 are independently selected from the group consisting of halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, CN, NO 2 , CO 2 R 37 , C( ⁇ O)NR 37 R 38 and Q 1 .
  • R 22 and R 33 are independently selected from the group consisting of halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, CN, NO 2 , CO 2 R 37 , C( ⁇ O)NR 37 R 38 and Q 1 .
  • R 22 and R 33 are independently selected from the group consisting of halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 alkylsulfonyl, CN, NO 2 , CO 2 R 37 , C( ⁇ O)NR 37 R 38 and Q 1 .
  • Q is Q-A
  • Z 1 is Z 1 -2;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN; and
  • R 1 is C 1 -C 3 haloalkyl.
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-A
  • Z 1 is Z 1 -2;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN; and
  • R 1 is C 1 -C 3 haloalkyl.
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • Q is Q-A
  • Z 1 is Z 1 -3;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • L 1 is C 2 -C 6 alkylene optionally substituted with halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-A
  • Z 1 is Z 1 -3;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • L 1 is C 2 -C 6 alkylene optionally substituted with halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 2 -3;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • R 11 is H
  • R 12 is H or C 1 -C 3 alkyl
  • R 13 is H or C 1 -C 3 alkyl
  • R 14 is C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl or C 4 -C 7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is H, halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, CN or NO 2 ; and Y 4 is CH.
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 2 -3;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • R 11 is H
  • R 12 is H or C 1 -C 3 alkyl
  • R 13 is H or C 1 -C 3 alkyl
  • R 14 is C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl or C 4 -C 7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is H, halogen, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, C 1 -C 6 haloalkylthio, C 1 -C 6 alkylsulfinyl, C 1 -C 6 haloalkylsulfinyl, C 1 -C 6 alkylsulfonyl, C 1 -C 6 haloalkylsulfonyl, CN or NO 2 .
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 2 -4;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 2 -4;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • R 16 and R 17 are independently C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN.
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 5 -5;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • L 1 is C 2 -C 6 alkylene optionally substituted with halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • Q is Q-B
  • Z 2 is Z 2 -5;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkoxy and CN;
  • R 1 is C 1 -C 3 haloalkyl
  • L 1 is C 2 -C 6 alkylene optionally substituted with halogen
  • R 19 is C 1 -C 3 alkyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 20 is H, CN, NO 2 or CO 2 R 24 ;
  • R 35 is halogen, C 1 -C 3 alkoxy, C 1 -C 3 alkylthio or CN;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group halogen, CH 3 , CF 3 , OCF 3 , OCF 2 H and CN; and
  • R 1 is CF 3 .
  • A is a phenyl ring substituted with 2 substituents independently selected from the group consisting of halogen, C 1 -C 2 haloalkyl and C 1 -C 2 haloalkoxy;
  • R 1 is CF 3 ;
  • R 12 is H
  • R 13 is H or CH 3 ;
  • R 14 is cyclopropyl or methylcyclopropyl optionally substituted with one or more substituents independently selected from R 35 ;
  • R 15 is H
  • R 35 is H or halogen.
  • Specific embodiments include compounds of Formula 1 selected from the group consisting of:
  • compositions for controlling an invertebrate pest comprising a compound of any of the preceding Embodiments (i.e. in a biologically effective amount), as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising at least one additional biologically active compound or agent.
  • a composition for protecting an animal from an invertebrate parasitic pest comprising a compound of Formula 1 or any one of Embodiments 1-27 or A-AK and at least one veterinarily acceptable carrier, said composition optionally further comprising at least one additional parasiticidally active compound.
  • composition of Embodiment A1 wherein at least one additional parasiticidally active compound is an anthelmintic.
  • composition of Embodiment A1 wherein at least one additional parasiticidally active compound is selected from the group consisting of macrocyclic lactones, benzimidazoles, salicylamides, substituted phenols, pyrimidines, cyclic depsipeptides, piperazine salts, nitroscanate, praziquantel and imidazothiazoles.
  • composition of Embodiment A3 wherein at least one additional parasiticidally active compound is selected from the group consisting of avermectins, milbemycins and spinosyns.
  • composition of Embodiment A1 wherein at least one additional parasiticidally active compound is selected from the group consisting of abamectin, doramectin, emamectin, eprinomectin, ivermectin, selamectin, milbemycin, moxidectin and pyrantel.
  • Embodiment A1 in a form for oral administration.
  • Embodiment A1 in a form for topical administration.
  • Embodiment A1 in a form for parenteral administration.
  • Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein).
  • a method for protecting an animal comprising administering to the animal a parasiticidally effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein).
  • the method for protecting an animal from an invertebrate parasitic pest comprising administering to the animal a parasiticidally effective amount of a compound of Formula 1 as described in the Summary of the Invention or any one of Embodiments 1-27 or A-AK.
  • Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered orally.
  • Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered parenterally.
  • Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered by injection.
  • Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered topically.
  • Embodiment B1 wherein the animal to be protected is a vertebrate.
  • Embodiment B7 wherein the animal to be protected is a mammal, avian or fish.
  • Embodiment B8 wherein the animal to be protected is a human.
  • Embodiment B8 wherein the animal to be protected is livestock.
  • Embodiment B8 wherein the animal to be protected is a canine.
  • Embodiment B8 wherein the animal to be protected is a dog.
  • Embodiment B8 wherein the animal to be protected is a feline.
  • Embodiment B8 wherein the animal to be protected is a cat.
  • Embodiment B1 wherein the invertebrate parasitic pest is an ectoparasite.
  • Embodiment B1 wherein the invertebrate parasitic pest is an endoparasite or helminth.
  • Embodiment B1 wherein the invertebrate parasitic pest is an arthropod.
  • Embodiment B1 wherein the invertebrate parasitic pest is a fly, mosquito, mite, tick, louse, flea, maggot, bed bug or kissing bug.
  • Embodiment B16 wherein the invertebrate parasitic pest is a mosquito.
  • Embodiment B16 wherein the invertebrate parasitic pest is a tick or mite.
  • Embodiment B16 wherein the invertebrate parasitic pest is a louse.
  • Embodiment B16 wherein the invertebrate parasitic pest is a flea.
  • Embodiment B16 wherein the invertebrate parasitic pest is a bed bug or kissing bug.
  • Embodiment B16 wherein the animal is a cat or dog and the invertebrate parasitic pest is a flea, tick or mite.
  • Embodiment B1 wherein the parasiticidally effective amount of a compound of Formula 1 is administered monthly or at a longer interval.
  • Embodiment B23 wherein the parasiticidally effective amount of a compound of Formula 1 is administered once a month.
  • Embodiment B23 wherein the parasiticidally effective amount of a compound of Formula 1 is administered once every six months.
  • the compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK can be used for the protection of an animal from an invertebrate parasitic pest by oral, topical or parenteral administration of the compound.
  • the invention is understood to include the compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK (and compositions containing them) for use as an animal medicament, or more particularly a parasiticidal animal medicament.
  • the animals to be protected are as defined in any of Embodiments B7-B12a.
  • the invertebrate parasitic pests are as defined in any of Embodiments B13-B21.
  • the medicament may be in oral, topical or parenteral dosage forms.
  • the invention is also understood to include the use of compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK in the manufacture of medicaments for the protection of an animal from a an invertebrate parasitic pest.
  • the animals to be protected are as defined in any of Embodiments B7-B12a.
  • the invertebrate parasitic pests are as defined in any of Embodiments B13-B21.
  • the medicament may be in oral, topical or parenteral dosage forms.
  • the invention is also understood to include compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK for use in the manufacture of medicaments for the protection of an animal from an invertebrate parasitic pest.
  • the animals to be protected are as defined in any of Embodiments B7-B12a.
  • the invertebrate parasitic pests are as defined in any of Embodiments B13-B21.
  • the medicament may be in oral, topical or parenteral dosage forms.
  • the invention is also understood to include compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK packaged and presented for the protection of an animal from an invertebrate parasitic pest.
  • the animals to be protected are as defined in any of Embodiments B7-B12a.
  • the invertebrate parasitic pests are as defined in any of Embodiments B13-B21.
  • the compounds of the invention may be packaged and presented as oral, topical or parenteral dosage forms.
  • the invention is also understood to include a process for manufacturing a composition for protecting an animal from an invertebrate parasitic pest characterized in that a compound of Claim 1 is admixed with at least one pharmaceutically or veterinarily acceptable carrier.
  • the animals to be protected are as defined in any of Embodiments B7-B12a.
  • the invertebrate parasitic pests are as defined in any of Embodiments B13-B21.
  • the compositions of the invention may be packaged and presented as oral, topical or parenteral dosage forms.
  • compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity controlling a spectrum of agronomic and nonagronomic invertebrate pests.
  • compositions comprising a compound of any of the preceding Embodiments, as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising at least one additional biologically active compound or agent.
  • compositions for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments, as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent.
  • Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein).
  • Embodiments of the invention also include a composition comprising a compound of any of the preceding Embodiments, in the form of a soil drench liquid formulation.
  • Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the soil with a liquid composition as a soil drench comprising a biologically effective amount of a compound of any of the preceding Embodiments.
  • Embodiments of the invention also include a spray composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments and a propellant.
  • Embodiments of the invention further include a bait composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments, one or more food materials, optionally an attractant, and optionally a humectant.
  • Embodiments of the invention also include a device for controlling an invertebrate pest comprising said bait composition and a housing adapted to receive said bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to said bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • compounds of Formula 1b (Formula 1 wherein Q is Q-A, Z 1 is Z 1 -1 and W 1 is S) can be prepared by treatment of corresponding amide compounds of Formula 1a (compounds of Formula 1 wherein Q is Q-A, Z 1 is Z 1 -1 and W 1 is O) with a thio transfer reagent, such as P 2 S 5 (see for example, E. Klingsberg et al., J. Am. Chem. Soc. 1951, 72, 4988; E. C. Taylor Jr. et al., J. Am. Chem. Soc. 1953, 75, 1904; R. Crossley et al., J. Chem. Soc. Perkin Trans.
  • a thio transfer reagent such as P 2 S 5
  • compounds of Formula 1a can be prepared by coupling carboxylic acids of Formula 2 with appropriately substituted amino compounds of Formula 3.
  • This reaction is generally carried out in the presence of a dehydrating coupling reagent, such as dicyclohexyl carbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-propanephosphonic acid cyclic anhydride or carbonyl diimidazole, in the presence of a base such as triethylamine, pyridine, 4-(dimethylamino)pyridine or N,N-diisopropylethylamine in an anhydrous aprotic solvent such as dichloromethane or tetrahydrofuran at a temperature typically between room temperature and 70° C.
  • a dehydrating coupling reagent such as dicyclohexyl carbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcar
  • compounds of Formula 1a can also be prepared by aminocarbonylation of aryl bromides of Formula 4 with appropriately substituted amino compounds of Formula 3.
  • This reaction is typically carried out with an aryl bromide of Formula 4 in the presence of a palladium catalyst under CO atmosphere.
  • the palladium catalysts used for the present method typically comprises palladium in a formal oxidation state of either 0 (i.e. Pd(0)) or 2 (i.e. Pd(II)).
  • Pd(0) 0
  • Pd(II) i.e. Pd(II)
  • Examples of palladium-containing compounds and complexes useful as catalysts in the method of Scheme 3 include PdCl 2 (PPh 3 ) 2 (bis(triphenylphosphine)palladium(II)dichloride), Pd(PPh 3 ) 4 (tetrakis(triphenylphosphine)palladium(0)), Pd(C 5 H 7 O 2 ) 2 (palladium(II)acetyl-acetonate), Pd 2 (dba) 3 (tris(dibenzylideneacetone)dipalladium(0)), and [1,1′-bis(diphenyl-phosphino)ferrocene]dichloropalladium(II).
  • PdCl 2 (PPh 3 ) 2 bis(triphenylphosphine)palladium(II)dichloride
  • Pd(PPh 3 ) 4 tetrakis(triphenylphosphine)palladium(0)
  • the method of Scheme 3 is generally conducted in a liquid phase, and therefore to be most effective the palladium catalyst preferably has good solubility in the liquid phase.
  • Useful solvents include, for example, ethers such as 1,2-dimethoxyethane, amides such as N,N-dimethylacetamide, and non-halogenated aromatic hydrocarbons such as toluene.
  • the method of Scheme 3 can be conducted over a wide range of temperatures, ranging from about 25 to about 150° C. Of note are temperatures from about 60 and about 110° C., which typically provide fast reaction rates and high product yields.
  • the general methods and procedures for aminocarbonylation with an aryl bromide and an amine are well known in the literature; see, for example, H. Horino et al., Synthesis 1989, 715; and J. J. Li, G. W. Gribble, editors, Palladium in Heterocyclic Chemistry: A Guide for the Synthetic Chemist , Elsevier Science Ltd, 2000.
  • compounds of Formula 1d (compounds of Formula 1 wherein Q is Q-A and Z 1 is Z 1 -2) wherein W 5 is the same as W 1 can be prepared by the condensation of compounds of Formula Ic (Formula 1 wherein Q is Q-A, Z 1 is Z 1 -1, and R 5 and R 6 are H) wherein W 1 is O or S with compounds of Formula 5 in the presence of condensing agents.
  • Suitable condensing agents include carboxylic acid anhydrides, dicyclohexylcarbodiimide, sulfuryl chloride, phosphorus(V) oxide and phosphorus oxychloride.
  • compounds of Formula 6 can be prepared from compounds of Formula 8 by treatment with m-chloroperbenzoic acid (MCPBA). Oxidation of thioethers of Formula 8 with 1.0 equivalent of MCPBA at low temperature, preferably at ⁇ 78 to ⁇ 40° C., provides the sulfoxides of Formula 6 in good yield.
  • MCPBA m-chloroperbenzoic acid
  • the compounds of Formula 8 can be prepared by the methods illustrated in Schemes 1, 2 and 3.
  • compounds of Formula 2 can be prepared by hydrolysis of the esters of Formula 9, wherein R a is methyl or ethyl.
  • compounds of Formula 9 are converted to the corresponding carboxylic acids of Formula 2 by general procedures well known in the art. For example, treatment of a methyl or ethyl ester of Formula 9 with aqueous lithium hydroxide in tetrahydrofuran, followed by acidification yields the corresponding carboxylic acid of Formula 2.
  • Alcohols of Formula 10 can substituted for the amines of Formula 3 in the reaction of Scheme 3, to yield the esters of Formula 9 as shown in Scheme 9.
  • compounds of Formula 4 can be prepared by the 1,3-dipolar cycloaddition of styrenes of Formula 12 with nitrile oxides derived from oximes of Formula 11. This reaction typically proceeds through the intermediacy of an in situ generated hydroxamyl chloride, which is dehydrochlorinated to the nitrile oxide, which then undergoes 1,3-dipolar cycloaddition with the styrene of Formula 12 to afford compounds of Formula 4.
  • a chlorinating reagent such as sodium hypochlorite, N-chlorosuccinimide, or chloramine-T is combined with the oxime in the presence of the styrene.
  • amine bases such as pyridine or triethylamine may be necessary to facilitate the dehydrochlorination reaction.
  • the reaction can be run in a wide variety of solvents including tetrahydrofuran, diethyl ether, methylene chloride, dioxane, and toluene with temperatures ranging from room temperature to the reflux temperature of the solvent.
  • solvents including tetrahydrofuran, diethyl ether, methylene chloride, dioxane, and toluene with temperatures ranging from room temperature to the reflux temperature of the solvent.
  • General procedures for cycloaddition of nitrile oxides with olefins are well documented in the chemical literature; for example, see Lee, Synthesis, 1982, 6, 508-509; Kanemasa et al., Tetrahedron, 2000, 56, 1057-1064; EP 1,538,138-A1, as well as references cited within.
  • the oximes of Formula 11 can be prepared by the reaction of aldehydes of Formula 13 with hydroxylamine according to known literature procedures. For example, see, H. K. Jung et al. Bioorg. Med. Chem. 2004, 12, 3965.
  • aldehydes of Formula 13 can be prepared by methods known in art.
  • preparation of the compounds of Formula 13, wherein Y 1 —Y 2 —Y 3 is —CH ⁇ CH—NH(R 3 )— or —NH(R 3 )—CH ⁇ CH— is disclosed by Lianhai Li et al. Tetrahedron Lett. 2003, 44, 5987.
  • the dibromo compounds of Formula 14, wherein Y 1 —Y 2 —Y 3 is —CH ⁇ CH—N(R 3 )— are a class of compounds reported in the chemical literature; for example, see, A. P. Dobbs et al. Synlett 1999, 10, 1594.
  • aldehydes of Formula 13 can also be prepared from methyl derivatives of Formula 15 by methods known in synthetic art, for example, see, E. R. Mewshaw et al. WO2004/1303941.
  • the compounds of Formula 15, wherein Y 1 —Y 2 —Y 3 is —CH ⁇ CH—O—, —CH ⁇ CH—S—, —O—CH ⁇ CH—, or —S—CH ⁇ CH— can be prepared by general methods known in the art; some are also commercially available.
  • compounds of Formula 1g (Formula 1 wherein Q is Q-B, Z 2 is Z 2 -1 or Z 2 -2 and W 2 or W 3 are S) can be prepared by treatment of corresponding amide compounds of Formula 1f (compounds of Formula 1 wherein Q is Q-B, Z 2 is Z 2 -1 or Z 2 -2 and W 2 or W 3 are O) with a thio transfer reagent.
  • the method of Scheme 14 is conducted as described for Scheme 1.
  • amides of Formula 1h can be prepared by coupling the corresponding acids of Formula 20 with appropriately substituted amino compounds of Formula 21.
  • Amide formation reactions are well known in the synthetic art.
  • Treating acids of Formula 20 with amino compounds of Formula 21 in the presence of dehydrating reagents, such as carboxylic acid chlorides, DCC or polymer-supported (PS)-carbodiimide, in an anhydrous aprotic solvent such as dichloromethane provides compounds of Formula 1h.
  • dehydrating reagents such as carboxylic acid chlorides, DCC or polymer-supported (PS)-carbodiimide
  • an anhydrous aprotic solvent such as dichloromethane
  • amides of Formula 1h-a can be prepared by the corresponding acids of Formula 20a (compounds of Formula 20 wherein R 11 is H) through intermediates of Formula 22 and further reaction with the appropriately substituted amino compounds of Formula 21.
  • the cyclization reaction is typically carried out using dehydrating reagents, such as polymer-supported (PS)-carbodiimide or dicyclohexyl carbodiimide (DCC) in an anhydrous aprotic solvent such as dichloromethane at room temperature.
  • dehydrating reagents such as polymer-supported (PS)-carbodiimide or dicyclohexyl carbodiimide (DCC) in an anhydrous aprotic solvent such as dichloromethane at room temperature.
  • the intermediates of Formula 22 can be used directly without any purification if polymer-supported DCC is used as the dehydrating reagent.
  • the subsequent amide bond formation can be achieved through mixing the intermediates of Formula 22 with amino compounds of Formula 21 in N,N
  • sulfoxides of Formula 25 can be prepared by treating sulfides of Formula 26 with MCPBA.
  • the method of Scheme 21 is conducted as described for Scheme 6 and is illustrated in Step B of Example 3.
  • carboxylic acids of Formula 16 can be prepared by hydrolysis of the corresponding esters of Formula 28, wherein R a is methyl or ethyl.
  • the method of Scheme 24 is conducted as described for Scheme 8.
  • compounds of Formula 28 can be prepared by coupling of the corresponding bromides of Formula 19 with alcohols of Formula 10, for example, methanol or ethanol, with carbon monoxide in the presence of palladium catalysts.
  • the method of Scheme 25 is conducted as described for Scheme 9.
  • carboxylic acids of Formula 20 can be prepared by hydrolysis of the corresponding esters of Formula 29.
  • the method of Scheme 26 is conducted as described for Scheme 8 and is illustrated in Step B of Example 1.
  • compounds of Formula 29a (Formula 29 wherein W 4 is O) can be prepared by coupling bromides of Formula 19 with appropriately substituted amino compounds of Formula 30 (or corresponding salts) in the presence of carbon monoxide.
  • the method of Scheme 27 is conducted as described for Scheme 3 and is illustrated in Step A of Example 1.
  • compounds of Formula 19 can be prepared by the 1,3-dipolar cyclization of styrenes of Formula 12 with oximes of Formula 31.
  • the method of Scheme 28 is conducted as described for Scheme 10.
  • oximes of Formula 31 can be prepared by reaction of the corresponding aldehydes of Formula 32 with hydroxylamine.
  • the method of Scheme 29 is conducted as described for Scheme 11.
  • aldehydes of Formula 32 can be prepared by treating compounds of Formula 33 with n-BuLi at ⁇ 78° C. and reacting the derived lithiated intermediate with N,N-dimethylformamide.
  • the bromo compounds of Formula 33 can be prepared by general methods known in literature, for example, see Synthesis, 2002, 83.
  • Step A N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine methyl ester
  • the reaction mixture was stirred overnight at 70° C. under carbon monoxide atmosphere.
  • the mixture was cooled to room temperature, filtered through a short pad of Celite® diatomaceous filter aid and rinsed with small amount of ethyl acetate.
  • the filtrate was concentrated, and the residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (4:1 to 1:1) as eluent to afford the title product as a white solid (310 mg, 58% yield).
  • Step B N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine
  • Step C 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-1-naphthalenecarboxamide
  • Step A 2-[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]-5(4H)-oxazolone
  • Step B N-[2-[(cyclopropylmethyl)amino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide
  • Step A 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylthio)ethyl]-1-naphthalenecarboxamide
  • Step B 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylsulfinyl)ethyl]-1-naphthalenecarboxamide
  • Step C 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methyl-N-(2,2,2-trifluoroacetyl)sulfonimidoyl)ethyl]-1-naphthalenecarboxamide
  • Step A 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfinimidoyl]ethyl]-1-naphthalenecarboxamide
  • Step B 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methylsulfinimidoyl)ethyl]-1-naphthalenecarboxamide
  • Compound 1-1 is the compound of Formula 1, as defined by Table 1, Line 1 wherein A is phenyl, Q is Q-A-1, R 2 is 3-CF 3 , R 5 is Et and R 6 is H.
  • Compound 17-4 is the compound of Formula 1, Table 17, Line 4 wherein A is phenyl, Q is Q-A-17, R 2 is 3-Cl, 5-Cl, R 19 is Et and R 20 is H.
  • A is:
  • A is:
  • R 2 R 19 R 20 1 3-Cl, 5-Cl Me H 2 3-Cl, 5-Cl Me C( ⁇ O)CF 3 3 3-Cl, 5-Cl Me CN 4 3-Cl, 5-Cl Et H 5 3-Cl, 5-Cl Et C( ⁇ O)CF 3 6 3-Br, 5-Br Me H 7 3-Br, 5-Br Me C( ⁇ O)CF 3 8 3-Br, 5-Br Me CN 9 3-Br, 5-Br Et H 10 3-Br, 5-Br Et C( ⁇ O)CF 3 11 3-Cl, 4-Cl, 5-Cl Me H 12 3-Cl, 4-Cl, 5-Cl Me C( ⁇ O)CF 3 13 3-Cl, 4-Cl, 5-Cl Me CN 14 3-Cl, 4-Cl, 5-Cl Et H 15 3-Cl, 4-Cl, 5-Cl Et C( ⁇ O)CF 3 16 3-Cl, 4-F, 5-Cl Me H 17 3-Cl, 4-F, 5-Cl Me C( ⁇ O)CF 3 18
  • R 2 R 19 R 20 1 3-Cl, 5-Cl Me H 2 3-Cl, 5-Cl Me C( ⁇ O)CF 3 3 3-Cl, 5-Cl Me CN 4 3-Cl, 5-Cl Et H 5 3-Cl, 5-Cl Et C( ⁇ O)CF 3 6 3-Br, 5-Br Me H 7 3-Br, 5-Br Me C( ⁇ O)CF 3 8 3-Br, 5-Br Me CN 9 3-Br, 5-Br Et H 10 3-Br, 5-Br Et C( ⁇ O)CF 3 11 3-Cl, 4-Cl, 5-Cl Me H 12 3-Cl, 4-Cl, 5-Cl Me C( ⁇ O)CF 3 13 3-Cl, 4-Cl, 5-Cl Me CN 14 3-Cl, 4-Cl, 5-Cl Et H 15 3-Cl, 4-Cl, 5-Cl Et C( ⁇ O)CF 3 16 3-Cl, 4-F, 5-Cl Me H 17 3-Cl, 4-F, 5-Cl Me C( ⁇ O)CF 3 18
  • a compound of this invention will generally be used as an invertebrate pest control active ingredient in a composition, i.e. formulation, with at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, which serves as a carrier.
  • a composition i.e. formulation
  • additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, which serves as a carrier.
  • the formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature.
  • Liquid compositions include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like, which optionally can be thickened into gels.
  • aqueous liquid compositions are soluble concentrate, suspension concentrate, capsule suspension, concentrated emulsion, microemulsion and suspo-emulsion.
  • nonaqueous liquid compositions are emulsifiable concentrate, microemulsifiable concentrate, dispersible concentrate and oil dispersion.
  • the general types of solid compositions are dusts, powders, granules, pellets, prills, pastilles, tablets, filled films (including seed coatings) and the like, which can be water-dispersible (“wettable”) or water-soluble. Films and coatings formed from film-forming solutions or flowable suspensions are particularly useful for seed treatment.
  • Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or “overcoated”). Encapsulation can control or delay release of the active ingredient.
  • An emulsifiable granule combines the advantages of both an emulsifiable concentrate formulation and a dry granular formulation. High-strength compositions are primarily used as intermediates for further formulation.
  • Sprayable formulations are typically extended in a suitable medium before spraying. Such liquid and solid formulations are formulated to be readily diluted in the spray medium, usually water. Spray volumes can range from about from about one to several thousand liters per hectare, but more typically are in the range from about ten to several hundred liters per hectare. Sprayable formulations can be tank mixed with water or another suitable medium for foliar treatment by aerial or ground application, or for application to the growing medium of the plant. Liquid and dry formulations can be metered directly into drip irrigation systems or metered into the furrow during planting. Liquid and solid formulations can be applied onto seeds of crops and other desirable vegetation as seed treatments before planting to protect developing roots and other subterranean plant parts and/or foliage through systemic uptake.
  • the formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up to 100 percent by weight.
  • Weight Percent Active Ingredient Diluent Surfactant Water-Dispersible and Water- 0.001-90 0-99.999 0-15 soluble Granules, Tablets and Powders Oil Dispersions, Suspensions, 1-50 40-99 0-50 Emulsions, Solutions (including Emulsifiable Concentrates) Dusts 1-25 70-99 0-5 Granules and Pellets 0.001-95 5-99.999 0-15 High Strength Compositions 90-99 0-10 0-2
  • Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (e.g., lactose, sucrose), silica, talc, mica, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate.
  • Typical solid diluents are described in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, N.J.
  • Liquid diluents include, for example, water, N,N-dimethylalkanamides (e.g., N,N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkypyrrolidones (e.g., N-methylpyrrolidinone), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (e.g., white mineral oils, normal paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, glycerine, glycerol triacetate, sorbitol, triacetin, aromatic hydrocarbons, dearomatized aliphatics, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2
  • Liquid diluents also include glycerol esters of saturated and unsaturated fatty acids (typically C 6 -C 22 ), such as plant seed and fruit oils (e.g, oils of olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut and palm kernel), animal-sourced fats (e.g., beef tallow, pork tallow, lard, cod liver oil, fish oil), and mixtures thereof.
  • plant seed and fruit oils e.g, oils of olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut and palm kernel
  • animal-sourced fats e.g., beef tallow, pork tallow, lard, cod liver oil, fish oil
  • Liquid diluents also include alkylated fatty acids (e.g., methylated, ethylated, butylated) wherein the fatty acids may be obtained by hydrolysis of glycerol esters from plant and animal sources, and can be purified by distillation.
  • alkylated fatty acids e.g., methylated, ethylated, butylated
  • Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950.
  • the solid and liquid compositions of the present invention often include one or more surfactants.
  • surfactants also known as “surface-active agents”
  • surface-active agents generally modify, most often reduce, the surface tension of the liquid.
  • surfactants can be useful as wetting agents, dispersants, emulsifiers or defoaming agents.
  • Nonionic surfactants useful for the present compositions include, but are not limited to: alcohol alkoxylates such as alcohol alkoxylates based on natural and synthetic alcohols (which may be branched or linear) and prepared from the alcohols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides such as ethoxylated soybean, castor and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylates, nonylphenol ethoxylates, dinonyl phenol ethoxylates and dodecyl phenol ethoxylates (prepared from the phenols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene
  • Useful anionic surfactants include, but are not limited to: alkylaryl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonate derivatives; lignin and lignin derivatives such as lignosulfonates; maleic or succinic acids or their anhydrides; olefin sulfonates; phosphate esters such as phosphate esters of alcohol alkoxylates, phosphate esters of alkylphenol alkoxylates and phosphate esters of styryl phenol ethoxylates; protein-based surfactants; sarcosine derivatives; styryl phenol ether sulfate; sulfates and sulfonates of oils and fatty acids; sulfates and sulfonates of ethoxylated alkylphenols; sulfates of alcohols; sulfates of e
  • Useful cationic surfactants include, but are not limited to: amides and ethoxylated amides; amines such as N-alkyl propanediamines, tripropylenetriamincs and dipropylenetetramines, and ethoxylated amines, ethoxylated diamines and propoxylated amines (prepared from the amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts and diquaternary salts; and amine oxides such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine oxides.
  • amines such as N-alkyl propanediamines, tripropylenetriamincs and dipropylenetetramines, and ethoxy
  • Nonionic, anionic and cationic surfactants and their recommended uses are disclosed in a variety of published references including McCutcheon's Emulsifiers and Detergents , annual American and International Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, Encyclopedia of Surface Active Agents , Chemical Publ. Co., Inc., New York, 1964; and A. S. Davidson and B. Milwidsky, Synthetic Detergents , Seventh Edition, John Wiley and Sons, New York, 1987.
  • compositions of this invention may also contain formulation auxiliaries and additives, known to those skilled in the art as formulation aids (some of which may be considered to also function as solid diluents, liquid diluents or surfactants).
  • formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing (antifreezes), color (dyes/pigment dispersions), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes.
  • Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes.
  • formulation auxiliaries and additives include those listed in McCutcheon's Volume 2: Functional Materials , annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO 03/024222.
  • the compound of Formula 1 and any other active ingredients are typically incorporated into the present compositions by dissolving the active ingredient in a solvent or by grinding in a liquid or dry diluent.
  • Solutions, including emulsifiable concentrates can be prepared by simply mixing the ingredients. If the solvent of a liquid composition intended for use as an emulsifiable concentrate is water-immiscible, an emulsifier is typically added to emulsify the active-containing solvent upon dilution with water.
  • Active ingredient slurries, with particle diameters of up to 2,000 ⁇ m can be wet milled using media mills to obtain particles with average diameters below 3 ⁇ m.
  • Aqueous slurries can be made into finished suspension concentrates (see, for example, U.S. Pat. No. 3,060,084) or further processed by spray drying to form water-dispersible granules. Dry formulations usually require dry milling processes, which produce average particle diameters in the 2 to 10 ⁇ m range. Dusts and powders can be prepared by blending and usually grinding (such as with a hammer mill or fluid-energy mill). Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, “Agglomeration”, Chemical Engineering , Dec.
  • Pellets can be prepared as described in U.S. Pat. No. 4,172,714.
  • Water-dispersible and water-soluble granules can be prepared as taught in U.S. Pat. No. 4,144,050, U.S. Pat. No. 3,920,442 and DE 3,246,493.
  • Tablets can be prepared as taught in U.S. Pat. No. 5,180,587, U.S. Pat. No. 5,232,701 and U.S. Pat. No. 5,208,030.
  • Films can be prepared as taught in GB 2,095,558 and U.S. Pat. No. 3,299,566.
  • Compound 44 65.0% dodecylphenol polyethylene glycol ether 2.0% sodium ligninsulfonate 4.0% sodium silicoaluminate 6.0% montmorillonite (calcined) 23.0%
  • Compound 49 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate 5.0% sodium alkylnaphthalenesulfonate 1.0% calcium/magnesium bentonite 59.0%
  • Compound 50 10.0% polyoxyethylene sorbitol hexoleate 20.0% C 6 -C 10 fatty acid methyl ester 70.0%
  • Compound 45 5.0% polyvinylpyrrolidone-vinyl acetate copolymer 30.0% alkylpolyglycoside 30.0% glyceryl monooleate 15.0% water 20.0%
  • Compound 66 20.00% polyvinylpyrrolidone-vinyl acetate copolymer 5.00% montan acid wax 5.00% calcium ligninsulfonate 1.00% polyoxyethylene/polyoxypropylene block copolymers 1.00% stearyl alcohol (POE 20) 2.00% polyorganosilane 0.20% colorant red dye 0.05% water 65.75%
  • invertebrate pests include invertebrates inhabiting a variety of environments such as, for example, plant foliage, roots, soil, harvested crops or other foodstuffs, building structures or animal integuments.
  • These pests include, for example, invertebrates feeding on foliage (including leaves, stems, flowers and fruits), seeds, wood, textile fibers or animal blood or tissues, and thereby causing injury or damage to, for example, growing or stored agronomic crops, forests, greenhouse crops, ornamentals, nursery crops, stored foodstuffs or fiber products, or houses or other structures or their contents, or being harmful to animal health or public health.
  • foliage including leaves, stems, flowers and fruits
  • seeds wood, textile fibers or animal blood or tissues
  • present compounds and compositions are thus useful agronomically for protecting field crops from phytophagous invertebrate pests, and also nonagronomically for protecting other horticultural crops and plants from phytophagous invertebrate pests.
  • This utility includes protecting crops and other plants (i.e. both agronomic and nonagronomic) that contain genetic material introduced by genetic engineering (i.e. transgenic) or modified by mutagenesis to provide advantageous traits.
  • traits include tolerance to herbicides, resistance to phytophagous pests (e.g., insects, mites, aphids, spiders, nematodes, snails, plant-pathogenic fungi, bacteria and viruses), improved plant growth, increased tolerance of adverse growing conditions such as high or low temperatures, low or high soil moisture, and high salinity, increased flowering or fruiting, greater harvest yields, more rapid maturation, higher quality and/or nutritional value of the harvested product, or improved storage or process properties of the harvested products.
  • Transgenic plants can be modified to express multiple traits.
  • plants containing traits provided by genetic engineering or mutagenesis include varieties of corn, cotton, soybean and potato expressing an insecticidal Bacillus thuringiensis toxin such as YIELD GARD®, KNOCKOUT®, STARLINK®, BOLLGARD®, NuCOTN® and NEWLEAF®, and herbicide-tolerant varieties of corn, cotton, soybean and rapeseed such as ROUNDUP READY®, LIBERTY LINK®, IMI®, STS® and CLEARFIELD®, as well as crops expressing N-acetyltransferase (GAT) to provide resistance to glyphosate herbicide, or crops containing the HRA gene providing resistance to herbicides inhibiting acetolactate synthase (ALS).
  • an insecticidal Bacillus thuringiensis toxin such as YIELD GARD®, KNOCKOUT®, STARLINK®, BOLLGARD®, NuCOTN® and NEWLEAF®
  • the present compounds and compositions may interact synergistically with traits introduced by genetic engineering or modified by mutagenesis, thus enhancing phenotypic expression or effectiveness of the traits or increasing the invertebrate pest control effectiveness of the present compounds and compositions.
  • the present compounds and compositions may interact synergistically with the phenotypic expression of proteins or other natural products toxic to invertebrate pests to provide greater-than-additive control of these pests.
  • compositions of this invention can also optionally comprise plant nutrients, e.g., a fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium, magnesium, iron, copper, boron, manganese, zinc, and molybdenum.
  • a fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium, magnesium, iron, copper, boron, manganese, zinc, and molybdenum.
  • compositions comprising at least one fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium and magnesium.
  • Compositions of the present invention which further comprise at least one plant nutrient can be in the form of liquids or solids.
  • Solid formulations comprising a fertilizer composition can be prepared by mixing the compound or composition of the present invention with the fertilizer composition together with formulating ingredients and then preparing the formulation by methods such as granulation or extrusion.
  • solid formulations can be prepared by spraying a solution or suspension of a compound or composition of the present invention in a volatile solvent onto a previous prepared fertilizer composition in the form of dimensionally stable mixtures, e.g., granules, small sticks or tablets, and then evaporating the solvent.
  • Examples of agronomic or nonagronomic invertebrate pests include eggs, larvae and adults of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., pink stem borer ( Sesamia inferens Walker), corn stalk borer ( Sesamia nonagrioides Lefebvre), southern armyworm ( Spodoptera eridania Cramer), fall armyworm ( Spodoptera fugiperda J. E.
  • Noctuidae e.g., pink stem borer ( Sesamia inferens Walker), corn stalk borer ( Sesamia nonagrioides Lefebvre), southern armyworm ( Spodoptera eridania Cramer), fall armyworm ( Spodoptera fugiperda J. E.
  • agronomic and nonagronomic pests include: eggs, adults and larvae of the order Dermaptera including earwigs from the family Forficulidae (e.g., European earwig ( Forficula auricularia Linnaeus), black earwig ( Chelisoches morio Fabricius)); eggs, immatures, adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers (e.g.
  • eggs, larvae, nymphs and adults of the order Acari such as spider mites and red mites in the family Tetranychidae (e.g., European red mite ( Panonychus ulmi Koch), two spotted spider mite ( Tetranychus urticae Koch), McDaniel mite ( Tetranychus mcdanieli McGregor)); flat mites in the family Tenuipalpidae (e.g., citrus flat mite ( Brevipalpus lewisi McGregor)); rust and bud mites in the family Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e.
  • Tetranychidae e.g., European red mite ( Panonychus ulmi Koch), two spotted spider mite ( Tetranychus urticae Koch), McDaniel mite ( Tetranychus mcdanieli McGregor)
  • serpentine vegetable leafminer Liriomyza sativae Blanchard
  • midges fruit flies
  • frit flies e.g., Oscinella frit Linnaeus
  • soil maggots e.g., house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F.
  • femoralis Stein stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chrysomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., Chrysops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimulium spp., Simulium s
  • Hymenoptera including bees (including carpenter bees), hornets, yellow jackets, wasps, and sawflies ( Neodiprion spp.; Cephus spp.); insect pests of the order Isoptera including termites in the Termitidae (e.g., Macrotermes sp., Odontotermes obesus Rambur), Kalotermitidae (e.g., Cryptotermes sp.), and Rhinotermitidae (e.g., Reticulitermes sp., Coptotermes sp., Heterotermes tenuis Hagen) families, the eastern subterranean termite ( Reticulitermes flavipes Kollar), western subterranean termite ( Reticulitermes hesperus Banks), Formosan subterranean termite ( Coptotermes formosanus Shiraki), West Indian drywood termite ( Incisitermes immigrans Snyder), powder post
  • insect pests of the order Thysanura such as silverfish ( Lepisma saccharina Linnaeus) and firebrat ( Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse ( Pediculus humanus capitis De Geer), body louse ( Pediculus humanus Linnaeus), chicken body louse ( Menacanthus stramineus Nitszch), dog biting louse ( Trichodectes canis De Geer), fluff louse ( Goniocotes gallinae De Geer), sheep body louse ( Bovicola ovis Schrank), short-nosed cattle louse ( Haematopinus eurysternus Nitzsch), long-nosed cattle louse ( Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea
  • Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider ( Loxosceles reclusa Gertsch & Mulaik) and the black widow spider ( Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede ( Scutigera coleoptrata Linnaeus).
  • spiders in the order Araneae such as the brown recluse spider ( Loxosceles reclusa Gertsch & Mulaik) and the black widow spider ( Latrodectus mactans Fabricius)
  • centipedes in the order Scutigeromorpha such as the house centipede ( Scutigera coleoptrata Linnaeus).
  • Compounds of the present invention also have activity on members of the Classes Nematoda, Cestoda, Trematoda, and Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne , lesion nematodes in the genus Pratylenchus , stubby root nematodes in the genus Trichodorus , etc.) and animal and human health pests (i.e.
  • Compounds of the invention show particularly high activity against pests in the order Lepidoptera (e.g., Alabama argillacea Hübner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenée (rice leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hübner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm
  • Compounds of the invention also have significant activity on members from the order Homoptera including: Acyrthosiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopter
  • Compounds of this invention also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Cimex lectularius Linnacus (bed bug) Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schäffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp.
  • Thysanoptera e.g., Frankliniella occidentalis Pergande (western flower thrips), Scirthothrips citri Moulton (citrus thrips), Sericothrips variabilis Beach (soybean thrips), and Thrips tabaci Lindeman (onion thrips); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius ).
  • Thysanoptera e.g., Frankliniella occidentalis Pergande (western flower thrips), Scirthothrips citri Moulton (citrus thrips), Sericothrips variabilis Beach (soybean thrips), and Thrips tabaci Lindeman (onion thrips);
  • compounds of this invention for controlling silverleaf whitefly ( Bemisia argentifolii ).
  • compounds of this invention for controlling western flower thrip ( Frankliniella occidentalis ).
  • compounds of this invention for controlling potato leafhopper ( Empoasca fabae ).
  • compounds of this invention for controlling corn planthopper ( Peregrinus maidis ).
  • cotton melon aphid Aphis gossypii
  • compounds of this invention for controlling green peach aphid ( Myzus persicae ).
  • compounds of this invention for controlling diamondback moth ( Plutella xylostella ).
  • compounds of this invention for controlling fall armyworm ( Spodoptera frugiperda ).
  • Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agronomic and nonagronomic utility.
  • insecticides fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners
  • growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopath
  • the present invention also pertains to a composition
  • a composition comprising a biologically effective amount of a compound of Formula 1, an N-oxide or salt thereof, and an effective amount of at least one additional biologically active compound or agent and can further comprise at least one of surfactants, solid diluents or liquid diluents.
  • the other biologically active compounds or agents can be formulated together with the present compounds, including the compounds of Formula 1, to form a premix, or the other biologically active compounds or agents can be formulated separately from the present compounds, including the compounds of Formula 1, and the two formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession.
  • insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluoron, borate, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofente
  • insecticides such as abamectin, acetamiprid, acrinathrin, amitraz, avermectin, azadirachtin, bifenthrin, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine,
  • One embodiment of biological agents for mixing with compounds of this invention include entomopathogenic bacteria such as Bacillus thuringiensis , and the encapsulated delta-endotoxins of Bacillus thuringiensis (e.g., Cellcap, MPV, MPVII); entomopathogenic fungi such as green muscardine fungus; and entomopathogenic (both naturally occurring and genetically modified) viruses including baculovirus, nucleopolyhedro virus (NPV) such as Helicoverpa zea nucleopolyhedrovirus (HzNPV), Anagrapha falcifera nucleopolyhedrovirus (AfNPV); and granulosis virus (GV) such as Cydia pomonella granulosis virus (CpGV).
  • NPV nucleopolyhedro virus
  • HzNPV Helicoverpa zea nucleopolyhedrovirus
  • AfNPV Anagraph
  • a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management.
  • a composition of the present invention can further comprise at least one additional invertebrate pest control active ingredient having a similar spectrum of control but belonging to a different chemical class or having a different site of action.
  • additional biologically active compounds or agents include, but are not limited to, sodium channel modulators such as bifenthrin, cypermethrin, cyhalothrin, lambda-cyhalothrin, cyfluthrin, beta-cyfluthrin, deltamethrin, dimefluthrin, esfenvalerate, fenvalerate, indoxacarb, metofluthrin, profluthrin, pyrethrin and tralomethrin; cholinesterase inhibitors such as chlorpyrifos, methomyl, oxamyl, thiodicarb and triazamate; neonicotinoids such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid and thiamethoxam; insecticidal macrocyclic lactones such as spinetoram, spin
  • biologically active compounds or agents with which compounds of this invention can be formulated are: fungicides such as acibenzolar, aldimorph, amisulbrom, azaconazole, azoxystrobin, benalaxyl, benomyl, benthiavalicarb, benthiavalicarb-isopropyl, binomial, biphenyl, bitertanol, blasticidin-S, Bordeaux mixture (Tribasic copper sulfate), boscalid/nicobifen, bromuconazole, bupirimate, buthiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, chlozolinate, clotrimazole, copper oxychloride, copper salts such as copper sulfate and copper hydroxide, cyazofamid, cyflunamid, cymoxanil,
  • combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable.
  • synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.
  • Compounds of this invention and compositions thereof can be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). Such an application may provide a broader spectrum of plant protection and be advantageous for resistance management.
  • the effect of the exogenously applied invertebrate pest control compounds of this invention may be synergistic with the expressed toxin proteins.
  • the weight ratio of these various mixing partners (in total) to the compound of Formula 1 is typically between about 1:3000 and about 3000:1. Of note are weight ratios between about 1:300 and about 300:1 (for example ratios between about 1:30 and about 30:1).
  • weight ratios between about 1:300 and about 300:1 for example ratios between about 1:30 and about 30:1.
  • One skilled in the art can easily determine through simple experimentation the biologically effective amounts of active ingredients necessary for the desired spectrum of biological activity. It will be evident that including these additional components may expand the spectrum of invertebrate pests controlled beyond the spectrum controlled by the compound of Formula 1 alone.
  • combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable.
  • synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.
  • a combination of a compound of Formula 1 with at least one other invertebrate pest control active ingredient is such a combination where the other invertebrate pest control active ingredient has a different site of action from the compound of Formula 1.
  • a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management.
  • a composition of the present invention can further comprise a biologically effective amount of at least one additional invertebrate pest control active ingredient having a similar spectrum of control but a different site of action.
  • a plant genetically modified to express an invertebrate pest compound e.g., protein
  • a biologically effective amount of a compound of this invention can also provide a broader spectrum of plant protection and be advantageous for resistance management.
  • Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention.
  • the first column of Table A lists the specific invertebrate pest control agents (e.g., “Abamectin” in the first line).
  • the second column of Table A lists the mode of action (if known) or chemical class of the invertebrate pest control agents.
  • the third column of Table A lists embodiment(s) of ranges of weight ratios for rates at which the invertebrate pest control agent can be applied relative to a compound of Formula 1, an N-oxide, or a salt thereof, (e.g., “50:1 to 1:50” of abamectin relative to a compound of Formula 1 by weight).
  • the first line of Table A specifically discloses the combination of a compound of Formula 1 with abamectin can be applied in a weight ratio between 50:1 to 1:50.
  • the remaining lines of Table A are to be construed similarly.
  • Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention and includes additional embodiments of weight ratio ranges for application rates.
  • the weight ratios of a compound, including a compound of Formula 1, an N-oxide or a salt thereof, to the additional invertebrate pest control agent typically are between 1000:1 and 1:1000, with one embodiment being between 500:1 and 1:500, another embodiment being between 250:1 and 1:200 and another embodiment being between 100:1 and 1:50.
  • Table B Listed below in Table B are embodiments of specific compositions comprising a compound of Formula 1 (compound numbers refer to compounds in Index Table A) and an additional invertebrate pest control agent.
  • Invertebrate pests are controlled in agronomic and nonagronomic applications by applying one or more compounds of this invention, typically in the form of a composition, in a biologically effective amount, to the environment of the pests, including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled.
  • the present invention comprises a method for controlling an invertebrate pest in agronomic and/or nonagronomic applications, comprising contacting the invertebrate pest or its environment with a biologically effective amount of one or more of the compounds of the invention, or with a composition comprising at least one such compound or a composition comprising at least one such compound and a biologically effective amount of at least one additional biologically active compound or agent.
  • suitable compositions comprising a compound of the invention and a biologically effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional active compound is present on the same granule as the compound of the invention or on granules separate from those of the compound of the invention.
  • the compound or composition is typically applied to the seed of the crop before planting, to the foliage (e.g., leaves, stems, flowers, fruits) of crop plants, or to the soil or other growth medium before or after the crop is planted.
  • foliage e.g., leaves, stems, flowers, fruits
  • a method of contact is by spraying.
  • a granular composition comprising a compound of the invention can be applied to the plant foliage or the soil.
  • Compounds of this invention can also be effectively delivered through plant uptake by contacting the plant with a composition comprising a compound of this invention applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants.
  • a composition of the present invention in the form of a soil drench liquid formulation.
  • a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of the present invention or with a composition comprising a biologically effective amount of a compound of the present invention.
  • this method wherein the environment is soil and the composition is applied to the soil as a soil drench formulation.
  • compounds of this invention are also effective by localized application to the locus of infestation.
  • Other methods of contact include application of a compound or a composition of the invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic uptake, baits, ear tags, boluses, foggers, fumigants, aerosols, dusts and many others.
  • One embodiment of a method of contact is a dimensionally stable fertilizer granule, stick or tablet comprising a compound or composition of the invention.
  • the compounds of this invention can also be impregnated into materials for fabricating invertebrate control devices (e.g., insect netting).
  • treating a seed means contacting the seed with a biologically effective amount of a compound of this invention, which is typically formulated as a composition of the invention.
  • This seed treatment protects the seed from invertebrate soil pests and generally can also protect roots and other plant parts in contact with the soil of the seedling developing from the germinating seed.
  • the seed treatment may also provide protection of foliage by translocation of the compound of this invention or a second active ingredient within the developing plant. Seed treatments can be applied to all types of seeds, including those from which plants genetically transformed to express specialized traits will germinate.
  • Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin or those expressing herbicide resistance such as glyphosate acetyltransferase, which provides resistance to glyphosate.
  • compositions formulated for seed treatment generally comprise a film former or adhesive agent. Therefore typically a seed coating composition of the present invention comprises a biologically effective amount of a compound of Formula 1, an N-oxide or salt thereof, and a film former or adhesive agent. Seed can be coated by spraying a flowable suspension concentrate directly into a tumbling bed of seeds and then drying the seeds. Alternatively, other formulation types such as wetted powders, solutions, suspoemulsions, emulsifiable concentrates and emulsions in water can be sprayed on the seed. This process is particularly useful for applying film coatings on seeds. Various coating machines and processes are available to one skilled in the art. Suitable processes include those listed in P. Kosters et al., Seed Treatment Progress and Prospects, 1994 BCPC Mongraph No. 57, and references listed therein.
  • the treated seed typically comprises a compound of the present invention in an amount from about 0.1 g to 1 kg per 100 kg of seed (i.e. from about 0.0001 to 1% by weight of the seed before treatment).
  • a flowable suspension formulated for seed treatment typically comprises from about 0.5 to about 70% of the active ingredient, from about 0.5 to about 30% of a film-forming adhesive, from about 0.5 to about 20% of a dispersing agent, from 0 to about 5% of a thickener, from 0 to about 5% of a pigment and/or dye, from 0 to about 2% of an antifoaming agent, from 0 to about 1% of a preservative, and from 0 to about 75% of a volatile liquid diluent.
  • the compounds of this invention can be incorporated into a bait composition that is consumed by an invertebrate pest or used within a device such as a trap, bait station, and the like.
  • a bait composition can be in the form of granules which comprise (a) active ingredients, namely a biologically effective amount of a compound of Formula 1, an N-oxide, or salt thereof; (b) one or more food materials; optionally (c) an attractant, and optionally (d) one or more humectants.
  • granules or bait compositions which comprise between about 0.001-5% active ingredients, about 40-99% food material and/or attractant; and optionally about 0.05-10% humectants, which are effective in controlling soil invertebrate pests at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact.
  • Some food materials can function both as a food source and an attractant.
  • Food materials include carbohydrates, proteins and lipids. Examples of food materials are vegetable flour, sugar, starches, animal fat, vegetable oil, yeast extracts and milk solids.
  • attractants are odorants and flavorants, such as fruit or plant extracts, perfume, or other animal or plant component, pheromones or other agents known to attract a target invertebrate pest.
  • humectants i.e. moisture retaining agents, are glycols and other polyols, glycerine and sorbitol.
  • a bait composition (and a method utilizing such a bait composition) used to control at least one invertebrate pest selected from the group consisting of ants, termites and cockroaches.
  • a device for controlling an invertebrate pest can comprise the present bait composition and a housing adapted to receive the bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to the bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • the compounds of this invention can be applied without other adjuvants, but most often application will be of a formulation comprising one or more active ingredients with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use.
  • One method of application involves spraying a water dispersion or refined oil solution of a compound of the present invention. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy.
  • Such sprays can be applied from spray containers such as a can, a bottle or other container, either by means of a pump or by releasing it from a pressurized container, e.g., a pressurized aerosol spray can.
  • Such spray compositions can take various forms, for example, sprays, mists, foams, fumes or fog.
  • Such spray compositions thus can further comprise propellants, foaming agents, etc. as the case may be.
  • a spray composition comprising a biologically effective amount of a compound or a composition of the present invention and a carrier.
  • a spray composition comprises a biologically effective amount of a compound or a composition of the present invention and a propellant.
  • propellants include, but are not limited to, methane, ethane, propane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures of the foregoing.
  • a spray composition (and a method utilizing such a spray composition dispensed from a spray container) used to control at least one invertebrate pest selected from the group consisting of mosquitoes, black flies, stable flies, deer flies, horse flies, wasps, yellow jackets, hornets, ticks, spiders, ants, gnats, and the like, including individually or in combinations.
  • Nonagronomic uses refer to invertebrate pest control in the areas other than fields of crop plants.
  • Nonagronomic uses of the present compounds and compositions include control of invertebrate pests in stored grains, beans and other foodstuffs, and in textiles such as clothing and carpets.
  • Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in ornamental plants, forests, in yards, along roadsides and railroad rights of way, and on turf such as lawns, golf courses and pastures.
  • Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in houses and other buildings which may be occupied by humans and/or companion, farm, ranch, zoo or other animals.
  • Nonagronomic uses of the present compounds and compositions also include the control of pests such as termites that can damage wood or other structural materials used in buildings.
  • Nonagronomic uses of the present compounds and compositions also include protecting human and animal health by controlling invertebrate pests that are parasitic or transmit infectious diseases.
  • the controlling of animal parasites includes controlling external parasites that are parasitic to the surface of the body of the host animal (e.g., shoulders, armpits, abdomen, inner part of the thighs) and internal parasites that are parasitic to the inside of the body of the host animal (e.g., stomach, intestine, lung, veins, under the skin, lymphatic tissue).
  • External parasitic or disease-transmitting pests include, for example, chiggers, ticks, lice, mosquitoes, flies, mites and fleas.
  • Internal parasites include heartworms, hookworms and helminths.
  • Compounds and compositions of the present invention are particularly suitable for combating external parasitic or disease-transmitting pests.
  • Compounds and compositions of the present invention are suitable for systemic and/or non-systemic control of infestation
  • Livestock is the term used to refer (singularly or plurally) to a domesticated animal intentionally reared in an agricultural setting to make produce such as food or fiber, or for its labor; examples of livestock include cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, hens, turkeys, ducks and geese (e.g., raised for meat, milk, butter, eggs, fur, leather, feathers and/or wool).
  • fatalities and performance reduction in terms of meat, milk, wool, skins, eggs, etc.
  • applying a composition comprising a compound of the present invention allows more economic and simple husbandry of animals.
  • Compounds and compositions of the present invention are especially suitable for combating parasites that infest companion animals and pets (e.g., dogs, cats, pet birds and aquarium fish), research and experimental animals (e.g., hamsters, guinea pigs, rats and mice), as well as animals raised for/in zoos, wild habitats and/or circuses.
  • companion animals and pets e.g., dogs, cats, pet birds and aquarium fish
  • research and experimental animals e.g., hamsters, guinea pigs, rats and mice
  • the animal is preferably a vertebrate, and more preferably a mammal, avian or fish.
  • the animal subject is a mammal (including great apes, such as humans).
  • Other mammalian subjects include primates (e.g., monkeys), bovine (e.g., cattle or dairy cows), porcine (e.g., hogs or pigs), ovine (e.g., goats or sheep), equine (e.g., horses), canine (e.g., dogs), feline (e.g., house cats), camels, deer, donkeys, buffalos, antelopes, rabbits, and rodents (e.g., guinea pigs, squirrels, rats, mice, gerbils, and hamsters).
  • primates e.g., monkeys
  • bovine e.g., cattle or dairy cows
  • porcine e.g., hogs or pigs
  • ovine
  • Avians include Anatidae (swans, ducks and geese), Columbidae (e.g., doves and pigeons), Phasianidae (e.g., partridges, grouse and turkeys), Thesienidae (e.g., domestic chickens), Psittacines (e.g., parakeets, macaws, and parrots), game birds, and ratites (e.g., ostriches).
  • Anatidae swans, ducks and geese
  • Columbidae e.g., doves and pigeons
  • Phasianidae e.g., partridges, grouse and turkeys
  • Thesienidae e.g., domestic chickens
  • Psittacines e.g., parakeets, macaws, and parrots
  • game birds e.g.,
  • the animals to be protected are domesticated dogs (i.e. Canis lupus familiaris ) and domestic house cats (i.e. Felis catus ).
  • Birds treated or protected by the inventive compounds can be associated with either commercial or noncommercial aviculture. These include Anatidae, such as swans, geese, and ducks, Columbidae, such as doves and domestic pigeons, Phasianidae, such as partridge, grouse and turkeys, Thesienidae, such as domestic chickens, and Psittacines, such as parakeets, macaws, and parrots raised for the pet or collector market, among others.
  • Anatidae such as swans, geese, and ducks
  • Columbidae such as doves and domestic pigeons
  • Phasianidae such as partridge, grouse and turkeys
  • Thesienidae such as domestic chickens
  • Psittacines such as parakeets, macaws, and parrots raised for the pet or collector market, among others.
  • fish shall be understood to include without limitation, the Teleosti grouping of fish, i.e., teleosts. Both the Salmoniformes order (which includes the Salmonidae family) and the Perciformes order (which includes the Centrarchidae family) are contained within the Teleosti grouping. Examples of potential fish recipients include the Salmonidae, Serranidae, Sparidae, Cichlidae, and Centrarchidae, among others.
  • inventions are also contemplated to benefit from the inventive methods, including marsupials (such as kangaroos), reptiles (such as farmed turtles), and other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.
  • marsupials such as kangaroos
  • reptiles such as farmed turtles
  • other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.
  • invertebrate parasitic pests controlled by administering a parasiticidally effective amount of a compound of this invention to an animal to be protected include ectoparasites (arthropods, acarines, etc) and endoparasites (helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.).
  • ectoparasites arthropods, acarines, etc
  • endoparasites helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.
  • helminthiasis The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths.
  • helminths The term “helminths” is meant to include nematodes, trematodes, cestodes and acanthocephalans.
  • Helminthiasis is a prevalent and serious economic problem with domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry.
  • Nematodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Acanthocheilonema, Aelurostrongylus, Ancylostoma, Angiostrongylus, Ascaridia, Ascaris, Brugia, Bunostomum, Capillaria, Chabertia, Cooperia, Crenosoma, Dictyocaulus, Dioctophyme, Dipetalonema, Diphyllobothrium, Dirofilaria, Dracunculus, Enterobius, Filaroides, Haemonchus, Heterakis, Lagochilascaris, Loa, Mansonella, Muellerius, Necator, Nematodirus, Oesophagostomum, Ostertagia, Oxyuris, Parafilaria, Parascaris
  • nematodes infecting the animals referred to above are Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostonum, Oesophagostomum, Chabertia, Trichuris, Strongylus, Trichonema, Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris .
  • Nematodirus such as Nematodirus, Cooperia and Oesophagostomum attack primarily the intestinal tract while others, such as Haemonchus and Ostertagia , are more prevalent in the stomach while others such as Dictyocaulus are found in the lungs.
  • Still other parasites may be located in other tissues such as the heart and blood vessels, subcutaneous and lymphatic tissue and the like.
  • Trematodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Alaria, Fasciola, Nanophyetus, Opisthorchis, Paragonimus and Schistosoma.
  • Cestodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Diphyllobothrium, Diplydium, Spirometra and Taenia.
  • the most common genera of parasites of the gastrointestinal tract of humans are Ancylostoma, Necator, Ascaris, Strongyloides, Trichinella, Capillaria, Trichuris and Enterobius .
  • Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filarial worms such as Wuchereria, Brugia, Onchocerca and Loa , as well as Dracunculus and extra intestinal stages of the intestinal worms Strongyloides and Trichinella.
  • helminth genera and species are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Textbook of Veterinary Clinical Parasitology, Volume 1 , Helminths , E. J. L. Soulsby, F. A. Davis Co., Philadelphia, Pa.; Helminths, Arthropods and Protozoa , (6 th Edition of Monnig's Veterinary Helminthology and Entomology ), E. J. L. Soulsby, The Williams and Wilkins Co., Baltimore, Md.
  • the compounds of Formula 1 are effective against a number of animal ectoparasites (e.g., arthropod ectoparasites of mammals and birds).
  • animal ectoparasites e.g., arthropod ectoparasites of mammals and birds.
  • Insect and acarine pests include, e.g., biting insects such as flies and mosquitoes, mites, ticks, lice, fleas, true bugs, parasitic maggots, and the like.
  • Adult flies include, e.g., the horn fly or Haematobia irritans , the horse fly or Tabanus spp., the stable fly or Stomoxys calcitrans , the black fly or Simulium spp., the deer fly or Chrysops spp., the louse fly or Melophagus ovinus , and the tsetse fly or Glossina spp.
  • Parasitic fly maggots include, e.g., the bot fly ( Oestrus ovis and Cuterebra spp.), the blow fly or Phaenicia spp., the screwworm or Cochliomyia hominivorax , the cattle grub or Hypoderma spp., the fleeceworm and the Gastrophilus of horses.
  • Mosquitoes include, for example, Culex spp., Anopheles spp. and Aedes spp.
  • Mites include Mesostigmata spp. e.g., mesostigmatids such as the chicken mite, Dermanyssus gallinae ; itch or scab mites such as Sarcoptidae spp. for example, Sarcoptes scabiei ; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis ; chiggers e.g., Trombiculidae spp. for example the North American chigger, Trombicula alfreddugesi.
  • mesostigmatids such as the chicken mite, Dermanyssus gallinae ; itch or scab mites such as Sarcoptidae spp. for example, Sarcoptes scabiei ; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis
  • Ticks include, e.g., soft-bodied ticks including Argasidae spp. for example Argas spp. and Ornithodoros spp.; hard-bodied ticks including Ixodidae spp., for example Rhipicephalus sanguineus, Dermacentor variabilis, Dermacentor andersoni, Amblyomma anmericanum, Ixodes scapularis and other Rhipicephalus spp. (including the former Boophilus genera).
  • soft-bodied ticks including Argasidae spp. for example Argas spp. and Ornithodoros spp.
  • hard-bodied ticks including Ixodidae spp., for example Rhipicephalus sanguineus, Dermacentor variabilis, Dermacentor andersoni, Amblyomma anmericanum, Ixodes scapularis and other Rhipicephalus spp. (including the former Boophilus genera).
  • Lice include, e.g., sucking lice, e.g., Menopon spp. and Bovicola spp.; biting lice, e.g., Haematopinus spp., Linognathus spp. and Solenopotes spp.
  • Fleas include, e.g., Ctenocephalides spp., such as dog flea ( Ctenocephalides canis ) and cat flea ( Ctenocephalides felis ); Xenopsylla spp. such as oriental rat flea ( Xenopsylla cheopis ); and Pulex spp. such as human flea ( Pulex irritans ).
  • Ctenocephalides spp. such as dog flea ( Ctenocephalides canis ) and cat flea ( Ctenocephalides felis ); Xenopsylla spp. such as oriental rat flea ( Xenopsylla cheopis ); and Pulex spp. such as human flea ( Pulex irritans ).
  • True bugs include, e.g., Cimicidae or e.g., the common bed bug ( Cinmex lectularius ); Triatominae spp. including triatomid bugs also known as kissing bugs; for example Rhodnius prolixus and Triatoma spp.
  • flies, fleas, lice, mosquitoes, gnats, mites, ticks and helminths cause tremendous losses to the livestock and companion animal sectors.
  • Arthropod parasites also are a nuisance to humans and can vector disease-causing organisms in humans and animals.
  • arthropod pests and ectoparasites are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Medical and Veterinary Entomology , D. S. Kettle, John Wiley & Sons, New York and Toronto; Control of Arthropod Pests of Livestock: A Review of Technology , R. O. Drummand, J. E. George, and S. E. Kunz, CRC Press, Boca Raton, Fla.
  • compositions of this invention may be effective against a number of protozoa endoparasites of animals, including those summarized by Table 1, as follows.
  • the compounds of this invention are effective against ectoparasites including: flies such as Haematobia ( Lyperosia ) irritans (horn fly), Stomoxys calcitrans (stable fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestica (house fly), Morellia simplex (sweat fly), Tabanus spp. (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green blowfly), Calliphora spp.
  • flies such as Haematobia ( Lyperosia ) irritans (horn fly), Stomoxys calcitrans (stable fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydro
  • cyanotis ear mites
  • ticks such as Ixodes spp., Boophilus spp., Rhipicephalus spp., Amblyomma spp., Dermacentor spp., Hyalomma spp. and Haemaphysalis spp.
  • fleas such as Ctenocephalides felis (cat flea) and Ctenocephalides canis (dog flea).
  • Organophosphate pesticides include, e.g., dicrotophos, terbufos, dimethoate, diazinon, disulfoton, trichlorfon, azinphos-methyl, chlorpyrifos, malathion, oxydemeton-methyl, methamidophos, acephate, ethyl parathion, methyl parathion, mevinphos, phorate, carbofenthion and phosalone.
  • carbamate-type pesticides including, e.g., carbaryl, carbofuran, aldicarb, molinate, methomyl, carbofuran, etc., as well as combinations with the organochlorine-type pesticides.
  • biological pesticides including repellents, the pyrethrins (as well as synthetic variations thereof, e.g., allethrin, resmethrin, permethrin, tralomethrin), and nicotine, that is often employed as an acaricide.
  • miscellaneous pesticides including: Bacillus thuringiensis , chlorobenzilate, formamidines (e.g., amitraz), copper compounds (e.g., copper hydroxide and cupric oxychloride sulfate), cyfluthrin, cypermethrin, dicofol, endosulfan, esfenvalerate, fenvalerate, lambda-cyhalothrin, methoxychlor and sulfur.
  • Bacillus thuringiensis chlorobenzilate, formamidines (e.g., amitraz), copper compounds (e.g., copper hydroxide and cupric oxychloride sulfate), cyfluthrin, cypermethrin, dicofol, endosulfan, esfenvalerate, fenvalerate, lambda-cyhalothrin, methoxychlor and sulfur.
  • formamidines
  • additional biologically active compounds or agents selected from art-known anthelmintics such as, for example, macrocyclic lactones (e.g., ivermectin, moxidectin, milbemycin), benzimidazoles (e.g., albendazole, triclabendazole), salicylanilides (e.g., closantel, oxyclozanide), substituted phenols (e.g., nitroxynil), pyrimidines (e.g., pyrantel), imidazothiazoles (e.g., levamisole), cyclic depsipeptides (e.g., emodepside), piperazine salts, nitroscanate and praziquantel.
  • macrocyclic lactones e.g., ivermectin, moxidectin, milbemycin
  • benzimidazoles e.g., albendazole, triclabendazole
  • IGRs Insect Growth Regulators
  • JHAs Juvenile Hormone Analogues
  • diflubenzuron, triflumuron, fluazuron, cyromazine, methoprene, etc. thereby providing both initial and sustained control of parasites (at all stages of insect development, including eggs) on the animal subject, as well as within the environment of the animal subject.
  • biologically active compounds or agents useful in the compositions of the present invention selected from the avermectin class of antiparasitic compounds.
  • the avermectin family of compounds includes very potent antiparasitic agents known to be useful against a broad spectrum of endoparasites and ectoparasites in mammals.
  • Ivermectin is a semi-synthetic derivative of avermectin and is generally produced as a mixture of at least 80% 22,23-dihydroavermectin B 1a and less than 20% 22,23-dihydroavermectin B 1b .
  • Ivermectin is disclosed in U.S. Pat. No. 4,199,569.
  • Abamectin is an avermectin that is disclosed as avermectin B 1a /B 1b in U.S. Pat. No. 4,310,519. Abamectin contains at least 80% of avermectin B 1a and not more than 20% of avermectin B 1b .
  • doramectin also known as 25-cyclohexyl-avermectin B 1 .
  • the structure and preparation of doramectin is disclosed in U.S. Pat. No. 5,089,480.
  • Moxidectin also known as LL-F28249 alpha, is known from U.S. Pat. No. 4,916,154.
  • avermectin is selamectin.
  • Selamectin is 25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22,23-dihydro-5-(hydroxyimino)-avermectin B 1 monosaccharide.
  • Milbemycin or B41
  • Milbemycin is a substance which is isolated from the fermentation broth of a milbemycin-producing strain of Streptomyces .
  • the microorganism, the fermentation conditions and the isolation procedures are described in U.S. Pat. Nos. 3,950,360 and 3,984,564.
  • Emamectin (4′′-deoxy-4′′-epi-methylaminoavermectin B 1 ), which can be prepared as described in U.S. Pat. Nos. 5,288,710 and 5,399,717, is a mixture of two homologues, 4′′-deoxy-4′′-epi-methylaminoavermectin B 1a and 4′′-deoxy-4′′-epi-methylaminoavermectin B 1b .
  • a salt of emamectin is used.
  • Non-limiting examples of salts of emamectin which may be used in the present invention include the salts described in U.S. Pat. No.
  • 5,288,710 e.g., salts derived from benzoic acid, substituted benzoic acid, benzenesulfonic acid, citric acid, phosphoric acid, tartaric acid, maleic acid, and the like.
  • the emamectin salt used in the present invention is emamectin benzoate.
  • Eprinomectin is chemically known as 4′′-epi-acetylamino-4′′-deoxy-avermectin B 1 .
  • Eprinomectin was specifically developed to be used in all cattle classes and age groups. It was the first avermectin to show broad-spectrum activity against both endo- and ecto-parasites while also leaving minimal residues in meat and milk. It has the additional advantage of being highly potent when delivered topically.
  • composition of the present invention optionally comprises combinations of one or more of the following antiparasite compounds: imidazo[1,2-b]pyridazine compounds as described by U.S. Patent Application Publication No. 2005/0182059 A1; 1-(4-mono and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanol compounds, as described by U.S. Pat. No. 7,361,689; trifluoromethanesulfonanilide oxime ether derivatives, as described by U.S. Pat. No.
  • compositions of the present invention may also further comprise a flukicide.
  • Suitable flukicides include, for example, triclabendazole, fenbendazole, albendazole, clorsulon and oxibendazole. It will be appreciated that the above combinations may further include combinations of antibiotic, antiparasitic and anti-fluke active compounds.
  • such antinfectives include one or more antibiotics that are optionally co-administered during treatment using the inventive compounds or methods, e.g., in a combined composition and/or in separate dosage forms.
  • antibiotics suitable for this purpose include, for example, those listed herein below.
  • florfenicol also known as D-(threo)-1-(4-methylsulfonylphenyl)-2-dichloroacetamido-3-fluoro-1-propanol.
  • Another preferred antibiotic compound is D-(threo)-1-(4-methylsulfonylphenyl)-2-difluoroacetamido-3-fluoro-1-propanol.
  • Another useful antibiotic is thiamphenicol. Processes for the manufacture of these antibiotic compounds, and intermediates useful in such processes, are described in U.S. Pat. Nos.
  • Tilmicosin is a macrolide antibiotic that is chemically defined as 20-dihydro-20-deoxy-20-(cis-3,5-dimethylpiperidin-1-yl)-desmycosin and is disclosed in U.S. Pat. No. 4,820,695.
  • Tulathromycin may be prepared in accordance with the procedures set forth in U.S. Pat. No. 6,825,327.
  • antibiotics for use in the present invention include the cephalosporins such as, for example, ceftiofur, cefquinome, etc.
  • concentration of the cephalosporin in the formulation of the present invention optionally varies between about 1 mg/mL to 500 mg/mL.
  • Another useful antibiotic includes the fluoroquinolones, such as, for example, enrofloxacin, danofloxacin, difloxacin, orbifloxacin and marbofloxacin.
  • fluoroquinolones such as, for example, enrofloxacin, danofloxacin, difloxacin, orbifloxacin and marbofloxacin.
  • enrofloxacin it may be administered in a concentration of about 100 mg/mL.
  • Danofloxacin may be present in a concentration of about 180 mg/mL.
  • Other useful macrolide antibiotics include compounds from the class of ketolides, or, more specifically, the azalides. Such compounds are described in, for example, U.S. Pat. Nos. 6,514,945; 6,472,371; 6,270,768; 6,437,151; 6,271,255; 6,239,12; 5,958,888; 6,339,063; and 6,054,434.
  • antibiotics include the tetracyclines, particularly chlortetracycline and oxytetracycline.
  • Other antibiotics may include ⁇ -lactams such as penicillins, e.g., penicillin, ampicillin, amoxicillin, or a combination of amoxicillin with clavulanic acid or other beta lactamase inhibitors.
  • Nonagronomic applications in the veterinary sector are by conventional means such as by enteral administration in the form of, for example, tablets, capsules, drinks, drenching preparations, granulates, pastes, boli, feed-through procedures, or suppositories; or by parenteral administration, such as by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; by nasal administration; by topical administration, for example, in the form of immersion or dipping, spraying, washing, coating with powder, or application to a small area of the animal, and through articles such as neck collars, ear tags, tail bands, limb bands or halters which comprise compounds or compositions of the present invention.
  • Any of the compounds of the present invention, or a suitable combination of such compounds, may be administered directly to the animal subject and/or indirectly by applying it to the local environment in which the animal dwells (such as bedding, enclosures, or the like).
  • Direct administration includes contacting the skin, fur or feathers of a subject animal with the compounds, or by feeding or injecting the compounds into the animal.
  • the compounds of the present invention may be administered in a controlled release form, e.g., in a subcutaneous slow release formulation, or in the form of a controlled release device affixed to an animal such as a flea collar.
  • Collars for the controlled release of an insecticide agent for long term protection against flea infestation in a companion animal are art-known, and are described, for example, by U.S. Pat. Nos. 3,852,416; 4,224,901; 5,555,848; and 5,184,573.
  • a parasiticidal composition comprises a mixture of a compound of Formula 1 with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with regard to the intended route of administration (e.g., oral, topical or parenteral administration such as injection) and in accordance with standard practice.
  • a suitable carrier is selected on the basis of compatibility with the one or more active ingredients in the composition, including such considerations as stability relative to pH and moisture content. Therefore of note is a composition for protecting an animal from an invertebrate parasitic pest comprising a compound of the invention (i.e. in a parasiticidally effective amount) and at least one veterinarily acceptable carrier.
  • a compound of the present invention can be formulated in suspension, solution or emulsion in oily or aqueous vehicles, and may contain adjuncts such as suspending, stabilizing and/or dispersing agents.
  • the compounds of the present invention may also be formulated for bolus injection or continuous infusion.
  • Pharmaceutical compositions for injection include aqueous solutions preferably in physiologically compatible buffers containing other excipients or auxiliaries as are known in the art of pharmaceutical formulation. Additionally, suspensions of the active compounds may be prepared in a lipophilic vehicle.
  • Suitable lipophilic vehicles include fatty oils such as sesame oil, synthetic fatty acid esters such as ethyl oleate and triglycerides, or materials such as liposomes.
  • Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran.
  • Formulations for injection may be presented in unit dosage form, e.g., in ampoules or in multi-dose containers.
  • the active ingredient may be in powder form for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use.
  • the compounds of the present invention may also be formulated as a depot preparation. Such long acting formulations may be administered by implantation (for example, subcutaneously or intramuscularly) or by intramuscular or subcutaneous injection.
  • the compounds of the present invention may be formulated for this route of administration with suitable polymeric or hydrophobic materials (e.g., in an emulsion with a pharmacologically acceptable oil).
  • the compounds of the present invention can be delivered in the form of an acrosol spray using a pressurized pack or a nebulizer and a suitable propellant, e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide.
  • a suitable propellant e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide.
  • the dosage unit may be controlled by providing a valve to deliver a metered amount.
  • Capsules and cartridges of, for example, gelatin for use in an inhaler or insufflator may be formulated containing a powder mix of the compound and a suitable powder base such as lactose or starch.
  • compositions for protecting an animal from an invertebrate parasite pest in a form for oral administration i.e. comprising, in addition to a parasiticidally effective amount of a compound of the invention, one or more carriers selected from binders and fillers suitable for oral administration and feed concentrate carriers).
  • a compound of the present invention can be formulated with binders/fillers known in the art to be suitable for oral administration compositions, such as sugars and sugar derivatives (e.g., lactose, sucrose, mannitol, sorbitol), starch (e.g., maize starch, wheat starch, rice starch, potato starch), cellulose and derivatives (e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose), protein derivatives (e.g., zein, gelatin), and synthetic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone).
  • sugars and sugar derivatives e.g., lactose, sucrose, mannitol, sorbitol
  • starch e.g., maize starch, wheat starch, rice starch, potato starch
  • cellulose and derivatives e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose
  • protein derivatives
  • lubricants e.g., magnesium stearate
  • disintegrating agents e.g., cross-linked polyvinylpyrrolidinone, agar, alginic acid
  • dyes or pigments can be added.
  • Pastes and gels often also contain adhesives (e.g., acacia, alginic acid, bentonite, cellulose, xanthan gum, colloidal magnesium aluminum silicate) to aid in keeping the composition in contact with the oral cavity and not being easily ejected.
  • a preferred embodiment is a composition formulated into a chewable and/or edible product (e.g., a chewable treat or edible tablet).
  • a chewable and/or edible product e.g., a chewable treat or edible tablet.
  • Such a product would ideally have a taste, texture and/or aroma favored by the animal to be protected so as to facilitate oral administration of the compound of Formula 1.
  • the carrier is typically selected from high-performance feed, feed cereals or protein concentrates.
  • feed concentrate-containing compositions can, in addition to the parasiticidal active ingredients, comprise additives promoting animal health or growth, improving quality of meat from animals for slaughter or otherwise useful to animal husbandry.
  • additives can include, for example, vitamins, antibiotics, chemotherapeutics, bacteriostats, fungistats, coccidiostats and hormones.
  • the compounds of Formula 1 may also be formulated in rectal compositions such as suppositories or retention enemas, using, e.g., conventional suppository bases such as cocoa butter or other glycerides.
  • Formulations for topical administration are typically in the form of a powder, cream, suspension, spray, emulsion, foam, paste, aerosol, ointment, salve or gel. More typically a topical formulation is a water-soluble solution, which can be in the form of a concentrate that is diluted before use.
  • Parasiticidal compositions suitable for topical administration typically comprise a compound of the present invention and one or more topically suitable carriers. In applications of a parasiticidal composition topically to the exterior of an animal as a line or spot (i.e. “spot-on” treatment), the active ingredient migrates over the surface of the animal to cover most or all of its external surface area.
  • formulations for topical localized administration often comprise at least one organic solvent to facilitate transport of the active ingredient over the skin and/or penetration into the epidermis of the animal.
  • Carriers in such formulations include propylene glycol, paraffins, aromatics, esters such as isopropyl myristate, glycol ethers, alcohols such as ethanol, n-propanol, 2-octyl dodecanol or oleyl alcohol; solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, caproic acid esters of saturated fatty alcohols of C 12 -C 18 chain length; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of
  • a pour-on formulation may also be prepared for control of parasites in an animal of agricultural value.
  • the pour-on formulations of this invention can be in the form of a liquid, powder, emulsion, foam, paste, aerosol, ointment, salve or gel.
  • the pour-on formulation is liquid.
  • These pour-on formulations can be effectively applied to sheep, cattle, goats, other ruminants, camelids, pigs and horses.
  • the pour-on formulation is typically applied by pouring in one or several lines or in a spot-on the dorsal midline (back) or shoulder of an animal. More typically, the formulation is applied by pouring it along the back of the animal, following the spine.
  • the formulation can also be applied to the animal by other conventional methods, including wiping an impregnated material over at least a small area of the animal, or applying it using a commercially available applicator, by means of a syringe, by spraying or by using a spray race.
  • the pour-on formulations include a carrier and can also include one or more additional ingredients. Examples of suitable additional ingredients are stabilizers such as antioxidants, spreading agents, preservatives, adhesion promoters, active solubilisers such as oleic acid, viscosity modifiers, UV blockers or absorbers, and colourants.
  • Surface active agents including anionic, cationic, non-ionic and ampholytic surface active agents, can also be included in these formulations.
  • the formulations of this invention typically include an antioxidant, such as BHT (butylated hydroxytoluene).
  • the antioxidant is generally present in amounts of at 0.1-5% (wt/vol).
  • Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is used.
  • Common spreading agents used in these pour-on formulations include isopropyl myristate, isopropyl palmitate, caprylic/capric acid esters of saturated C 12 -C 18 fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and dipropylene glycol methyl ether.
  • the pour-on formulations of this invention are prepared according to known techniques.
  • the pour-on formulation is a solution
  • the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring if required.
  • Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. If the pour-on formulation is an emulsion or suspension, the formulations can be similarly prepared using known techniques.
  • Liposomes and emulsions are well-known examples of delivery vehicles or carriers for hydrophobic drugs.
  • organic solvents such as dimethylsulfoxide can be used, if needed.
  • the rate of application required for effective control (i.e. “biologically effective amount”) will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredients per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required.
  • effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required.
  • One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control.
  • a compound of Formula 1 is administered in a parasiticidally effective amount to an animal to be protected from invertebrate parasite pests.
  • a parasiticidally effective amount is the amount of active ingredient needed to achieve an observable effect diminishing the occurrence or activity of the target invertebrate parasite pest.
  • the parasitically effective dose can vary for the various compounds and compositions of the present invention, the desired parasitical effect and duration, the target invertebrate pest species, the animal to be protected, the mode of application and the like, and the amount needed to achieve a particular result can be determined through simple experimentation.
  • a dose of a compound of the present invention administered at suitable intervals typically ranges from about 0.01 mg/kg to about 100 mg/kg, and preferably from about 0.01 mg/kg to about 30 mg/kg of animal body weight.
  • a dose typically contains from about 0.01 ppm to about 150,000 ppm, more typically from about 0.01 ppm to about 100,000 ppm, preferably from about 0.01 ppm to about 5,000 ppm, and most preferably from about 0.01 ppm to about 3,000 ppm, of a compound of the present invention.
  • Suitable intervals for the administration of compounds of the present invention to homeothermic animals range from about daily to about yearly. Of note are administration intervals ranging from about weekly to about once every 6 months. Of particular note are monthly administration intervals (i.e. administering the compound to the animal once every month).
  • Control efficacy represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding.
  • the pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-G for compound descriptions. See Index Table H for 1 H NMR data. For mass spectral data, the numerical value reported is the molecular weight of the highest isotopic abundance parent ion (M+1) formed by addition of H + (molecular weight of 1) to the molecule, observed by mass spectrometry using atmospheric pressure chemical ionization (AP + ).
  • Cmpd means Compound, t is tertiary, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, Bu is butyl, c-Pr is cyclopropyl, c-Pn is cyclopentyl, c-Hx is cyclohexyl, t-Bu is tertiary-butyl, Ph is phenyl, OMe is methoxy, SMe is methylthio, and SO 2 Me means methylsulfonyl.
  • R or (S) denotes the absolute chirality of the asymmetric carbon center.
  • the variable “R 2 ” represents one or a combination of substituents as listed in the Index Tables.
  • the abbreviation “Ex.” stands for “Example” and is followed by a number indicating in which example the compound is prepared.
  • Couplings are designated by (s)—singlet, (d)—doublet, (t)—triplet, (q)—quartet, (dd)—doublet of doublets, (dt)—doublet of triplets, (br)—broad peaks, (m)—multiplet.
  • Control efficacy represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding.
  • the pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-G for compound descriptions.
  • test unit For evaluating control of diamondback moth ( Plutella xylostella ) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with about 50 neonate larvae that were dispensed into the test unit via corn-cob grits using a apelooka inoculator. The larvae moved onto the test plant after being dispensed into the test unit.
  • Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77TM Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc. Greeley, Colo., USA). The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with 1 ⁇ 8 JJ custom body (Spraying Systems Co. Wheaton, Ill., USA) positioned 1.27 cm (0.5 inches) above the top of each test unit. All experimental compounds in these tests were sprayed at 50 ppm, and the test was replicated three times.
  • each test unit was allowed to dry for 1 h and then a black, screened cap was placed on top.
  • the test units were held for 6 days in a growth chamber at 25° C. and 70% relative humidity. Plant feeding damage was then visually assessed based on foliage consumed and a pest mortality rating was also counted and calculated for each test unit.
  • test unit For evaluating control of fall armyworm ( Spodoptera frugiperda ) the test unit consisted of a small open container with a 4-5-day-old corn (maize) plant inside. This was pre-infested (using a core sampler) with 10-15 1-day-old larvae on a piece of insect diet. Test compounds were formulated and sprayed at 50 ppm as described for Test A and replicated three times. After spraying, the test units were maintained in a growth chamber and then the control efficacy was rated for each test unit as described for Test A.
  • test unit For evaluating control of potato leafhopper ( Empoasca fabae ) through contact and/or systemic means, the test unit consisted of a small open container with a 5-6 day old Soleil bean plant (primary leaves emerged) inside. White sand was added to the top of the soil and one of the primary leaves was excised prior to application. Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 or 50 ppm as noted, and the test was replicated three times. After spraying, the test units were allowed to dry for 1 hour before they were post-infested with 5 potato leafhoppers (18- to 21-day old adults). A black, screened cap was placed on the top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. The control efficacy of each test unit was then visually assessed by the insect mortality.
  • control efficacy 80% or more mortality: 3, 4, 5, 6, 14, 19, 21, 22, 27, 31, 32, 43, 44, 45, 47, 48, 49, 50, 53, 54, 55, 60, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 90, 91, 93, 94, 103, 104 and 106.
  • test unit For evaluating control of corn planthopper ( Peregrinus maidis ) through contact and/or systemic means, the test unit consisted of a small open container with a 3-4-day-old maize plant (spike) inside. White sand was added to the top of the soil prior to application. Test compounds were formulated and sprayed at 250 ppm and replicated three times as described for Test A. After spraying, the test units were allowed to dry for 1 h before they were post-infested with 10-20 corn planthoppers (18- to 20-day-old nymphs) by sprinkling them onto the sand with a salt shaker. A black, screened cap was placed on the top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. Each test unit was then visually assessed for insect mortality.
  • test unit For evaluating control of the western flower thrips ( Frankliniella occidentalis ) through contact and/or systemic means, the test unit consisted of a small open container with a 5-7 day old Soleil Bean plant inside. Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 or 50 ppm as noted, and the test was replicated three times. After spraying, the test units were allowed to dry for 1 hour and then 22-27 adult thrips were added to each unit and then a black, screened cap was placed on top. The test units were held for 6 days at 25° C. and 45-55% relative humidity. A mortality rating was assessed along with a plant damage rating for each test unit.
  • the test unit consisted of a small open container with a 12-15-day-old radish plant inside. This was pre-infested by placing on a leaf of the test plant 30-40 aphids on a piece of leaf excised from a culture plant (cut-leaf method). The larvae moved onto the test plant as the leaf piece desiccated. After pre-infestation, the soil of the test unit was covered with a layer of sand.
  • Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 ppm, and the test was replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 h and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. Each test unit was then visually assessed for insect mortality.
  • test unit For evaluating control of cotton melon aphid ( Aphis gossypii ) through contact and/or systemic means, the test unit consisted of a small open container with a 6-7-day-old cotton plant inside. This was pre-infested with 30-40 insects on a piece of leaf according to the cut-leaf method described for Test F, and the soil of the test unit was covered with a layer of sand.
  • Test compounds were formulated and sprayed at 250 ppm and the test was replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated assessed for insect mortality.
  • test unit For evaluating control of silverleaf whitefly ( Bemisia tabaci ), the test unit consisted of a 14-21-day-old cotton plant grown in Redi-earth® media (Scotts Co.) with at least two true leaves infested with 2nd and 3rd instar nymphs on the underside of the leaves.
  • Test compounds were formulated in no more than 2 mL of acetone and then diluted with water to 25-30 mL.
  • the formulated compounds were applied using a flat fan air-assisted nozzle (Spraying Systems 122440) at 10 psi (69 kPa). Plants were sprayed to run-off on a turntable sprayer (patent publication EP-1110617-A1). All experimental compounds in this screen were sprayed at 250 ppm and replicated three times. After spraying of the test compound, the test units were held for 6 days in a growth chamber at 50-60% relative humidity and 28° C. daytime and 24° C. nighttime temperature. Then the leaves were removed and then dead and live nymphs were counted to calculate percent mortality.
  • a CD-1® mouse (about 30 g, male, obtained from Charles River Laboratories, Wilmington, Mass.) was orally dosed with a test compound in an amount of 10 mg/kg solubilized in propylene glycol/glycerol formal (60:40). Two hours after oral administration of the test compound, approximately 8 to 16 adult fleas were applied to each mouse. The fleas were then evaluated for mortality 48 hours after flea application to the mouse.
  • the following compounds caused 50% or more mortality: 4, 21, 22, 43, 44, 47, 50, 54, 55, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 93 and 107.
  • a test compound was solubilized in acetone/water (75:25) to provide a final test concentration of 500 ppm. Then 20 ⁇ L of the 500 ppm solution was applied to filter paper in the bottom of a tube. The tube is allowed to dry for 3 hours. Then approximately 10 adult fleas were added to the tube and the tube was capped. The fleas were evaluated for mortality 48 hours later.
  • test compound was solubilized in propylene glycol/glycerol formal (60:40) and then diluted in bovine blood to provide a final test concentration of 30 ppm.
  • the treated blood was placed in a tube, and the top of the tube was covered with a membrane. Approximately 5 O. turicata nymphs were placed on the membrane and allowed to feed on the treated blood until fully engorged. The ticks were then evaluated for mortality 48 hours later.

Abstract

Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof,
Figure US20150098928A9-20150409-C00001
wherein
    • A is a 6-membered aromatic ring containing carbon atoms and 0-3 nitrogen atoms as ring members, said ring optionally substituted with 1-5 substituents independently selected from R2;
    • R1 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R21;
    • R21 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2; and
    • Q is as defined in the disclosure.
Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.

Description

    FIELD OF THE INVENTION
  • This invention relates to certain isoxazolines, their N-oxides, salts and compositions suitable for agronomic, nonagronomic and animal health uses, methods of their use for controlling invertebrate pests such as arthropods in both agronomic and nonagronomic environments, and for treatment of parasite infections in animals or infestations in the general environment.
    • BACKGROUND OF THE INVENTION
  • The control of invertebrate pests is extremely important in achieving high crop efficiency. Damage by invertebrate pests to growing and stored agronomic crops can cause significant reduction in productivity and thereby result in increased costs to the consumer. The control of invertebrate pests in forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, turf, wood products, and public health is also important. Many products are commercially available for these purposes, but the need continues for new compounds that are more effective, less costly, less toxic, environmentally safer or have different sites of action.
  • The control of animal parasites in animal health is essential, especially in the areas of food production and companion animals. Existing methods of treatment and parasite control are being compromised due to growing resistance to many current commercial parasiticides. The discovery of more effective ways to control animal parasites is therefore imperative.
  • PCT Patent Publication WO 05/085216 discloses isoxazoline derivatives of Formula i as insecticides
  • Figure US20150098928A9-20150409-C00002
  • wherein, inter alia, each of A1, A2 and A3 are independently C or N; G is a benzene ring; W is O or S; and X is halogen or C1-C6 haloalkyl.
  • The isoxazolines of the present invention are not disclosed in this publication.
    • SUMMARY OF THE INVENTION
  • This invention is directed to compounds of Formula 1 including all geometric and stereoisomers, N-oxides, and salts thereof, and compositions containing them and their use for controlling invertebrate pests:
  • Figure US20150098928A9-20150409-C00003
  • wherein
      • A is a 6-membered aromatic ring containing carbon atoms and 0-3 nitrogen atoms as ring members, said ring optionally substituted with 1-5 substituents independently selected from R2;
      • Q is
  • Figure US20150098928A9-20150409-C00004
      • Y1—Y2—Y3 is —CH═CH—S—, —CH═CH—O—, —CH═CH—NH—, —CH═N—NH—, —S—CH═CH—, —O—CH═CH—, —NH—CH═CH— or —NH—N═CH—;
      • Y4 is CR4 or N;
      • Z1 is
  • Figure US20150098928A9-20150409-C00005
      • Z2 is
  • Figure US20150098928A9-20150409-C00006
      • each W1, W2, W3, W4, W5 and W6 is independently O or S;
      • L1 is C2-C6 alkylene optionally substituted with one or more substituents independently selected from R22;
      • R1 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R21;
      • each R2 is independently halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
      • each R3 and R4 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
      • R5 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R22; or C(═O)R23CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32 or Q1;
      • R6 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R33; or C(═O)R23 CO 2R24, C(═O)NR25R26 or Q1; or
      • R5 and R6 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24, C(═O)NR25R26, CN and NO2;
      • R7 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl;
      • R8 is C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C18 alkylcycloalkyl or C4-C18 cycloalkylalkyl, each substituted with one or more substituents independently selected from R34 and optionally substituted with one or more substituents independently selected from R35; or
      • R7 and R8 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24 and C(═O)NR25R26;
      • each R9 and R18 is independently H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35;
      • R10 is C1-C12 alkyl substituted with one or more R35; or CN, SCN, S(═O)uR37, SO2NR37R38, N═CR38R39, N═CR38OR39, NR37C(═O)R38, NR37C(═O)OR38, SiR41R42R43, CO2R36, C(═O)R36, C(═O)NR37R38, C(═S)SR39, C(═S)OR39, C(═S)R38, C(═S)NR37R38, P(═O)(OR39)2 or P(═S)(OR39)2; provided that when R9 is H or an unsubstituted group of C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, then R10 is CN, SCN, S(═O)uR37, SO2NR37R38, N═CR38R39, N═CR38OR39, SiR41R42R43, CO2R36, C(═O)R36, C(═O)NR37R38, C(═S)SR39, C(═S)OR39, C(═S)R38, C(═S)NR37R38, P(═O)(OR39)2 or P(═S)(OR39)2
      • R11 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R23, CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38, SO2NR37R38, NR37C(═O)R38, NR37SO2R29 or Q1;
      • R12 is H; or C1-C12 alkyl, C3-C7 cycloalkyl, C4-C12 alkylcycloalkyl, C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
      • R13 is H; or C1-C12 alkyl, C3-C7 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R36, C(═O)OR37, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38 or Q1; or
      • R12 and R13 are taken together with the carbon atom to which they are attached to form a carbocyclic ring containing as ring members from 3 to 6 carbon atoms, said ring optionally substituted with one or more substituents independently selected from R35;
      • R14 and R15 are independently H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R23, CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38, SO2NR37R38, NR37C(═O)R38, NR37SO2R29 or Q1; or
      • R14 and R15 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24, C(═O)NR25R26, CN and NO2; provided that R14 and R15 are other than C1-C6 alkyl or C1-C6 haloalkyl when R11 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl;
      • each R16 and R17 is independently C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35; or
      • R16 and R17 are taken together with the sulfur atom to which they are attached to form a ring containing as ring members in addition to the attaching sulfur atom from 3 to 6 carbon atoms, said ring optionally substituted with one or more substituents independently selected from R35;
      • R19 is C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35;
      • R20 is H; or C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R24, CO2R24 or NO2;
      • R21 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
      • each R22, R33 and R35 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN, NO2, SCN, C(═O)R37, CO2R37, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═O)NR37R38, C(═S)NR37R38, SO2NR37R38, NR37R38, SiR41R42R43 or Q1;
      • each R23, R25, R26, R27, R28, R31 and R32 is independently H; or C1-C18 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C9 cycloalkyl, C4-C10 alkylcycloalkyl or C4-C10 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
      • each R24, R29 and R30 is independently H; or C1-C18 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C9 cycloalkyl, C4-C10 alkylcycloalkyl or C4-C10 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
      • R34 is OR36, OC(═O)R37, OC(═O)NR37R38, OCO2R37, OSO2R39, SH, SR36, S(═O)R36, SO2R36, SO2NR37R38, NR36R37, N═CR37R40, N═CR40OR37, NR37C(═O)R38, SCN, SiR41R42R43, CO2H, CO2R46, C(═O)R46, C(═S)SR40, C(═S)OR40, C(═O)SR40, C(═S)R37, C(═S)NR37R38, P(═O)(OR37)2 or P(═S)(OR37)2;
      • R36 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each substituted with one or more substituents independently selected from halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44 and C(═O)NR44R45;
      • each R37 and R38 is independently H; or Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each optionally substituted with one of more substituents independently selected from the group consisting of halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44, C(═O)NR44R45 and Q1;
      • R39 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44, C(═O)NR44R45 and Q1;
      • R40 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl, C2-C7 alkoxycarbonyl or a phenyl ring, each optionally substituted with one of more substituents independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, CN and NO2;
      • each R41, R42 and R43 is independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl or a phenyl ring, each optionally substituted with one of more substituents selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN and NO2;
      • each R44 and R45 is independently H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one of more substituents selected from R35; or Q1;
      • R46 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each substituted with one or more substituents selected from CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44 and C(═O)NR44R45;
      • each Q1 is a 3- to 10-membered ring or 7- to 10-membered bicyclic ring system containing as ring members from 2 to 10 carbon atoms and from 0 to 5 heteroatoms selected from the group consisting of carbon, sulfur and nitrogen atoms, of which up to two of the carbon or sulfur atoms are present as C(═O), S(═O) or SO2, said ring or ring system optionally substituted with one or more substituents independently selected from R2;
      • m is an integer from 0 to 5;
      • n is an integer from 0 to 4;
      • q is 0 or 1; and
      • u is 0, 1 or 2.
  • This invention also provides a composition comprising a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents. In one embodiment, this invention also provides a composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent.
  • This invention further provides a spray composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, or the composition described above, and a propellant. This invention also provides a bait composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, or the compositions described in the embodiments above, one or more food materials, optionally an attractant, and optionally a humectant.
  • This invention further provides a trap device for controlling an invertebrate pest comprising said bait composition and a housing adapted to receive said bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to said bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • This invention provides a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein). This invention also relates to such method wherein the invertebrate pest or its environment is contacted with a composition comprising a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent.
  • This invention also provides a method for protecting a seed from an invertebrate pest comprising contacting the seed with a biologically effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein). This invention also relates to the treated seed.
  • This invention further provides a method for protecting an animal from an invertebrate parasitic pest comprising administering to the animal a parasiticidally effective amount of a compound of Formula 1, an N-oxide or a salt thereof, (e.g., as a composition described herein). This invention further provides a method for treating, preventing, inhibiting and/or killing ecto- and/or endoparasites comprising administering to and/or on the animal a parasiticidally effective amount of a compound of Formula 1 (e.g., as a composition described herein). This invention also relates to such method wherein a parasiticidally effective amount of a compound of Formula 1 (e.g., as a composition described herein) is administered to the environment (e.g., a stall or blanket) in which an animal resides.
    • DETAILS OF THE INVENTION
  • As used herein, the terms “comprises,” “comprising,” “includes,” “including,” “has,” “having,” “contains” or “containing,” or any other variation thereof, are intended to cover a non-exclusive inclusion. For example, a composition, a mixture, process, method, article, or apparatus that comprises a list of elements is not necessarily limited to only those elements but may include other elements not expressly listed or inherent to such composition, mixture, process, method, article, or apparatus. Further, unless expressly stated to the contrary, “or” refers to an inclusive or and not to an exclusive or. For example, a condition A or B is satisfied by any one of the following: A is true (or present) and B is false (or not present), A is false (or not present) and B is true (or present), and both A and B are true (or present).
  • Also, the indefinite articles “a” and “an” preceding an element or component of the invention are intended to be nonrestrictive regarding the number of instances (i.e. occurrences) of the element or component. Therefore “a” or “an” should be read to include one or at least one, and the singular word form of the element or component also includes the plural unless the number is obviously meant to be singular.
  • As referred to in this disclosure, the term “invertebrate pest” includes arthropods, gastropods and nematodes of economic importance as pests. The term “arthropod” includes insects, mites, spiders, scorpions, centipedes, millipedes, pill bugs and symphylans. The term “gastropod” includes snails, slugs and other Stylommatophora. The term “nematode” includes all of the helminths, such as roundworms, heartworms, and phytophagous nematodes (Nematoda), flukes (Tematoda), Acanthocephala, and tapeworms (Cestoda).
  • In the context of this disclosure “invertebrate pest control” means inhibition of invertebrate pest development (including mortality, feeding reduction, and/or mating disruption), and related expressions are defined analogously.
  • The term “agronomic” refers to the production of field crops such as for food and fiber and includes the growth of corn, soybeans and other legumes, rice, cereal (e.g., wheat, oats, barley, rye, rice, maize), leafy vegetables (e.g., lettuce, cabbage, and other cole crops), fruiting vegetables (e.g., tomatoes, pepper, eggplant, crucifers and cucurbits), potatoes, sweet potatoes, grapes, cotton, tree fruits (e.g., pome, stone and citrus), small fruit (berries, cherries) and other specialty crops (e.g., canola, sunflower, olives). The term “nonagronomic” refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • The term “nonagronomic” refers to other than field crops, such as horticultural crops (e.g., greenhouse, nursery or ornamental plants not grown in a field), residential, agricultural, commercial and industrial structures, turf (e.g., sod farm, pasture, golf course, lawn, sports field, etc.), wood products, stored product, agro-forestry and vegetation management, public health (i.e. human) and animal health (e.g., domesticated animals such as pets, livestock and poultry, undomesticated animals such as wildlife) applications.
  • Nonagronomic applications include protecting an animal from an invertebrate parasitic pest by administering a parasiticidally effective (i.e. biologically effective) amount of a compound of the invention, typically in the form of a composition formulated for veterinary use, to the animal to be protected. As referred to in the present disclosure and claims, the terms “parasiticidal” and “parasiticidally” refers to observable effects on an invertebrate parasite pest to provide protection of an animal from the pest. Parasiticidal effects typically relate to diminishing the occurrence or activity of the target invertebrate parasitic pest. Such effects on the pest include necrosis, death, retarded growth, diminished mobility or lessened ability to remain on or in the host animal, reduced feeding and inhibition of reproduction. These effects on invertebrate parasite pests provide control (including prevention, reduction or elimination) of parasitic infestation or infection of the animal.
  • A parasite “infestation” refers to the presence of parasites in numbers that pose a risk to humans or animals. The infestation can be in the environment (e.g., in human or animal housing, bedding, and surrounding property or structures), on agricultural crops or other types of plants, or on the skin or fur of an animal. When the infestation is within an animal (e.g., in the blood or other internal tissues), the term infestation is also intended to be synonymous with the term “infection” as that term is generally understood in the art, unless otherwise stated.
  • In the present disclosure and claims, the radical “SO2” means sulfonyl, “CN” means cyano, and “NO2” means nitro.
  • In the above recitations, the term “alkyl”, used either alone or in compound words such as “alkylthio” or “haloalkyl” includes straight-chain or branched alkyl, such as, methyl, ethyl, n-propyl, i-propyl, or the different butyl, pentyl or hexyl isomers. “Alkenyl” includes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different butenyl, pentenyl and hexenyl isomers. “Alkenyl” also includes polyenes such as 1,2-propadienyl and 2,4-hexadienyl. “Alkynyl” includes straight-chain or branched alkynes such as ethynyl, 1-propynyl, 2-propynyl and the different butynyl, pentynyl and hexynyl isomers. “Alkynyl” can also include moieties comprised of multiple triple bonds such as 2,5-hexadiynyl. “Alkylene” denotes a straight-chain or branched alkanediyl. Examples of “alkylene” include CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH2CH(CH3) and the different butylene isomers.
  • “Alkoxy” includes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different butoxy, pentoxy and hexyloxy isomers. “Alkylthio” includes branched or straight-chain alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. “Alkylsulfinyl” includes both enantiomers of an alkylsulfinyl group. Examples of “alkylsulfinyl” include CH3S(═O)—, CH3CH2S(═O)—, CH3CH2CH2S(═O)—, (CH3)2CHS(═O)— and the different butylsulfinyl, pentylsulfinyl and hexylsulfinyl isomers. Examples of “alkylsulfonyl” include CH3SO2—, CH3CH2SO2—, CH3CH2CH2SO2—, (CH3)2CHSO2—, and the different butylsulfonyl, pentylsulfonyl and hexylsulfonyl isomers.
  • “Cycloalkyl” includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term “alkylcycloalkyl” denotes alkyl substitution on a cycloalkyl moiety and includes, for example, ethylcyclopropyl, i-propylcyclobutyl, 3-methylcyclopentyl and 4-methylcyclohexyl. The term “cycloalkylalkyl” denotes cycloalkyl substitution on an alkyl moiety. Examples of “cycloalkylalkyl” include cyclopropylmethyl, cyclopentylethyl, and other cycloalkyl moieties bonded to straight-chain or branched alkyl groups.
  • The term “halogen”, either alone or in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” includes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as “haloalkyl”, or when used in descriptions such as “alkyl substituted with halogen” said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of “haloalkyl” or “alkyl substituted with halogen” include F3C—, ClCH2—, CF3CH2— and CF3CCl2—. The terms “haloalkoxy” and “haloalkylthio” and the like, are defined analogously to the term “haloalkyl”. Examples of “haloalkoxy” include CF3O—, CCl3CH2O—, HCF2CH2CH2O— and CF3CH2O—. Examples of “haloalkylthio” include CCl3S—, CF3S—, CCl3CH2S— and ClCH2CH2CH2S—. Examples of “haloalkylsulfinyl” include CF3S(═O)—, CCl3S(═O)—, CF3CH2S(═O)— and CF3CF2S(═O)—. Examples of “haloalkylsulfonyl” include CF3SO2—, CCl3SO2—, CF3CH2SO2— and CF3CF2SO2—.
  • “Alkylcarbonyl” denotes a straight-chain or branched alkyl moieties bonded to a C(═O) moiety. Examples of “alkylcarbonyl” include CH3C(═O)—, CH3CH2CH2C(═O)— and (CH3)2CHC(═O)—. Examples of “alkoxycarbonyl” include CH3C(═O)—, CH3CH2OC(═O)—, CH3CH2CH2C(═O)—, (CH3)2CHOC(═O)— and the different butoxy- or pentoxycarbonyl isomers.
  • The total number of carbon atoms in a substituent group is indicated by the “Ci-Cj” prefix where i and j are numbers from 1 to 18. For example, C1-C4 alkylsulfonyl designates methylsulfonyl through butylsulfonyl.
  • When a compound is substituted with a substituent bearing a subscript that indicates the number of said substituents can exceed 1, said substituents (when they exceed 1) are independently selected from the group of defined substituents, e.g., (R3)m or (R4)n, m is 0, 1, 2, 3, 4 or 5 and n is 0, 1, 2, 3 or 4. As (R3)m or (R4)n are optional substituents on bicyclic rings, Q-A and Q-B respectively, each may substitute any available carbon or nitrogen ring member(s) of the bicyclic ring. For example, when Q is Q-A and Y1—Y2—Y3 is —CH═CH—S—, then the (R3)m substituents can also be attached to the two available carbon atoms of the —CH═CH—S— moiety (e.g., —C(R3)═CH—S—, —CH═C(R3)—S— or —C(R3)═C(R3)—S—. When a group contains a substituent which can be hydrogen, for example R3 or R4, then when this substituent is taken as hydrogen, it is recognized that this is equivalent to said group being unsubstituted. When a variable group is shown to be optionally attached to a position, for example (R3)m wherein m may be 0, then hydrogen may be at the position even if not recited in the variable group definition. When one or more positions on a group are said to be “not substituted” or “unsubstituted”, then hydrogen atoms are attached to take up any free valency.
  • The orientation of the Y1—Y2—Y3 substitutents is as depicted in Q-A. For example, when Y1—Y2—Y3 is —CH═CH—S—, then Y1 is CH, Y2 is CH and Y3 is S.
  • The attachment point of a substituent to a structure is represented by a wavy line bisecting the bond joining the substituent to the remainder of the structure. For example, a benzyl substituent can be represented as
  • Figure US20150098928A9-20150409-C00007
  • Unless otherwise indicated, a “ring” or “ring system” as a component of Formula 1 (e.g., substituent A or Q1) is carbocyclic or heterocyclic. The term “ring system” denotes two or more fused rings. The term “bicyclic ring system” denotes a ring system consisting of two fused rings, in which either ring can be saturated, partially unsaturated, or fully unsaturated unless otherwise indicated. The term “ring member” refers to an atom or other moiety (e.g., C(═O), C(═S), S(═O) or SO2) forming the backbone of a ring or ring system.
  • The terms “carbocyclic ring” or “carbocyclic ring system” denote a ring or ring system wherein the atoms forming the ring backbone are selected only from carbon. Unless otherwise indicated, a carbocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated carbocyclic ring satisfies Hückel's rule, then said ring is also called an “aromatic ring”. “Saturated carbocyclic” refers to a ring having a backbone consisting of carbon atoms linked to one another by single bonds; unless otherwise specified, the remaining carbon valences are occupied by hydrogen atoms.
  • The terms “heterocyclic ring”, “heterocycle” or “heterocyclic ring system” denote a ring or ring system in which at least one atom forming the ring backbone is not carbon, e.g., nitrogen, oxygen or sulfur. Typically a heterocyclic ring contains no more than 4 nitrogens, no more than 2 oxygens and no more than 2 sulfurs. Unless otherwise indicated, a heterocyclic ring can be a saturated, partially unsaturated, or fully unsaturated ring. When a fully unsaturated heterocyclic ring satisfies Hückel's rule, then said ring is also called a “heteroaromatic ring” or “aromatic heterocyclic ring”. Unless otherwise indicated, heterocyclic rings and ring systems can be attached through any available carbon or nitrogen by replacement of a hydrogen on said carbon or nitrogen.
  • “Aromatic” indicates that each of the ring atoms is essentially in the same plane and has a p-orbital perpendicular to the ring plane, and in which (4n+2)π electrons, where n is a positive integer, are associated with the ring to comply with Hückel's rule. The term “aromatic ring system” denotes a carbocyclic or heterocyclic ring system in which at least one ring of the ring system is aromatic. The term “aromatic carbocyclic ring system” denotes a carbocyclic ring system in which at least one ring of the ring system is aromatic. The term “aromatic heterocyclic ring system” denotes a heterocyclic ring system in which at least one ring of the ring system is aromatic. The term “nonaromatic ring system” denotes a carbocyclic or heterocyclic ring system that may be fully saturated, as well as partially or fully unsaturated, provided that none of the rings in the ring system are aromatic. The term “nonaromatic carbocyclic ring system” denotes a carbocyclic ring in which no ring in the ring system is aromatic. The term “nonaromatic heterocyclic ring system” denotes a heterocyclic ring system in which no ring in the ring system is aromatic.
  • As is generally known in the art, the chemical name “pyridyl” is synonymous with “pyridinyl”.
  • The term “optionally substituted” is used herein interchangeably with the phrase “substituted or unsubstituted” or with the term “(un)substituted”. Unless otherwise indicated, an optionally substituted group may have a substituent at each substitutable position of the group, and each substitution is independent of the other. An optionally substituted group also may have no substituents. Therefore the phrase “optionally substituted with one or more substituents” means that the number of substituents may vary from zero up to the number of available positions for substitution. Similarly the phrase “optionally substituted with 1-5 substituents” means that the number of substituents may vary from zero up to the number of available position but not exceeding 5.
  • As already defined, Q1 is a 3- to 10-membered ring or 7- or 10-membered bicyclic ring system containing as ring members from 2 to 10 carbon atoms and from 0 to 5 heteroatoms selected from the group consisting of carbon, sulfur and nitrogen atoms, of which up to two of the carbon or sulfur atoms are present as C(═O), S(═O) or SO2, said ring or ring system optionally substituted with one or more substituents independently selected from R2. Therefore the ring or bicyclic ring system of Q1 may be saturated, partially saturated or fully unsaturated (including aromatic if Hückel's rule is satisfied). Furthermore the ring or bicyclic ring system may contain only carbon atoms as ring members (i.e. carbocyclic) or a combination of carbon atoms and heteroatoms (i.e. heterocyclic). In particular, the ring members of Q1 may include up to 5 heteroatoms selected from C, S and N as ring members. The possible number of heteroatoms is limited by the number of ring members in the ring or ring system. Up to two of the carbon or sulfur atom ring members (including combinations thereof) may be present as C(═O), S(═O) or SO2 (including combinations thereof).
  • As defined above, A is a 6-membered aromatic ring containing carbon atoms and 0-3 nitrogen atoms as ring members, said ring optionally substituted with 1-5 substituents independently selected from R2. Examples of these rings optionally substituted by 1 to 5 substituents include the rings A-1 through A-14 illustrated in Exhibit 1 wherein Rv is any substituent as defined in the Summary of the Invention for A (i.e. R2) and r is an integer from 0 to 5, limited by the number of available positions on each A group.
  • Figure US20150098928A9-20150409-C00008
    Figure US20150098928A9-20150409-C00009
  • When Q1 is a nitrogen-containing heterocyclic ring or ring system, it may be attached to the remainder of Formula 1 though any available carbon or nitrogen ring atom, unless otherwise described. As noted above, Q1 can be (among others) phenyl optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention. An example of phenyl optionally substituted with one to five substituents is the ring illustrated as U-1 in Exhibit 1, wherein Rv is R2 as defined in the Summary of the Invention for Q1 and r is an integer from 0 to 5.
  • As noted above, Q1 can be (among others) a 5- or 6-membered heterocyclic ring, which may be saturated or unsaturated, optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention. Examples of a 5- or 6-membered aromatice unsaturated heterocyclic ring optionally substituted with one or more substituents include the rings U-2 through U-61 illustrated in Exhibit 2 wherein Rv is any substituent as defined in the Summary of the Invention for Q1 (i.e. R2) and r is an integer from 0 to 4, limited by the number of available positions on each U group. As U-29, U-30, U-36, U-37, U-38, U-39, U-40, U-41, U-42 and U-43 have only one available position, for these U groups r is limited to the integers 0 or 1, and r being 0 means that the U group is unsubstituted and a hydrogen is present at the position indicated by (RV)r.
  • Figure US20150098928A9-20150409-C00010
    Figure US20150098928A9-20150409-C00011
    Figure US20150098928A9-20150409-C00012
    Figure US20150098928A9-20150409-C00013
    Figure US20150098928A9-20150409-C00014
  • Note that when Q1 is a 5- or 6-membered saturated or non-aromatic unsaturated heterocyclic ring optionally substituted with one or more substituents selected from the group of substituents as defined in the Summary of Invention for Q1, one or two carbon ring members of the heterocycle can optionally be in the oxidized form of a carbonyl moiety.
  • Examples of a 5- or 6-membered saturated or non-aromatic unsaturated heterocyclic ring include the rings G-1 through G-35 as illustrated in Exhibit 3. Note that when the attachment point on the G group is illustrated as floating, the G group can be attached to the remainder of Formula 1 through any available carbon or nitrogen of the G group by replacement of a hydrogen atom. The optional substituents corresponding to Rv can be attached to any available carbon or nitrogen by replacing a hydrogen atom. For these G rings, r is typically an integer from 0 to 4, limited by the number of available positions on each G group.
  • Note that when Q1 comprises a ring selected from G-28 through G-35, G2 is selected from O, S or N. Note that when G2 is N, the nitrogen atom can complete its valence by substitution with either H or the substituents corresponding to Rv as defined in the Summary of Invention for Q1 (i.e. R2).
  • Figure US20150098928A9-20150409-C00015
    Figure US20150098928A9-20150409-C00016
    Figure US20150098928A9-20150409-C00017
    Figure US20150098928A9-20150409-C00018
  • As noted above, Q1 can be (among others) an 8-, 9- or 10-membered fused bicyclic ring system optionally substituted with one or more substituents selected from a group of substituents as defined in the Summary of Invention (i.e. R2). Examples of 8-, 9- or 10-membered fused bicyclic ring system optionally substituted with from one or more substituents include the rings U-81 through U-123 illustrated in Exhibit 4 wherein Rv is any substituent as defined in the Summary of the Invention for Q1 (i.e. R2), and r is typically an integer from 0 to 4.
  • Figure US20150098928A9-20150409-C00019
    Figure US20150098928A9-20150409-C00020
    Figure US20150098928A9-20150409-C00021
    Figure US20150098928A9-20150409-C00022
  • Although Rv groups are shown in the structures U-1 through U-123, it is noted that they do not need to be present since they are optional substituents. Note that when Rv is H when attached to an atom, this is the same as if said atom is unsubstituted. The nitrogen atoms that require substitution to fill their valence are substituted with H or Rv. Note that when the attachment point between (Rv)r and the U group is illustrated as floating, (Rv)r can be attached to any available carbon atom or nitrogen atom of the U group. Note that when the attachment point on the U group is illustrated as floating, the U group can be attached to the remainder of Formula 1 through any available carbon or nitrogen of the U group by replacement of a hydrogen atom. Note that some U groups can only be substituted with less than 4 Rv groups (e.g., U-2 through U-5, U-7 through U-48, and U-52 through U-61).
  • A wide variety of synthetic methods are known in the art to enable preparation of aromatic and nonaromatic heterocyclic rings and ring systems; for extensive reviews see the eight volume set of Comprehensive Heterocyclic Chemistry, A. R. Katritzky and C. W. Rees editors-in-chief, Pergamon Press, Oxford, 1984 and the twelve volume set of Comprehensive Heterocyclic Chemistry II, A. R. Katritzky, C. W. Rees and E. F. V. Scriven editors-in-chief, Pergamon Press, Oxford, 1996.
  • Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers, atropisomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate, enrich, and/or to selectively prepare said stereoisomers. The compounds of the invention may be present as a mixture of stereoisomers, individual stereoisomers or as an optically active form. For example, two possible enantiomers of Formula 1 are depicted as Formula 1′ and Formula 1″ involving the isoxazoline chiral center identified with an asterisk (*). Analogously, other chiral centers are possible at, for example, R5.
  • Figure US20150098928A9-20150409-C00023
  • Molecular depictions drawn herein follow standard conventions for depicting stereochemistry. To indicate stereoconfiguration, bonds rising from the plane of the drawing and towards the viewer are denoted by solid wedges wherein the broad end of the wedge is attached to the atom rising from the plane of the drawing towards the viewer. Bonds going below the plane of the drawing and away from the viewer are denoted by dashed wedges wherein the narrow end of the wedge is attached to the atom further away from the viewer. Constant width lines indicate bonds with a direction opposite or neutral relative to bonds shown with solid or dashed wedges; constant width lines also depict bonds in molecules or parts of molecules in which no particular stereoconfiguration is intended to be specified.
  • The more biologically active enantiomer is believed to be Formula 1′. Formula 1′ often has the (S) configuration at the chiral carbon and Formula 1″ often has the (R) configuration at the chiral carbon (e.g., when Q is phenyl and R1 is trifluoromethyl).
  • This invention comprises racemic mixtures, for example, equal amounts of the enantiomers of Formulae 1′ and 1″. In addition, this invention includes compounds that are enriched compared to the racemic mixture in an enantiomer of Formula 1. Also included are the essentially pure enantiomers of compounds of Formula 1, for example, Formula 1′ and Formula 1″.
  • When enantiomerically enriched, one enantiomer is present in greater amounts than the other, and the extent of enrichment can be defined by an expression of enantiomeric excess (“ee”), which is defined as (2x−1)·100%, where x is the mole fraction of the dominant enantiomer in the mixture (e.g., an ee of 20% corresponds to a 60:40 ratio of enantiomers).
  • Preferably the compositions of this invention have at least a 50% enantiomeric excess; more preferably at least a 75% enantiomeric excess; still more preferably at least a 90% enantiomeric excess; and the most preferably at least a 94% enantiomeric excess of the more active isomer. Of particular note are enantiomerically pure embodiments of the more active isomer.
  • Compounds of Formula 1 can comprise additional chiral centers. For example, substituents and other molecular constituents such as R5 may themselves contain chiral centers. This invention comprises racemic mixtures as well as enriched and essentially pure stereoconfigurations at these additional chiral centers.
  • Compounds of this invention can exist as one or more conformational isomers due to restricted rotation about the amide bond linking Q-A to Z1 and Q-B to Z2. This invention comprises mixtures of conformational isomers. In addition, this invention includes compounds that are enriched in one conformer relative to others.
  • Compounds of this invention may exist as one or more crystalline polymorphs. This invention comprises both individual polymorphs and mixtures of polymorphs, including mixtures enriched in one polymorph relative to others.
  • One skilled in the art will appreciate that not all nitrogen-containing heterocycles can form N-oxides since the nitrogen requires an available lone pair for oxidation to the oxide; one skilled in the art will recognize those nitrogen containing heterocycles which can form N-oxides. One skilled in the art will also recognize that tertiary amines can form N-oxides. Synthetic methods for the preparation of N-oxides of heterocycles and tertiary amines are very well known by one skilled in the art including the oxidation of heterocycles and tertiary amines with peroxy acids such as peracetic and m-chloroperbenzoic acid (MCPBA), hydrogen peroxide, alkyl hydroperoxides such as t-butyl hydroperoxide, sodium perborate, and dioxiranes such as dimethyldioxirane. These methods for the preparation of N-oxides have been extensively described and reviewed in the literature, see for example: T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. V. Ley, Ed., Pergamon Press; M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-20, A. J. Boulton and A. McKillop, Eds., Pergamon Press; M. R. Grimmett and B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, A. R. Katritzky, Ed., Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky and A. J. Boulton, Eds., Academic Press; and G. W. H. Cheeseman and E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. Katritzky and A. J. Boulton, Eds., Academic Press.
  • One skilled in the art recognizes that because in the environment and under physiological conditions salts of chemical compounds are in equilibrium with their corresponding nonsalt forms, salts share the biological utility of the nonsalt forms. Thus a wide variety of salts of the compounds of Formula 1 are useful for control of invertebrate pests (i.e. are agriculturally suitable). The salts of the compounds of Formula 1 include acid-addition salts with inorganic or organic acids such as hydrobromic, hydrochloric, nitric, phosphoric, sulfuric, acetic, butyric, fumaric, lactic, maleic, malonic, oxalic, propionic, salicylic, tartaric, 4-toluenesulfonic or valeric acids. When a compound of Formula 1 contains an acidic moiety such as a carboxylic acid or phenol, salts also include those formed with organic or inorganic bases such as pyridine, triethylamine or ammonia, or amides, hydrides, hydroxides or carbonates of sodium, potassium, lithium, calcium, magnesium or barium. As is well known in the art, when a compound containing a carboxylic acid group (i.e. CO2H) is contacted with a base, the carboxylic acid group is converted to its salt derivative, also known as a carboxylate salt. For example, when a carboxylic acid group is reacted with sodium hydroxide, a sodium salt derivative is formed (i.e. CO2 ⊖Na⊕). Accordingly, the present invention comprises compounds selected from Formula 1, N-oxides and agriculturally suitable salts thereof.
  • Embodiments of the present invention as described in the Summary of the Invention include (where Formula 1 as used in the following Embodiments includes N-oxides and salts thereof):
    • Embodiment 1
  • A compound of Formula 1 wherein Q is Q-A.
    • Embodiment 2
  • A compound of Embodiment 1 wherein Z1 is Z1-1.
    • Embodiment 3
  • A compound of Embodiment 1 wherein Z1 is Z1-2.
    • Embodiment 4
  • A compound of Embodiment 1 wherein Z1 is Z1-3.
    • Embodiment 5
  • A compound of Embodiment 1 wherein Y1—Y2—Y3 is —CH═CH—S—, —CH═CH—O—, —S—CH═CH— or —O—CH═CH—.
    • Embodiment 6
  • A compound of Formula 1 wherein Q is Q-B.
    • Embodiment 7
  • A compound of Embodiment 6 wherein Z2 is Z2-1.
    • Embodiment 8
  • A compound of Embodiment 6 wherein Z2 is Z2-2.
    • Embodiment 9
  • A compound of Formula 1 wherein when Q is Q-B, Z2 is Z2-2, R10 is C1 alkyl substituted with one R35, and R35 is CO2H or a sodium salt derivative thereof, then R9 is other than H.
    • Embodiment 10
  • A compound of Formula 1 wherein when Q is Q-B, Z2 is Z2-2, R10 is C1 alkyl substituted with one R35, and R35 is CO2H or a salt derivative thereof, then R9 is other than H.
    • Embodiment 11
  • A compound of Embodiment 6 wherein Z2 is Z2-3.
    • Embodiment 12
  • A compound of Embodiment 11 wherein
  • R11 is H;
  • R12 is H or C1-C3 alkyl;
  • R13 is H or C1-C3 alkyl;
  • R14 is C1-C6 alkyl, C3-C6 cycloalkyl or C4-C7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R35;
  • R35 is H, halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2; and Y4 is CH.
    • Embodiment 12a
  • A compound of Embodiment 12 wherein
  • R12 is H;
  • R13 is H or CH3;
  • R14 is cyclopropyl or methylcyclopropyl optionally substituted with one or more substituents independently selected from R35;
  • R15 is H; and
  • R35 is H or halogen.
    • Embodiment 13
  • A compound of Embodiment 6 wherein Z2 is Z2-4.
    • Embodiment 14
  • A compound of Embodiment 6 wherein Z2 is Z2-5.
    • Embodiment 15
  • A compound of Formula 1 wherein R1 is C1-C3 haloalkyl.
    • Embodiment 16
  • A compound of Embodiment 15 wherein R1 is CF3.
    • Embodiment 17
  • A compound of Formula 1 wherein A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN.
    • Embodiment 17a
  • A compound of Embodiment 17 wherein A is a phenyl ring substituted with 2 substituents independently selected from the group consisting of halogen, C1-C2 haloalkyl and C1-C2 haloalkoxy.
    • Embodiment 18
  • A compound of Embodiment 17 wherein A is a phenyl ring substituted
  • with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN.
    • Embodiment 19
  • A compound of Formula 1 wherein A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN.
    • Embodiment 20
  • A compound of Embodiment 19 wherein A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN.
    • Embodiment 21
  • A compound of Formula 1 wherein W1, W2, W3, W4, W5 and W6 are O.
    • Embodiment 22
  • A compound of Embodiment 2 wherein
  • R5 is H; or C1-C6 alkyl substituted with one or more substituents independently selected from R22; and
  • R6 is C1-C6 alkyl or C3-C7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R33.
    • Embodiment 23
  • A compound of Embodiment 22 wherein R22 and R33 are independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN, NO2, CO2R37, C(═O)NR37R38 and Q1.
    • Embodiment 24
  • A compound of Embodiment 3 wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment 25
  • A compound of Embodiment 4 wherein
  • L1 is C2-C6 alkylene optionally substituted with halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
    • Embodiment 26
  • A compound of Embodiment 13 wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment 27
  • A compound of Embodiment 14 wherein
  • L1 is C2-C6 alkylene optionally substituted with one or more halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
  • Embodiments of this invention, including Embodiments 1-27 above as well as any other embodiments described herein, can be combined in any manner, and the descriptions of variables in the embodiments pertain not only to the compounds of Formula 1 but also to the starting compounds and intermediate compounds useful for preparing the compounds of Formula 1. In addition, embodiments of this invention, including Embodiments 1-27 above as well as any other embodiments described herein, and any combination thereof, pertain to the compositions and methods of the present invention.
  • Combinations of Embodiments 1-27 are illustrated by:
    • Embodiment A
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-1;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN; and
  • R1 is C1-C3 haloalkyl.
    • Embodiment B
  • A compound of Embodiment A wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment C
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-1;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN; and
  • R1 is C1-C3 haloalkyl.
    • Embodiment D
  • A compound of Embodiment C wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment E
  • A compound of Embodiment A wherein
  • R5 is H; or C1-C6 alkyl substituted with one or more substituents independently selected from R22; and
  • R6 is C1-C6 alkyl or C3-C7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R33.
    • Embodiment F
  • A compound of Embodiment B wherein
  • R5 is H; or C1-C6 alkyl substituted with one or more substituents independently selected from R22; and
  • R6 is C1-C6 alkyl or C3-C7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R33.
    • Embodiment G
  • A compound of Embodiment C wherein
  • R5 is H; or C1-C6 alkyl substituted with one or more substituents independently selected from R22; and
  • R6 is C1-C6 alkyl or C3-C7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R33.
    • Embodiment H
  • A compound of Embodiment D wherein
  • R5 is H; or C1-C6 alkyl substituted with one or more substituents independently selected from R22; and
  • R6 is C1-C6 alkyl or C3-C7 alkylcycloalkyl, each optionally substituted with one or more substituents independently selected from R33.
    • Embodiment I
  • A compound of Embodiment E wherein
  • R22 and R33 are independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN, NO2, CO2R37, C(═O)NR37R38 and Q1.
    • Embodiment J
  • A compound of Embodiment F wherein
  • R22 and R33 are independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN, NO2, CO2R37, C(═O)NR37R38 and Q1.
    • Embodiment K
  • A compound of Embodiment G wherein
  • R22 and R33 are independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN, NO2, CO2R37, C(═O)NR37R38 and Q1.
    • Embodiment L
  • A compound of Embodiment H wherein
  • R22 and R33 are independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN, NO2, CO2R37, C(═O)NR37R38 and Q1.
    • Embodiment M
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-2;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN; and
  • R1 is C1-C3 haloalkyl.
    • Embodiment N
  • A compound of Embodiment M wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment O
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-2;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN; and
  • R1 is C1-C3 haloalkyl.
    • Embodiment P
  • A compound of Embodiment O wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment Q
  • A compound of Embodiment M wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment R
  • A compound of Embodiment N wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment S
  • A compound of Embodiment O wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment T
  • A compound of Embodiment P wherein
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment U
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-3;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • L1 is C2-C6 alkylene optionally substituted with halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
    • Embodiment V
  • A compound of Embodiment U wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment W
  • A compound of Formula 1 wherein
  • Q is Q-A;
  • Z1 is Z1-3;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • L1 is C2-C6 alkylene optionally substituted with halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
    • Embodiment X
  • A compound of Embodiment W wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment Y
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z2-3;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • R11 is H;
  • R12 is H or C1-C3 alkyl;
  • R13 is H or C1-C3 alkyl;
  • R14 is C1-C6 alkyl, C3-C6 cycloalkyl or C4-C7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is H, halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2; and Y4 is CH.
    • Embodiment Z
  • A compound of Embodiment Y wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AA
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z2-3;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • R11 is H;
  • R12 is H or C1-C3 alkyl;
  • R13 is H or C1-C3 alkyl;
  • R14 is C1-C6 alkyl, C3-C6 cycloalkyl or C4-C7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is H, halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2.
    • Embodiment AB
  • A compound of Embodiment AA wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AC
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z2-4;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment AD
  • A compound of Embodiment AC wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AE
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z2-4;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • R16 and R17 are independently C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35; and
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN.
    • Embodiment AF
  • A compound of Embodiment AE wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AG
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z5-5;
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • L1 is C2-C6 alkylene optionally substituted with halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
    • Embodiment AH
  • A compound of Embodiment AG wherein
  • A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AI
  • A compound of Formula 1 wherein
  • Q is Q-B;
  • Z2 is Z2-5;
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
  • R1 is C1-C3 haloalkyl;
  • L1 is C2-C6 alkylene optionally substituted with halogen;
  • R19 is C1-C3 alkyl optionally substituted with one or more substituents independently selected from R35;
  • R20 is H, CN, NO2 or CO2R24;
  • R35 is halogen, C1-C3 alkoxy, C1-C3 alkylthio or CN; and
  • q is 1.
    • Embodiment AJ
  • A compound of Embodiment AI wherein
  • A is a pyridyl ring substituted with 1 to 3 substituents independently selected from the group halogen, CH3, CF3, OCF3, OCF2H and CN; and
  • R1 is CF3.
    • Embodiment AK
  • A compound of Embodiment Y wherein
  • A is a phenyl ring substituted with 2 substituents independently selected from the group consisting of halogen, C1-C2 haloalkyl and C1-C2 haloalkoxy;
  • R1 is CF3;
  • R12 is H;
  • R13 is H or CH3;
  • R14 is cyclopropyl or methylcyclopropyl optionally substituted with one or more substituents independently selected from R35;
  • R15 is H;
  • R35 is H or halogen.
  • Specific embodiments include compounds of Formula 1 selected from the group consisting of:
    • N-[2-[(cyclopropylmethyl)amino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methylsulfonimidoyl)ethyl]-1-naphthalenecarboxamide,
    • N-[2-[(cyclopropyl-1-methylethyl)amino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-[(2-pyridinylmethyl)amino]ethyl]-1-naphthalenecarboxamide,
    • N-[2-(cyclopropylamino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide,
    • 1,1-dimethylethyl N-[2-[[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]amino]ethyl]carbamate,
    • 1,1-dimethylethyl N-[3-[[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]amino]propyl]-N-methylcarbamate,
    • N-[3-(acetylmethylamino)propyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[[2-(methylthio)ethyl]amino]-2-oxoethyl]-1-naphthalenecarboxamide,
    • 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[[2-(methylthio)ethyl]amino]-2-oxoethyl]-1-naphthalenecarboxamide,
    • N-[2-(cyclopentylamino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-oxo-2-(1-piperidinyl)ethyl]-1-naphthalenecarboxamide,
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(3,3-difluoro-1-pyrrolidinyl)-2-oxoethyl]-1-naphthalenecarboxamide, and
    • 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfonimidoyl]ethyl]-1-naphthalenecarboxamide.
  • Further specific embodiments include compounds of Formula 1 selected from Table A. The following abbreviations are used in Table A: c-Pr is cyclopropyl and entry a) is
  • Figure US20150098928A9-20150409-C00024
  • TABLE A
    Figure US20150098928A9-20150409-C00025
    Ra Rb Rc Rd
    Cl Cl H c-Pr
    Cl Cl H CH2—c-Pr
    Cl Cl H a)
    Cl Cl CH3 c-Pr
    Cl Cl CH3 CH2—c-Pr
    Cl Cl CH3 a)
    Cl CF3 H c-Pr
    Cl CF3 H CH2—c-Pr
    Cl CF3 H a)
    Cl CF3 CH3 c-Pr
    Cl CF3 CH3 CH2—c-Pr
    Cl CF3 CH3 a)
    Cl OCH2CF3 H c-Pr
    Cl OCH2CF3 H CH2—c-Pr
    Cl OCH2CF3 H a)
    Cl OCH2CF3 CH3 c-Pr
    Cl OCH2CF3 CH3 CH2—c-Pr
    Cl OCH2CF3 CH3 a)
    Br CF3 H c-Pr
    Br CF3 H CH2—c-Pr
    Br CF3 H a)
    Br CF3 CH3 c-Pr
    Br CF3 CH3 CH2—c-Pr
    Br CF3 CH3 a)
    CF3 CF3 H c-Pr
    CF3 CF3 H CH2—c-Pr
    CF3 CF3 H a)
    CF3 CF3 CH3 c-Pr
    CF3 CF3 CH3 CH2—c-Pr
    CF3 CF3 CH3 a)
  • Further noteworthy as embodiments of the present invention are compositions for controlling an invertebrate pest comprising a compound of any of the preceding Embodiments (i.e. in a biologically effective amount), as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising at least one additional biologically active compound or agent.
  • Further Embodiments of the present invention include:
    • Embodiment A1
  • A composition for protecting an animal from an invertebrate parasitic pest comprising a compound of Formula 1 or any one of Embodiments 1-27 or A-AK and at least one veterinarily acceptable carrier, said composition optionally further comprising at least one additional parasiticidally active compound.
    • Embodiment A2
  • The composition of Embodiment A1 wherein at least one additional parasiticidally active compound is an anthelmintic.
    • Embodiment A3
  • The composition of Embodiment A1 wherein at least one additional parasiticidally active compound is selected from the group consisting of macrocyclic lactones, benzimidazoles, salicylamides, substituted phenols, pyrimidines, cyclic depsipeptides, piperazine salts, nitroscanate, praziquantel and imidazothiazoles.
    • Embodiment A4
  • The composition of Embodiment A3 wherein at least one additional parasiticidally active compound is selected from the group consisting of avermectins, milbemycins and spinosyns.
    • Embodiment A5
  • The composition of Embodiment A1 wherein at least one additional parasiticidally active compound is selected from the group consisting of abamectin, doramectin, emamectin, eprinomectin, ivermectin, selamectin, milbemycin, moxidectin and pyrantel.
    • Embodiment A6
  • The composition of Embodiment A1 in a form for oral administration.
    • Embodiment A7
  • The composition of Embodiment A1 in a form for topical administration.
    • Embodiment A8
  • The composition of Embodiment A1 in a form for parenteral administration.
  • Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein). Of particular note is a method for protecting an animal comprising administering to the animal a parasiticidally effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein).
  • Further Embodiments of the present invention include:
    • Embodiment B1
  • The method for protecting an animal from an invertebrate parasitic pest comprising administering to the animal a parasiticidally effective amount of a compound of Formula 1 as described in the Summary of the Invention or any one of Embodiments 1-27 or A-AK.
    • Embodiment B3
  • The method of Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered orally.
    • Embodiment B4
  • The method of Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered parenterally.
    • Embodiment B5
  • The method of Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered by injection.
    • Embodiment B6
  • The method of Embodiment B1 wherein the parasiticidally effective amount of the compound of Formula 1 is administered topically.
    • Embodiment B7
  • The method of Embodiment B1 wherein the animal to be protected is a vertebrate.
    • Embodiment B8
  • The method of Embodiment B7 wherein the animal to be protected is a mammal, avian or fish.
    • Embodiment B9
  • The method of Embodiment B8 wherein the animal to be protected is a human.
    • Embodiment B10
  • The method of Embodiment B8 wherein the animal to be protected is livestock.
    • Embodiment B11
  • The method of Embodiment B8 wherein the animal to be protected is a canine.
    • Embodiment B11a
  • The method of Embodiment B8 wherein the animal to be protected is a dog.
    • Embodiment B12
  • The method of Embodiment B8 wherein the animal to be protected is a feline.
    • Embodiment B12a
  • The method of Embodiment B8 wherein the animal to be protected is a cat.
    • Embodiment B13
  • The method of Embodiment B1 wherein the invertebrate parasitic pest is an ectoparasite.
    • Embodiment B14
  • The method of Embodiment B1 wherein the invertebrate parasitic pest is an endoparasite or helminth.
    • Embodiment B15
  • The method of Embodiment B1 wherein the invertebrate parasitic pest is an arthropod.
    • Embodiment B16
  • The method of Embodiment B1 wherein the invertebrate parasitic pest is a fly, mosquito, mite, tick, louse, flea, maggot, bed bug or kissing bug.
    • Embodiment B17
  • The method of Embodiment B16 wherein the invertebrate parasitic pest is a mosquito.
    • Embodiment B18
  • The method of Embodiment B16 wherein the invertebrate parasitic pest is a tick or mite.
    • Embodiment B19
  • The method of Embodiment B16 wherein the invertebrate parasitic pest is a louse.
    • Embodiment B20
  • The method of Embodiment B16 wherein the invertebrate parasitic pest is a flea.
    • Embodiment B21
  • The method of Embodiment B16 wherein the invertebrate parasitic pest is a bed bug or kissing bug.
    • Embodiment B22
  • The method of Embodiment B16 wherein the animal is a cat or dog and the invertebrate parasitic pest is a flea, tick or mite.
    • Embodiment B23
  • The method of Embodiment B1 wherein the parasiticidally effective amount of a compound of Formula 1 is administered monthly or at a longer interval.
    • Embodiment B24
  • The method of Embodiment B23 wherein the parasiticidally effective amount of a compound of Formula 1 is administered once a month.
    • Embodiment B25
  • The method of Embodiment B23 wherein the parasiticidally effective amount of a compound of Formula 1 is administered once every six months.
  • The compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK can be used for the protection of an animal from an invertebrate parasitic pest by oral, topical or parenteral administration of the compound.
  • Therefore, the invention is understood to include the compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK (and compositions containing them) for use as an animal medicament, or more particularly a parasiticidal animal medicament. The animals to be protected are as defined in any of Embodiments B7-B12a. The invertebrate parasitic pests are as defined in any of Embodiments B13-B21. The medicament may be in oral, topical or parenteral dosage forms.
  • The invention is also understood to include the use of compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK in the manufacture of medicaments for the protection of an animal from a an invertebrate parasitic pest. The animals to be protected are as defined in any of Embodiments B7-B12a. The invertebrate parasitic pests are as defined in any of Embodiments B13-B21. The medicament may be in oral, topical or parenteral dosage forms.
  • The invention is also understood to include compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK for use in the manufacture of medicaments for the protection of an animal from an invertebrate parasitic pest. The animals to be protected are as defined in any of Embodiments B7-B12a. The invertebrate parasitic pests are as defined in any of Embodiments B13-B21. The medicament may be in oral, topical or parenteral dosage forms.
  • The invention is also understood to include compounds of Formula 1 or any of Embodiments 1-27 or Embodiments A-AK packaged and presented for the protection of an animal from an invertebrate parasitic pest. The animals to be protected are as defined in any of Embodiments B7-B12a. The invertebrate parasitic pests are as defined in any of Embodiments B13-B21. The compounds of the invention may be packaged and presented as oral, topical or parenteral dosage forms.
  • The invention is also understood to include a process for manufacturing a composition for protecting an animal from an invertebrate parasitic pest characterized in that a compound of Claim 1 is admixed with at least one pharmaceutically or veterinarily acceptable carrier. The animals to be protected are as defined in any of Embodiments B7-B12a. The invertebrate parasitic pests are as defined in any of Embodiments B13-B21. The compositions of the invention may be packaged and presented as oral, topical or parenteral dosage forms.
  • Of note is that compounds of this invention are characterized by favorable metabolic and/or soil residual patterns and exhibit activity controlling a spectrum of agronomic and nonagronomic invertebrate pests.
  • Of particular note, for reasons of invertebrate pest control spectrum and economic importance, protection of agronomic crops from damage or injury caused by invertebrate pests by controlling invertebrate pests are embodiments of the invention. Compounds of this invention because of their favorable translocation properties or systemicity in plants also protect foliar or other plant parts which are not directly contacted with a compound of Formula 1 or a composition comprising the compound.
  • Also noteworthy as embodiments of the present invention are compositions comprising a compound of any of the preceding Embodiments, as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising at least one additional biologically active compound or agent.
  • Further noteworthy as embodiments of the present invention are compositions for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments, as well as any other embodiments described herein, and any combinations thereof, and at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, said compositions optionally further comprising a biologically effective amount of at least one additional biologically active compound or agent. Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of any of the preceding Embodiments (e.g., as a composition described herein).
  • Embodiments of the invention also include a composition comprising a compound of any of the preceding Embodiments, in the form of a soil drench liquid formulation. Embodiments of the invention further include methods for controlling an invertebrate pest comprising contacting the soil with a liquid composition as a soil drench comprising a biologically effective amount of a compound of any of the preceding Embodiments.
  • Embodiments of the invention also include a spray composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments and a propellant. Embodiments of the invention further include a bait composition for controlling an invertebrate pest comprising a biologically effective amount of a compound of any of the preceding Embodiments, one or more food materials, optionally an attractant, and optionally a humectant. Embodiments of the invention also include a device for controlling an invertebrate pest comprising said bait composition and a housing adapted to receive said bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to said bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • One or more of the following methods and variations as described in Schemes 1-30 can be used to prepare the compounds of Formula 1. The definitions of R1, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, A, L1, W1, W4, W5, Y1, Y2, Y3, Y4, m and n in the compounds of Formulae 1-33 below are as defined above in the Summary of the Invention unless otherwise noted. Formulae 1a-1j are various subsets of Formula 1, and all substituents for Formulae 1a-1j are as defined above for Formula 1.
  • Figure US20150098928A9-20150409-C00026
  • As shown in Scheme 1, compounds of Formula 1b (Formula 1 wherein Q is Q-A, Z1 is Z1-1 and W1 is S) can be prepared by treatment of corresponding amide compounds of Formula 1a (compounds of Formula 1 wherein Q is Q-A, Z1 is Z1-1 and W1 is O) with a thio transfer reagent, such as P2S5 (see for example, E. Klingsberg et al., J. Am. Chem. Soc. 1951, 72, 4988; E. C. Taylor Jr. et al., J. Am. Chem. Soc. 1953, 75, 1904; R. Crossley et al., J. Chem. Soc. Perkin Trans. 1 1976, 977) or Lawesson's reagent (2,5-bis(4-methoxyphenyl)-1,3-dithia-2,4-diphosphetane-2,4-disulfide; see, for example, S. Prabhakar et al. Synthesis, 1984, 829). The method of Scheme 1 can be conducted over a wide range of temperatures, including from about 50 to about 150° C. Of note are temperatures from about 70 to about 120° C., which typically provide fast reaction rates and high product yields.
  • Figure US20150098928A9-20150409-C00027
  • As shown in Scheme 2, compounds of Formula 1a can be prepared by coupling carboxylic acids of Formula 2 with appropriately substituted amino compounds of Formula 3. This reaction is generally carried out in the presence of a dehydrating coupling reagent, such as dicyclohexyl carbodiimide (DCC), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-propanephosphonic acid cyclic anhydride or carbonyl diimidazole, in the presence of a base such as triethylamine, pyridine, 4-(dimethylamino)pyridine or N,N-diisopropylethylamine in an anhydrous aprotic solvent such as dichloromethane or tetrahydrofuran at a temperature typically between room temperature and 70° C.
  • Figure US20150098928A9-20150409-C00028
  • As shown in Scheme 3, compounds of Formula 1a can also be prepared by aminocarbonylation of aryl bromides of Formula 4 with appropriately substituted amino compounds of Formula 3. This reaction is typically carried out with an aryl bromide of Formula 4 in the presence of a palladium catalyst under CO atmosphere. The palladium catalysts used for the present method typically comprises palladium in a formal oxidation state of either 0 (i.e. Pd(0)) or 2 (i.e. Pd(II)). A wide variety of such palladium-containing compounds and complexes are useful as catalysts for the present method. Examples of palladium-containing compounds and complexes useful as catalysts in the method of Scheme 3 include PdCl2(PPh3)2(bis(triphenylphosphine)palladium(II)dichloride), Pd(PPh3)4(tetrakis(triphenylphosphine)palladium(0)), Pd(C5H7O2)2(palladium(II)acetyl-acetonate), Pd2(dba)3(tris(dibenzylideneacetone)dipalladium(0)), and [1,1′-bis(diphenyl-phosphino)ferrocene]dichloropalladium(II). The method of Scheme 3 is generally conducted in a liquid phase, and therefore to be most effective the palladium catalyst preferably has good solubility in the liquid phase. Useful solvents include, for example, ethers such as 1,2-dimethoxyethane, amides such as N,N-dimethylacetamide, and non-halogenated aromatic hydrocarbons such as toluene.
  • The method of Scheme 3 can be conducted over a wide range of temperatures, ranging from about 25 to about 150° C. Of note are temperatures from about 60 and about 110° C., which typically provide fast reaction rates and high product yields. The general methods and procedures for aminocarbonylation with an aryl bromide and an amine are well known in the literature; see, for example, H. Horino et al., Synthesis 1989, 715; and J. J. Li, G. W. Gribble, editors, Palladium in Heterocyclic Chemistry: A Guide for the Synthetic Chemist, Elsevier Science Ltd, 2000.
  • Figure US20150098928A9-20150409-C00029
  • As shown in Scheme 4, compounds of Formula 1d (compounds of Formula 1 wherein Q is Q-A and Z1 is Z1-2) wherein W5 is the same as W1 can be prepared by the condensation of compounds of Formula Ic (Formula 1 wherein Q is Q-A, Z1 is Z1-1, and R5 and R6 are H) wherein W1 is O or S with compounds of Formula 5 in the presence of condensing agents. The reaction conditions are well illustrated in previous art; for example, see, T. Schmidt et al., WO2007/006670. Suitable condensing agents include carboxylic acid anhydrides, dicyclohexylcarbodiimide, sulfuryl chloride, phosphorus(V) oxide and phosphorus oxychloride.
  • Figure US20150098928A9-20150409-C00030
  • As shown in Scheme 5, compounds of Formula 1e (Formula 1 wherein Q is Q-A, Z1 is Z1-3, and q is 1) wherein W6 is the same as W1 can be prepared by treating the sulfoxides of Formula 6 with amino compounds of Formula 7 using Rh2(OAc)4 as a catalyst in combination with iodobenzene diacetate and magnesium oxide. The general procedure is well demonstrated in the literature, for example, see, H. Okamura & C. Bolm, Org. Lett., 2004, 6, 1305.
  • Figure US20150098928A9-20150409-C00031
  • As shown in Scheme 6, compounds of Formula 6 can be prepared from compounds of Formula 8 by treatment with m-chloroperbenzoic acid (MCPBA). Oxidation of thioethers of Formula 8 with 1.0 equivalent of MCPBA at low temperature, preferably at −78 to −40° C., provides the sulfoxides of Formula 6 in good yield. The compounds of Formula 8 can be prepared by the methods illustrated in Schemes 1, 2 and 3.
  • Figure US20150098928A9-20150409-C00032
  • As shown in Scheme 7, compounds of Formula 1e-a (Formula 1 wherein Q is Q-A, Z1 is Z1-3, and q is 0) wherein W6 is the same as W1 can be prepared from compounds of Formula 8 analogous to the method of Scheme 5 using Rh2(OAc)4 as a catalyst in combination with iodobenzene diacetate and magnesium oxide.
  • Figure US20150098928A9-20150409-C00033
  • As shown in Scheme 8, compounds of Formula 2 can be prepared by hydrolysis of the esters of Formula 9, wherein Ra is methyl or ethyl. In this method, compounds of Formula 9 are converted to the corresponding carboxylic acids of Formula 2 by general procedures well known in the art. For example, treatment of a methyl or ethyl ester of Formula 9 with aqueous lithium hydroxide in tetrahydrofuran, followed by acidification yields the corresponding carboxylic acid of Formula 2.
  • Figure US20150098928A9-20150409-C00034
  • Alcohols of Formula 10 can substituted for the amines of Formula 3 in the reaction of Scheme 3, to yield the esters of Formula 9 as shown in Scheme 9.
  • Figure US20150098928A9-20150409-C00035
  • As shown in Scheme 10, compounds of Formula 4 can be prepared by the 1,3-dipolar cycloaddition of styrenes of Formula 12 with nitrile oxides derived from oximes of Formula 11. This reaction typically proceeds through the intermediacy of an in situ generated hydroxamyl chloride, which is dehydrochlorinated to the nitrile oxide, which then undergoes 1,3-dipolar cycloaddition with the styrene of Formula 12 to afford compounds of Formula 4. In a typical procedure, a chlorinating reagent such as sodium hypochlorite, N-chlorosuccinimide, or chloramine-T is combined with the oxime in the presence of the styrene. Depending on the conditions, amine bases such as pyridine or triethylamine may be necessary to facilitate the dehydrochlorination reaction. The reaction can be run in a wide variety of solvents including tetrahydrofuran, diethyl ether, methylene chloride, dioxane, and toluene with temperatures ranging from room temperature to the reflux temperature of the solvent. General procedures for cycloaddition of nitrile oxides with olefins are well documented in the chemical literature; for example, see Lee, Synthesis, 1982, 6, 508-509; Kanemasa et al., Tetrahedron, 2000, 56, 1057-1064; EP 1,538,138-A1, as well as references cited within.
  • Figure US20150098928A9-20150409-C00036
  • As shown in Scheme 11, the oximes of Formula 11 can be prepared by the reaction of aldehydes of Formula 13 with hydroxylamine according to known literature procedures. For example, see, H. K. Jung et al. Bioorg. Med. Chem. 2004, 12, 3965.
  • Figure US20150098928A9-20150409-C00037
  • As shown in Scheme 12, aldehydes of Formula 13 can be prepared by methods known in art. For example, preparation of the compounds of Formula 13, wherein Y1—Y2—Y3 is —CH═CH—NH(R3)— or —NH(R3)—CH═CH—, is disclosed by Lianhai Li et al. Tetrahedron Lett. 2003, 44, 5987. The dibromo compounds of Formula 14, wherein Y1—Y2—Y3 is —CH═CH—N(R3)—, are a class of compounds reported in the chemical literature; for example, see, A. P. Dobbs et al. Synlett 1999, 10, 1594.
  • Figure US20150098928A9-20150409-C00038
  • As shown in Scheme 13, aldehydes of Formula 13 can also be prepared from methyl derivatives of Formula 15 by methods known in synthetic art, for example, see, E. R. Mewshaw et al. WO2004/1303941. The compounds of Formula 15, wherein Y1—Y2—Y3 is —CH═CH—O—, —CH═CH—S—, —O—CH═CH—, or —S—CH═CH—, can be prepared by general methods known in the art; some are also commercially available.
  • Figure US20150098928A9-20150409-C00039
  • As shown in Scheme 14, compounds of Formula 1g (Formula 1 wherein Q is Q-B, Z2 is Z2-1 or Z2-2 and W2 or W3 are S) can be prepared by treatment of corresponding amide compounds of Formula 1f (compounds of Formula 1 wherein Q is Q-B, Z2 is Z2-1 or Z2-2 and W2 or W3 are O) with a thio transfer reagent. The method of Scheme 14 is conducted as described for Scheme 1.
  • Figure US20150098928A9-20150409-C00040
  • As shown in Scheme 15, compounds of Formula 1f (Formula 1 wherein Q is Q-B, Z2 is Z2-1 or Z2-2 and W2 or W3 are O) can be prepared by coupling the corresponding carboxylic acids of Formula 16 with appropriately substituted amino compounds of Formula 17 or 18. The method of Scheme 15 is conducted as described for Scheme 2.
  • Figure US20150098928A9-20150409-C00041
  • As shown in Scheme 16, compounds of Formula 1f (Formula 1 wherein Q is Q-B, Z2 is Z2-1 or Z2-2, and W2 or W3 are O) can also be prepared by aminocarbonylation of aryl bromides of Formula 19 with appropriately substituted amino compounds of Formula 17 or 18. The method of Scheme 16 is conducted as described for Scheme 3.
  • Figure US20150098928A9-20150409-C00042
  • As shown in Scheme 17, amides of Formula 1h (Formula 1 wherein Q is Q-B and Z2 is Z2-3) can be prepared by coupling the corresponding acids of Formula 20 with appropriately substituted amino compounds of Formula 21. Amide formation reactions are well known in the synthetic art. Treating acids of Formula 20 with amino compounds of Formula 21 in the presence of dehydrating reagents, such as carboxylic acid chlorides, DCC or polymer-supported (PS)-carbodiimide, in an anhydrous aprotic solvent such as dichloromethane provides compounds of Formula 1h. The method of Scheme 17 is illustrated in Step C of Example 1.
  • Figure US20150098928A9-20150409-C00043
  • As shown in Scheme 18, amides of Formula 1h-a (Formula 1h wherein R11 is H) can be prepared by the corresponding acids of Formula 20a (compounds of Formula 20 wherein R11 is H) through intermediates of Formula 22 and further reaction with the appropriately substituted amino compounds of Formula 21. The cyclization reaction is typically carried out using dehydrating reagents, such as polymer-supported (PS)-carbodiimide or dicyclohexyl carbodiimide (DCC) in an anhydrous aprotic solvent such as dichloromethane at room temperature. The intermediates of Formula 22 can be used directly without any purification if polymer-supported DCC is used as the dehydrating reagent. The subsequent amide bond formation can be achieved through mixing the intermediates of Formula 22 with amino compounds of Formula 21 in N,N-dimethylformamide heated to a temperature between 100 and 180° C. using microwave irradiation. The method of Scheme 18 is illustrated in Example 2.
  • Figure US20150098928A9-20150409-C00044
  • As shown in Scheme 19, compounds of Formula 11 (Formula 1 wherein Q is Q-B and Z2 is Z2-4) wherein W5 is O or S can be prepared by coupling compounds of Formula 23 with compounds of Formula 5. The method of Scheme 19 is conducted as described for Scheme 4.
  • Figure US20150098928A9-20150409-C00045
  • As shown in Scheme 20, compounds of Formula 1j (Formula 1 wherein Q is Q-B, Z2 is Z2-5, and q is 1) wherein W5 is O or S can be prepared by treating sulfoxides of Formula 25 with amines of Formula 7. The method of Scheme 20 is conducted as described for Scheme 5 and is illustrated in Step C of Example 3.
  • Figure US20150098928A9-20150409-C00046
  • As shown in Scheme 21, sulfoxides of Formula 25 can be prepared by treating sulfides of Formula 26 with MCPBA. The method of Scheme 21 is conducted as described for Scheme 6 and is illustrated in Step B of Example 3.
  • Figure US20150098928A9-20150409-C00047
  • As shown in Scheme 22, compounds of Formula 1j-a (Formula 1 wherein Q is Q-B, Z2 is Z2-5, and q is 0) can be prepared from sulfides of Formula 26 and amines of Formula 7. The method of Scheme 22 is conducted as described for Scheme 7.
  • Figure US20150098928A9-20150409-C00048
  • As shown in Scheme 23, compounds of Formula 26a (Formula 26 wherein W6 is O) can be prepared by coupling the acids of Formula 16 with appropriately substituted amino compounds of Formula 27. The method of Scheme 23 is conducted as described for Scheme 2 and is illustrated in Step A of Example 3.
  • Figure US20150098928A9-20150409-C00049
  • As shown in Scheme 24, carboxylic acids of Formula 16 can be prepared by hydrolysis of the corresponding esters of Formula 28, wherein Ra is methyl or ethyl. The method of Scheme 24 is conducted as described for Scheme 8.
  • Figure US20150098928A9-20150409-C00050
  • As shown in Scheme 25, compounds of Formula 28 can be prepared by coupling of the corresponding bromides of Formula 19 with alcohols of Formula 10, for example, methanol or ethanol, with carbon monoxide in the presence of palladium catalysts. The method of Scheme 25 is conducted as described for Scheme 9.
  • Figure US20150098928A9-20150409-C00051
  • As shown in Scheme 26, carboxylic acids of Formula 20 can be prepared by hydrolysis of the corresponding esters of Formula 29. The method of Scheme 26 is conducted as described for Scheme 8 and is illustrated in Step B of Example 1.
  • Figure US20150098928A9-20150409-C00052
  • As shown in Scheme 27, compounds of Formula 29a (Formula 29 wherein W4 is O) can be prepared by coupling bromides of Formula 19 with appropriately substituted amino compounds of Formula 30 (or corresponding salts) in the presence of carbon monoxide. The method of Scheme 27 is conducted as described for Scheme 3 and is illustrated in Step A of Example 1.
  • Figure US20150098928A9-20150409-C00053
  • As shown in Scheme 28, compounds of Formula 19 can be prepared by the 1,3-dipolar cyclization of styrenes of Formula 12 with oximes of Formula 31. The method of Scheme 28 is conducted as described for Scheme 10.
  • Figure US20150098928A9-20150409-C00054
  • As shown in Scheme 29, oximes of Formula 31 can be prepared by reaction of the corresponding aldehydes of Formula 32 with hydroxylamine. The method of Scheme 29 is conducted as described for Scheme 11.
  • Figure US20150098928A9-20150409-C00055
  • As shown in Scheme 30, aldehydes of Formula 32 can be prepared by treating compounds of Formula 33 with n-BuLi at −78° C. and reacting the derived lithiated intermediate with N,N-dimethylformamide. The bromo compounds of Formula 33 can be prepared by general methods known in literature, for example, see Synthesis, 2002, 83.
  • It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula 1 may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences or functional group interconversions into the synthesis will aid in obtaining the desired products. The use and choice of the protecting groups will be apparent to one skilled in chemical synthesis (see, for example, Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). One skilled in the art will recognize that, in some cases, after the introduction of a given reagent as it is depicted in any individual scheme, it may be necessary to perform additional routine synthetic steps not described in detail to complete the synthesis of compounds of Formula 1. One skilled in the art will also recognize that it may be necessary to perform a combination of the steps illustrated in the above schemes in an order other than that implied by the particular sequence presented to prepare the compounds of Formula 1.
  • One skilled in the art will also recognize that compounds of Formula 1 and the intermediates described herein can be subjected to various electrophilic, nucleophilic, radical, organometallic, oxidation, and reduction reactions to add substituents or modify existing substituents.
  • Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be construed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Steps in the following Examples illustrate a procedure for each step in an overall synthetic transformation, and the starting material for each step may not have necessarily been prepared by a particular preparative run whose procedure is described in other Examples or Steps. Percentages are by weight except for chromatographic solvent mixtures or where otherwise indicated. Parts and percentages for chromatographic solvent mixtures are by volume unless otherwise indicated. 1H NMR spectra are reported in ppm downfield from tetramethylsilane; “s” means singlet, “d” means doublet, “t” means triplet, “q” means quartet, “m” means multiplet, “dd” means doublet of doublets, “dt” means doublet of triplets and “br” means broad.
    • Example 1 Preparation of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-1-naphthalenecarboxamide Step A: N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine methyl ester
  • A mixture of 3-(4-bromo-1-naphthalenyl)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)isoxazole (500 mg), [1,1′-bis(diphenylphosphino)ferrocene]-dichloropalladium(II) (PdCl2(dppf)) (82 mg), glycine methyl ester hydrochloride (514 mg) and triethylamine (2.8 mL) in toluene (10 mL) in a vial was purged with carbon monoxide for 15 minutes. The reaction vial was maintained with carbon monoxide using a balloon. The reaction mixture was stirred overnight at 70° C. under carbon monoxide atmosphere. The mixture was cooled to room temperature, filtered through a short pad of Celite® diatomaceous filter aid and rinsed with small amount of ethyl acetate. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (4:1 to 1:1) as eluent to afford the title product as a white solid (310 mg, 58% yield).
  • 1H NMR (CDCl3) δ 8.75 (d, 1H), 8.28 (d, 1H), 7.45-7.60 (m, 7H), 7.36 (d, 1H), 6.78 (t, br., 1H), 4.26 (d, 2H), 4.21 (d, 1H), 3.87 (d, 1H), 3.80 (s, 3H).
    • Step B: N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine
  • To a stirred solution of N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine methyl ester (i.e. the title product of Step A) (620 mg) in tetrahydrofuran (5 mL) was added an aqueous solution of lithium hydroxide (300 mg in 5 mL of water). After stirring at room temperature for 1 h, the reaction mixture was diluted with water and extracted with hexane. The aqueous layer was acidified with 6.0 N HCl to pH=2, causing a white precipitate to form. The aqueous mixture was extracted with ethyl acetate, washed with brine, dried with anhydrous sodium sulfate, and concentrated to afford the title compound as a white solid (600 mg, 99% yield).
  • 1H NMR (CD3S(═O)CD3) δ 9.02 (t, 1H), 8.81 (d, 1H), 8.37 (d, 1H), 7.92 (d, 1H), 7.83 (t, 1H), 7.65-7.74 (m, 5H), 4.58 (d, 1H), 4.54 (d, 1H), 4.02 (d, 2H).
    • Step C: 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-1-naphthalenecarboxamide
  • To a stirred solution of N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine (i.e. the title product of Step B) (100 mg) and pyridine (0.019 mL) in dichloromethane (3 mL) was added trimethylacetyl chloride (0.029 mL). The reaction mixture was stirred at room temperature for 2 h, and then 2-methoxyethylamine (0.11 mL) and triethylamine (0.68 mL, 5.0 mmol) were added. The reaction mixture was stirred at room temperature overnight, quenched with water, extracted with dichloromethane, washed with brine, dried with anhydrous sodium sulfate and concentrated. The residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (3:2 to 1:4) as eluent to afford the title compound, a compound of the present invention, as a white solid (71 mg, 0.13 mmol, 65% yield).
  • 1H NMR (CDCl3) δ 8.82 (d, 1H), 8.32 (d, 1H), 7.45-7.66 (m, 7H), 7.00 (br s, 1H), 6.45 (br s, 1H), 4.25 (d, 1H), 4.21 (d, 2H), 3.89 (d, 1H), 3.49 (m, 4H), 3.36 (s, 3H).
    • Example 2 Preparation of N-[2-[(cyclopropylmethyl)amino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide Step A: 2-[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]-5(4H)-oxazolone
  • A mixture of N—[[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]carbonyl]glycine (510 mg) and PS (polymer supported)-carbodiimide (1.69 g, 123 mmol/g) in dichloromethane (25 mL) was stirred at room temperature overnight. The reaction mixture was filtered through a short pad of Celite® diatomaceous filter aid and rinsed with dichloromethane. The filtrate was concentrated to provide the title compound (400 mg, 81% yield) as a pale yellow solid used directly for next step.
  • 1H NMR (CDCl3) δ 9.33 (m, 1H), 8.87 (m, 1H), 8.15 (d, 1H), 7.73 (m, 2H), 7.59 (d, 1H), 7.57 (d, 2H), 7.46 (dd, 1H), 4.62 (s, 2H), 4.29 (d, 1H), 3.93 (d, 1H).
    • Step B: N-[2-[(cyclopropylmethyl)amino]-2-oxoethyl]-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide
  • A mixture of 2-[4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenyl]-5(4H)-oxazolone (i.e. the title product of Step A) (50 mg) and (aminomethyl)cyclopropane (0.1 mL) in N,N-dimethylformamide (1 mL) was irradiated with microwave radiation to maintain a temperature around 150° C. for 30 minutes. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, dried with anhydrous sodium sulfate, and concentrated. The residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (3:2 to 3:7) as eluent to afford the title compound, a compound of the present invention, as a pale yellow solid (47 mg, 82% yield).
  • 1H NMR (CDCl3) δ 8.83 (d, 1H), 8.31 (d, 1H), 7.45-7.67 (m, 7H), 7.10 (br s, 1H), 6.40 (br s, 1H), 4.25 (d, 1H), 4.21 (d, 2H), 3.89 (d, 1H), 3.17 (dd, 2H), 0.97 (m, 1H), 0.52 (m, 2H), 0.21 (m, 2H).
    • Example 3 Preparation of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfonimidoyl]ethyl]-1-naphthalenecarboxamide Step A: 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylthio)ethyl]-1-naphthalenecarboxamide
  • To a stirred suspension of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxylic acid (620 mg) in dichloromethane (20 mL) at room temperature was added oxalyl chloride (0.24 mL), followed by two drops of N,N-dimethylformamide. The reaction mixture was stirred at room temperature for 1.5 h and then concentrated under vacuum. The residue was dissolved in dichloromethane (10 mL) and added to a stirred solution of 2-(methylthio)ethylamine (0.13 mL) and Et3N (0.38 mL) in dichloromethane (10 mL) at room temperature. The resulting reaction mixture was stirred at room temperature overnight. The reaction mixture was quenched with water and extracted with dichloromethane, washed with brine, dried with sodium sulfate and concentrated, and the residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (7:3 to 1:1) as eluent to afford the title compound as a white solid (510 mg, 71% yield).
  • 1H NMR (CDCl3) δ 8.78 (d, 1H), 8.27 (d, 1H), 7.56-7.64 (m, 4H), 7.49 (d, 1H), 7.46 (dd, 1H), 7.40 (d, 1H), 6.57 (br t, 1H), 4.23 (d, 1H), 3.88 (d, 1H), 3.71 (q, 2H), 2.79 (t, 2H), 2.15 (s, 3H).
    • Step B: 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylsulfinyl)ethyl]-1-naphthalenecarboxamide
  • To a stirred solution of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylthio)ethyl]-1-naphthalenecarboxamide (i.e. the title product of Step A) (100 mg) in dichloromethane (10 mL) was added MCPBA (47 mg, 70%) at −78° C. The reaction mixture was stirred at −78 to −70° C. for 2.5 h, then quenched with saturated sodium bicarbonate, extracted with dichloromethane, washed with brine, dried with sodium sulfate, and concentrated to afford the title compound as a white solid (102 mg, 99% yield).
  • 1H NMR (CDCl3) δ 8.78 (d, 1H), 8.29 (d, 1H), 7.42-7.64 (m, 7H), 7.37 (br t, 1H), 4.23 (d, 1H), 4.00 (q, 2H), 3.88 (d, 1H), 3.18 (dt, 1H), 2.89 (dt, 1H), 2.62 (s, 3H).
    • Step C: 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methyl-N-(2,2,2-trifluoroacetyl)sulfonimidoyl)ethyl]-1-naphthalenecarboxamide
  • To a stirred suspension of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylsulfinyl)ethyl]-1-naphthalenecarboxamide (i.e. the title product of Step B) (180 mg), 2,2,2-trifluoroacetamide (75 mg), MgO (53 mg), and Rh2(OAc)4 (4 mg) in dichloromethane (4 mL) was added PhI(OAc)2 (160 mg) at room temperature. The resulting mixture was stirred for 5 h at room temperature, then filtered through a short pad of Celite® diatomaceous filter aid, and rinsed with ethyl acetate. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using hexanes/ethyl acetate (3:7 to 1:9) as eluent to afford the title compound, a compound of the present invention, as yellow oil (100 mg, 46% yield).
  • 1H NMR (CDCl3) δ 8.80 (d, 1H), 8.26 (d, 1H), 7.42-7.65 (m, 7H), 6.99 (br t, 1H), 4.24 (d, 1H), 4.11 (m, 2H), 3.89 (d, 1H), 3.82 (m, 2H), 3.48 (s, 3H).
    • Example 4 Preparation of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methylsulfonimidoyl)ethyl]-1-naphthalenecarboxamide
  • To a stirred solution of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfonimidoyl]ethyl]-1-naphthalenecarboxamide (i.e. the title compound of Example 3) (60 mg) in methanol (4 mL) was added potassium carbonate (230 mg) at room temperature. After stirring for 30 minutes at room temperature, the reaction mixture was filtered through a short pad of silical gel and rinsed with ethyl acetate. After concentration, the residue was purified by column chromatography on silica gel using dichloromethane/methanol (98:2 to 92:8) as eluent to provide the title product, a compound of the present invention, as a white solid (39 mg, 76% yield).
  • 1H NMR (CD3COCD3) δ 8.91 (d, 1H), 8.43 (d, 1H), 8.18 (br s, 1H), 7.87 (d, 1H), 7.63-7.76 (m, 6H), 4.61 (d, 1H), 4.47 (d, 1H), 3.99 (m, 2H), 3.50 (m, 2H), 3.35 (br s, 1H), 3.07 (s, 3H).
    • Example 5 Preparation of 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methylsulfinimidoyl)ethyl]-1-naphthalenecarboxamide Step A: 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfinimidoyl]ethyl]-1-naphthalenecarboxamide
  • To a stirred suspension of 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(methylthio)ethyl]-1-naphthalenecarboxamide (prepared analogously as described for the compound of Example 3, Step A) (200 mg), 2,2,2-trifluoroacetamide (80 mg), MgO (57 mg), and Rh2(OAc)4 (4 mg) in dichloromethane (4 mL) was added PhI(OAc)2 (172 mg) at room temperature. The resulting mixture was stirred overnight at room temperature, then filtered through a short pad of Celite® diatomaceous filter aid, and rinsed with ethyl acetate. The filtrate was concentrated, and the residue was purified by column chromatography on silica gel using hexanes/ethyl acetates (1:1 to 1:4) as eluent to afford the title compound as a semisolid (70 mg, 30% yield).
  • 1H NMR (CDCl3) δ 8.77 (d, 1H), 8.31 (d, 1H), 7.70 (s, 2H), 7.54-7.66 (m, 4H), 7.44 (d, 1H), 4.25 (d, 1H), 4.16 (m, 1H), 3.88 (d, 1H), 3.58 (m, 2H), 3.22 (m, 1H), 2.87 (s, 3H).
    • Step B: 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-(S-methylsulfinimidoyl)ethyl]-1-naphthalenecarboxamide
  • To a stirred solution of 4-[4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-N-[2-[S-methyl-N-(2,2,2-trifluoroacetyl)sulfinimidoyl]ethyl]-1-naphthalenecarboxamide (70 mg) (i.e. the title compound of Step A) in methanol (2 mL) was added potassium carbonate (300 mg) at room temperature. After stirring overnight at room temperature, the reaction mixture was filtered through a short pad of silica gel and rinsed with ethyl acetate. After concentration, the residue was purified by column chromatography on silica gel using dichloromethane/methanol (98:2 to 92:8) as eluent to afford the title compound, a compound of the present invention, as a semisolid (9 mg, 15% yield).
  • 1H NMR (CDCl3) δ 8.81 (d, 1H), 8.35 (d, 1H), 7.61-7.70 (m, 5H), 7.49 (d, 1H), 7.11 (br t, 1H), 4.26 (d, 1H), 4.11 (m, 2H), 3.88 (d, 1H), 3.24 (m, 1H), 2.95 (m, 1H), 2.70 (s, 3H).
    • Example 6 Preparation of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-N-(dimethyl-)λ4-sulfanylidene)-1-naphthalenecarboxamide
  • To a stirred solution of dimethylsulfoxide (38 mg) in dichloromethane (1 mL) at −60° C. was added trifluoroacetic anhydride (105 mg). After the reaction mixture was stirred for 10 minutes at −60° C., a solution of 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-1-naphthalenecarboxamide (75 mg, in 1.5 mL of dichloromethane and 0.4 mL of dimethylsulfoxide) was added. The reaction mixture was allowed to warm to −20° C. over 1 h, then quenched with water and extracted with dichloromethane. The combined organic extract was washed with aqueous 1.0 N of NaOH and brine, dried with anhydrous sodium sulfate and concentrated. The residue was purified by column chromatography on silica gel using dichloromethane/methanol (98:2 to 95:5) as eluent to afford the title product, a compound of the present invention, as semi-solid (70 mg, 82% yield).
  • 1H NMR (CDCl3) δ 8.80 (m, 1H), 8.69 (m, 1H), 7.85 (d, 1H), 7.44-7.62 (m, 6H), 4.26 (d, 1H), 3.89 (d, 1H), 2.86 (s, 6H).
  • By the procedures described herein together with methods known in the art, the following compounds of Tables 1 to 52 can be prepared. The following abbreviations are used in the Tables which follow: Cmpd. means compound, n means normal, i means iso, c means cyclo, Me means methyl, Et means ethyl, Pr means propyl, i-Pr means isopropyl, Ph means phenyl, OMe means methoxy, SMe means methylthio, CN means cyano, Ph means phenyl, Py means pyridinyl, S(═O)Me means methylsulfinyl, and SO2Me means methylsulfonyl. In the Tables the variable “R2” represents one or a combination of substituents as defined.
  • In Table 49, compounds are specifically named by first indicating the relevant preceding Table number (i.e. from Tables 1-48) defining a Markush structure and then the line number for the preceding Table defining substituents attached to the Markush structure. Each such designation specifically identifies a unique compound of the present invention. For example, Compound 1-1 is the compound of Formula 1, as defined by Table 1, Line 1 wherein A is phenyl, Q is Q-A-1, R2 is 3-CF3, R5 is Et and R6 is H. Similarly, Compound 17-4 is the compound of Formula 1, Table 17, Line 4 wherein A is phenyl, Q is Q-A-17, R2 is 3-Cl, 5-Cl, R19 is Et and R20 is H.
    • Tables 1-8
  • Figure US20150098928A9-20150409-C00056
    • Q is:
  • TABLE 1
    Figure US20150098928A9-20150409-C00057
         		Q-A-1
  • TABLE 2
    Figure US20150098928A9-20150409-C00058
         		Q-A-2
  • TABLE 3
    Figure US20150098928A9-20150409-C00059
         		Q-A-3
  • TABLE 4
    Figure US20150098928A9-20150409-C00060
         		Q-A-4
  • TABLE 5
    Figure US20150098928A9-20150409-C00061
         		Q-A-5
  • TABLE 6
    Figure US20150098928A9-20150409-C00062
         		Q-A-6
  • TABLE 7
    Q-A-7
    Figure US20150098928A9-20150409-C00063
  • TABLE 8
    Q-A-8
    Figure US20150098928A9-20150409-C00064
  • Line R5 R6
    wherein R2 is 3-CF3
    1 Et H
    2 CH2-2-Py H
    3 CH2—c-Pr H
    4 CH2CF3 H
    5 CH2CH2OMe H
    6 CH2CH2SMe H
    7 CH2CH2(S═O)Me H
    8 CH2CH2SO2Me H
    9 CH2C(═O)NHCH3 H
    10 CH2C(═O)NHCH2CH3 H
    11 CH2C(═O)NH—c-Pr H
    12 CH2C(═O)NHCH2CF3 H
    13 CH(CH3)C(═O)NHCH2CF3 H
    14 CH2C(═O)NH(CH2)2OMe H
    15 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-Br, 5-Br
    16 Et H
    17 CH2-2-Py H
    18 CH2—c-Pr H
    19 CH2CF3 H
    20 CH2CH2OMe H
    21 CH2CH2SMe H
    22 CH2CH2(S═O)Me H
    23 CH2CH2SO2Me H
    24 CH2C(═O)NHCH3 H
    25 CH2C(═O)NHCH2CH3 H
    26 CH2C(═O)NH—c-Pr H
    27 CH2C(═O)NHCH2CF3 H
    28 CH(CH3)C(═O)NHCH2CF3 H
    29 CH2C(═O)NH(CH2)2OMe H
    30 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-Cl, 4-F, 5-Cl
    31 Et H
    32 CH2-2-Py H
    33 CH2—c-Pr H
    34 CH2CF3 H
    35 CH2CH2OMe H
    36 CH2CH2SMe H
    37 CH2CH2(S═O)Me H
    38 CH2CH2SO2Me H
    39 CH2C(═O)NHCH3 H
    40 CH2C(═O)NHCH2CH3 H
    41 CH2C(═O)NH—c-Pr H
    42 CH2C(═O)NHCH2CF3 H
    43 CH(CH3)C(═O)NHCH2CF3 H
    44 CH2C(═O)NH(CH2)2OMe H
    45 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-Cl, 5-Cl
    46 CH2CF3 Me
    47 CH2-2-Py Me
    48 CH2CH2SMe Me
    49 CH2CH2S(═O)Me Me
    50 CH2CH2SO2Me Me
    51 CH2C(═O)NHCH2CF3 Me
    52 CH(CH3)C(═O)NHCH2CF3 Me
    53 CH2CF3 C(═O)Me
    54 CH2-2-Py C(═O)Me
    55 CH2CH2SMe C(═O)Me
    56 CH2CH2S(═O)Me C(═O)Me
    57 CH2CH2SO2Me C(═O)Me
    58 CH2C(═O)NHCH2CF3 C(═O)Me
    59 CH(CH3)C(═O)NHCH2CF3 C(═O)Me
    60 CH2CF3 CO2Me
    61 CH2-2-Py CO2Me
    62 CH2CH2SMe CO2Me
    63 CH2CH2S(═O)Me CO2Me
    64 CH2CH2SO2Me CO2Me
    65 CH2C(═O)NHCH2CF3 CO2Me
    66 CH(CH3)C(═O)NHCH2CF3 CO2Me
    wherein R2 is 3-Cl
    67 CH2CF3 H
    68 CH2-2-Py H
    69 CH2CH2SMe H
    70 CH2—c-Pr H
    71 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-Br, 5-OCF3
    72 CH2CF3 H
    73 CH2-2-Py H
    74 CH2CH2SMe H
    75 CH2—c-Pr H
    76 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-Cl, 5-Br
    77 CH2CF3 H
    78 CH2-2-Py H
    79 CH2CH2SMe H
    80 CH2—c-Pr H
    81 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-CF3, 5-Cl
    82 CH2CF3 H
    83 CH2-2-Py H
    84 CH2CH2SMe H
    85 CH2—c-Pr H
    86 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-Cl, 4-CN, 5-Cl
    87 CH2CF3 H
    88 CH2-2-Py H
    89 CH2CH2SMe H
    91 CH2—c-Pr H
    92 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-Cl, 5-Cl
    93 Et H
    94 CH2-2-Py H
    95 CH2—c-Pr H
    96 CH2CF3 H
    97 CH2CH2OMe H
    98 CH2CH2SMe H
    99 CH2CH2(S═O)Me H
    100 CH2CH2SO2Me H
    101 CH2C(═O)NHCH3 H
    102 CH2C(═O)NHCH2CH3 H
    103 CH2C(═O)NH—c-Pr H
    104 CH2C(═O)NHCH2CF3 H
    105 CH(CH3)C(═O)NHCH2CF3 H
    106 CH2C(═O)NH(CH2)2OMe H
    107 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-Cl, 4-Cl, 5-Cl
    108 Et H
    109 CH2-2-Py H
    110 CH2—c-Pr H
    111 CH2CF3 H
    112 CH2CH2OMe H
    113 CH2CH2SMe H
    114 CH2CH2(S═O)Me H
    115 CH2CH2SO2Me H
    116 CH2C(═O)NHCH3 H
    117 CH2C(═O)NHCH2CH3 H
    118 CH2C(═O)NH—c-Pr H
    119 CH2C(═O)NHCH2CF3 H
    120 CH(CH3)C(═O)NHCH2CF3 H
    121 CH2C(═O)NH(CH2)2OMe H
    122 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-CF3, 5-CF3
    123 Et H
    124 CH2-2-Py H
    125 CH2—c-Pr H
    126 CH2CF3 H
    127 CH2CH2OMe H
    128 CH2CH2SMe H
    129 CH2CH2(S═O)Me H
    130 CH2CH2SO2Me H
    131 CH2C(═O)NHCH3 H
    132 CH2C(═O)NHCH2CH3 H
    133 CH2C(═O)NH—c-Pr H
    134 CH2C(═O)NHCH2CF3 H
    135 CH(CH3)C(═O)NHCH2CF3 H
    136 CH2C(═O)NH(CH2)2OMe H
    137 CH2C(═O)NH(CH2)2SMe H
    wherein R2 is 3-Br, 5-Br
    138 CH2CF3 Me
    139 CH2-2-Py Me
    140 CH2CH2SMe Me
    141 CH2CH2S(═O)Me Me
    142 CH2CH2SO2Me Me
    143 CH2C(═O)NHCH2CF3 Me
    144 CH(CH3)C(═O)NHCH2CF3 Me
    145 CH2CF3 C(═O)Me
    146 CH2-2-Py C(═O)Me
    147 CH2CH2SMe C(═O)Me
    148 CH2CH2S(═O)Me C(═O)Me
    149 CH2CH2SO2Me C(═O)Me
    150 CH2C(═O)NHCH2CF3 C(═O)Me
    151 CH(CH3)C(═O)NHCH2CF3 C(═O)Me
    152 CH2CF3 CO2Me
    153 CH2-2-Py CO2Me
    154 CH2CH2SMe CO2Me
    155 CH2CH2S(═O)Me CO2Me
    156 CH2CH2SO2Me CO2Me
    157 CH2C(═O)NHCH2CF3 CO2Me
    158 CH(CH3)C(═O)NHCH2CF3 CO2Me
    wherein R2 is 3-Br
    159 CH2CF3 H
    160 CH2-2-Py H
    162 CH2CH2SMe H
    163 CH2—c-Pr H
    164 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-CF3, 5-CF3
    165 CH2CF3 H
    166 CH2-2-Py H
    167 CH2CH2SMe H
    168 CH2—c-Pr H
    169 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-CF3, 5-F
    170 CH2CF3 H
    171 CH2-2-Py H
    172 CH2CH2SMe H
    173 CH2—c-Pr H
    174 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-CF3, 5-Br
    175 CH2CF3 H
    176 CH2-2-Py H
    177 CH2CH2SMe H
    178 CH2—c-Pr H
    179 CH2C(═O)NHCH2CF3 H
    wherein R2 is 3-Cl, 4-Me, 5-Cl
    180 CH2CF3 H
    181 CH2-2-Py H
    182 CH2CH2SMe H
    183 CH2—c-Pr H
    184 CH2C(═O)NHCH2CF3 H
    • Tables 9-16
  • Figure US20150098928A9-20150409-C00065
  • TABLE 9
    Q-A-9
    Figure US20150098928A9-20150409-C00066
  • TABLE 10
    Q-A-10
    Figure US20150098928A9-20150409-C00067
  • TABLE 11
    Q-A-11
    Figure US20150098928A9-20150409-C00068
  • TABLE 12
    Q-A-12
    Figure US20150098928A9-20150409-C00069
  • TABLE 13
    Q-A-13
    Figure US20150098928A9-20150409-C00070
  • TABLE 14
    Q-A-14
    Figure US20150098928A9-20150409-C00071
  • TABLE 15
    Q-A-14
    Figure US20150098928A9-20150409-C00072
  • TABLE 16
    Q-A-16
    Figure US20150098928A9-20150409-C00073
  • Line R2 R16 R17
    1 3-Cl, 5-Cl Me Me
    2 3-Cl, 5-Cl Et Me
    3 3-Cl, 5-Cl n-Pr Me
    4 3-Cl, 5-Cl Et Et
    5 3-Cl, 5-Cl i-Pr i-Pr
    6 3-Br, 5-Br Me Me
    7 3-Br, 5-Br Et Me
    8 3-Br, 5-Br n-Pr Me
    9 3-Br, 5-Br Et Et
    10 3-Br, 5-Br i-Pr i-Pr
    11 3-Cl, 4-Cl, 5-Cl Me Me
    12 3-Cl, 4-Cl, 5-Cl Et Me
    13 3-Cl, 4-Cl, 5-Cl n-Pr Me
    14 3-Cl, 4-Cl, 5-Cl Et Et
    15 3-Cl, 4-Cl, 5-Cl i-Pr i-Pr
    16 3-Cl, 4-F, 5-Cl Me Me
    17 3-Cl, 4-F, 5-Cl Et Me
    18 3-Cl, 4-F, 5-Cl n-Pr Me
    19 3-Cl, 4-F, 5-Cl Et Et
    20 3-Cl, 4-F, 5-Cl i-Pr i-Pr
    21 3-Cl Me Me
    22 3-Cl Et Me
    23 3-Cl n-Pr Me
    24 3-Cl Et Et
    25 3-Cl i-Pr i-Pr
    26 3-Br Me Me
    27 3-Br Et Me
    28 3-Br n-Pr Me
    29 3-Br Et Et
    30 3-Br i-Pr i-Pr
    31 3-CF3, 5-CF3 Me Me
    32 3-CF3, 5-CF3 Et Me
    33 3-CF3, 5-CF3 n-Pr Me
    34 3-CF3, 5-CF3 Et Et
    35 3-CF3, 5-CF3 i-Pr i-Pr
    36 3-CF3, 5-Cl Me Me
    37 3-CF3, 5-Cl Et Me
    38 3-CF3, 5-Cl n-Pr Me
    39 3-CF3, 5-Cl Et Et
    40 3-CF3, 5-Cl i-Pr i-Pr
    41 3-CF3, 5-Br Me Me
    42 3-CF3, 5-Br Et Me
    43 3-CF3, 5-Br n-Pr Me
    44 3-CF3, 5-Br Et Et
    45 3-CF3, 5-Br i-Pr i-Pr
    46 3-Cl, 4-CN, 5-Cl Me Me
    47 3-Cl, 4-CN, 5-Cl Et Me
    48 3-Cl, 4-CN, 5-Cl n-Pr Me
    49 3-Cl, 4-CN, 5-Cl Et Et
    50 3-Cl, 4-CN, 5-Cl i-Pr i-Pr
    51 3-Cl, 4-Me, 5-Cl Me Me
    52 3-Cl, 4-Me, 5-Cl Et Me
    53 3-Cl, 4-Me, 5-Cl n-Pr Me
    54 3-Cl, 4-Me, 5-Cl Et Et
    55 3-Cl, 4-Me, 5-Cl i-Pr i-Pr
    56 3-CF3 Me H
    57 3-CF3 Me C(═O)CF3
    58 3-CF3 Me CN
    59 3-CF3 Et H
    60 3-CF3 Et C(═O)CF3
    • Tables 17-24
  • Figure US20150098928A9-20150409-C00074
    • Q is:
  • TABLE 17
    Q-A-17
    Figure US20150098928A9-20150409-C00075
  • TABLE 18
    Q-A-18
    Figure US20150098928A9-20150409-C00076
  • TABLE 19
    Q-A-19
    Figure US20150098928A9-20150409-C00077
  • TABLE 20
    Q-A-20
    Figure US20150098928A9-20150409-C00078
  • TABLE 21
    Q-A-21
    Figure US20150098928A9-20150409-C00079
  • TABLE 22
    Figure US20150098928A9-20150409-C00080
         		Q-A-22
  • TABLE 23
    Figure US20150098928A9-20150409-C00081
         		Q-A-23
  • TABLE 24
    Figure US20150098928A9-20150409-C00082
         		Q-A-24
  • Line R2 R19 R20
    1 3-Cl, 5-Cl Me H
    2 3-Cl, 5-Cl Me C(═O)CF3
    3 3-Cl, 5-Cl Me CN
    4 3-Cl, 5-Cl Et H
    5 3-Cl, 5-Cl Et C(═O)CF3
    6 3-Br, 5-Br Me H
    7 3-Br, 5-Br Me C(═O)CF3
    8 3-Br, 5-Br Me CN
    9 3-Br, 5-Br Et H
    10 3-Br, 5-Br Et C(═O)CF3
    11 3-Cl, 4-Cl, 5-Cl Me H
    12 3-Cl, 4-Cl, 5-Cl Me C(═O)CF3
    13 3-Cl, 4-Cl, 5-Cl Me CN
    14 3-Cl, 4-Cl, 5-Cl Et H
    15 3-Cl, 4-Cl, 5-Cl Et C(═O)CF3
    16 3-Cl, 4-F, 5-Cl Me H
    17 3-Cl, 4-F, 5-Cl Me C(═O)CF3
    18 3-Cl, 4-F, 5-Cl Me CN
    19 3-Cl, 4-F, 5-Cl Et H
    20 3-Cl, 4-F, 5-Cl Et C(═O)CF3
    21 3-Cl Me H
    22 3-Cl Me C(═O)CF3
    23 3-Cl Me CN
    24 3-Cl Et H
    25 3-Cl Et C(═O)CF3
    26 3-Br Me H
    27 3-Br Me C(═O)CF3
    28 3-Br Me CN
    29 3-Br Et H
    30 3-Br Et C(═O)CF3
    31 3-CF3, 5-CF3 Me H
    32 3-CF3, 5-CF3 Me C(═O)CF3
    33 3-CF3, 5-CF3 Me CN
    34 3-CF3, 5-CF3 Et H
    35 3-CF3, 5-CF3 Et C(═O)CF3
    36 3-CF3, 5-Cl Me C(═O)CF3
    37 3-CF3, 5-Cl Me CN
    38 3-CF3, 5-Cl Me H
    39 3-CF3, 5-Cl Et C(═O)CF3
    40 3-CF3, 5-Cl Et i-Pr
    41 3-CF3, 5-Br Me H
    42 3-CF3, 5-Br Me C(═O)CF3
    43 3-CF3, 5-Br Me CN
    44 3-CF3, 5-Br Et H
    45 3-CF3, 5-Br Et C(═O)CF3
    46 3-Cl, 4-CN, 5-Cl Me H
    47 3-Cl, 4-CN, 5-Cl Me C(═O)CF3
    48 3-Cl, 4-CN, 5-Cl Me CN
    49 3-Cl, 4-CN, 5-Cl Et H
    50 3-Cl, 4-CN, 5-Cl Et C(═O)CF3
    51 3-Cl, 4-Me, 5-Cl Me H
    52 3-Cl, 4-Me, 5-Cl Me C(═O)CF3
    53 3-Cl, 4-Me, 5-Cl Me CN
    54 3-Cl, 4-Me, 5-Cl Et H
    55 3-Cl, 4-Me, 5-Cl Et C(═O)CF3
    56 3-CF3 Me H
    57 3-CF3 Me C(═O)CF3
    58 3-CF3 Me CN
    59 3-CF3 Et H
    60 3-CF3 Et C(═O)CF3
    • Tables 25-32
  • Figure US20150098928A9-20150409-C00083
  • TABLE 25
    Figure US20150098928A9-20150409-C00084
         		A-1-1
  • TABLE 26
    Figure US20150098928A9-20150409-C00085
         		A-1-2
  • TABLE 27
    Figure US20150098928A9-20150409-C00086
         		A-1-3
  • TABLE 28
    Figure US20150098928A9-20150409-C00087
         		A-1-4
  • TABLE 29
    Figure US20150098928A9-20150409-C00088
         		A-1-5
  • TABLE 30
    Figure US20150098928A9-20150409-C00089
         		A-1-6
  • TABLE 31
    Figure US20150098928A9-20150409-C00090
         		A-1-7
  • TABLE 32
    Figure US20150098928A9-20150409-C00091
         		A-1-8
  • Line Y4 R7 R8
    1 CH H CH2CH2OCH2CF3
    2 CH H CH2CH2OCH2CH2OPh
    3 CH H CH2CH2OCH2CH2OMe
    4 CH H CH2CH2OCH2CH2SH
    5 CH H CH2CH2OCH2CH2SMe
    6 CH H CH2CH2OCH2CH2S(═O)Me
    7 CH H CH2CH2OCH2CH2SO2Me
    8 CH H CH2CH2OCH2CH2SO2NHMe
    9 CH H CH2CH2O(CH2)2SO2N(Me)2
    10 CH H (CH2)2O(CH2)2OC(═O)NHMe
    11 CH H (CH2)2O(CH2)2OC(═O)N(Me)2
    12 CH H CH2CH2OCH2CH2OCO2Me
    13 CH H CH2CH2OCH2OCO2Me
    14 CH H CH2CH2OCH2C(═O)NHMe
    15 CH H CH2CH2NHCH2CF3
    16 CH H CH2CH2N(Me)CH2CF3
    17 CH H CH2CH2N═CH-(2-Py)
    18 CH H CH2CH2N═CH-(3-Py)
    19 CH H CH2CH2NHC(═O)Me
    20 CH H CH2CH2SCN
    21 CH H CH2Si(Me)3
    22 CH H CH2Si(Me)2Ph
    23 CH H CH2Si(Me)2Et
    24 CH H CH2C(═O)OCH2CH2OMe
    25 CH H CH2C(═O)OCH2CH2OEt
    26 CH H CH2C(═S)SMe
    27 CH H CH2C(═S)OMe
    28 CH H CH2C(═O)SMe
    29 CH H CH2C(═S)Me
    30 CH H CH2C(═S)N(Me)2
    31 CH H CH2C(═S)NHMe
    32 CH H CH2C(═S)NHCH2CF3
    33 CH H CH2P(═O)(OMe)2
    34 CH H CH2P(═S)(OMe)2
    35 CH Me (CH2)2O(CH2)2SMe
    36 CH Me (CH2)2O(CH2)2S(═O)Me
    37 CH Me (CH2)2O(CH2)2SO2Me
    38 CH C(═O)Me (CH2)2O(CH2)2SMe
    39 CH C(═O)Me (CH2)2O(CH2)2S(═O)Me
    40 CH C(═O)Me (CH2)2O(CH2)2SO2Me
    41 N H CH2CH2OCH2CF3
    42 N H CH2CH2OCH2CH2OPh
    43 N H CH2CH2OCH2CH2OMe
    44 N H CH2CH2OCH2CH2SH
    45 N H CH2CH2OCH2CH2SMe
    46 N H CH2CH2OCH2CH2S(═O)Me
    47 N H CH2CH2OCH2CH2SO2Me
    48 N H CH2CH2OCH2CH2SO2NHMe
    49 N H CH2CH2O(CH2)2SO2N(Me)2
    50 N H (CH2)2O(CH2)2OC(═O)NHMe
    51 N H (CH2)2O(CH2)2OC(═O)N(Me)2
    52 N H CH2CH2OCH2CH2OCO2Me
    53 N H CH2CH2OCH2OCO2Me
    54 N H CH2CH2OCH2C(═O)NHMe
    55 N H CH2CH2NHCH2CF3
    56 N H CH2CH2N(Me)CH2CF3
    57 N H CH2CH2N═CH-(2-Py)
    58 N H CH2CH2N═CH-(3-Py)
    59 N H CH2CH2NHC(═O)Me
    60 N H CH2CH2SCN
    61 N H CH2Si(Me)3
    62 N H CH2Si(Me)2Ph
    63 N H CH2Si(Me)2Et
    64 N H CH2C(═O)OCH2CH2OMe
    65 N H CH2C(═O)OCH2CH2OEt
    66 N H CH2C(═S)SMe
    67 N H CH2C(═S)OMe
    68 N H CH2C(═O)SMe
    69 N H CH2C(═S)Me
    70 N H CH2C(═S)N(Me)2
    71 N H CH2C(═S)NHMe
    72 N H CH2C(═S)NHCH2CF3
    73 N H CH2P(═O)(OMe)2
    74 N H CH2P(═S)(OMe)2
    75 CH CO2Me (CH2)2O(CH2)2SMe
    76 CH CO2Me (CH2)2O(CH2)2S(═O)Me
    77 CH CO2Me (CH2)2O(CH2)2SO2Me
    78 CH Et (CH2)2O(CH2)2SMe
    79 CH Et (CH2)2O(CH2)2S(═O)Me
    80 CH Et (CH2)2O(CH2)2SO2Me
    • Tables 33-40
  • Figure US20150098928A9-20150409-C00092
    • A is:
  • TABLE 33
    Figure US20150098928A9-20150409-C00093
         		A-1-1
  • TABLE 34
    Figure US20150098928A9-20150409-C00094
         		A-1-2
  • TABLE 35
    Figure US20150098928A9-20150409-C00095
         		A-1-3
  • TABLE 36
    Figure US20150098928A9-20150409-C00096
         		A-1-4
  • TABLE 37
    Figure US20150098928A9-20150409-C00097
         		A-1-5
  • TABLE 38
    Figure US20150098928A9-20150409-C00098
         		A-1-6
  • TABLE 39
    Figure US20150098928A9-20150409-C00099
         		A-1-7
  • TABLE 40
    Figure US20150098928A9-20150409-C00100
         		A-1-8
  • Line Y4 R9 R10
    1 CH H CN
    2 CH H SO2Me
    3 CH H SO2Ph
    4 CH H SO2N(Me)2
    5 CH H NHMe
    6 CH H N(Me)2
    7 CH H C(═O)CF3
    8 CH H CO2CH2CF3
    9 CH H C(═O)N(Me)2
    10 CH H C(═O)NHMe
    11 CH CH2CF3 CN
    12 CH CH2CF3 SO2Me
    13 CH CH2CF3 SO2Ph
    14 CH CH2CF3 SO2N(Me)2
    15 CH CH2CF3 NHMe
    16 CH CH2CF3 N(Me)2
    17 CH CH2CF3 C(═O)CF3
    18 CH CH2CF3 CO2CH2CF3
    19 CH CH2CF3 C(═O)N(Me)2
    20 CH CH2CF3 C(═O)NHMe
    21 CH CH2-2-Py CN
    22 CH CH2-2-Py SO2Me
    23 CH CH2-2-Py SO2Ph
    24 CH CH2-2-Py SO2N(Me)2
    25 CH CH2-2-Py NHMe
    26 CH CH2-2-Py N(Me)2
    27 CH CH2-2-Py C(═O)CF3
    28 CH CH2-2-Py CO2CH2CF3
    29 CH CH2-2-Py C(═O)N(Me)2
    30 CH CH2-2-Py C(═O)NHMe
    31 N CH2CF3 CH2OMe
    32 N CH2-2-Py CH2OMe
    33 N CH2CH2SMe CH2OMe
    34 N CH2CH2SO2Me CH2OMe
    35 N CH2CH2S(═O)Me CH2OMe
    36 N Et CN
    37 N Et SO2Me
    38 N Et SO2Ph
    39 N Et SO2N(Me)2
    40 N Et NHMe
    41 N Et N(Me)2
    42 N Et C(═O)CF3
    43 N Et CO2CH2CF3
    44 N Et C(═O)N(Me)2
    45 N Et C(═O)NHMe
    46 CH CH2—c-Pr CN
    47 CH CH2—c-Pr SO2Me
    48 CH CH2—c-Pr SO2Ph
    49 CH CH2—c-Pr SO2N(Me)2
    50 CH CH2—c-Pr NHMe
    51 CH CH2—c-Pr N(Me)2
    52 CH CH2—c-Pr C(═O)CF3
    53 CH CH2—c-Pr CO2CH2CF3
    54 CH CH2—c-Pr C(═O)N(Me)2
    55 CH CH2—c-Pr C(═O)NHMe
    56 N CH2CH2SMe CN
    57 N CH2CH2SMe SO2Me
    58 N CH2CH2SMe SO2Ph
    59 N CH2CH2SMe SO2N(Me)2
    60 N CH2CH2SMe NHMe
    61 N CH2CH2SMe N(Me)2
    62 N CH2CH2SMe C(═O)CF3
    63 N CH2CH2SMe CO2CH2CF3
    64 N CH2CH2SMe C(═O)N(Me)2
    65 N CH2CH2SMe C(═O)NHMe
    66 N CH2CF3 CH2CO2Me
    67 N CH2-2-Py CH2CO2Me
    68 N CH2CH2SMe CH2CO2Me
    69 N CH2CH2SO2Me CH2CO2Me
    70 N CH2CH2S(═O)Me CH2CO2Me
    • Tables 41-48 A is:
  • Figure US20150098928A9-20150409-C00101
  • TABLE 41
    Figure US20150098928A9-20150409-C00102
         		A-1-1
  • TABLE 42
    Figure US20150098928A9-20150409-C00103
         		A-1-2
  • TABLE 43
    Figure US20150098928A9-20150409-C00104
         		A-1-3
  • TABLE 44
    Figure US20150098928A9-20150409-C00105
         		A-1-4
  • TABLE 45
    Figure US20150098928A9-20150409-C00106
         		A-1-5
  • TABLE 46
    Figure US20150098928A9-20150409-C00107
         		A-1-6
  • TABLE 47
    Figure US20150098928A9-20150409-C00108
         		A-1-7
  • TABLE 48
    Figure US20150098928A9-20150409-C00109
         		A-1-8
  • Line R11 R12 R13 R14 R15
    1 H H H H CH2Ph
    2 H H H H CH2-2-Py
    3 H H H H CH2-3-Py
    4 H H H H CH2CH2OH
    5 H H H H CH(CH3)CH2OH
    6 H H H H C(CH3)2CH2OH
    7 H H H H CH2CH2OMe
    8 H H H H CH(CH3)CH2OMe
    9 H H H H C(CH3)2CH2OMe
    10 H H H H CH2CH2SMe
    11 H H H H CH2CH2S(═O)Me
    12 H H H H CH2CH2SO2Me
    13 H H H H CH(Me)CH2SMe
    14 H H H H CHMeCH2S(═O)Me
    15 H H H H CH(Me)CH2SO2Me
    16 H H H H C(Me)2CH2SMe
    17 H H H H C(Me)2CH2S(═O)Me
    18 H H H H C(Me)2CH2SO2Me
    19 H H H H CH2C(═O)NHMe
    20 H H H H CH2C(═O)N(Me)2
    21 H H H H CH2C(═O)NHEt
    22 H H H H CH2C(═O)NH—c-Pr
    23 H H H H CH2C(═O)NHCH2CF3
    24 Me H H H CH2Ph
    25 Me H H H CH2-2-Py
    26 Me H H H CH2-3-Py
    27 Me H H H CH2CH2OH
    28 Me H H H CH(CH3)CH2OH
    29 Me H H H C(CH3)2CH2OH
    30 Me H H H CH2CH2OMe
    31 Me H H H CH(CH3)CH2OMe
    32 Me H H H C(CH3)2CH2OMe
    33 Me H H H CH2CH2SMe
    34 Me H H H CH2CH2S(═O)Me
    35 Me H H H CH2CH2SO2Me
    36 Me H H H CH(Me)CH2SMe
    37 Me H H H CHMeCH2S(═O)Me
    38 Me H H H CH(Me)CH2SO2Me
    39 Me H H H C(Me)2CH2SMe
    40 Me H H H C(Me)2CH2S(═O)Me
    41 Me H H H C(Me)2CH2SO2Me
    42 Me H H H CH2C(═O)NHMe
    43 Me H H H CH2C(═O)N(Me)2
    44 Me H H H CH2C(═O)NHEt
    45 Me H H H CH2C(═O)NH—c-Pr
    46 Me H H H CH2C(═O)NHCH2CF3
    47 H H H Me CH2Ph
    48 H H H Me CH2-2-Py
    49 H H H Me CH2-3-Py
    50 H H H Me CH2CH2OH
    51 H H H Me CH(CH3)CH2OH
    52 H H H Me C(CH3)2CH2OH
    53 H H H Me CH2CH2OMe
    54 H H H Me CH(CH3)CH2OMe
    55 H H H Me C(CH3)2CH2OMe
    56 H H H Me CH2CH2SMe
    57 H H H Me CH2CH2S(═O)Me
    58 H H H Me CH2CH2SO2Me
    59 H H H Me CH(Me)CH2SMe
    60 H H H Me CHMeCH2S(═O)Me
    61 H H H Me CH(Me)CH2SO2Me
    62 H H H Me C(Me)2CH2SMe
    63 H H H Me C(Me)2CH2S(═O)Me
    64 H H H Me C(Me)2CH2SO2Me
    65 H H H Me CH2C(═O)NHMe
    66 H H H Me CH2C(═O)N(Me)2
    67 H H H Me CH2C(═O)NHEt
    68 H H H Me CH2C(═O)NH—c-Pr
    69 H H H Me CH2C(═O)NHCH2CF3
    70 H Me H H CH2Ph
    71 H Me H H CH2-2-Py
    72 H Me H H CH2-3-Py
    73 H Me H H CH2CH2OH
    74 H Me H H CH(CH3)CH2OH
    75 H Me H H C(CH3)2CH2OH
    76 H Me H H CH2CH2OMe
    77 H Me H H CH(CH3)CH2OMe
    78 H Me H H C(CH3)2CH2OMe
    79 H Me H H CH2CH2SMe
    80 H Me H H CH2CH2S(═O)Me
    81 H Me H H CH2CH2SO2Me
    82 H Me H H CH(Me)CH2SMe
    83 H Me H H CHMeCH2S(═O)Me
    84 H Me H H CH(Me)CH2SO2Me
    85 H Me H H C(Me)2CH2SMe
    86 H Me H H C(Me)2CH2S(═O)Me
    87 H Me H H C(Me)2CH2SO2Me
    88 H Me H H CH2C(═O)NHMe
    89 H Me H H CH2C(═O)N(Me)2
    90 H Me H H CH2C(═O)NHEt
    91 H Me H H CH2C(═O)NH—c-Pr
    92 H Me H H CH2C(═O)NHCH2CF3
    93 H Me Me H CH2Ph
    94 H Me Me H CH2-2-Py
    95 H Me Me H CH2-3-Py
    96 H Me Me H CH2CH2OH
    97 H Me Me H CH(CH3)CH2OH
    98 H Me Me H C(CH3)2CH2OH
    99 H Me Me H CH2CH2OMe
    100 H Me Me H CH(CH3)CH2OMe
    101 H Me Me H C(CH3)2CH2OMe
    102 H Me Me H CH2CH2SMe
    103 H Me Me H CH2CH2S(═O)Me
    104 H Me Me H CH2CH2SO2Me
    105 H Me Me H CH(Me)CH2SMe
    106 H Me Me H CHMeCH2S(═O)Me
    107 H Me Me H CH(Me)CH2SO2Me
    108 H Me Me H C(Me)2CH2SMe
    109 H Me Me H C(Me)2CH2S(═O)Me
    110 H Me Me H C(Me)2CH2SO2Me
    111 H Me Me H CH2C(═O)NHMe
    112 H Me Me H CH2C(═O)N(Me)2
    113 H Me Me H CH2C(═O)NHEt
    114 H Me Me H CH2C(═O)NH—c-Pr
    115 H Me Me H CH2C(═O)NHCH2CF3
    116 H H Me Me CH2Ph
    117 H H Me Me CH2-2-Py
    118 H H Me Me CH2-3-Py
    119 H H Me Me CH2CH2OH
    120 H H Me Me CH(CH3)CH2OH
    121 H H Me Me C(CH3)2CH2OH
    122 H H Me Me CH2CH2OMe
    123 H H Me Me CH(CH3)CH2OMe
    124 H H Me Me C(CH3)2CH2OMe
    125 H H Me Me CH2CH2SMe
    126 H H Me Me CH2CH2S(═O)Me
    127 H H Me Me CH2CH2SO2Me
    128 H H Me Me CH(Me)CH2SMe
    129 H H Me Me CHMeCH2S(═O)Me
    130 H H Me Me CH(Me)CH2SO2Me
    131 H H Me Me C(Me)2CH2SMe
    132 H H Me Me C(Me)2CH2S(═O)Me
    133 H H Me Me C(Me)2CH2SO2Me
    134 H H Me Me CH2C(═O)NHMe
    135 H H Me Me CH2C(═O)N(Me)2
    136 H H Me Me CH2C(═O)NHEt
    137 H H Me Me CH2C(═O)NH—c-Pr
    138 H H Me Me CH2C(═O)NHCH2CF3
  • TABLE 49
    Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd. Cmpd.
    1-1 1-2 1-3 1-4 1-5 1-6 1-7 1-8 1-9  1-10  1-11
     1-12  1-13  1-14  1-15  1-16  1-17  1-18  1-19  1-20  1-21  1-22
     1-23  1-24  1-25  1-26  1-27  1-28  1-29  1-30  1-31  1-32  1-33
     1-34  1-35  1-36  1-37  1-38  1-39  1-40  1-41  1-42  1-43  1-44
     1-45  1-46  1-47  1-48  1-49  1-50  1-51  1-52  1-53  1-54  1-55
     1-56  1-57  1-58  1-59  1-60  1-61  1-62  1-63  1-64  1-65  1-66
     1-67  1-68  1-69  1-70  1-71  1-72  1-73  1-74  1-75  1-76  1-77
     1-78  1-79  1-80  1-81  1-82  1-83  1-84  1-85  1-86  1-87  1-88
     1-89  1-90  1-91  1-92  1-93  1-94  1-95  1-96  1-97  1-98  1-99
     1-100  1-101  1-102  1-103  1-104  1-105  1-106  1-107  1-108  1-109  1-110
     1-111  1-112  1-113  1-114  1-115  1-116  1-117  1-118  1-119  1-120  1-121
     1-122  1-123  1-124  1-125  1-126  1-127  1-128  1-129  1-130  1-131  1-132
     1-133  1-134  1-135  1-136  1-137  1-138  1-139  1-140  1-141  1-142  1-143
     1-144  1-145  1-146  1-147  1-148  1-149  1-150  1-151  1-152  1-153  1-154
     1-155  1-156  1-157  1-158  1-159  1-160  1-161  1-162  1-163  1-164  1-165
     1-166  1-167  1-168  1-169  1-170  1-171  1-172  1-173  1-174  1-175  1-176
     1-177  1-178  1-179  1-180  1-181  1-182  1-183  1-184  2-93  2-94  2-95
     2-96  2-97  2-98  2-99  2-100  2-101  2-102  2-103  2-104  2-105  2-106
     2-107  3-93  3-94  3-95  3-96  3-97  3-98  3-99  3-100  3-101  3-102
     3-103  3-104  3-105  3-106  3-107  4-93  4-94  4-95  4-96  4-97  4-98
     4-99  4-100  4-101  4-102  4-103  4-104  4-105  4-106  4-107  4-108  4-109
    5-1 5-2 5-3 5-4 5-5 5-6 5-7 5-8 5-9  5-10  5-11
     5-12  5-13  5-14  5-15  5-16  5-17  5-18  5-19  5-20  5-21  5-22
     5-23  5-24  5-25  5-26  5-27  5-28  5-29  5-30  5-31  5-32  5-33
     5-34  5-35  5-36  5-37  5-38  5-39  5-40  5-41  5-42  5-43  5-44
     5-45  5-46  5-47  5-48  5-49  5-50  5-51  5-52  5-53  5-54  5-55
     5-56  5-57  5-58  5-59  5-60  5-61  5-62  5-63  5-64  5-65  5-66
     5-67  5-68  5-69  5-70  5-71  5-72  5-73  5-74  5-75  5-76  5-77
     5-78  5-79  5-80  5-81  5-82  5-83  5-84  5-85  5-86  5-87  5-88
     5-89  5-90  5-91  5-92  5-93  5-94  5-95  5-96  5-97  5-98  5-99
     5-100  5-101  5-102  5-103  5-104  5-105  5-106  5-107  5-108  5-109  5-110
     5-111  5-112  5-113  5-114  5-115  5-116  5-117  5-118  5-119  5-120  5-121
     5-122  5-123  5-124  5-125  5-126  5-127  5-128  5-129  5-130  5-131  5-132
     5-133  5-134  5-135  5-136  5-137  5-138  5-139  5-140  5-141  5-142  5-143
     5-144  5-145  5-146  5-147  5-148  5-149  5-150  5-151  5-152  5-153  5-154
     5-155  5-156  5-157  5-158  5-159  5-160  5-161  5-162  5-163  5-164  5-165
     5-166  5-167  5-168  5-169  5-170  5-171  5-172  5-173  5-174  5-175  5-176
     5-177  5-178  5-179  5-180  5-181  5-182  5-183  5-184  6-93  6-94  6-95
     6-96  6-97  6-98  6-99  6-100  6-101  6-102  6-103  6-104  6-105  6-106
     6-107  7-93  7-94  7-95  7-96  7-97  7-98  7-99  7-100  7-101  7-102
     7-103  7-104  7-105  7-106  7-107  8-93  8-94  8-95  8-96  8-97  8-98
     8-99  8-100  8-101  8-102  8-103  8-104  8-105  8-106  8-107  8-108  8-109
    9-1 9-2 9-3 9-4 9-5 9-6 9-7 9-8 9-9  9-10  9-11
     9-12  9-13  9-14  9-15  9-16  9-17  9-18  9-19  9-20  9-21  9-22
     9-23  9-24  9-25  9-26  9-27  9-28  9-29  9-30  9-31  9-32  9-33
     9-34  9-35  9-36  9-37  9-38  9-39  9-40  9-41  9-42  9-43  9-44
     9-45  9-46  9-47  9-48  9-49  9-50  9-51  9-52  9-53  9-54  9-55
     9-56  9-57  9-58  9-59  9-60 10-1  10-2  10-3  10-4  10-5  10-6 
    10-7  10-8  10-9  10-10 11-1  11-2  11-3  11-4  11-5  11-6  11-7 
    11-8  11-9  11-10 12-1  12-2  12-3  12-4  12-5  12-6  12-7  12-8 
    12-9  12-10 13-1  13-2  13-3  13-4  13-5  13-6  13-7  13-8  13-9 
    13-10 14-1  14-2  14-3  14-4  14-5  14-6  14-7  14-8  14-9  14-10
    15-1  15-2  15-3  15-4  15-5  15-6  15-7  15-8  15-9  15-10 16-1 
    16-2  16-3  16-4  16-5  16-6  16-7  16-8  16-9  16-10 16-11 16-12
    17-1  17-2  17-3  17-4  17-5  17-6  17-7  17-8  17-9  17-10 17-11
    17-12 17-13 17-14 17-15 17-16 17-17 17-18 17-19 17-20 17-21 17-22
    17-23 17-24 17-25 17-26 17-27 17-28 17-29 17-30 17-31 17-32 17-33
    17-34 17-35 17-36 17-37 17-38 17-39 17-40 17-41 17-42 17-43 17-44
    17-45 17-46 17-47 17-48 17-49 17-50 17-51 17-52 17-53 17-54 17-55
    17-56 17-57 17-58 17-59 17-60 18-1  18-2  18-3  18-4  18-5  18-6 
    18-7  18-9  18-9  18-10 19-1  19-2  19-3  19-4  19-5  19-6  19-7 
    19-8  19-9  19-10 20-1  20-2  20-3  20-4  20-5  20-6  20-7  20-8 
    20-9  20-10 20-11 20-12 20-13 20-14 20-15 20-16 20-17 20-18 20-19
    21-1  21-2  21-3  21-4  21-5  21-6  21-7  21-8  21-9  21-10 21-11
    21-12 21-13 21-14 21-15 21-16 21-17 21-18 21-19 21-20 21-21 21-22
    21-23 21-24 21-25 21-26 21-27 21-28 21-29 21-30 21-31 21-32 21-33
    21-34 21-35 21-36 21-37 21-38 21-39 21-40 21-41 21-42 21-43 21-44
    21-45 21-46 21-47 21-48 21-49 21-50 21-51 21-52 21-53 21-54 21-55
    21-56 21-57 21-58 21-59 21-60 22-1  22-2  22-3  22-4  22-5  22-6 
    22-7  22-9  22-9  22-10 23-1  23-2  23-3  23-4  23-5  23-6  23-7 
    23-8  23-9  23-10 24-1  24-2  24-3  24-4  24-5  24-6  24-7  24-8 
    24-9  24-10 24-11 24-12 24-13 24-14 24-15 24-16 24-17 24-18 24-19
    25-1  25-2  25-3  25-4  25-5  25-6  25-7  25-8  25-9  25-10 25-11
    25-12 25-13 25-14 25-15 25-16 25-17 25-18 25-19 25-20 25-21 25-22
    25-23 25-24 25-25 25-26 25-27 25-28 25-29 25-30 25-31 25-32 25-33
    25-34 25-35 25-36 25-37 25-38 25-39 25-40 25-41 25-42 25-43 25-44
    25-45 25-46 25-47 25-48 25-49 25-50 25-51 25-52 25-53 25-54 25-55
    25-56 25-57 25-58 25-59 25-60 25-61 25-62 25-63 25-64 25-65 25-66
    25-67 25-68 25-69 25-70 25-71 25-72 25-73 25-74 25-75 25-76 25-77
    25-78 25-79 25-80 26-1  26-2  26-3  26-4  26-5  26-6  26-7  27-1 
    27-2  27-3  27-4  27-5  27-6  27-7  28-1  28-2  28-3  28-4  28-5 
    28-6  28-7  29-1  29-2  29-3  29-4  29-5  29-6  29-7  30-1  30-2 
    30-3  30-4  30-5  30-6  30-7  31-1  31-2  31-3  31-4  31-5  31-6 
    31-7  32-1  32-2  32-3  32-4  32-5  32-6  32-7  32-8  32-9  32-10
    33-1  33-2  33-3  33-4  33-5  33-6  33-7  33-8  33-9  33-10 33-11
    33-12 33-13 33-14 33-15 33-16 33-17 33-18 33-19 33-20 33-21 33-22
    33-23 33-24 33-25 33-26 33-27 33-28 33-29 33-30 33-31 33-32 33-33
    33-34 33-35 33-36 33-37 33-38 33-39 33-40 33-41 33-42 33-43 33-44
    33-45 33-46 33-47 33-48 33-49 33-50 33-51 33-52 33-53 33-54 33-55
    33-56 33-57 33-58 33-59 33-60 33-61 33-62 33-63 33-64 33-65 33-66
    33-67 33-68 33-69 33-70 34-11 34-12 34-13 34-14 34-15 34-16 34-17
    34-18 34-19 34-20 34-21 34-22 34-23 34-24 34-25 34-26 34-27 34-28
    34-29 34-30 34-46 34-47 34-48 34-49 34-50 34-51 34-52 34-53 34-54
    34-55 35-11 35-12 35-13 35-14 35-15 35-16 35-17 35-18 35-19 35-20
    35-20 35-21 35-22 35-23 35-24 35-25 35-26 35-27 35-28 35-29 35-30
    35-46 35-47 35-48 35-49 35-50 35-51 35-52 35-53 35-54 35-55 36-11
    36-12 36-13 36-14 36-15 36-16 36-17 36-18 36-19 36-20 36-22 36-23
    36-24 36-25 36-26 36-27 36-28 36-29 36-30 36-46 36-47 36-48 36-49
    36-49 36-50 36-51 36-52 36-53 36-54 36-55 37-11 37-12 37-13 37-14
    37-14 37-15 37-16 37-17 37-18 37-19 37-20 37-22 37-23 37-24 37-25
    37-26 37-27 37-28 37-29 37-30 37-46 37-47 37-48 37-49 37-50 37-51
    37-52 37-53 37-54 37-55 38-11 38-12 38-13 38-14 38-15 38-16 38-17
    38-18 38-19 38-20 38-21 38-22 38-23 38-24 38-25 38-26 38-27 38-28
    38-29 38-30 38-46 38-47 38-48 38-49 38-50 38-51 38-52 38-53 38-54
    38-55 39-11 39-12 39-13 39-14 39-15 39-16 39-17 39-18 39-19 39-20
    39-20 39-21 39-22 39-23 39-24 39-25 39-26 39-27 39-28 39-29 39-30
    39-46 39-47 39-48 39-49 39-50 39-51 39-52 39-53 39-54 39-55 40-11
    40-12 40-13 40-14 40-15 40-16 40-17 40-18 40-19 40-20 40-22 40-23
    40-24 40-25 40-26 40-27 40-28 40-29 40-30 40-46 40-47 40-48 40-49
    40-50 40-51 40-52 40-53 40-54 40-55 40-56 40-57 40-58 40-59 40-60
    41-1  41-2  41-3  41-4  41-5  41-6  41-7  41-8  41-9  41-10 41-11
    41-12 41-13 41-14 41-15 41-16 41-17 41-18 41-19 41-20 41-21 41-22
    41-23 41-24 41-25 41-26 41-27 41-28 41-29 41-30 41-31 41-32 41-33
    41-34 41-35 41-36 41-37 41-38 41-39 41-40 41-41 41-42 41-43 41-44
    41-45 41-46 41-47 41-48 41-49 41-50 41-51 41-52 41-53 41-54 41-55
    41-56 41-57 41-58 41-59 41-60 41-61 41-62 41-63 41-64 41-65 41-66
    41-67 41-68 41-69 41-70 41-71 41-72 41-73 41-74 41-75 41-76 41-77
    41-78 41-79 41-80 41-81 41-82 41-83 41-84 41-85 41-86 41-87 41-88
    41-89 41-90 41-91 41-92 41-93 41-94 41-95 41-96 41-97 41-98 41-99
     41-100  41-101  41-102  41-103  41-104  41-105  41-106  41-107  41-108  41-109  41-110
     41-111  41-112  41-113  41-114  41-115  41-116  41-117  41-118  41-119  41-120  41-121
     41-122  41-123  41-124  41-125  41-126  41-127  41-128  41-129  41-130  41-131  41-132
     41-133  41-134  41-135  41-136  41-137  41-138 42-1  42-2  42-3  42-4  42-5 
    42-6  42-7  42-8  42-9  42-10 42-11 42-12 42-13 42-14 42-15 42-16
    42-17 42-18 42-19 42-20 42-21 42-22 42-23 42-70 42-71 42-72 42-73
    42-74 42-75 42-76 42-77 42-78 42-79 42-80 42-81 42-82 42-83 42-84
    42-85 42-86 42-87 42-88 42-89 42-90 42-91 42-92 43-1  43-2  43-3 
    43-4  43-5  43-6  43-7  43-8  43-9  43-10 43-11 43-12 43-13 43-14
    43-15 43-16 43-17 43-18 43-19 43-20 43-21 43-22 43-23 43-70 43-71
    43-72 43-73 43-74 43-75 43-76 43-77 43-78 43-79 43-80 43-81 43-82
    43-83 43-84 43-85 43-86 43-87 43-88 43-89 43-90 43-91 43-92 44-1 
    44-2  44-3  44-4  44-5  44-6  44-7  44-8  44-9  44-10 44-11 44-12
    44-13 44-14 44-15 44-16 44-17 44-18 44-19 44-20 44-21 44-22 44-23
    44-70 44-71 44-72 44-73 44-74 44-75 44-76 44-77 44-78 44-79 44-80
    44-81 44-82 44-83 44-84 44-85 44-86 44-87 44-88 44-89 44-90 44-91
    44-92 45-1  45-2  45-3  45-4  45-5  45-6  45-7  45-8  45-9  45-10
    45-11 45-12 45-13 45-14 45-15 45-16 45-17 45-18 45-19 45-20 45-21
    45-22 45-23 45-70 45-71 45-72 45-73 45-74 45-75 45-76 45-77 45-78
    45-79 45-80 45-81 45-82 45-83 45-84 45-85 45-86 45-87 45-88 45-89
    45-90 45-91 45-92 46-1  46-2  46-3  46-4  46-5  46-6  46-7  46-8 
    46-9  46-10 46-11 46-12 46-13 46-14 46-15 46-16 46-17 46-18 46-19
    46-20 46-21 46-22 46-23 46-70 46-71 46-72 46-73 46-74 46-75 46-76
    46-77 46-78 46-79 46-80 46-81 46-82 46-83 46-84 46-85 46-86 46-87
    46-88 46-89 46-90 46-91 46-92 47-1  47-2  47-3  47-4  47-5  47-6 
    47-7  47-8  47-9  47-10 47-11 47-12 47-13 47-14 47-15 47-16 47-17
    47-18 47-19 47-20 47-21 47-22 47-23 47-70 47-71 47-72 47-73 47-74
    47-75 47-76 47-77 47-78 47-79 47-80 47-81 47-82 47-83 47-84 47-85
    47-86 47-87 47-88 47-89 47-90 47-91 47-92 48-1  48-2  48-3  48-4 
    48-5  48-6  48-7  48-8  48-9  48-10 48-11 48-12 48-13 48-14 48-15
    48-16 48-17 48-18 48-19 48-20 48-21 48-22 48-23 48-70 48-71 48-72
    48-73 48-74 48-75 48-76 48-77 48-78 48-79 48-80 48-81 48-82 48-83
    48-84 48-85 48-86 48-87 48-88 48-89 48-90 48-91 48-92 48-93 48-94
  • TABLE 50
    Figure US20150098928A9-20150409-C00110
    Cmpd. R2 R16 R17
    1 3-Cl, 5-Cl Me Me
    2 3-Cl, 5-Cl Et Me
    3 3-Cl, 5-Cl n-Pr Me
    4 3-Cl, 5-Cl Et Et
    5 3-Cl, 5-Cl i-Pr i-Pr
    6 3-Br, 5-Br Me Me
    7 3-Br, 5-Br Et Me
    8 3-Br, 5-Br n-Pr Me
    9 3-Br, 5-Br Et Et
    10 3-Br, 5-Br i-Pr i-Pr
    11 3-Cl, 4-Cl, 5-Cl Me Me
    12 3-Cl, 4-Cl, 5-Cl Et Me
    13 3-Cl, 4-Cl, 5-Cl n-Pr Me
    14 3-Cl, 4-Cl, 5-Cl Et Et
    15 3-Cl, 4-Cl, 5-Cl i-Pr i-Pr
    16 3-Cl, 4-F, 5-Cl Me Me
    17 3-Cl, 4-F, 5-Cl Et Me
    18 3-Cl, 4-F, 5-Cl n-Pr Me
    19 3-Cl, 4-F, 5-Cl Et Et
    20 3-Cl, 4-F, 5-Cl i-Pr i-Pr
    21 3-Cl Me Me
    22 3-Cl Et Me
    23 3-Cl n-Pr Me
    24 3-Cl Et Et
    25 3-Cl i-Pr i-Pr
    26 3-Br Me Me
    27 3-Br Et Me
    28 3-Br n-Pr Me
    29 3-Br Et Et
    30 3-Br i-Pr i-Pr
    31 3-CF3, 5-CF3 Me Me
    32 3-CF3, 5-CF3 Et Me
    33 3-CF3, 5-CF3 n-Pr Me
    34 3-CF3, 5-CF3 Et Et
    35 3-CF3, 5-CF3 i-Pr i-Pr
    36 3-CF3, 5-Cl Me Me
    37 3-CF3, 5-Cl Et Me
    38 3-CF3, 5-Cl n-Pr Me
    39 3-CF3, 5-Cl Et Et
    40 3-CF3, 5-Cl i-Pr i-Pr
    41 3-CF3, 5-Br Me Me
    42 3-CF3, 5-Br Et Me
    43 3-CF3, 5-Br n-Pr Me
    44 3-CF3, 5-Br Et Et
    45 3-CF3, 5-Br i-Pr i-Pr
    46 3-Cl, 4-CN, 5-Cl Me Me
    47 3-Cl, 4-CN, 5-Cl Et Me
    48 3-Cl, 4-CN, 5-Cl n-Pr Me
    49 3-Cl, 4-CN, 5-Cl Et Et
    50 3-Cl, 4-CN, 5-Cl i-Pr i-Pr
    51 3-Cl, 4-Me, 5-Cl Me Me
    52 3-Cl, 4-Me, 5-Cl Et Me
    53 3-Cl, 4-Me, 5-Cl n-Pr Me
    54 3-Cl, 4-Me, 5-Cl Et Et
    55 3-Cl, 4-Me, 5-Cl i-Pr i-Pr
    56 3-CF3 Me H
    57 3-CF3 Me C(═O)CF3
    58 3-CF3 Me CN
    59 3-CF3 Et H
    60 3-CF3 Et C(═O)CF3
  • TABLE 51
    Figure US20150098928A9-20150409-C00111
    Cmpd. R2 R19 R20
    1 3-Cl, 5-Cl Me H
    2 3-Cl, 5-Cl Me C(═O)CF3
    3 3-Cl, 5-Cl Me CN
    4 3-Cl, 5-Cl Et H
    5 3-Cl, 5-Cl Et C(═O)CF3
    6 3-Br, 5-Br Me H
    7 3-Br, 5-Br Me C(═O)CF3
    8 3-Br, 5-Br Me CN
    9 3-Br, 5-Br Et H
    10 3-Br, 5-Br Et C(═O)CF3
    11 3-Cl, 4-Cl, 5-Cl Me H
    12 3-Cl, 4-Cl, 5-Cl Me C(═O)CF3
    13 3-Cl, 4-Cl, 5-Cl Me CN
    14 3-Cl, 4-Cl, 5-Cl Et H
    15 3-Cl, 4-Cl, 5-Cl Et C(═O)CF3
    16 3-Cl, 4-F, 5-Cl Me H
    17 3-Cl, 4-F, 5-Cl Me C(═O)CF3
    18 3-Cl, 4-F, 5-Cl Me CN
    19 3-Cl, 4-F, 5-Cl Et H
    20 3-Cl, 4-F, 5-Cl Et C(═O)CF3
    21 3-Cl Me H
    22 3-Cl Me C(═O)CF3
    23 3-Cl Me CN
    24 3-Cl Et H
    25 3-Cl Et C(═O)CF3
    26 3-Br Me H
    27 3-Br Me C(═O)CF3
    28 3-Br Me CN
    29 3-Br Et H
    30 3-Br Et C(═O)CF3
    31 3-CF3, 5-CF3 Me H
    32 3-CF3, 5-CF3 Me C(═O)CF3
    33 3-CF3, 5-CF3 Me CN
    34 3-CF3, 5-CF3 Et H
    35 3-CF3, 5-CF3 Et C(═O)CF3
    36 3-CF3, 5-Cl Me C(═O)CF3
    37 3-CF3, 5-Cl Me CN
    38 3-CF3, 5-Cl Me H
    39 3-CF3, 5-Cl Et C(═O)CF3
    40 3-CF3, 5-Cl Et i-Pr
    41 3-CF3, 5-Br Me H
    42 3-CF3, 5-Br Me C(═O)CF3
    43 3-CF3, 5-Br Me CN
    44 3-CF3, 5-Br Et H
    45 3-CF3, 5-Br Et C(═O)CF3
    46 3-Cl, 4-CN, 5-Cl Me H
    47 3-Cl, 4-CN, 5-Cl Me C(═O)CF3
    48 3-Cl, 4-CN, 5-Cl Me CN
    49 3-Cl, 4-CN, 5-Cl Et H
    50 3-Cl, 4-CN, 5-Cl Et C(═O)CF3
    51 3-Cl, 4-Me, 5-Cl Me H
    52 3-Cl, 4-Me, 5-Cl Me C(═O)CF3
    53 3-Cl, 4-Me, 5-Cl Me CN
    54 3-Cl, 4-Me, 5-Cl Et H
    55 3-Cl, 4-Me, 5-Cl Et C(═O)CF3
    56 3-CF3 Me H
    57 3-CF3 Me C(═O)CF3
    58 3-CF3 Me CN
    59 3-CF3 Et H
    60 3-CF3 Et C(═O)CF3
  • TABLE 52
    Figure US20150098928A9-20150409-C00112
    Cmpd. R2 R19 R20
    1 3-Cl, 5-Cl Me H
    2 3-Cl, 5-Cl Me C(═O)CF3
    3 3-Cl, 5-Cl Me CN
    4 3-Cl, 5-Cl Et H
    5 3-Cl, 5-Cl Et C(═O)CF3
    6 3-Br, 5-Br Me H
    7 3-Br, 5-Br Me C(═O)CF3
    8 3-Br, 5-Br Me CN
    9 3-Br, 5-Br Et H
    10 3-Br, 5-Br Et C(═O)CF3
    11 3-Cl, 4-Cl, 5-Cl Me H
    12 3-Cl, 4-Cl, 5-Cl Me C(═O)CF3
    13 3-Cl, 4-Cl, 5-Cl Me CN
    14 3-Cl, 4-Cl, 5-Cl Et H
    15 3-Cl, 4-Cl, 5-Cl Et C(═O)CF3
    16 3-Cl, 4-F, 5-Cl Me H
    17 3-Cl, 4-F, 5-Cl Me C(═O)CF3
    18 3-Cl, 4-F, 5-Cl Me CN
    19 3-Cl, 4-F, 5-Cl Et H
    20 3-Cl, 4-F, 5-Cl Et C(═O)CF3
    21 3-Cl Me H
    22 3-Cl Me C(═O)CF3
    23 3-Cl Me CN
    24 3-Cl Et H
    25 3-Cl Et C(═O)CF3
    26 3-Br Me H
    27 3-Br Me C(═O)CF3
    28 3-Br Me CN
    29 3-Br Et H
    30 3-Br Et C(═O)CF3
    31 3-CF3, 5-CF3 Me H
    32 3-CF3, 5-CF3 Me C(═O)CF3
    33 3-CF3, 5-CF3 Me CN
    34 3-CF3, 5-CF3 Et H
    35 3-CF3, 5-CF3 Et C(═O)CF3
    36 3-CF3, 5-Cl Me C(═O)CF3
    37 3-CF3, 5-Cl Me CN
    38 3-CF3, 5-Cl Me H
    39 3-CF3, 5-Cl Et C(═O)CF3
    40 3-CF3, 5-Cl Et i-Pr
    41 3-CF3, 5-Br Me H
    42 3-CF3, 5-Br Me C(═O)CF3
    43 3-CF3, 5-Br Me CN
    44 3-CF3, 5-Br Et H
    45 3-CF3, 5-Br Et C(═O)CF3
    46 3-Cl, 4-CN, 5-Cl Me H
    47 3-Cl, 4-CN, 5-Cl Me C(═O)CF3
    48 3-Cl, 4-CN, 5-Cl Me CN
    49 3-Cl, 4-CN, 5-Cl Et H
    50 3-Cl, 4-CN, 5-Cl Et C(═O)CF3
    51 3-Cl, 4-Me, 5-Cl Me H
    52 3-Cl, 4-Me, 5-Cl Me C(═O)CF3
    53 3-Cl, 4-Me, 5-Cl Me CN
    54 3-Cl, 4-Me, 5-Cl Et H
    55 3-Cl, 4-Me, 5-Cl Et C(═O)CF3
    56 3-CF3 Me H
    57 3-CF3 Me C(═O)CF3
    58 3-CF3 Me CN
    59 3-CF3 Et H
    60 3-CF3 Et C(═O)CF3
    • Formulation/Utility
  • A compound of this invention will generally be used as an invertebrate pest control active ingredient in a composition, i.e. formulation, with at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, which serves as a carrier. The formulation or composition ingredients are selected to be consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature.
  • Useful formulations include both liquid and solid compositions. Liquid compositions include solutions (including emulsifiable concentrates), suspensions, emulsions (including microemulsions and/or suspoemulsions) and the like, which optionally can be thickened into gels. The general types of aqueous liquid compositions are soluble concentrate, suspension concentrate, capsule suspension, concentrated emulsion, microemulsion and suspo-emulsion.
  • The general types of nonaqueous liquid compositions are emulsifiable concentrate, microemulsifiable concentrate, dispersible concentrate and oil dispersion.
  • The general types of solid compositions are dusts, powders, granules, pellets, prills, pastilles, tablets, filled films (including seed coatings) and the like, which can be water-dispersible (“wettable”) or water-soluble. Films and coatings formed from film-forming solutions or flowable suspensions are particularly useful for seed treatment. Active ingredient can be (micro)encapsulated and further formed into a suspension or solid formulation; alternatively the entire formulation of active ingredient can be encapsulated (or “overcoated”). Encapsulation can control or delay release of the active ingredient. An emulsifiable granule combines the advantages of both an emulsifiable concentrate formulation and a dry granular formulation. High-strength compositions are primarily used as intermediates for further formulation.
  • Sprayable formulations are typically extended in a suitable medium before spraying. Such liquid and solid formulations are formulated to be readily diluted in the spray medium, usually water. Spray volumes can range from about from about one to several thousand liters per hectare, but more typically are in the range from about ten to several hundred liters per hectare. Sprayable formulations can be tank mixed with water or another suitable medium for foliar treatment by aerial or ground application, or for application to the growing medium of the plant. Liquid and dry formulations can be metered directly into drip irrigation systems or metered into the furrow during planting. Liquid and solid formulations can be applied onto seeds of crops and other desirable vegetation as seed treatments before planting to protect developing roots and other subterranean plant parts and/or foliage through systemic uptake.
  • The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up to 100 percent by weight.
  • Weight Percent
    Active
    Ingredient Diluent Surfactant
    Water-Dispersible and Water- 0.001-90 0-99.999 0-15
    soluble Granules, Tablets and
    Powders
    Oil Dispersions, Suspensions,    1-50 40-99    0-50
    Emulsions, Solutions
    (including Emulsifiable
    Concentrates)
    Dusts    1-25 70-99    0-5 
    Granules and Pellets 0.001-95 5-99.999 0-15
    High Strength Compositions   90-99 0-10    0-2 
  • Solid diluents include, for example, clays such as bentonite, montmorillonite, attapulgite and kaolin, gypsum, cellulose, titanium dioxide, zinc oxide, starch, dextrin, sugars (e.g., lactose, sucrose), silica, talc, mica, diatomaceous earth, urea, calcium carbonate, sodium carbonate and bicarbonate, and sodium sulfate. Typical solid diluents are described in Watkins et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, N.J.
  • Liquid diluents include, for example, water, N,N-dimethylalkanamides (e.g., N,N-dimethylformamide), limonene, dimethyl sulfoxide, N-alkypyrrolidones (e.g., N-methylpyrrolidinone), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propylene carbonate, butylene carbonate, paraffins (e.g., white mineral oils, normal paraffins, isoparaffins), alkylbenzenes, alkylnaphthalenes, glycerine, glycerol triacetate, sorbitol, triacetin, aromatic hydrocarbons, dearomatized aliphatics, alkylbenzenes, alkylnaphthalenes, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate, nonyl acetate, tridecyl acetate and isobornyl acetate, other esters such as alkylated lactate esters, dibasic esters and γ-butyrolactone, and alcohols, which can be linear, branched, saturated or unsaturated, such as methanol, ethanol, n-propanol, isopropyl alcohol, n-butanol, isobutyl alcohol, n-hexanol, 2-ethylhexanol, n-octanol, decanol, isodecyl alcohol, isooctadecanol, cetyl alcohol, lauryl alcohol, tridecyl alcohol, oleyl alcohol, cyclohexanol, tetrahydrofurfuryl alcohol, diacetone alcohol and benzyl alcohol. Liquid diluents also include glycerol esters of saturated and unsaturated fatty acids (typically C6-C22), such as plant seed and fruit oils (e.g, oils of olive, castor, linseed, sesame, corn (maize), peanut, sunflower, grapeseed, safflower, cottonseed, soybean, rapeseed, coconut and palm kernel), animal-sourced fats (e.g., beef tallow, pork tallow, lard, cod liver oil, fish oil), and mixtures thereof. Liquid diluents also include alkylated fatty acids (e.g., methylated, ethylated, butylated) wherein the fatty acids may be obtained by hydrolysis of glycerol esters from plant and animal sources, and can be purified by distillation. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950.
  • The solid and liquid compositions of the present invention often include one or more surfactants. When added to a liquid, surfactants (also known as “surface-active agents”) generally modify, most often reduce, the surface tension of the liquid. Depending on the nature of the hydrophilic and lipophilic groups in a surfactant molecule, surfactants can be useful as wetting agents, dispersants, emulsifiers or defoaming agents.
  • Surfactants can be classified as nonionic, anionic or cationic. Nonionic surfactants useful for the present compositions include, but are not limited to: alcohol alkoxylates such as alcohol alkoxylates based on natural and synthetic alcohols (which may be branched or linear) and prepared from the alcohols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof; amine ethoxylates, alkanolamides and ethoxylated alkanolamides; alkoxylated triglycerides such as ethoxylated soybean, castor and rapeseed oils; alkylphenol alkoxylates such as octylphenol ethoxylates, nonylphenol ethoxylates, dinonyl phenol ethoxylates and dodecyl phenol ethoxylates (prepared from the phenols and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); block polymers prepared from ethylene oxide or propylene oxide and reverse block polymers where the terminal blocks are prepared from propylene oxide; ethoxylated fatty acids; ethoxylated fatty esters and oils; ethoxylated methyl esters; ethoxylated tristyrylphenol (including those prepared from ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); fatty acid esters, glycerol esters, lanolin-based derivatives, polyethoxylate esters such as polyethoxylated sorbitan fatty acid esters, polyethoxylated sorbitol fatty acid esters and polyethoxylated glycerol fatty acid esters; other sorbitan derivatives such as sorbitan esters; polymeric surfactants such as random copolymers, block copolymers, alkyd peg (polyethylene glycol) resins, graft or comb polymers and star polymers; polyethylene glycols (pegs); polyethylene glycol fatty acid esters; silicone-based surfactants; and sugar-derivatives such as sucrose esters, alkyl polyglycosides and alkyl polysaccharides.
  • Useful anionic surfactants include, but are not limited to: alkylaryl sulfonic acids and their salts; carboxylated alcohol or alkylphenol ethoxylates; diphenyl sulfonate derivatives; lignin and lignin derivatives such as lignosulfonates; maleic or succinic acids or their anhydrides; olefin sulfonates; phosphate esters such as phosphate esters of alcohol alkoxylates, phosphate esters of alkylphenol alkoxylates and phosphate esters of styryl phenol ethoxylates; protein-based surfactants; sarcosine derivatives; styryl phenol ether sulfate; sulfates and sulfonates of oils and fatty acids; sulfates and sulfonates of ethoxylated alkylphenols; sulfates of alcohols; sulfates of ethoxylated alcohols; sulfonates of amines and amides such as N,N-alkyltaurates; sulfonates of benzene, cumene, toluene, xylene, and dodecyl and tridecylbenzenes; sulfonates of condensed naphthalenes; sulfonates of naphthalene and alkyl naphthalene; sulfonates of fractionated petroleum; sulfosuccinamates; and sulfosuccinates and their derivatives such as dialkyl sulfosuccinate salts.
  • Useful cationic surfactants include, but are not limited to: amides and ethoxylated amides; amines such as N-alkyl propanediamines, tripropylenetriamincs and dipropylenetetramines, and ethoxylated amines, ethoxylated diamines and propoxylated amines (prepared from the amines and ethylene oxide, propylene oxide, butylene oxide or mixtures thereof); amine salts such as amine acetates and diamine salts; quaternary ammonium salts such as quaternary salts, ethoxylated quaternary salts and diquaternary salts; and amine oxides such as alkyldimethylamine oxides and bis-(2-hydroxyethyl)-alkylamine oxides.
  • Also useful for the present compositions are mixtures of nonionic and anionic surfactants or mixtures of nonionic and cationic surfactants. Nonionic, anionic and cationic surfactants and their recommended uses are disclosed in a variety of published references including McCutcheon's Emulsifiers and Detergents, annual American and International Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964; and A. S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987.
  • Compositions of this invention may also contain formulation auxiliaries and additives, known to those skilled in the art as formulation aids (some of which may be considered to also function as solid diluents, liquid diluents or surfactants). Such formulation auxiliaries and additives may control: pH (buffers), foaming during processing (antifoams such polyorganosiloxanes), sedimentation of active ingredients (suspending agents), viscosity (thixotropic thickeners), in-container microbial growth (antimicrobials), product freezing (antifreezes), color (dyes/pigment dispersions), wash-off (film formers or stickers), evaporation (evaporation retardants), and other formulation attributes. Film formers include, for example, polyvinyl acetates, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymer, polyvinyl alcohols, polyvinyl alcohol copolymers and waxes. Examples of formulation auxiliaries and additives include those listed in McCutcheon's Volume 2: Functional Materials, annual International and North American editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; and PCT Publication WO 03/024222.
  • The compound of Formula 1 and any other active ingredients are typically incorporated into the present compositions by dissolving the active ingredient in a solvent or by grinding in a liquid or dry diluent. Solutions, including emulsifiable concentrates, can be prepared by simply mixing the ingredients. If the solvent of a liquid composition intended for use as an emulsifiable concentrate is water-immiscible, an emulsifier is typically added to emulsify the active-containing solvent upon dilution with water. Active ingredient slurries, with particle diameters of up to 2,000 μm can be wet milled using media mills to obtain particles with average diameters below 3 μm. Aqueous slurries can be made into finished suspension concentrates (see, for example, U.S. Pat. No. 3,060,084) or further processed by spray drying to form water-dispersible granules. Dry formulations usually require dry milling processes, which produce average particle diameters in the 2 to 10 μm range. Dusts and powders can be prepared by blending and usually grinding (such as with a hammer mill or fluid-energy mill). Granules and pellets can be prepared by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, “Agglomeration”, Chemical Engineering, Dec. 4, 1967, pp 147-48, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and WO 91/13546. Pellets can be prepared as described in U.S. Pat. No. 4,172,714. Water-dispersible and water-soluble granules can be prepared as taught in U.S. Pat. No. 4,144,050, U.S. Pat. No. 3,920,442 and DE 3,246,493. Tablets can be prepared as taught in U.S. Pat. No. 5,180,587, U.S. Pat. No. 5,232,701 and U.S. Pat. No. 5,208,030. Films can be prepared as taught in GB 2,095,558 and U.S. Pat. No. 3,299,566.
  • For further information regarding the art of formulation, see T. S. Woods, “The Formulator's Toolbox—Product Forms for Modern Agriculture” in Pesticide Chemistry and Bioscience, The Food-Environment Challenge, T. Brooks and T. R. Roberts, Eds., Proceedings of the 9th International Congress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. Pat. No. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. Pat. No. 3,309,192, Col. 5, line 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138-140, 162-164, 166, 167 and 169-182; U.S. Pat. No. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989; and Developments in formulation technology, PJB Publications, Richmond, UK, 2000.
  • In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Tables A-G. Without further elaboration, it is believed that one skilled in the art using the preceding description can utilize the present invention to its fullest extent. The following Examples are, therefore, to be constructed as merely illustrative, and not limiting of the disclosure in any way whatsoever. Percentages are by weight except where otherwise indicated.
    • Example A
  • High Strength Concentrate
  •
    Compound 4 98.5%
    silica aerogel 0.5%
    synthetic amorphous fine silica 1.0%
    • Example B
  • Wettable Powder
  •
    Compound 44 65.0%
    dodecylphenol polyethylene glycol ether 2.0%
    sodium ligninsulfonate 4.0%
    sodium silicoaluminate 6.0%
    montmorillonite (calcined) 23.0%
    • Example C
  • Granule
  •
    Compound 47 10.0%
    attapulgite granules (low volatile matter, 90.0%
    0.71/0.30 mm; U.S.S. No. 25-50 sieves)
    • Example D
  • Extruded Pellet
  •
    Compound 49 25.0%
    anhydrous sodium sulfate 10.0%
    crude calcium ligninsulfonate 5.0%
    sodium alkylnaphthalenesulfonate 1.0%
    calcium/magnesium bentonite 59.0%
    • Example E
  • Emulsifiable Concentrate
  •
    Compound 50 10.0%
    polyoxyethylene sorbitol hexoleate 20.0%
    C6-C10 fatty acid methyl ester 70.0%
    • Example F
  • Microemulsion
  •
    Compound 45 5.0%
    polyvinylpyrrolidone-vinyl acetate copolymer 30.0%
    alkylpolyglycoside 30.0%
    glyceryl monooleate 15.0%
    water 20.0%
    • Example G
  • Seed Treatment
  •
    Compound 66 20.00%
    polyvinylpyrrolidone-vinyl acetate copolymer 5.00%
    montan acid wax 5.00%
    calcium ligninsulfonate 1.00%
    polyoxyethylene/polyoxypropylene block copolymers 1.00%
    stearyl alcohol (POE 20) 2.00%
    polyorganosilane 0.20%
    colorant red dye 0.05%
    water 65.75%
    • Example H
  • Fertilizer Stick
  •
    Compound 76 2.50%
    pyrrolidone-styrene copolymer 4.80%
    tristyrylphenyl 16-ethoxylate 2.30%
    talc 0.80%
    corn starch 5.00%
    Nitrophoska ® Permanent 15-9-15 slow-release fertilizer 36.00%
    (BASF)
    kaolin 38.00%
    water 10.60%
  • Compounds of this invention exhibit activity against a wide spectrum of invertebrate pests. These pests include invertebrates inhabiting a variety of environments such as, for example, plant foliage, roots, soil, harvested crops or other foodstuffs, building structures or animal integuments. These pests include, for example, invertebrates feeding on foliage (including leaves, stems, flowers and fruits), seeds, wood, textile fibers or animal blood or tissues, and thereby causing injury or damage to, for example, growing or stored agronomic crops, forests, greenhouse crops, ornamentals, nursery crops, stored foodstuffs or fiber products, or houses or other structures or their contents, or being harmful to animal health or public health. Those skilled in the art will appreciate that not all compounds are equally effective against all growth stages of all pests.
  • These present compounds and compositions are thus useful agronomically for protecting field crops from phytophagous invertebrate pests, and also nonagronomically for protecting other horticultural crops and plants from phytophagous invertebrate pests. This utility includes protecting crops and other plants (i.e. both agronomic and nonagronomic) that contain genetic material introduced by genetic engineering (i.e. transgenic) or modified by mutagenesis to provide advantageous traits. Examples of such traits include tolerance to herbicides, resistance to phytophagous pests (e.g., insects, mites, aphids, spiders, nematodes, snails, plant-pathogenic fungi, bacteria and viruses), improved plant growth, increased tolerance of adverse growing conditions such as high or low temperatures, low or high soil moisture, and high salinity, increased flowering or fruiting, greater harvest yields, more rapid maturation, higher quality and/or nutritional value of the harvested product, or improved storage or process properties of the harvested products. Transgenic plants can be modified to express multiple traits. Examples of plants containing traits provided by genetic engineering or mutagenesis include varieties of corn, cotton, soybean and potato expressing an insecticidal Bacillus thuringiensis toxin such as YIELD GARD®, KNOCKOUT®, STARLINK®, BOLLGARD®, NuCOTN® and NEWLEAF®, and herbicide-tolerant varieties of corn, cotton, soybean and rapeseed such as ROUNDUP READY®, LIBERTY LINK®, IMI®, STS® and CLEARFIELD®, as well as crops expressing N-acetyltransferase (GAT) to provide resistance to glyphosate herbicide, or crops containing the HRA gene providing resistance to herbicides inhibiting acetolactate synthase (ALS). The present compounds and compositions may interact synergistically with traits introduced by genetic engineering or modified by mutagenesis, thus enhancing phenotypic expression or effectiveness of the traits or increasing the invertebrate pest control effectiveness of the present compounds and compositions. In particular, the present compounds and compositions may interact synergistically with the phenotypic expression of proteins or other natural products toxic to invertebrate pests to provide greater-than-additive control of these pests.
  • Compositions of this invention can also optionally comprise plant nutrients, e.g., a fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium, magnesium, iron, copper, boron, manganese, zinc, and molybdenum. Of note are compositions comprising at least one fertilizer composition comprising at least one plant nutrient selected from nitrogen, phosphorus, potassium, sulfur, calcium and magnesium. Compositions of the present invention which further comprise at least one plant nutrient can be in the form of liquids or solids. Of note are solid formulations in the form of granules, small sticks or tablets. Solid formulations comprising a fertilizer composition can be prepared by mixing the compound or composition of the present invention with the fertilizer composition together with formulating ingredients and then preparing the formulation by methods such as granulation or extrusion. Alternatively solid formulations can be prepared by spraying a solution or suspension of a compound or composition of the present invention in a volatile solvent onto a previous prepared fertilizer composition in the form of dimensionally stable mixtures, e.g., granules, small sticks or tablets, and then evaporating the solvent.
  • Examples of agronomic or nonagronomic invertebrate pests include eggs, larvae and adults of the order Lepidoptera, such as armyworms, cutworms, loopers, and heliothines in the family Noctuidae (e.g., pink stem borer (Sesamia inferens Walker), corn stalk borer (Sesamia nonagrioides Lefebvre), southern armyworm (Spodoptera eridania Cramer), fall armyworm (Spodoptera fugiperda J. E. Smith), beet armyworm (Spodoptera exigua Hübner), cotton leafworm (Spodoptera littoralis Boisduval), yellowstriped armyworm (Spodoptera ornithogalli Guenée), black cutworm (Agrotis ipsilon Hufnagel), velvetbean caterpillar (Anticarsia gemmatalis Hübner), green fruitworm (Lithophane antennata Walker), cabbage armyworm (Barathra brassicae Linnaeus), soybean looper (Pseudoplusia includens Walker), cabbage looper (Trichoplusia ni Hübner), tobacco budworm (Heliothis virescens Fabricius)); borers, casebearers, webworms, coneworms, cabbageworms and skeletonizers from the family Pyralidae (e.g., European corn borer (Ostrinia nubilalis Hübner), navel orangeworm (Amyelois transitella Walker), corn root webworm (Crambus caliginosellus Clemens), sod webworms (Pyralidae: Crambinae) such as sod worm (Herpetogramma licarsisalis Walker), sugarcane stem borer (Chilo infuscatellus Snellen), tomato small borer (Neoleucinodes elegantalis Guenée), green leafroller (Cnaphalocerus medinalis), grape leaffolder (Desmia funeralis Hübner), melon worm (Diaphania nitidalis Stoll), cabbage center grub (Helluala hydralis Guenée), yellow stem borer (Scirpophaga incertulas Walker), early shoot borer (Scirpophaga infuscatellus Snellen), white stem borer (Scirpophaga innotata Walker), top shoot borer (Scirpophaga nivella Fabricius), dark-headed rice borer (Chilo polychrysus Meyrick), cabbage cluster caterpillar (Crocidolomia binotalis English)); leafrollers, budworms, seed worms, and fruit worms in the family Tortricidae (e.g., codling moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza viteana Clemens), oriental fruit moth (Grapholita molesta Busck), citrus false codling moth (Cryptophlebia leucotreta Meyrick), citrus borer (Ecdytolopha aurantiana Lima), redbanded leafroller (Argyrotaenia velutinana Walker), obliquebanded leafroller (Choristoneura rosaceana Harris), light brown apple moth (Epiphyas postvittana Walker), European grape berry moth (Eupoecilia anmbiguella Hübner), apple bud moth (Pandemis pyrusana Kearfott), omnivorous leafroller (Platynota stultana Walsingham), barred fruit-tree tortrix (Pandemis cerasana Hübner), apple brown tortrix (Pandemis heparana Denis & Schiffermüller)); and many other economically important lepidoptera (e.g., diamondback moth (Plutella xylostella Linnaeus), pink bollworm (Pectinophora gossypiella Saunders), gypsy moth (Lymantria dispar Linnaeus), peach fruit borer (Carposina niponensis Walsingham), peach twig borer (Anarsia lineatella Zeller), potato tuberworm (Phthorimaea operculella Zeller), spotted teniform leafminer (Lithocolletis blancardella Fabricius), Asiatic apple leafminer (Lithocolletis ringoniella Matsumura), rice leaffolder (Lerodea eufala Edwards), apple leafminer (Leucoptera scitella Zeller)); eggs, nymphs and adults of the order Blattodea including cockroaches from the families Blattellidae and Blattidae (e.g., oriental cockroach (Blatta orientalis Linnaeus), Asian cockroach (Blatella asahinai Mizukubo), German cockroach (Blattella germanica Linnaeus), brownbanded cockroach (Supella longipalpa Fabricius), American cockroach (Periplaneta americana Linnaeus), brown cockroach (Periplaneta brunnea Burmeister), Madeira cockroach (Leucophaea maderae Fabricius)), smoky brown cockroach (Periplaneta fuliginosa Service), Australian Cockroach (Periplaneta australasiae Fabr.), lobster cockroach (Nauphoeta cinerea Olivier) and smooth cockroach (Symploce pallens Stephens)); eggs, foliar feeding, fruit feeding, root feeding, seed feeding and vesicular tissue feeding larvae and adults of the order Coleoptera including weevils from the families Anthribidae, Bruchidae, and Curculionidae (e.g., boll weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus Kuschel), granary weevil (Sitophilus granarius Linnaeus), rice weevil (Sitophilus oryzae Linnaeus)), annual bluegrass weevil (Listronotus maculicollis Dictz), bluegrass billbug (Sphenophorus parvulus Gyllenhal), hunting billbug (Sphenophorus venatus vestitus), Denver billbug (Sphenophorus cicatristriatus Fahraeus)); flea beetles, cucumber beetles, rootworms, leaf beetles, potato beetles, and leafminers in the family Chrysomelidae (e.g., Colorado potato beetle (Leptinotarsa decemlineata Say), western corn rootworm (Diabrotica virgifera virgifera LeConte)); chafers and other beetles from the family Scarabaeidae (e.g., Japanese beetle (Popillia japonica Newman), oriental beetle (Anomala orientalis Waterhouse, Exomala orientalis (Waterhouse) Baraud), northern masked chafer (Cyclocephala borealis Arrow), southern masked chafer (Cyclocephala immaculata Olivier or C. lurida Bland), dung beetle and white grub (Aphodius spp.), black turfgrass ataenius (Ataenius spretulus Haldeman), green June beetle (Cotinis nitida Linnaeus), Asiatic garden beetle (Maladera castanea Arrow), May/June beetles (Phyllophaga spp.) and European chafer (Rhizotrogus majalis Razoumowsky)); carpet beetles from the family Dermestidae; wireworms from the family Elateridae; bark beetles from the family Scolytidae and flour beetles from the family Tenebrionidae. In addition, agronomic and nonagronomic pests include: eggs, adults and larvae of the order Dermaptera including earwigs from the family Forficulidae (e.g., European earwig (Forficula auricularia Linnaeus), black earwig (Chelisoches morio Fabricius)); eggs, immatures, adults and nymphs of the orders Hemiptera and Homoptera such as, plant bugs from the family Miridae, cicadas from the family Cicadidae, leafhoppers (e.g. Empoasca spp.) from the family Cicadellidae, bed bugs (e.g., Cimex lectularius Linnaeus) from the family Cimicidae, planthoppers from the families Fulgoroidae and Delphacidae, treehoppers from the family Membracidae, psyllids from the family Psyllidae, whiteflies from the family Aleyrodidae, aphids from the family Aphididae, phylloxera from the family Phylloxeridae, mealybugs from the family Pseudococcidae, scales from the families Coccidae, Diaspididae and Margarodidae, lace bugs from the family Tingidae, stink bugs from the family Pentatomidae, chinch bugs (e.g., hairy chinch bug (Blissus leucopterus hirtus Montandon) and southern chinch bug (Blissus insularis Barber)) and other seed bugs from the family Lygaeidae, spittlebugs from the family Cercopidae squash bugs from the family Coreidae, and red bugs and cotton stainers from the family Pyrrhocoridae. Also included are eggs, larvae, nymphs and adults of the order Acari (mites) such as spider mites and red mites in the family Tetranychidae (e.g., European red mite (Panonychus ulmi Koch), two spotted spider mite (Tetranychus urticae Koch), McDaniel mite (Tetranychus mcdanieli McGregor)); flat mites in the family Tenuipalpidae (e.g., citrus flat mite (Brevipalpus lewisi McGregor)); rust and bud mites in the family Eriophyidae and other foliar feeding mites and mites important in human and animal health, i.e. dust mites in the family Epidermoptidae, follicle mites in the family Demodicidae, grain mites in the family Glycyphagidae; ticks in the family Ixodidae, commonly known as hard ticks (e.g., deer tick (Ixodes scapularis Say), Australian paralysis tick (Ixodes holocyclus Neumann), American dog tick (Dermacentor variabilis Say), lone star tick (Amblyomma americanum Linnacus)) and ticks in the family Argasidae, commonly known as soft ticks (e.g., relapsing fever tick (Ornithodoros turicata), common fowl tick (Argas radiatus)); scab and itch mites in the families Psoroptidae, Pyemotidae, and Sarcoptidae; eggs, adults and immatures of the order Orthoptera including grasshoppers, locusts and crickets (e.g., migratory grasshoppers (e.g., Melanoplus sanguinipes Fabricius, M. differentialis Thomas), American grasshoppers (e.g., Schistocerca americana Drury), desert locust (Schistocerca gregaria Forskal), migratory locust (Locusta migratoria Linnaeus), bush locust (Zonocerus spp.), house cricket (Acheta domesticus Linnaeus), mole crickets (e.g., tawny mole cricket (Scapteriscus vicinus Scudder) and southern mole cricket (Scapteriscus borellii Giglio-Tos)); eggs, adults and immatures of the order Diptera including leafminers (e.g., Liriomyza spp. such as serpentine vegetable leafminer (Liriomyza sativae Blanchard)), midges, fruit flies (Tephritidae), frit flies (e.g., Oscinella frit Linnaeus), soil maggots, house flies (e.g., Musca domestica Linnaeus), lesser house flies (e.g., Fannia canicularis Linnaeus, F. femoralis Stein), stable flies (e.g., Stomoxys calcitrans Linnaeus), face flies, horn flies, blow flies (e.g., Chrysomya spp., Phormia spp.), and other muscoid fly pests, horse flies (e.g., Tabanus spp.), bot flies (e.g., Gastrophilus spp., Oestrus spp.), cattle grubs (e.g., Hypoderma spp.), deer flies (e.g., Chrysops spp.), keds (e.g., Melophagus ovinus Linnaeus) and other Brachycera, mosquitoes (e.g., Aedes spp., Anopheles spp., Culex spp.), black flies (e.g., Prosimulium spp., Simulium spp.), biting midges, sand flies, sciarids, and other Nematocera; eggs, adults and immatures of the order Thysanoptera including onion thrips (Thrips tabaci Lindeman), flower thrips (Frankliniella spp.), and other foliar feeding thrips; insect pests of the order Hymenoptera including ants of the Family Formicidae including the Florida carpenter ant (Camponotus floridanus Buckley), red carpenter ant (Camponotus ferrugineus Fabricius), black carpenter ant (Camponotus pennsylvanicus De Geer), white-footed ant (Technomyrmex albipes fr. Smith), big headed ants (Pheidole sp.), ghost ant (Tapinoma melanocephalum Fabricius); Pharaoh ant (Monomorium pharaonis Linnaeus), little fire ant (Wasmannia auropunctata Roger), fire ant (Solenopsis geminata Fabricius), red imported fire ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), crazy ant (Paratrechina longicornis Latreille), pavement ant (Tetramorium caespitum Linnaeus), cornfield ant (Lasius alienus Förster) and odorous house ant (Tapinoma sessile Say). Other Hymenoptera including bees (including carpenter bees), hornets, yellow jackets, wasps, and sawflies (Neodiprion spp.; Cephus spp.); insect pests of the order Isoptera including termites in the Termitidae (e.g., Macrotermes sp., Odontotermes obesus Rambur), Kalotermitidae (e.g., Cryptotermes sp.), and Rhinotermitidae (e.g., Reticulitermes sp., Coptotermes sp., Heterotermes tenuis Hagen) families, the eastern subterranean termite (Reticulitermes flavipes Kollar), western subterranean termite (Reticulitermes hesperus Banks), Formosan subterranean termite (Coptotermes formosanus Shiraki), West Indian drywood termite (Incisitermes immigrans Snyder), powder post termite (Cryptotermes brevis Walker), drywood termite (Incisitermes snyderi Light), southeastern subterranean termite (Reticulitermes virginicus Banks), western drywood termite (Incisitermes minor Hagen), arboreal termites such as Nasutitermes sp. and other termites of economic importance; insect pests of the order Thysanura such as silverfish (Lepisma saccharina Linnaeus) and firebrat (Thermobia domestica Packard); insect pests of the order Mallophaga and including the head louse (Pediculus humanus capitis De Geer), body louse (Pediculus humanus Linnaeus), chicken body louse (Menacanthus stramineus Nitszch), dog biting louse (Trichodectes canis De Geer), fluff louse (Goniocotes gallinae De Geer), sheep body louse (Bovicola ovis Schrank), short-nosed cattle louse (Haematopinus eurysternus Nitzsch), long-nosed cattle louse (Linognathus vituli Linnaeus) and other sucking and chewing parasitic lice that attack man and animals; insect pests of the order Siphonoptera including the oriental rat flea (Xenopsylla cheopis Rothschild), cat flea (Ctenocephalides felis Bouche), dog flea (Ctenocephalides canis Curtis), hen flea (Ceratophyllus gallinae Schrank), sticktight flea (Echidnophaga gallinacea Westwood), human flea (Pulex irritans Linnaeus) and other fleas afflicting mammals and birds. Additional arthropod pests covered include: spiders in the order Araneae such as the brown recluse spider (Loxosceles reclusa Gertsch & Mulaik) and the black widow spider (Latrodectus mactans Fabricius), and centipedes in the order Scutigeromorpha such as the house centipede (Scutigera coleoptrata Linnaeus). Compounds of the present invention also have activity on members of the Classes Nematoda, Cestoda, Trematoda, and Acanthocephala including economically important members of the orders Strongylida, Ascaridida, Oxyurida, Rhabditida, Spirurida, and Enoplida such as but not limited to economically important agricultural pests (i.e. root knot nematodes in the genus Meloidogyne, lesion nematodes in the genus Pratylenchus, stubby root nematodes in the genus Trichodorus, etc.) and animal and human health pests (i.e. all economically important flukes, tapeworms, and roundworms, such as Strongylus vulgaris in horses, Toxocara canis in dogs, Haemonchus contortus in sheep, Dirofilaria immitis Leidy in dogs, Anoplocephala peifoliata in horses, Fasciola hepatica Linnaeus in ruminants, etc.).
  • Compounds of the invention show particularly high activity against pests in the order Lepidoptera (e.g., Alabama argillacea Hübner (cotton leaf worm), Archips argyrospila Walker (fruit tree leaf roller), A. rosana Linnaeus (European leaf roller) and other Archips species, Chilo suppressalis Walker (rice stem borer), Cnaphalocrosis medinalis Guenée (rice leaf roller), Crambus caliginosellus Clemens (corn root webworm), Crambus teterrellus Zincken (bluegrass webworm), Cydia pomonella Linnaeus (codling moth), Earias insulana Boisduval (spiny bollworm), Earias vittella Fabricius (spotted bollworm), Helicoverpa armigera Hübner (American bollworm), Helicoverpa zea Boddie (corn earworm), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (sod webworm), Lobesia botrana Denis & Schiffermüller (grape berry moth), Pectinophora gossypiella Saunders (pink bollworm), Phyllocnistis citrella Stainton (citrus leafminer), Pieris brassicae Linnaeus (large white butterfly), Pieris rapae Linnaeus (small white butterfly), Plutella xylostella Linnaeus (diamondback moth), Spodoptera exigua Hübner (beet armyworm), Spodoptera litura Fabricius (tobacco cutworm, cluster caterpillar), Spodoptera frugiperda J. E. Smith (fall armyworm), Trichoplusia ni Hübner (cabbage looper) and Tuta absoluta Meyrick (tomato leafminer)).
  • Compounds of the invention also have significant activity on members from the order Homoptera including: Acyrthosiphon pisum Harris (pea aphid), Aphis craccivora Koch (cowpea aphid), Aphis fabae Scopoli (black bean aphid), Aphis gossypii Glover (cotton aphid, melon aphid), Aphis pomi De Geer (apple aphid), Aphis spiraecola Patch (spirea aphid), Aulacorthum solani Kaltenbach (foxglove aphid), Chaetosiphon fragaefolii Cockerell (strawberry aphid), Diuraphis noxia Kurdjumov/Mordvilko (Russian wheat aphid), Dysaphis plantaginea Paaserini (rosy apple aphid), Eriosoma lanigerum Hausmann (woolly apple aphid), Hyalopterus pruni Geoffroy (mealy plum aphid), Lipaphis erysimi Kaltenbach (turnip aphid), Metopolophium dirrhodum Walker (cereal aphid), Macrosiphum euphorbiae Thomas (potato aphid), Myzus persicae Sulzer (peach-potato aphid, green peach aphid), Nasonovia ribisnigri Mosley (lettuce aphid), Pemphigus spp. (root aphids and gall aphids), Rhopalosiphum maidis Fitch (corn leaf aphid), Rhopalosiphum padi Linnaeus (bird cherry-oat aphid), Schizaphis graminum Rondani (greenbug), Sitobion avenae Fabricius (English grain aphid), Therioaphis maculata Buckton (spotted alfalfa aphid), Toxoptera aurantii Boyer de Fonscolombe (black citrus aphid), and Toxoptera citricida Kirkaldy (brown citrus aphid); Adelges spp. (adelgids); Phylloxera devastatrix Pergande (pecan phylloxera); Bemisia tabaci Gennadius (tobacco whitefly, sweetpotato whitefly), Bemisia argentifolii Bellows & Perring (silverleaf whitefly), Dialeurodes citri Ashmead (citrus whitefly) and Trialeurodes vaporariorum Westwood (greenhouse whitefly); Empoasca fabae Harris (potato leafhopper), Laodelphax striatellus Fallen (smaller brown planthopper), Macrolestes quadrilineatus Forbes (aster leafhopper), Nephotettix cinticeps Uhler (green leafhopper), Nephotettix nigropictus Stål (rice leafhopper), Nilaparvata lugens Stål (brown planthopper), Peregrinus mzaidis Ashmead (corn planthopper), Sogatella furcifera Horvath (white-backed planthopper), Sogatodes orizicola Muir (rice delphacid), Typhlocyba pomaria McAtee white apple leafhopper, Erythroneoura spp. (grape leafhoppers); Magicidada septendecim Linnaeus (periodical cicada); Icerya purchasi Maskell (cottony cushion scale), Quadraspidiotus perniciosus Comstock (San Jose scale); Planococcus citri Risso (citrus mealybug); Pseudococcus spp. (other mealybug complex); Cacopsylla pyricola Foerster (pear psylla), Trioza diospyri Ashmead (persimmon psylla).
  • Compounds of this invention also have activity on members from the order Hemiptera including: Acrosternum hilare Say (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus leucopterus Say (chinch bug), Cimex lectularius Linnacus (bed bug) Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Herrich-Schäffer (cotton stainer), Euchistus servus Say (brown stink bug), Euchistus variolarius Palisot de Beauvois (one-spotted stink bug), Graptosthetus spp. (complex of seed bugs), Leptoglossus corculus Say (leaf-footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatonoscelis seriatus Reuter (cotton fleahopper). Other insect orders controlled by compounds of the invention include Thysanoptera (e.g., Frankliniella occidentalis Pergande (western flower thrips), Scirthothrips citri Moulton (citrus thrips), Sericothrips variabilis Beach (soybean thrips), and Thrips tabaci Lindeman (onion thrips); and the order Coleoptera (e.g., Leptinotarsa decemlineata Say (Colorado potato beetle), Epilachna varivestis Mulsant (Mexican bean beetle) and wireworms of the genera Agriotes, Athous or Limonius).
  • Note that some contemporary classification systems place Homoptera as a suborder within the order Hemiptera.
  • Of note is use of compounds of this invention for controlling silverleaf whitefly (Bemisia argentifolii). Of note is use of compounds of this invention for controlling western flower thrip (Frankliniella occidentalis). Of note is use of compounds of this invention for controlling potato leafhopper (Empoasca fabae). Of note is use of compounds of this invention for controlling corn planthopper (Peregrinus maidis). Of note is use of compounds of this invention for controlling cotton melon aphid (Aphis gossypii). Of note is use of compounds of this invention for controlling green peach aphid (Myzus persicae). Of note is use of compounds of this invention for controlling diamondback moth (Plutella xylostella). Of note is use of compounds of this invention for controlling fall armyworm (Spodoptera frugiperda).
  • Compounds of this invention can also be mixed with one or more other biologically active compounds or agents including insecticides, fungicides, nematocides, bactericides, acaricides, herbicides, herbicide safeners, growth regulators such as insect molting inhibitors and rooting stimulants, chemosterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, other biologically active compounds or entomopathogenic bacteria, virus or fungi to form a multi-component pesticide giving an even broader spectrum of agronomic and nonagronomic utility. Thus the present invention also pertains to a composition comprising a biologically effective amount of a compound of Formula 1, an N-oxide or salt thereof, and an effective amount of at least one additional biologically active compound or agent and can further comprise at least one of surfactants, solid diluents or liquid diluents. For mixtures of the present invention, the other biologically active compounds or agents can be formulated together with the present compounds, including the compounds of Formula 1, to form a premix, or the other biologically active compounds or agents can be formulated separately from the present compounds, including the compounds of Formula 1, and the two formulations combined together before application (e.g., in a spray tank) or, alternatively, applied in succession.
  • Examples of such biologically active compounds or agents with which compounds of this invention can be formulated are insecticides such as abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluoron, borate, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methiodicarb, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumuron, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.
  • Of note are insecticides such as abamectin, acetamiprid, acrinathrin, amitraz, avermectin, azadirachtin, bifenthrin, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, fosthiazate, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, nitenpyram, nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, tebufenozide, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, Bacillus thuringiensis delta-endotoxins, all strains of Bacillus thuringiensis and all strains of Nucleo polyhydrosis viruses.
  • One embodiment of biological agents for mixing with compounds of this invention include entomopathogenic bacteria such as Bacillus thuringiensis, and the encapsulated delta-endotoxins of Bacillus thuringiensis (e.g., Cellcap, MPV, MPVII); entomopathogenic fungi such as green muscardine fungus; and entomopathogenic (both naturally occurring and genetically modified) viruses including baculovirus, nucleopolyhedro virus (NPV) such as Helicoverpa zea nucleopolyhedrovirus (HzNPV), Anagrapha falcifera nucleopolyhedrovirus (AfNPV); and granulosis virus (GV) such as Cydia pomonella granulosis virus (CpGV).
  • Of particular note is such a combination where the other invertebrate pest control active ingredient belongs to a different chemical class or has a different site of action than the compound of Formula 1. In certain instances, a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a composition of the present invention can further comprise at least one additional invertebrate pest control active ingredient having a similar spectrum of control but belonging to a different chemical class or having a different site of action. These additional biologically active compounds or agents include, but are not limited to, sodium channel modulators such as bifenthrin, cypermethrin, cyhalothrin, lambda-cyhalothrin, cyfluthrin, beta-cyfluthrin, deltamethrin, dimefluthrin, esfenvalerate, fenvalerate, indoxacarb, metofluthrin, profluthrin, pyrethrin and tralomethrin; cholinesterase inhibitors such as chlorpyrifos, methomyl, oxamyl, thiodicarb and triazamate; neonicotinoids such as acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, nithiazine, thiacloprid and thiamethoxam; insecticidal macrocyclic lactones such as spinetoram, spinosad, abamectin, avermectin and emamectin; GABA (γ-aminobutyric acid)-gated chloride channel antagonists such as avermectin or blockers such as ethiprole and fipronil; chitin synthesis inhibitors such as buprofezin, cyromazine, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron and triflumuron; juvenile hormone mimics such as diofenolan, fenoxycarb, methoprene and pyriproxyfen; octopamine receptor ligands such as amitraz; molting inhibitors and ecdysone agonists such as azadirachtin, methoxyfenozide and tebufenozide; ryanodine receptor ligands such as ryanodine, anthranilic diamides such as chlorantraniliprole (see U.S. Pat. No. 6,747,047, PCT Publications WO 2003/015518 and WO 2004/067528) and flubendiamide (see U.S. Pat. No. 6,603,044); nereistoxin analogs such as cartap; mitochondrial electron transport inhibitors such as chlorfenapyr, hydramethylnon and pyridaben; lipid biosynthesis inhibitors such as spirodiclofen and spiromesifen; cyclodiene insecticides such as dieldrin or endosulfan; pyrethroids; carbamates; insecticidal ureas; and biological agents including nucleopolyhedro viruses (NPV), members of Bacillus thuringiensis, encapsulated delta-endotoxins of Bacillus thuringiensis, and other naturally occurring or genetically modified insecticidal viruses.
  • Further examples of biologically active compounds or agents with which compounds of this invention can be formulated are: fungicides such as acibenzolar, aldimorph, amisulbrom, azaconazole, azoxystrobin, benalaxyl, benomyl, benthiavalicarb, benthiavalicarb-isopropyl, binomial, biphenyl, bitertanol, blasticidin-S, Bordeaux mixture (Tribasic copper sulfate), boscalid/nicobifen, bromuconazole, bupirimate, buthiobate, carboxin, carpropamid, captafol, captan, carbendazim, chloroneb, chlorothalonil, chlozolinate, clotrimazole, copper oxychloride, copper salts such as copper sulfate and copper hydroxide, cyazofamid, cyflunamid, cymoxanil, cyproconazole, cyprodinil, dichlofluanid, diclocymet, diclomezine, dicloran, diethofencarb, difenoconazole, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinocap, discostrobin, dithianon, dodemorph, dodine, econazole, etaconazole, edifenphos, epoxiconazole, ethaboxam, ethirimol, ethridiazole, famoxadone, fenamidone, fenarimol, fenbuconazole, fencaramid, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferfurazoate, ferimzone, fluazinam, fludioxonil, flumetover, fluopicolide, fluoxastrobin, fluquinconazole, fluquinconazole, flusilazole, flusulfamide, flutolanil, flutriafol, folpet, fosetyl-aluminum, fuberidazole, furalaxyl, furametapyr, hexaconazole, hymexazole, guazatine, imazalil, imibenconazole, iminoctadine, iodicarb, ipconazole, iprobenfos, iprodione, iprovalicarb, isoconazole, isoprothiolane, kasugamycin, kresoxim-methyl, mancozeb, mandipropamid, maneb, mapanipyrin, mefenoxam, mepronil, metalaxyl, metconazole, methasulfocarb, metiram, metominostrobin/fenominostrobin, mepanipyrim, metrafenone, miconazole, myclobutanil, neo-asozin (ferric methanearsonate), nuarimol, octhilinone, ofurace, orysastrobin, oxadixyl, oxolinic acid, oxpoconazole, oxycarboxin, paclobutrazol, penconazole, pencycuron, penthiopyrad, perfurazoate, phosphonic acid, phthalide, picobenzamid, picoxystrobin, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propamocarb-hydrochloride, propiconazole, propineb, proquinazid, prothioconazole, pyraclostrobin, pryazophos, pyrifenox, pyrimethanil, pyrifenox, pyrolnitrine, pyroquilon, quinconazole, quinoxyfen, quintozene, silthiofam, simeconazole, spiroxamine, streptomycin, sulfur, tebuconazole, techrazene, tecloftalam, tecnazene, tetraconazole, thiabendazole, thifluzamide, thiophanate, thiophanate-methyl, thiram, tiadinil, tolclofos-methyl, tolyfluanid, triadimefon, triadimenol, triarimol, triazoxide, tridemorph, trimoprhamide tricyclazole, trifloxystrobin, triforine, triticonazole, uniconazole, validamycin, vinclozolin, zineb, ziram, and zoxamide; nematocides such as aldicarb, imicyafos, oxamyl and fenamiphos; bactericides such as streptomycin; acaricides such as amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad.
  • In certain instances, combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents (i.e. active ingredients) can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable. When synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.
  • Compounds of this invention and compositions thereof can be applied to plants genetically transformed to express proteins toxic to invertebrate pests (such as Bacillus thuringiensis delta-endotoxins). Such an application may provide a broader spectrum of plant protection and be advantageous for resistance management. The effect of the exogenously applied invertebrate pest control compounds of this invention may be synergistic with the expressed toxin proteins.
  • General references for these agricultural protectants (i.e. insecticides, fungicides, nematocides, acaricides, herbicides and biological agents) include The Pesticide Manual, 13th Edition, C. D. S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2003 and The BioPesticide Manual, 2nd Edition, L. G. Copping, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2001.
  • For embodiments where one or more of these various mixing partners are used, the weight ratio of these various mixing partners (in total) to the compound of Formula 1 is typically between about 1:3000 and about 3000:1. Of note are weight ratios between about 1:300 and about 300:1 (for example ratios between about 1:30 and about 30:1). One skilled in the art can easily determine through simple experimentation the biologically effective amounts of active ingredients necessary for the desired spectrum of biological activity. It will be evident that including these additional components may expand the spectrum of invertebrate pests controlled beyond the spectrum controlled by the compound of Formula 1 alone.
  • In certain instances, combinations of a compound of this invention with other biologically active (particularly invertebrate pest control) compounds or agents (i.e. active ingredients) can result in a greater-than-additive (i.e. synergistic) effect. Reducing the quantity of active ingredients released in the environment while ensuring effective pest control is always desirable. When synergism of invertebrate pest control active ingredients occurs at application rates giving agronomically satisfactory levels of invertebrate pest control, such combinations can be advantageous for reducing crop production cost and decreasing environmental load.
  • Of note is a combination of a compound of Formula 1 with at least one other invertebrate pest control active ingredient. Of particular note is such a combination where the other invertebrate pest control active ingredient has a different site of action from the compound of Formula 1. In certain instances, a combination with at least one other invertebrate pest control active ingredient having a similar spectrum of control but a different site of action will be particularly advantageous for resistance management. Thus, a composition of the present invention can further comprise a biologically effective amount of at least one additional invertebrate pest control active ingredient having a similar spectrum of control but a different site of action. Contacting a plant genetically modified to express an invertebrate pest compound (e.g., protein) or the locus of the plant with a biologically effective amount of a compound of this invention can also provide a broader spectrum of plant protection and be advantageous for resistance management.
  • Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention. The first column of Table A lists the specific invertebrate pest control agents (e.g., “Abamectin” in the first line). The second column of Table A lists the mode of action (if known) or chemical class of the invertebrate pest control agents. The third column of Table A lists embodiment(s) of ranges of weight ratios for rates at which the invertebrate pest control agent can be applied relative to a compound of Formula 1, an N-oxide, or a salt thereof, (e.g., “50:1 to 1:50” of abamectin relative to a compound of Formula 1 by weight). Thus, for example, the first line of Table A specifically discloses the combination of a compound of Formula 1 with abamectin can be applied in a weight ratio between 50:1 to 1:50. The remaining lines of Table A are to be construed similarly. Of further note Table A lists specific combinations of a compound of Formula 1 with other invertebrate pest control agents illustrative of the mixtures, compositions and methods of the present invention and includes additional embodiments of weight ratio ranges for application rates.
  • TABLE A
    Invertebrate
    Pest Control Mode of Action or Typical
    Agent Chemical Class Weight Ratio
    Abamectin macrocyclic lactones 50:1 to 1:50
    Acetamiprid neonicotinoids 150:1 to 1:200
    Amitraz octopamine receptor ligands 200:1 to 1:100
    Avermectin macrocyclic lactones 50:1 to 1:50
    Azadirachtin ecdysone agonists 100:1 to 1:120
    Beta-cyfluthrin sodium channel modulators 150:1 to 1:200
    Bifenthrin sodium channel modulators 100:1 to 1:10 
    Buprofezin chitin synthesis inhibitors 500:1 to 1:50 
    Cartap nereistoxin analogs 100:1 to 1:200
    Chloran- ryanodine receptor ligands 100:1 to 1:120
    traniliprole
    Chlorfenapyr mitochondrial electron 300:1 to 1:200
    transport inhibitors
    Chlorpyrifos cholinesterase inhibitors 500:1 to 1:200
    Clothianidin neonicotinoids 100:1 to 1:400
    Cyfluthrin sodium channel modulators 150:1 to 1:200
    Cyhalothrin sodium channel modulators 150:1 to 1:200
    Cypermethrin sodium channel modulators 150:1 to 1:200
    Cyromazine chitin synthesis inhibitors 400:1 to 1:50 
    Deltamethrin sodium channel modulators  50:1 to 1:400
    Dieldrin cyclodiene insecticides 200:1 to 1:100
    Dinotefuran neonicotinoids 150:1 to 1:200
    Diofenolan molting inhibitor 150:1 to 1:200
    Emamectin macrocyclic lactones 50:1 to 1:10
    Endosulfan cyclodiene insecticides 200:1 to 1:100
    Esfenvalerate sodium channel modulators 100:1 to 1:400
    Ethiprole GABA-regulated chloride 200:1 to 1:100
    channel blockers
    Fenothiocarb 150:1 to 1:200
    Fenoxycarb juvenile hormone mimics 500:1 to 1:100
    Fenvalerate sodium channel modulators 150:1 to 1:200
    Fipronil GABA-regulated chloride 150:1 to 1:100
    channel blockers
    Flonicamid 200:1 to 1:100
    Flubendiamide ryanodine receptor ligands 100:1 to 1:120
    Flufenoxuron chitin synthesis inhibitors 200:1 to 1:100
    Hexaflumuron chitin synthesis inhibitors 300:1 to 1:50 
    Hydramethylnon mitochondrial electron 150:1 to 1:250
    transport inhibitors
    Imidacloprid neonicotinoids 1000:1 to 1:1000
    Indoxacarb sodium channel modulators 200:1 to 1:50 
    Lambda- sodium channel modulators  50:1 to 1:250
    cyhalothrin
    Lufenuron chitin synthesis inhibitors 500:1 to 1:250
    Metaflumizone 200:1 to 1:200
    Methomyl cholinesterase inhibitors 500:1 to 1:100
    Methoprene juvenile hormone mimics 500:1 to 1:100
    Methoxyfenozide ecdysone agonists 50:1 to 1:50
    Nitenpyram neonicotinoids 150:1 to 1:200
    Nithiazine neonicotinoids 150:1 to 1:200
    Novaluron chitin synthesis inhibitors 500:1 to 1:150
    Oxamyl cholinesterase inhibitors 200:1 to 1:200
    Pymetrozine 200:1 to 1:100
    Pyrethrin sodium channel modulators 100:1 to 1:10 
    Pyridaben mitochondrial electron 200:1 to 1:100
    transport inhibitors
    Pyridalyl 200:1 to 1:100
    Pyriproxyfen juvenile hormone mimics 500:1 to 1:100
    Ryanodine ryanodine receptor ligands 100:1 to 1:120
    Spinetoram macrocyclic lactones 150:1 to 1:100
    Spinosad macrocyclic lactones 500:1 to 1:10 
    Spirodiclofen lipid biosynthesis 200:1 to 1:200
    inhibitors
    Spiromesifen lipid biosynthesis 200:1 to 1:200
    inhibitors
    Tebufenozide ecdysone agonists 500:1 to 1:250
    Thiacloprid neonicotinoids 100:1 to 1:200
    Thiamethoxam neonicotinoids 1250:1 to 1:1000
    Thiodicarb cholinesterase inhibitors 500:1 to 1:400
    Thiosultap- 150:1 to 1:100
    sodium
    Tralomethrin sodium channel modulators 150:1 to 1:200
    Triazamate cholinesterase inhibitors 250:1 to 1:100
    Triflumuron chitin synthesis inhibitors 200:1 to 1:100
    Bacillus biological agents 50:1 to 1:10
    thuringiensis
    Bacillus biological agents 50:1 to 1:10
    thuringiensis
    delta-endotoxin
    NPV (e.g., biological agents 50:1 to 1:10
    Gemstar)
  • The weight ratios of a compound, including a compound of Formula 1, an N-oxide or a salt thereof, to the additional invertebrate pest control agent typically are between 1000:1 and 1:1000, with one embodiment being between 500:1 and 1:500, another embodiment being between 250:1 and 1:200 and another embodiment being between 100:1 and 1:50.
  • Listed below in Table B are embodiments of specific compositions comprising a compound of Formula 1 (compound numbers refer to compounds in Index Table A) and an additional invertebrate pest control agent.
  • TABLE B
    Invertebrate Pest
    Mixture No. Comp. No. and Control Agent
    A-1 66 and Abamectin
    A-2 66 and Acetamiprid
    A-3 66 and Amitraz
    A-4 66 and Avermectin
    A-5 66 and Azadirachtin
    A-6 66 and Beta-cyfluthrin
    A-7 66 and Bifenthrin
    A-8 66 and Buprofezin
    A-9 66 and Cartap
    A-10 66 and Chlorantraniliprole
    A-11 66 and Chlorfenapyr
    A-12 66 and Chlorpyrifos
    A-13 66 and Clothianidin
    A-14 66 and Cyfluthrin
    A-15 66 and Cyhalothrin
    A-16 66 and Cypermethrin
    A-17 66 and Cyromazine
    A-18 66 and Deltamethrin
    A-19 66 and Dieldrin
    A-20 66 and Dinotefuran
    A-21 66 and Diofenolan
    A-22 66 and Emamectin
    A-23 66 and Endosulfan
    A-24 66 and Esfenvalerate
    A-25 66 and Ethiprole
    A-26 66 and Fenothiocarb
    A-27 66 and Fenoxycarb
    A-28 66 and Fenvalerate
    A-29 66 and Fipronil
    A-30 66 and Flonicamid
    A-31 66 and Flubendiamide
    A-32 66 and Flufenoxuron
    A-33 66 and Hexaflumuron
    A-34 66 and Hydramethylnon
    A-35 66 and Imidacloprid
    A-36 66 and Indoxacarb
    A-37 66 and Lambda-cyhalothrin
    A-38 66 and Lufenuron
    A-39 66 and Metaflumizone
    A-40 66 and Methomyl
    A-41 66 and Methoprene
    A-42 66 and Methoxyfenozide
    A-43 66 and Nitenpyram
    A-44 66 and Nithiazine
    A-45 66 and Novaluron
    A-46 66 and Oxamyl
    A-47 66 and Pymetrozine
    A-48 66 and Pyrethrin
    A-49 66 and Pyridaben
    A-50 66 and Pyridalyl
    A-51 66 and Pyriproxyfen
    A-52 66 and Ryanodine
    A-53 66 and Spinetoram
    A-54 66 and Spinosad
    A-55 66 and Spirodiclofen
    A-56 66 and Spiromesifen
    A-57 66 and Tebufenozide
    A-58 66 and Thiacloprid
    A-59 66 and Thiamethoxam
    A-60 66 and Thiodicarb
    A-61 66 and Thiosultap-sodium
    A-62 66 and Tralomethrin
    A-63 66 and Triazamate
    A-64 66 and Triflumuron
    A-65 66 and Bacillus thuringiensis
    A-66 66 and Bacillus thuringiensis
    delta-endotoxin
    A-67 66 and NPV (e.g., Gemstar)
    B-1 76 and Abamectin
    B-2 76 and Acetamiprid
    B-3 76 and Amitraz
    B-4 76 and Avermectin
    B-5 76 and Azadirachtin
    B-6 76 and Beta-cyfluthrin
    B-7 76 and Bifenthrin
    B-8 76 and Buprofezin
    B-9 76 and Cartap
    B-10 76 and Chlorantraniliprole
    B-11 76 and Chlorfenapyr
    B-12 76 and Chlorpyrifos
    B-13 76 and Clothianidin
    B-14 76 and Cyfluthrin
    B-15 76 and Cyhalothrin
    B-16 76 and Cypermethrin
    B-17 76 and Cyromazine
    B-18 76 and Deltamethrin
    B-19 76 and Dieldrin
    B-20 76 and Dinotefuran
    B-21 76 and Diofenolan
    B-22 76 and Emamectin
    B-23 76 and Endosulfan
    B-24 76 and Esfenvalerate
    B-25 76 and Ethiprole
    B-26 76 and Fenothiocarb
    B-27 76 and Fenoxycarb
    B-28 76 and Fenvalerate
    B-29 76 and Fipronil
    B-30 76 and Flonicamid
    B-31 76 and Flubendiamide
    B-32 76 and Flufenoxuron
    B-33 76 and Hexaflumuron
    B-34 76 and Hydramethylnon
    B-35 76 and Imidacloprid
    B-36 76 and Indoxacarb
    B-37 76 and Lambda-cyhalothrin
    B-38 76 and Lufenuron
    B-39 76 and Metaflumizone
    B-40 76 and Methomyl
    B-41 76 and Methoprene
    B-42 76 and Methoxyfenozide
    B-43 76 and Nitenpyram
    B-44 76 and Nithiazine
    B-45 76 and Novaluron
    B-46 76 and Oxamyl
    B-47 76 and Pymetrozine
    B-48 76 and Pyrethrin
    B-49 76 and Pyridaben
    B-50 76 and Pyridalyl
    B-51 76 and Pyriproxyfen
    B-52 76 and Ryanodine
    B-53 76 and Spinetoram
    B-54 76 and Spinosad
    B-55 76 and Spirodiclofen
    B-56 76 and Spiromesifen
    B-57 76 and Tebufenozide
    B-58 76 and Thiacloprid
    B-59 76 and Thiamethoxam
    B-60 76 and Thiodicarb
    B-61 76 and Thiosultap-sodium
    B-62 76 and Tralomethrin
    B-63 76 and Triazamate
    B-64 76 and Triflumuron
    B-65 76 and Bacillus thuringiensis
    B-66 76 and Bacillus thuringiensis
    delta-endotoxin
    B-67 76 and NPV (e.g., Gemstar)
  • The specific mixtures listed in Table B typically combine a compound of Formula 1 with the other invertebrate pest agent in the ratios specified in Table A.
  • Invertebrate pests are controlled in agronomic and nonagronomic applications by applying one or more compounds of this invention, typically in the form of a composition, in a biologically effective amount, to the environment of the pests, including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled.
  • Thus the present invention comprises a method for controlling an invertebrate pest in agronomic and/or nonagronomic applications, comprising contacting the invertebrate pest or its environment with a biologically effective amount of one or more of the compounds of the invention, or with a composition comprising at least one such compound or a composition comprising at least one such compound and a biologically effective amount of at least one additional biologically active compound or agent. Examples of suitable compositions comprising a compound of the invention and a biologically effective amount of at least one additional biologically active compound or agent include granular compositions wherein the additional active compound is present on the same granule as the compound of the invention or on granules separate from those of the compound of the invention.
  • To achieve contact with a compound or composition of the invention to protect a field crop from invertebrate pests, the compound or composition is typically applied to the seed of the crop before planting, to the foliage (e.g., leaves, stems, flowers, fruits) of crop plants, or to the soil or other growth medium before or after the crop is planted.
  • One embodiment of a method of contact is by spraying. Alternatively, a granular composition comprising a compound of the invention can be applied to the plant foliage or the soil. Compounds of this invention can also be effectively delivered through plant uptake by contacting the plant with a composition comprising a compound of this invention applied as a soil drench of a liquid formulation, a granular formulation to the soil, a nursery box treatment or a dip of transplants. Of note is a composition of the present invention in the form of a soil drench liquid formulation. Also of note is a method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of the present invention or with a composition comprising a biologically effective amount of a compound of the present invention. Of further note is this method wherein the environment is soil and the composition is applied to the soil as a soil drench formulation. Of further note is that compounds of this invention are also effective by localized application to the locus of infestation. Other methods of contact include application of a compound or a composition of the invention by direct and residual sprays, aerial sprays, gels, seed coatings, microencapsulations, systemic uptake, baits, ear tags, boluses, foggers, fumigants, aerosols, dusts and many others. One embodiment of a method of contact is a dimensionally stable fertilizer granule, stick or tablet comprising a compound or composition of the invention. The compounds of this invention can also be impregnated into materials for fabricating invertebrate control devices (e.g., insect netting).
  • Compounds of this invention are also useful in seed treatments for protecting seeds from invertebrate pests. In the context of the present disclosure and claims, treating a seed means contacting the seed with a biologically effective amount of a compound of this invention, which is typically formulated as a composition of the invention. This seed treatment protects the seed from invertebrate soil pests and generally can also protect roots and other plant parts in contact with the soil of the seedling developing from the germinating seed. The seed treatment may also provide protection of foliage by translocation of the compound of this invention or a second active ingredient within the developing plant. Seed treatments can be applied to all types of seeds, including those from which plants genetically transformed to express specialized traits will germinate. Representative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis toxin or those expressing herbicide resistance such as glyphosate acetyltransferase, which provides resistance to glyphosate.
  • One method of seed treatment is by spraying or dusting the seed with a compound of the invention (i.e. as a formulated composition) before sowing the seeds. Compositions formulated for seed treatment generally comprise a film former or adhesive agent. Therefore typically a seed coating composition of the present invention comprises a biologically effective amount of a compound of Formula 1, an N-oxide or salt thereof, and a film former or adhesive agent. Seed can be coated by spraying a flowable suspension concentrate directly into a tumbling bed of seeds and then drying the seeds. Alternatively, other formulation types such as wetted powders, solutions, suspoemulsions, emulsifiable concentrates and emulsions in water can be sprayed on the seed. This process is particularly useful for applying film coatings on seeds. Various coating machines and processes are available to one skilled in the art. Suitable processes include those listed in P. Kosters et al., Seed Treatment Progress and Prospects, 1994 BCPC Mongraph No. 57, and references listed therein.
  • The treated seed typically comprises a compound of the present invention in an amount from about 0.1 g to 1 kg per 100 kg of seed (i.e. from about 0.0001 to 1% by weight of the seed before treatment). A flowable suspension formulated for seed treatment typically comprises from about 0.5 to about 70% of the active ingredient, from about 0.5 to about 30% of a film-forming adhesive, from about 0.5 to about 20% of a dispersing agent, from 0 to about 5% of a thickener, from 0 to about 5% of a pigment and/or dye, from 0 to about 2% of an antifoaming agent, from 0 to about 1% of a preservative, and from 0 to about 75% of a volatile liquid diluent.
  • The compounds of this invention can be incorporated into a bait composition that is consumed by an invertebrate pest or used within a device such as a trap, bait station, and the like. Such a bait composition can be in the form of granules which comprise (a) active ingredients, namely a biologically effective amount of a compound of Formula 1, an N-oxide, or salt thereof; (b) one or more food materials; optionally (c) an attractant, and optionally (d) one or more humectants. Of note are granules or bait compositions which comprise between about 0.001-5% active ingredients, about 40-99% food material and/or attractant; and optionally about 0.05-10% humectants, which are effective in controlling soil invertebrate pests at very low application rates, particularly at doses of active ingredient that are lethal by ingestion rather than by direct contact. Some food materials can function both as a food source and an attractant. Food materials include carbohydrates, proteins and lipids. Examples of food materials are vegetable flour, sugar, starches, animal fat, vegetable oil, yeast extracts and milk solids. Examples of attractants are odorants and flavorants, such as fruit or plant extracts, perfume, or other animal or plant component, pheromones or other agents known to attract a target invertebrate pest. Examples of humectants, i.e. moisture retaining agents, are glycols and other polyols, glycerine and sorbitol. Of note is a bait composition (and a method utilizing such a bait composition) used to control at least one invertebrate pest selected from the group consisting of ants, termites and cockroaches. A device for controlling an invertebrate pest can comprise the present bait composition and a housing adapted to receive the bait composition, wherein the housing has at least one opening sized to permit the invertebrate pest to pass through the opening so the invertebrate pest can gain access to the bait composition from a location outside the housing, and wherein the housing is further adapted to be placed in or near a locus of potential or known activity for the invertebrate pest.
  • The compounds of this invention can be applied without other adjuvants, but most often application will be of a formulation comprising one or more active ingredients with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. One method of application involves spraying a water dispersion or refined oil solution of a compound of the present invention. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, other solvents, and synergists such as piperonyl butoxide often enhance compound efficacy. For nonagronomic uses such sprays can be applied from spray containers such as a can, a bottle or other container, either by means of a pump or by releasing it from a pressurized container, e.g., a pressurized aerosol spray can. Such spray compositions can take various forms, for example, sprays, mists, foams, fumes or fog. Such spray compositions thus can further comprise propellants, foaming agents, etc. as the case may be. Of note is a spray composition comprising a biologically effective amount of a compound or a composition of the present invention and a carrier. One embodiment of such a spray composition comprises a biologically effective amount of a compound or a composition of the present invention and a propellant. Representative propellants include, but are not limited to, methane, ethane, propane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons, chlorofluorocarbons, dimethyl ether, and mixtures of the foregoing. Of note is a spray composition (and a method utilizing such a spray composition dispensed from a spray container) used to control at least one invertebrate pest selected from the group consisting of mosquitoes, black flies, stable flies, deer flies, horse flies, wasps, yellow jackets, hornets, ticks, spiders, ants, gnats, and the like, including individually or in combinations.
  • Nonagronomic uses refer to invertebrate pest control in the areas other than fields of crop plants. Nonagronomic uses of the present compounds and compositions include control of invertebrate pests in stored grains, beans and other foodstuffs, and in textiles such as clothing and carpets. Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in ornamental plants, forests, in yards, along roadsides and railroad rights of way, and on turf such as lawns, golf courses and pastures. Nonagronomic uses of the present compounds and compositions also include invertebrate pest control in houses and other buildings which may be occupied by humans and/or companion, farm, ranch, zoo or other animals. Nonagronomic uses of the present compounds and compositions also include the control of pests such as termites that can damage wood or other structural materials used in buildings.
  • Nonagronomic uses of the present compounds and compositions also include protecting human and animal health by controlling invertebrate pests that are parasitic or transmit infectious diseases. The controlling of animal parasites includes controlling external parasites that are parasitic to the surface of the body of the host animal (e.g., shoulders, armpits, abdomen, inner part of the thighs) and internal parasites that are parasitic to the inside of the body of the host animal (e.g., stomach, intestine, lung, veins, under the skin, lymphatic tissue). External parasitic or disease-transmitting pests include, for example, chiggers, ticks, lice, mosquitoes, flies, mites and fleas. Internal parasites include heartworms, hookworms and helminths. Compounds and compositions of the present invention are particularly suitable for combating external parasitic or disease-transmitting pests. Compounds and compositions of the present invention are suitable for systemic and/or non-systemic control of infestation or infection by parasites on animals.
  • Compounds and compositions of the present invention are suitable for combating parasites that infest animal subjects including those in the wild, livestock and agricultural working animals. Livestock is the term used to refer (singularly or plurally) to a domesticated animal intentionally reared in an agricultural setting to make produce such as food or fiber, or for its labor; examples of livestock include cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, hens, turkeys, ducks and geese (e.g., raised for meat, milk, butter, eggs, fur, leather, feathers and/or wool). By combating parasites, fatalities and performance reduction (in terms of meat, milk, wool, skins, eggs, etc.) are reduced, so that applying a composition comprising a compound of the present invention allows more economic and simple husbandry of animals.
  • Compounds and compositions of the present invention are especially suitable for combating parasites that infest companion animals and pets (e.g., dogs, cats, pet birds and aquarium fish), research and experimental animals (e.g., hamsters, guinea pigs, rats and mice), as well as animals raised for/in zoos, wild habitats and/or circuses.
  • In an embodiment of this invention, the animal is preferably a vertebrate, and more preferably a mammal, avian or fish. In a particular embodiment, the animal subject is a mammal (including great apes, such as humans). Other mammalian subjects include primates (e.g., monkeys), bovine (e.g., cattle or dairy cows), porcine (e.g., hogs or pigs), ovine (e.g., goats or sheep), equine (e.g., horses), canine (e.g., dogs), feline (e.g., house cats), camels, deer, donkeys, buffalos, antelopes, rabbits, and rodents (e.g., guinea pigs, squirrels, rats, mice, gerbils, and hamsters). Avians include Anatidae (swans, ducks and geese), Columbidae (e.g., doves and pigeons), Phasianidae (e.g., partridges, grouse and turkeys), Thesienidae (e.g., domestic chickens), Psittacines (e.g., parakeets, macaws, and parrots), game birds, and ratites (e.g., ostriches).
  • Of particular note is the embodiment wherein the animals to be protected are domesticated dogs (i.e. Canis lupus familiaris) and domestic house cats (i.e. Felis catus).
  • Birds treated or protected by the inventive compounds can be associated with either commercial or noncommercial aviculture. These include Anatidae, such as swans, geese, and ducks, Columbidae, such as doves and domestic pigeons, Phasianidae, such as partridge, grouse and turkeys, Thesienidae, such as domestic chickens, and Psittacines, such as parakeets, macaws, and parrots raised for the pet or collector market, among others.
  • For purposes of the present invention, the term “fish” shall be understood to include without limitation, the Teleosti grouping of fish, i.e., teleosts. Both the Salmoniformes order (which includes the Salmonidae family) and the Perciformes order (which includes the Centrarchidae family) are contained within the Teleosti grouping. Examples of potential fish recipients include the Salmonidae, Serranidae, Sparidae, Cichlidae, and Centrarchidae, among others.
  • Other animals are also contemplated to benefit from the inventive methods, including marsupials (such as kangaroos), reptiles (such as farmed turtles), and other economically important domestic animals for which the inventive methods are safe and effective in treating or preventing parasite infection or infestation.
  • Examples of invertebrate parasitic pests controlled by administering a parasiticidally effective amount of a compound of this invention to an animal to be protected include ectoparasites (arthropods, acarines, etc) and endoparasites (helminths, e.g., nematodes, trematodes, cestodes, acanthocephalans, etc.).
  • The disease or group of diseases described generally as helminthiasis is due to infection of an animal host with parasitic worms known as helminths. The term “helminths” is meant to include nematodes, trematodes, cestodes and acanthocephalans. Helminthiasis is a prevalent and serious economic problem with domesticated animals such as swine, sheep, horses, cattle, goats, dogs, cats and poultry.
  • Among the helminths, the group of worms described as nematodes causes widespread and at times serious infection in various species of animals. Nematodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Acanthocheilonema, Aelurostrongylus, Ancylostoma, Angiostrongylus, Ascaridia, Ascaris, Brugia, Bunostomum, Capillaria, Chabertia, Cooperia, Crenosoma, Dictyocaulus, Dioctophyme, Dipetalonema, Diphyllobothrium, Dirofilaria, Dracunculus, Enterobius, Filaroides, Haemonchus, Heterakis, Lagochilascaris, Loa, Mansonella, Muellerius, Necator, Nematodirus, Oesophagostomum, Ostertagia, Oxyuris, Parafilaria, Parascaris, Physaloptera, Protostrongylus, Setaria, Spirocerca, Stephanofilaria, Strongyloides, Strongylus, Thelazia, Toxascaris, Toxocara, Trichinella, Trichonena, Trichostrongylus, Trichuris, Uncinaria and Wuchereria.
  • Of the above, the most common genera of nematodes infecting the animals referred to above are Haemonchus, Trichostrongylus, Ostertagia, Nematodirus, Cooperia, Ascaris, Bunostonum, Oesophagostomum, Chabertia, Trichuris, Strongylus, Trichonema, Dictyocaulus, Capillaria, Heterakis, Toxocara, Ascaridia, Oxyuris, Ancylostoma, Uncinaria, Toxascaris and Parascaris. Certain of these, such as Nematodirus, Cooperia and Oesophagostomum attack primarily the intestinal tract while others, such as Haemonchus and Ostertagia, are more prevalent in the stomach while others such as Dictyocaulus are found in the lungs. Still other parasites may be located in other tissues such as the heart and blood vessels, subcutaneous and lymphatic tissue and the like.
  • Trematodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Alaria, Fasciola, Nanophyetus, Opisthorchis, Paragonimus and Schistosoma.
  • Cestodes that are contemplated to be treated by the compounds of this invention and by the inventive methods include, without limitation, the following genera: Diphyllobothrium, Diplydium, Spirometra and Taenia.
  • The most common genera of parasites of the gastrointestinal tract of humans are Ancylostoma, Necator, Ascaris, Strongyloides, Trichinella, Capillaria, Trichuris and Enterobius. Other medically important genera of parasites which are found in the blood or other tissues and organs outside the gastrointestinal tract are the filarial worms such as Wuchereria, Brugia, Onchocerca and Loa, as well as Dracunculus and extra intestinal stages of the intestinal worms Strongyloides and Trichinella.
  • Numerous other helminth genera and species are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Textbook of Veterinary Clinical Parasitology, Volume 1, Helminths, E. J. L. Soulsby, F. A. Davis Co., Philadelphia, Pa.; Helminths, Arthropods and Protozoa, (6th Edition of Monnig's Veterinary Helminthology and Entomology), E. J. L. Soulsby, The Williams and Wilkins Co., Baltimore, Md.
  • The compounds of Formula 1 are effective against a number of animal ectoparasites (e.g., arthropod ectoparasites of mammals and birds).
  • Insect and acarine pests include, e.g., biting insects such as flies and mosquitoes, mites, ticks, lice, fleas, true bugs, parasitic maggots, and the like.
  • Adult flies include, e.g., the horn fly or Haematobia irritans, the horse fly or Tabanus spp., the stable fly or Stomoxys calcitrans, the black fly or Simulium spp., the deer fly or Chrysops spp., the louse fly or Melophagus ovinus, and the tsetse fly or Glossina spp. Parasitic fly maggots include, e.g., the bot fly (Oestrus ovis and Cuterebra spp.), the blow fly or Phaenicia spp., the screwworm or Cochliomyia hominivorax, the cattle grub or Hypoderma spp., the fleeceworm and the Gastrophilus of horses. Mosquitoes include, for example, Culex spp., Anopheles spp. and Aedes spp.
  • Mites include Mesostigmata spp. e.g., mesostigmatids such as the chicken mite, Dermanyssus gallinae; itch or scab mites such as Sarcoptidae spp. for example, Sarcoptes scabiei; mange mites such as Psoroptidae spp. including Chorioptes bovis and Psoroptes ovis; chiggers e.g., Trombiculidae spp. for example the North American chigger, Trombicula alfreddugesi.
  • Ticks include, e.g., soft-bodied ticks including Argasidae spp. for example Argas spp. and Ornithodoros spp.; hard-bodied ticks including Ixodidae spp., for example Rhipicephalus sanguineus, Dermacentor variabilis, Dermacentor andersoni, Amblyomma anmericanum, Ixodes scapularis and other Rhipicephalus spp. (including the former Boophilus genera).
  • Lice include, e.g., sucking lice, e.g., Menopon spp. and Bovicola spp.; biting lice, e.g., Haematopinus spp., Linognathus spp. and Solenopotes spp.
  • Fleas include, e.g., Ctenocephalides spp., such as dog flea (Ctenocephalides canis) and cat flea (Ctenocephalides felis); Xenopsylla spp. such as oriental rat flea (Xenopsylla cheopis); and Pulex spp. such as human flea (Pulex irritans).
  • True bugs include, e.g., Cimicidae or e.g., the common bed bug (Cinmex lectularius); Triatominae spp. including triatomid bugs also known as kissing bugs; for example Rhodnius prolixus and Triatoma spp.
  • Generally, flies, fleas, lice, mosquitoes, gnats, mites, ticks and helminths cause tremendous losses to the livestock and companion animal sectors. Arthropod parasites also are a nuisance to humans and can vector disease-causing organisms in humans and animals.
  • Numerous other arthropod pests and ectoparasites are known to the art, and are also contemplated to be treated by the compounds of the invention. These are enumerated in great detail in Medical and Veterinary Entomology, D. S. Kettle, John Wiley & Sons, New York and Toronto; Control of Arthropod Pests of Livestock: A Review of Technology, R. O. Drummand, J. E. George, and S. E. Kunz, CRC Press, Boca Raton, Fla.
  • It is also contemplated that the compounds and compositions of this invention may be effective against a number of protozoa endoparasites of animals, including those summarized by Table 1, as follows.
  • TABLE 1
    Exemplary Parasitic Protozoa and Associated Human Diseases
    Representative Human Disease
    Phylum Subphylum Genera or Disorder
    Sarcomastigophora Mastigophora Leishmania Visceral,
    (with flagella, (Flagella) cutaneous and
    pseudopodia, or mucocutaneous
    both) Infection
    Trypansoma Sleeping
    sickness
    Chagas'
    disease
    Giardia Diarrhea
    Trichomonas Vaginitis
    Sarcodina Entamoeba Dysentery,
    (pseudopodia) liver
    Abscess
    Dientamoeba Colitis
    Naegleria and Central
    Acanthamoeba nervous
    system and
    corneal
    ulcers
    Babesia Babesiesis
    Apicomplexa Plasmodium Malaria
    (apical complex)
    Isospora Diarrhea
    Sarcocystis Diarrhea
    Cryptosporidum Diarrhea
    Toxoplasma Toxoplasmosis
    Eimeria Chicken
    coccidiosis
    Microspora Enterocytozoon Diarrhea
    Ciliaphora (with Balantidium Dysentery
    cilia)
    Unclassified Pneumocystis Pneumonia
  • In particular, the compounds of this invention are effective against ectoparasites including: flies such as Haematobia (Lyperosia) irritans (horn fly), Stomoxys calcitrans (stable fly), Simulium spp. (blackfly), Glossina spp. (tsetse flies), Hydrotaea irritans (head fly), Musca autumnalis (face fly), Musca domestica (house fly), Morellia simplex (sweat fly), Tabanus spp. (horse fly), Hypoderma bovis, Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green blowfly), Calliphora spp. (blowfly), Protophormia spp., Oestrus ovis (nasal botfly), Culicoides spp. (midges), Hippobosca equine, Gastrophilus instestinalis, Gastrophilus haemorrhoidalis and Gastrophilus naslis; lice such as Bovicola (Damalinia) bovis, Bovicola equi, Haematopinus asini, Felicola subrostratus, Heterodoxus spiniger, Lignonathus setosus and Trichodectes canis; keds such as Melophagus ovinus; mites such as Psoroptes spp., Sarcoptes scabei, Chorioptes bovis, Demodex equi, Cheyletiella spp., Notoedres cati, Trombicula spp. and Otodectes cyanotis (ear mites); ticks such as Ixodes spp., Boophilus spp., Rhipicephalus spp., Amblyomma spp., Dermacentor spp., Hyalomma spp. and Haemaphysalis spp.; and fleas such as Ctenocephalides felis (cat flea) and Ctenocephalides canis (dog flea).
  • Biologically active compounds or agents useful in the compositions of the present invention include the organophosphate pesticides. This class of pesticides has very broad activity as insecticides and, in certain instances, anthelmintic activity. Organophosphate pesticides include, e.g., dicrotophos, terbufos, dimethoate, diazinon, disulfoton, trichlorfon, azinphos-methyl, chlorpyrifos, malathion, oxydemeton-methyl, methamidophos, acephate, ethyl parathion, methyl parathion, mevinphos, phorate, carbofenthion and phosalone. It is also contemplated to include combinations of the inventive methods and compounds with carbamate-type pesticides, including, e.g., carbaryl, carbofuran, aldicarb, molinate, methomyl, carbofuran, etc., as well as combinations with the organochlorine-type pesticides. It is further contemplated to include combinations with biological pesticides, including repellents, the pyrethrins (as well as synthetic variations thereof, e.g., allethrin, resmethrin, permethrin, tralomethrin), and nicotine, that is often employed as an acaricide. Other contemplated combinations are with miscellaneous pesticides including: Bacillus thuringiensis, chlorobenzilate, formamidines (e.g., amitraz), copper compounds (e.g., copper hydroxide and cupric oxychloride sulfate), cyfluthrin, cypermethrin, dicofol, endosulfan, esfenvalerate, fenvalerate, lambda-cyhalothrin, methoxychlor and sulfur.
  • Of note are additional biologically active compounds or agents selected from art-known anthelmintics, such as, for example, macrocyclic lactones (e.g., ivermectin, moxidectin, milbemycin), benzimidazoles (e.g., albendazole, triclabendazole), salicylanilides (e.g., closantel, oxyclozanide), substituted phenols (e.g., nitroxynil), pyrimidines (e.g., pyrantel), imidazothiazoles (e.g., levamisole), cyclic depsipeptides (e.g., emodepside), piperazine salts, nitroscanate and praziquantel.
  • Other biologically active compounds or agents useful in the compositions of the present invention can be selected from Insect Growth Regulators (IGRs) and Juvenile Hormone Analogues (JHAs) such as diflubenzuron, triflumuron, fluazuron, cyromazine, methoprene, etc., thereby providing both initial and sustained control of parasites (at all stages of insect development, including eggs) on the animal subject, as well as within the environment of the animal subject.
  • Of note are biologically active compounds or agents useful in the compositions of the present invention selected from the avermectin class of antiparasitic compounds. As stated above, the avermectin family of compounds includes very potent antiparasitic agents known to be useful against a broad spectrum of endoparasites and ectoparasites in mammals.
  • A preferred compound for use within the scope of the present invention is ivermectin. Ivermectin is a semi-synthetic derivative of avermectin and is generally produced as a mixture of at least 80% 22,23-dihydroavermectin B1a and less than 20% 22,23-dihydroavermectin B1b. Ivermectin is disclosed in U.S. Pat. No. 4,199,569.
  • Abamectin is an avermectin that is disclosed as avermectin B1a/B1b in U.S. Pat. No. 4,310,519. Abamectin contains at least 80% of avermectin B1a and not more than 20% of avermectin B1b.
  • Another preferred avermectin is doramectin, also known as 25-cyclohexyl-avermectin B1. The structure and preparation of doramectin is disclosed in U.S. Pat. No. 5,089,480.
  • Another preferred avermectin is moxidectin. Moxidectin, also known as LL-F28249 alpha, is known from U.S. Pat. No. 4,916,154.
  • Another preferred avermectin is selamectin. Selamectin is 25-cyclohexyl-25-de(1-methylpropyl)-5-deoxy-22,23-dihydro-5-(hydroxyimino)-avermectin B1 monosaccharide.
  • Milbemycin, or B41, is a substance which is isolated from the fermentation broth of a milbemycin-producing strain of Streptomyces. The microorganism, the fermentation conditions and the isolation procedures are described in U.S. Pat. Nos. 3,950,360 and 3,984,564.
  • Emamectin (4″-deoxy-4″-epi-methylaminoavermectin B1), which can be prepared as described in U.S. Pat. Nos. 5,288,710 and 5,399,717, is a mixture of two homologues, 4″-deoxy-4″-epi-methylaminoavermectin B1a and 4″-deoxy-4″-epi-methylaminoavermectin B1b. Preferably, a salt of emamectin is used. Non-limiting examples of salts of emamectin which may be used in the present invention include the salts described in U.S. Pat. No. 5,288,710, e.g., salts derived from benzoic acid, substituted benzoic acid, benzenesulfonic acid, citric acid, phosphoric acid, tartaric acid, maleic acid, and the like. Most preferably, the emamectin salt used in the present invention is emamectin benzoate.
  • Eprinomectin is chemically known as 4″-epi-acetylamino-4″-deoxy-avermectin B1. Eprinomectin was specifically developed to be used in all cattle classes and age groups. It was the first avermectin to show broad-spectrum activity against both endo- and ecto-parasites while also leaving minimal residues in meat and milk. It has the additional advantage of being highly potent when delivered topically.
  • The composition of the present invention optionally comprises combinations of one or more of the following antiparasite compounds: imidazo[1,2-b]pyridazine compounds as described by U.S. Patent Application Publication No. 2005/0182059 A1; 1-(4-mono and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanol compounds, as described by U.S. Pat. No. 7,361,689; trifluoromethanesulfonanilide oxime ether derivatives, as described by U.S. Pat. No. 7,312,248; and n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives, as described by PCT Patent Application Publication WO 2006/135648.
  • The compositions of the present invention may also further comprise a flukicide. Suitable flukicides include, for example, triclabendazole, fenbendazole, albendazole, clorsulon and oxibendazole. It will be appreciated that the above combinations may further include combinations of antibiotic, antiparasitic and anti-fluke active compounds.
  • In addition to the above combinations, it is also contemplated to provide combinations of the inventive methods and compounds, as described herein, with other animal health remedies such as trace elements, anti-inflammatories, anti-infectives, hormones, dermatological preparations, including antiseptics and disinfectants, and immunobiologicals such as vaccines and antisera for the prevention of disease.
  • For example, such antinfectives include one or more antibiotics that are optionally co-administered during treatment using the inventive compounds or methods, e.g., in a combined composition and/or in separate dosage forms. Art-known antibiotics suitable for this purpose include, for example, those listed herein below.
  • One useful antibiotic is florfenicol, also known as D-(threo)-1-(4-methylsulfonylphenyl)-2-dichloroacetamido-3-fluoro-1-propanol. Another preferred antibiotic compound is D-(threo)-1-(4-methylsulfonylphenyl)-2-difluoroacetamido-3-fluoro-1-propanol. Another useful antibiotic is thiamphenicol. Processes for the manufacture of these antibiotic compounds, and intermediates useful in such processes, are described in U.S. Pat. Nos. 4,31,857; 4,582,918; 4,973,750; 4,876,352; 5,227,494; 4,743,700; 5,567,844; 5,105,009; 5,382,673; 5,352,832; and 5,663,361. Other florfenicol analogs and/or prodrugs have been disclosed and such analogs also can be used in the compositions and methods of the present invention (see e.g., U.S. Pat. Nos. 7,041,670 and 7,153,842).
  • Another useful antibiotic compound is tilmicosin. Tilmicosin is a macrolide antibiotic that is chemically defined as 20-dihydro-20-deoxy-20-(cis-3,5-dimethylpiperidin-1-yl)-desmycosin and is disclosed in U.S. Pat. No. 4,820,695.
  • Another useful antibiotic for use in the present invention is tulathromycin. Tulathromycin may be prepared in accordance with the procedures set forth in U.S. Pat. No. 6,825,327.
  • Further antibiotics for use in the present invention include the cephalosporins such as, for example, ceftiofur, cefquinome, etc. The concentration of the cephalosporin in the formulation of the present invention optionally varies between about 1 mg/mL to 500 mg/mL.
  • Another useful antibiotic includes the fluoroquinolones, such as, for example, enrofloxacin, danofloxacin, difloxacin, orbifloxacin and marbofloxacin. In the case of enrofloxacin, it may be administered in a concentration of about 100 mg/mL. Danofloxacin may be present in a concentration of about 180 mg/mL.
  • Other useful macrolide antibiotics include compounds from the class of ketolides, or, more specifically, the azalides. Such compounds are described in, for example, U.S. Pat. Nos. 6,514,945; 6,472,371; 6,270,768; 6,437,151; 6,271,255; 6,239,12; 5,958,888; 6,339,063; and 6,054,434.
  • Other useful antibiotics include the tetracyclines, particularly chlortetracycline and oxytetracycline. Other antibiotics may include β-lactams such as penicillins, e.g., penicillin, ampicillin, amoxicillin, or a combination of amoxicillin with clavulanic acid or other beta lactamase inhibitors.
  • Nonagronomic applications in the veterinary sector are by conventional means such as by enteral administration in the form of, for example, tablets, capsules, drinks, drenching preparations, granulates, pastes, boli, feed-through procedures, or suppositories; or by parenteral administration, such as by injection (including intramuscular, subcutaneous, intravenous, intraperitoneal) or implants; by nasal administration; by topical administration, for example, in the form of immersion or dipping, spraying, washing, coating with powder, or application to a small area of the animal, and through articles such as neck collars, ear tags, tail bands, limb bands or halters which comprise compounds or compositions of the present invention.
  • Any of the compounds of the present invention, or a suitable combination of such compounds, may be administered directly to the animal subject and/or indirectly by applying it to the local environment in which the animal dwells (such as bedding, enclosures, or the like). Direct administration includes contacting the skin, fur or feathers of a subject animal with the compounds, or by feeding or injecting the compounds into the animal.
  • The compounds of the present invention may be administered in a controlled release form, e.g., in a subcutaneous slow release formulation, or in the form of a controlled release device affixed to an animal such as a flea collar. Collars for the controlled release of an insecticide agent for long term protection against flea infestation in a companion animal are art-known, and are described, for example, by U.S. Pat. Nos. 3,852,416; 4,224,901; 5,555,848; and 5,184,573.
  • Typically a parasiticidal composition according to the present invention comprises a mixture of a compound of Formula 1 with one or more pharmaceutically or veterinarily acceptable carriers comprising excipients and auxiliaries selected with regard to the intended route of administration (e.g., oral, topical or parenteral administration such as injection) and in accordance with standard practice. In addition, a suitable carrier is selected on the basis of compatibility with the one or more active ingredients in the composition, including such considerations as stability relative to pH and moisture content. Therefore of note is a composition for protecting an animal from an invertebrate parasitic pest comprising a compound of the invention (i.e. in a parasiticidally effective amount) and at least one veterinarily acceptable carrier.
  • For parenteral administration including intravenous, intramuscular and subcutaneous injection, a compound of the present invention can be formulated in suspension, solution or emulsion in oily or aqueous vehicles, and may contain adjuncts such as suspending, stabilizing and/or dispersing agents. The compounds of the present invention may also be formulated for bolus injection or continuous infusion. Pharmaceutical compositions for injection include aqueous solutions preferably in physiologically compatible buffers containing other excipients or auxiliaries as are known in the art of pharmaceutical formulation. Additionally, suspensions of the active compounds may be prepared in a lipophilic vehicle. Suitable lipophilic vehicles include fatty oils such as sesame oil, synthetic fatty acid esters such as ethyl oleate and triglycerides, or materials such as liposomes. Aqueous injection suspensions may contain substances that increase the viscosity of the suspension, such as sodium carboxymethyl cellulose, sorbitol, or dextran. Formulations for injection may be presented in unit dosage form, e.g., in ampoules or in multi-dose containers. Alternatively, the active ingredient may be in powder form for constitution with a suitable vehicle, e.g., sterile, pyrogen-free water, before use.
  • In addition to the formulations described supra, the compounds of the present invention may also be formulated as a depot preparation. Such long acting formulations may be administered by implantation (for example, subcutaneously or intramuscularly) or by intramuscular or subcutaneous injection. The compounds of the present invention may be formulated for this route of administration with suitable polymeric or hydrophobic materials (e.g., in an emulsion with a pharmacologically acceptable oil).
  • For administration by inhalation, the compounds of the present invention can be delivered in the form of an acrosol spray using a pressurized pack or a nebulizer and a suitable propellant, e.g., without limitation, dichlorodifluoromethane, trichlorofluoromethane, dichlorotetrafluoroethane or carbon dioxide. In the case of a pressurized aerosol, the dosage unit may be controlled by providing a valve to deliver a metered amount. Capsules and cartridges of, for example, gelatin for use in an inhaler or insufflator may be formulated containing a powder mix of the compound and a suitable powder base such as lactose or starch.
  • Compounds of the present invention have been discovered to have favorable pharmacokinetic and pharmacodynamic properties providing systemic availability from oral administration and ingestion. Therefore after ingestion by the animal to be protected, parasiticidally effective concentrations of compounds of the invention in the bloodstream protect the treated animal from blood-sucking pests such as fleas, ticks and lice. Therefore of note is a composition for protecting an animal from an invertebrate parasite pest in a form for oral administration (i.e. comprising, in addition to a parasiticidally effective amount of a compound of the invention, one or more carriers selected from binders and fillers suitable for oral administration and feed concentrate carriers).
  • For oral administration in the form of solutions (the most readily available form for absorption), emulsions, suspensions, pastes, gels, capsules, tablets, boluses, powders, granules, rumen-retention and feed/water/lick blocks, a compound of the present invention can be formulated with binders/fillers known in the art to be suitable for oral administration compositions, such as sugars and sugar derivatives (e.g., lactose, sucrose, mannitol, sorbitol), starch (e.g., maize starch, wheat starch, rice starch, potato starch), cellulose and derivatives (e.g., methylcellulose, carboxymethylcellulose, ethylhydroxycellulose), protein derivatives (e.g., zein, gelatin), and synthetic polymers (e.g., polyvinyl alcohol, polyvinylpyrrolidone). If desired, lubricants (e.g., magnesium stearate), disintegrating agents (e.g., cross-linked polyvinylpyrrolidinone, agar, alginic acid) and dyes or pigments can be added. Pastes and gels often also contain adhesives (e.g., acacia, alginic acid, bentonite, cellulose, xanthan gum, colloidal magnesium aluminum silicate) to aid in keeping the composition in contact with the oral cavity and not being easily ejected.
  • A preferred embodiment is a composition formulated into a chewable and/or edible product (e.g., a chewable treat or edible tablet). Such a product would ideally have a taste, texture and/or aroma favored by the animal to be protected so as to facilitate oral administration of the compound of Formula 1.
  • If the parasiticidal compositions are in the form of feed concentrates, the carrier is typically selected from high-performance feed, feed cereals or protein concentrates. Such feed concentrate-containing compositions can, in addition to the parasiticidal active ingredients, comprise additives promoting animal health or growth, improving quality of meat from animals for slaughter or otherwise useful to animal husbandry. These additives can include, for example, vitamins, antibiotics, chemotherapeutics, bacteriostats, fungistats, coccidiostats and hormones.
  • The compounds of Formula 1 may also be formulated in rectal compositions such as suppositories or retention enemas, using, e.g., conventional suppository bases such as cocoa butter or other glycerides.
  • Formulations for topical administration are typically in the form of a powder, cream, suspension, spray, emulsion, foam, paste, aerosol, ointment, salve or gel. More typically a topical formulation is a water-soluble solution, which can be in the form of a concentrate that is diluted before use. Parasiticidal compositions suitable for topical administration typically comprise a compound of the present invention and one or more topically suitable carriers. In applications of a parasiticidal composition topically to the exterior of an animal as a line or spot (i.e. “spot-on” treatment), the active ingredient migrates over the surface of the animal to cover most or all of its external surface area. As a result, the treated animal is particularly protected from invertebrate pests that feed off the epidermis of the animal such as ticks, fleas and lice. Therefore formulations for topical localized administration often comprise at least one organic solvent to facilitate transport of the active ingredient over the skin and/or penetration into the epidermis of the animal. Carriers in such formulations include propylene glycol, paraffins, aromatics, esters such as isopropyl myristate, glycol ethers, alcohols such as ethanol, n-propanol, 2-octyl dodecanol or oleyl alcohol; solutions in esters of monocarboxylic acids, such as isopropyl myristate, isopropyl palmitate, lauric acid oxalic ester, oleic acid oleyl ester, oleic acid decyl ester, hexyl laurate, oleyl oleate, decyl oleate, caproic acid esters of saturated fatty alcohols of C12-C18 chain length; solutions of esters of dicarboxylic acids, such as dibutyl phthalate, diisopropyl isophthalate, adipic acid diisopropyl ester, di-n-butyl adipate or solutions of esters of aliphatic acids, e.g., glycols. It may be advantageous for a crystallization inhibitor or a dispersant known from the pharmaceutical or cosmetic industry also to be present.
  • A pour-on formulation may also be prepared for control of parasites in an animal of agricultural value. The pour-on formulations of this invention can be in the form of a liquid, powder, emulsion, foam, paste, aerosol, ointment, salve or gel. Typically, the pour-on formulation is liquid. These pour-on formulations can be effectively applied to sheep, cattle, goats, other ruminants, camelids, pigs and horses. The pour-on formulation is typically applied by pouring in one or several lines or in a spot-on the dorsal midline (back) or shoulder of an animal. More typically, the formulation is applied by pouring it along the back of the animal, following the spine. The formulation can also be applied to the animal by other conventional methods, including wiping an impregnated material over at least a small area of the animal, or applying it using a commercially available applicator, by means of a syringe, by spraying or by using a spray race. The pour-on formulations include a carrier and can also include one or more additional ingredients. Examples of suitable additional ingredients are stabilizers such as antioxidants, spreading agents, preservatives, adhesion promoters, active solubilisers such as oleic acid, viscosity modifiers, UV blockers or absorbers, and colourants. Surface active agents, including anionic, cationic, non-ionic and ampholytic surface active agents, can also be included in these formulations.
  • The formulations of this invention typically include an antioxidant, such as BHT (butylated hydroxytoluene). The antioxidant is generally present in amounts of at 0.1-5% (wt/vol). Some of the formulations require a solubilizer, such as oleic acid, to dissolve the active agent, particularly if spinosad is used. Common spreading agents used in these pour-on formulations include isopropyl myristate, isopropyl palmitate, caprylic/capric acid esters of saturated C12-C18 fatty alcohols, oleic acid, oleyl ester, ethyl oleate, triglycerides, silicone oils and dipropylene glycol methyl ether. The pour-on formulations of this invention are prepared according to known techniques. When the pour-on formulation is a solution, the parasiticide/insecticide is mixed with the carrier or vehicle, using heat and stirring if required. Auxiliary or additional ingredients can be added to the mixture of active agent and carrier, or they can be mixed with the active agent prior to the addition of the carrier. If the pour-on formulation is an emulsion or suspension, the formulations can be similarly prepared using known techniques.
  • Other delivery systems for relatively hydrophobic pharmaceutical compounds can be employed. Liposomes and emulsions are well-known examples of delivery vehicles or carriers for hydrophobic drugs. In addition, organic solvents such as dimethylsulfoxide can be used, if needed.
  • For agronomic applications, the rate of application required for effective control (i.e. “biologically effective amount”) will depend on such factors as the species of invertebrate to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredients per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.0001 kg/hectare may be sufficient or as much as 8 kg/hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required. One skilled in the art can easily determine the biologically effective amount necessary for the desired level of invertebrate pest control.
  • In general for veterinary use, a compound of Formula 1 is administered in a parasiticidally effective amount to an animal to be protected from invertebrate parasite pests. A parasiticidally effective amount is the amount of active ingredient needed to achieve an observable effect diminishing the occurrence or activity of the target invertebrate parasite pest. One skilled in the art will appreciate that the parasitically effective dose can vary for the various compounds and compositions of the present invention, the desired parasitical effect and duration, the target invertebrate pest species, the animal to be protected, the mode of application and the like, and the amount needed to achieve a particular result can be determined through simple experimentation.
  • For oral, subcutaneous or spot-on administration to homeothermic animals, a dose of a compound of the present invention administered at suitable intervals typically ranges from about 0.01 mg/kg to about 100 mg/kg, and preferably from about 0.01 mg/kg to about 30 mg/kg of animal body weight. For other topical (e.g., dermal) administration, including dips and sprays, a dose typically contains from about 0.01 ppm to about 150,000 ppm, more typically from about 0.01 ppm to about 100,000 ppm, preferably from about 0.01 ppm to about 5,000 ppm, and most preferably from about 0.01 ppm to about 3,000 ppm, of a compound of the present invention.
  • Suitable intervals for the administration of compounds of the present invention to homeothermic animals range from about daily to about yearly. Of note are administration intervals ranging from about weekly to about once every 6 months. Of particular note are monthly administration intervals (i.e. administering the compound to the animal once every month).
  • The following Tests demonstrate the control efficacy of compounds of this invention on specific pests. “Control efficacy” represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-G for compound descriptions. See Index Table H for 1H NMR data. For mass spectral data, the numerical value reported is the molecular weight of the highest isotopic abundance parent ion (M+1) formed by addition of H+ (molecular weight of 1) to the molecule, observed by mass spectrometry using atmospheric pressure chemical ionization (AP+). The following abbreviations are used in the Index Tables which follow: Cmpd means Compound, t is tertiary, c is cyclo, Me is methyl, Et is ethyl, Pr is propyl, i-Pr is isopropyl, Bu is butyl, c-Pr is cyclopropyl, c-Pn is cyclopentyl, c-Hx is cyclohexyl, t-Bu is tertiary-butyl, Ph is phenyl, OMe is methoxy, SMe is methylthio, and SO2Me means methylsulfonyl. (R) or (S) denotes the absolute chirality of the asymmetric carbon center. The variable “R2” represents one or a combination of substituents as listed in the Index Tables. The abbreviation “Ex.” stands for “Example” and is followed by a number indicating in which example the compound is prepared.
  • INDEX TABLE A
    Figure US20150098928A9-20150409-C00113
    m.p. (° C.) or
    Cmpd R2 R AP+ (M + 1)
    1 3-Cl, 5-Cl CH2CH2NH(C═O)O—t-Bu *
    2 3-Cl, 5-Cl (CH2)6NH(C═O)O—t-Bu *
    3 3-Cl, 5-Cl (CH2)3NMe(C═O)O—t-Bu *
    4 3-Cl, 5-Cl (CH2)3NMe(C═O)Me *
    5 3-Cl, 5-Cl (S)-CH(Ph)CO2H *
    6 3-Cl, 5-Cl C(Me)2CO2H *
    7 3-Cl, 5-Cl CH2CH2CO2H *
    8 3-Cl, 4-Cl, 5-Cl CH2CO2H *
    9 3-Br, 5-Br CH2CO2H *
    10 3-Cl, 5-Cl SO2Me *
    11 3-Cl, 5-Cl SO2Ph *
    12 3-Cl, 5-Cl CH2CO2H *
    13 3-Cl, 5-Cl CH2CO2Na *
    14 3-Cl, 5-Cl CH2CH(Cl)CH2CH2CH2Cl *
    15 3-CF3, 5-CF3 CH2CO2H *
    16 3-CF3 CH(Et)CH2OH
    17 3-CF3
    Figure US20150098928A9-20150409-C00114
         		*
    18 3-CF3
    Figure US20150098928A9-20150409-C00115
         		*
    19 3-CF3
    Figure US20150098928A9-20150409-C00116
         		*
    20 3-CF3
    Figure US20150098928A9-20150409-C00117
         		*
    21 3-CF3 (CH2)3SCH2CF3 609
    22 3-CF3 (CH2)2SCH2CF3 594
    23 3-Br, 5-CF3 CH2CO2H *
    24 3-CF3
    Figure US20150098928A9-20150409-C00118
         		629
    25 3-CF3, 5-CF3 CH2C(═O)ON═C(CH3)2 *
    26 3-Cl, 5-CF3 CH2CO2H *
    27 3-CF3, 5-CF3
    Figure US20150098928A9-20150409-C00119
         		*
    28 3-F, 5-F CH2CO2H 187-190
    29 3-F CH2CO2H 182-184
    30 3-Br CH2CO2H *
    31 3-CF3, 5-CF3 CH(CH3)COOH 118 119
    32 3-Cl, 5-CF3 (R)-CH(CH3)COOH *
    34 3-Cl, 5-OCF3 CH2CO2H *
    35 3-Cl, 5-OCF3 (R)-CH(CH3)COOH *
    36 3-Cl, 5-OCH2CF3 CH2CO2H *
    37 3-Cl, 5-OCH2CF3 (R)-CH(CH3)COOH *
    38 3-Br, 5-CF3 (R)-CH(CH3)COOH *
    39 3-CF3, 5-CF3 (R)-CH(i-Pr)COOH
    40 3-F, 5-CF3 (R)-CH(CH3)COOH *
    41 3-CF3, 5-CF3 (R)-CH(CH3)COOH 593
    88 3-Cl, 5-CF3 CH(Et)COOH
    * See Index Table H for 1H NMR data.
  • INDEX TABLE B
    Figure US20150098928A9-20150409-C00120
    Cmpd R2 R12 R13 R15 m.p. (° C.)
    42 3-Cl, 5-Cl H H (CH2)3NHMe *
    43 3-Cl, 5-Cl CH3 CH3 CH2—c-Pr *
    44 (Ex. 2) 3-Cl, 5-Cl H H CH2—c-Pr **
    45 3-Cl, 5-Cl H H CH2-2-Py *
    46 3-Cl, 5-Cl H H C6H4-4-CF3 *
    47 (Ex. 1) 3-Cl, 5-Cl H H CH2CH2OCH3 **
    48 3-Cl, 5-Cl H H CH2CH2SCH3 *
    49 3-Cl, 4-Cl, 5-Cl H H CH2CH2SCH3 *
    50 3-Cl, 5-Cl H H c-Pr *
    51 3-Cl, 5-Cl H H c-Hx *
    52 3-Cl, 5-Cl H H c-Pn *
    53 3-Cl, 5-Cl H (R)-CH3 c-Pr *
    54 3-CF3 H H c-Pr *
    55 3-CF3, 5-CF3 H H c-Pr *
    56 3-Br H H CH2—c-Pr *
    57 3-Br H H CH2CH2SCH3 *
    58 3-OCF3 H H CH2COOH *
    59 3-OCF3 H H CH2-2-Py *
    60 3-OCF3 H H CH2—c-Pr *
    61 3-OCF3 H H CH2CH2SCH3 *
    62 3-F, 5-F H H c-Pr *
    63 3-F H H c-Pr *
    64 3-CF3, 5-CF3 H (R)-CH3 c-Pr *
    65 3-CF3, 5-CF3 H (R)-CH3 H *
    66 3-CF3, 5-CF3 H (R)-CH3 CH2—c-Pr *
    67 3-CF3, 5-CF3 H CH3 c-Pr 115-116
    68 3-CF3, 5-CF3 H CH3 CH2—c-Pr 114-115
    69 3-CF3, 5-CF3 H CH3 H 113-114
    70 3-CF3, 5-CF3 H H H *
    71 3-CF3, 5-CF3 H H CH2—c-Pr *
    72 3-Cl, 5-CF3 H (R)-CH3 c-Pr *
    73 3-Cl, 5-CF3 H (R)-CH3 CH2—c-Pr *
    74 3-Cl, 5-CF3 H (R)-CH3 H *
    75 3-Cl, 5-CF3 H H c-Pr 133-134
    76 3-Cl, 5-CF3 H H CH2—c-Pr 92-93
    77 3-Cl, 5-CF3 H H H  99-100
    78 3-Cl, 5-CF3 H CH3 c-Pr 120 121
    79 3-Cl, 5-CF3 H CH3 CH2—c-Pr 94-95
    80 3-CF3, 5-CF3 H (R)-CH3
    Figure US20150098928A9-20150409-C00121
         		*
    81 3-Cl, 5-OCF3 H H CH2—c-Pr *
    82 3-Cl, 5-OCF3 H H c-Pr *
    83 3-Br, 5-CF3 H (R)-CH3 H *
    84 3-Cl, 5-OCH2CF3 H H CH2—c-Pr *
    85 3-Cl, 5-OCH2CF3 H H c-Pr *
    86 3-Cl, 5-CF3 H (R)-Et H *
    87 3-Cl, 5-CF3 H (R)-i-Pr H *
    * See Index Table H for 1H NMR data.
    ** See synthesis example for 1H NMR data.
  • INDEX TABLE C
    Figure US20150098928A9-20150409-C00122
    Cmpd R2 R14/R15 m.p. (° C.)
    89 3-Cl, 5-Cl —(CH2)5— *
    90 3-Cl, 5-Cl —(CH2CF2CH2CH2)— *
    91 3-Cl, 5-Cl —(CH(CF3)CH2CH2CH2)— *
    92 3-CF3 —(CH2CH2N(SO2Et)CH2CH2)— *
    * See Index Table H for 1H NMR data.
  • INDEX TABLE D
    Figure US20150098928A9-20150409-C00123
    Cmpd R2 R20 q m.p. (° C.)
    93 (Ex. 3) 3-Cl, 5-Cl C(═O)CF3 1 **
    94 (Ex. 4) 3-Cl, 5-Cl H 1 **
    95 (Ex. 5) 3-Cl, 4-Cl, 5-Cl H 0 **
    ** See synthesis example for 1H NMR data.
  • INDEX TABLE E
    Figure US20150098928A9-20150409-C00124
    Cmpd R2 R16 R17 m.p. (° C.)
    96 (Ex. 6) 3-Cl, 5-Cl Me Me **
    ** See synthesis example for 1H NMR data.
  • INDEX TABLE F
    Figure US20150098928A9-20150409-C00125
    Cmpd R2 R m.p. (° C.)
    97 3-Cl, 5-Cl (S)-CO2CH3 *
    98 3-Cl, 5-Cl (R)-CO2CH3 *
    99 3-Cl, 5-Cl (S)-CO2H *
    100 3-Cl, 5-Cl (R)-CO2H *
    101 3-Cl, 5-Cl (S)-C(═O)NHCH2CF3 *
    102 3-Cl, 5-Cl (R)-C(═O)NHCH2CF3 *
    103 3-Cl, 5-Cl (S)-C(═O)NHCH3 *
    104 3-Cl, 5-Cl (R)-C(═O)NHCH3 *
    105 3-Cl, 5-Cl (S)-C(═O)NHCH2CH3 *
    106 3-Cl, 5-Cl (R)-C(═O)NHCH2CH3 *
    * See Index Table H for 1H NMR data.
  • INDEX TABLE G
    Figure US20150098928A9-20150409-C00126
    Cmpd R2 R m.p. (° C.)
    107 3-Cl, 5-Cl
    Figure US20150098928A9-20150409-C00127
         		*
    108 3-Cl, 5-Cl
    Figure US20150098928A9-20150409-C00128
         		*
    109 3-Cl, 5-Cl
    Figure US20150098928A9-20150409-C00129
         		*
    110 3-CF3, 5-CF3
    Figure US20150098928A9-20150409-C00130
         		*
    111 3-Cl, 5-Cl
    Figure US20150098928A9-20150409-C00131
         		*
    * See Index Table H for 1H NMR data.
  • INDEX TABLE H
    Compound 1H NMR Data (CDCl3 solution unless indicated otherwise)a
    1 δ 8.79 (d, 1H), 8.32 (d, 1H), 7.43-7.65 (m, 7H), 6.90 (br s, 1H), 5.04 (br s, 1H), 4.25 (d, 1H), 3.89
    (d, 1H), 3.64 (m, 2H), 3.43 (m, 2H), 1.40 (s, 9H).
    2 δ 8.80 (d, 1H), 8.25 (d, 1H), 7.45-7.66 (m, 7H), 6.31 (br s, 1H), 4.56 (br s, 1H), 4.24 (d, 1H), 3.89
    (d, 1H), 3.52 (m, 2H), 3.11 (m, 2H), 1.40-1.69 (m, 8H), 1.40 (s, 9H).
    3 δ 8.80 (d, 1H), 8.35 (d, br., 1H), 7.45-7.65 (m, 8H), 4.25 (d, 1H), 3.90 (d, 1H), 3.50 (m, 2H), 3.38
    (m, 2H), 2.86 (s, 3H), 1.84 (m, 2H), 1.37 (s, 9H).
    4 δ 8.81 (d, 1H), 8.36 (d, 1H), 7.44-7.64 (m H), 4.24 (d, 1H), 3.89 (d, 1H), 3.50 (m, 2H), 3.43 (m,
    2H), 3.01 (s, 3H), 2.04 (s, 3H), 1.84 (m, 2H).
    5 δ 8.70 (m, 1H), 8.14 (m, 1H), 8.04 (br s, 1H), 7.29-7.55 (m, 12H), 7.17 (m, 1H), 5.81 (d, 1H),
    4.15 (d, 1H), 3.80 (d, 1H).
    6 δ (CD3C(═O)CD3) 8.89 (d, 1H), 8.42 (d, 1H), 7.99 (br s, 1H), 7.86 (d, 1H), 7.61-7.74 (m, 6H),
    4.59 (d, 1H), 4.47 (d, 1H), 1.67 (s, 6H).
    7 δ 8.78 (d, 1H), 8.24 (d, 1H), 7.44-7.64 (m, 7H), 6.61 (t, 1H), 4.23 (d, 1H), 3.87 (d, 1H), 3.80 (q,
    2H), 2.77 (m, 1H).
    8 δ 8.76 (d, 1H), 8.27 (d, 1H), 7.68 (s, 2H), 7.59 (m, 2H), 7.54 (d, 1H), 7.40 (d, 1H), 6.74 (t, 1H),
    4.32 (d, 2H), 4.22 (d, 1H), 3.85 (d, 1H).
    9 δ 10.41 (br s, 1H), 8.71 (d, 1H), 8.20 (d, 1H), 7.48-7.75 (m, 5H), 7.44 (d, 1H), 7.31 (d, 1H), 6.92
    (br s, 1H), 4.26 (d, 2H), 4.17 (d, 1H), 3.83 (d, 1H).
    10 (CD3S(═O)CD3) δ 8.80 (d, 1H), 8.35 (dd, 1H), 7.95 (d, 1H), 7.80-7.90 (m, 2H), 7.60-7.75 (m,
    4H), 4.56 (s, 2H), 3.37 (s, 3H).
    11 (CD3C(═O)CD3) δ 8.86 (d, 1H), 8.32 (d, 1H), 8.08-8.24 (m, 2H), 7.76-7.93 (m, 4H), 7.44-7.76
    (m, 6H), 4.57 (d, 1H), 4.45 (d, 1H).
    12 (CD3S(═O)CD3) δ 9.02 (t, 1H), 8.81 (d, 1H), 8.37 (d, 1H), 7.92 (d, 1H), 7.83 (t, 1H), 7.65-7.74
    (m, 5H), 4.58 (d, 1H), 4.54 (d, 1H), 4.02 (d, 2H).
    13 (CD3S(═O)CD3) δ 8.86 (d, 1H), 8.50 (d, 1H), 7.67-7.96 (m, 8H), 4.61 (apparent s, 2H), 3.64 (d,
    2H).
    14 δ 8.77 (d, 1H), 8.25 (d, 1H), 7.40-7.64 (m, H), 6.63 (br t, 1H), 4.23 (m, 2H), 4.00 (m, 1H), 3.87
    (d, 1H), 3.61 (m, 3H), 1.88-2.12 (m, 4H).
    15 δ 8.63 (d, 1H), 8.12 (d, 1H), 8.10 (s, 2H), 7.99 (s, 1H), 7.23-7.48 (m, 4H), 6.17 (br s, 2H), 4.20
    (d, 1H), 4.19 (s, 2H), 3.83 (d, 1H).
    16 (CD3C(═O)CD3) δ 8.80 (m, 1H), 8.35 (m, 1H), 8.05-8.10 (m, 2H), 7.45-7.80 (m, 7H), 4.60 (d,
    1H), 4.45 (d, 1H), 4.13 (m, 1H), 4.0 (m, 1H), 3.67-3.72 (m, 2H), 1.77 (m, 1H), 1.60 (m, 1H), 1.04
    (t, 3H)
    17 δ 8.82 (d, 1H), 8.21 (d, 1H), 7.83 (s, 1H), 7.85 (m, 1H), 7.45-7.75 (m, 7H), 6.55-6.6 (m, 2H), 4.5
    (m, 2H), 4.30 (d, 1H), 4.0 (m, 2H), 3.94 (d, 1H).
    18 δ 8.82 (d, 1H), 8.2 (m, 1H), 8.13 (s, 1H), 7.9-7.95 (m, 2H), 7.85 (m, 1H), 7.48 (m, 1H), 7.45-7.65
    (m, 5H), 6.70 (br t, 1H), 4.52 (m, 2H), 4.30 (d, 1H), 3.99 (m, 2H), 3.93 (d, 1H).
    19 (CD3C(═O)CD3) δ 8.92 (d, 1H), 8.36 (d, 1H), 8.05 (s, 2H), 7.80 7.90 (m, 4H), 7.6 7.7 (m, 3H),
    4.65 (d, 1H), 4.48 (d, 1H), 4.40 (m, 1H), 4.13 (m, 1H), 3.86 (m, 1H), 3.57-3.72 (m, 2H), 1.39 (s,
    3H), 1.30 (s, 3H).
    20 (CD3C(═O)CD3) δ 8.91 (d, 1H), 8.36 (d, 1H), 8.05 (s, 2H), 7.8-7.9 (m, 3H), 7.6-7.74 (m, 4H),
    4.65 (d, 1H), 4.47 (d, 1H), 4.1 (m, 1H), 3.83 (m, 1H), 3.70 (m, 1H), 3.49-3.63 (m, 2H), 2.0-2.1
    (m, 1H), 1.85-1.95 (m, 2H), 1.74 (m, 1H).
    23 δ 8.81 (d, 1H), 8.33 (d, 1H), 8.02 (s, 1H), 7.87 (s, 1H), 7.85 (s, 1H), 7.61-7.67 (m, 3H), 7.49 (d,
    1H), 6.60 (t, 1H), 4.37 (d, 2H), 4.30 (d, 1H), 3.91 (d, 1H).
    25 δ 8.83 (d, 1H), 8.38 (d, 1H), 8.14 (s, 2H), 8.00 (s, 1H), 7.61-7.69 (m, 3H), 7.51 (d, 1H), 6.68 (br t,
    1H), 4.48 (d, 2H), 4.38 (d, 1H), 3.96 (d, 1H), 2.07 (s, 3H), 2.06 (s, 3H).
    26 δ 8.78 (d, 1H), 8.29 (d, 1H), 7.86 (s, 1H), 7.80 (s, 1H), 7.72 (s, 1H), 7.60 (m, 2H), 7.56 (d, 1H),
    7.43 (d, 1H), 6.70 (br t, 1H), 4.33 (d, 2H), 4.28 (d, 1H), 3.89 (d, 1H).
    27 δ 8.77 (d, 1H), 8.23 (m, 1H), 8.15 (s, 2H), 8.01 (s, 1H), 7.5-7.6 (m, 2H), 7.35-7.45 (m, 2H), 6.63
    (br t, 1H), 4.33 (d, 1H), 4.1 (m, 2H), 3.96 (d, 1H), 3.8 (m, 2H), 3.4 (m, 1H), 2.05 (m, 1H), 1.9 (m,
    2H), 1.65 (m, 1H).
    30 (CD3CN) δ 8.79-8.88 (m, 1H), 8.32-8.41 (m, 1H), 7.89 (s, 1H), 7.61-7.77 (m, 6H), 7.43-7.50
    (m, 1H), 7.35 (br s, 1H), 4.43 (d, 1H), 4.14-4.22 (m, 3H).
    32 δ 8.78 (d, 1H), 8.28 (d, 1H), 7.86 (s, 1H), 7.80 (s, 1H), 7.72 (s, 1H), 7.42-7.64 (m, 4H), 6.64 (m,
    1H), 4.90 (m, 1H), 4.28 (dd, 1H), 3.89 (dd, 1H), 1.62 (d, 3H).
    34 δ 8.79 (d, 1H), 8.32 (d, 1H), 7.53-7.74 (m, 4H), 7.40-7.51 (m, 2H), 7.34 (s, 1H), 6.64 (br s, 1H),
    4.36 (d, 2H), 4.26 (d, 1H), 3.88 (d, 1H).
    35 δ 8.78-8.85 (m, 1H), 8.29-8.36 (m, 1H), 7.59-7.71 (m, 4H), 7.50 (dd, 1H), 7.44 (s, 1H), 7.34 (s,
    1H), 6.53 (d, 1H), 4.93 (q, 1H), 4.27 (d, 1 H), 3.89 (d, 1H), 1.65 (d, 3H).
    36 δ 9.58 (br s, 1H), 8.64 (d, 1H), 8.13 (d, 1H), 7.39-7.52 (m, 2H), 7.35 (d, 1H), 7.27 (s, 1H), 7.20
    (d, 1H), 7.16 (s, 1H), 7.04-7.11 (m, 1H), 7.01 (t, 1H), 4.40 (q, 2H), 4.19 (d, 2H), 4.11 (d, 1H),
    3.78 (d, 1H).
    37 δ 8.79 (s, 1H), 8.31 (d, 1H), 7.55-7.71 (m, 3H), 7.47 (d, 1H), 7.32 (s, 1H), 7.20 (s, 1H), 7.04 (t,
    1H), 6.56 (br s, 1H), 4.92 (q, 1H), 4.41 (q, 2H), 4.23 (d, 1H), 3.89 (d, 1H), 1.64 (d, 3H).
    38 δ 8.74 (m, 1H), 8.24 (m, 1H), 8.01 (s, 1H), 7.87 (m, 2H), 7.36-7.60 (m, 4H), 6.75 (m, 1H), 4.87
    (m, 1H), 4.24 (m, 1H), 3.86 (m, 1H), 1.59 (d, 3H).
    40 (CD3C(O)CD3) δ 11.25 (br s, 1H), 8.90 (d, 1H), 8.45 (d, 1H), 8.00 (br d, 1H), 7.92 (s, 1H), 7.85
    7.90 (m, 2H), 7.6-7.75 (m, 4H), 4.76 (m, 1H), 4.66 (d, 1H), 4.52 (d, 1H), 1.56 (d, 3H).
    42 (CD3OD) δ 8.85 (d, 1H), 8.38 (d, 1H), 7.57-7.78 (m, 7H), 4.44 (d, 1H), 4.19 (d, 1H), 4.08 (s,
    2H), 3.38 (m, 2H), 3.06 (m, 2H), 2.68 (s, 3H), 1.92 (m, 2H).
    43 δ 8.82 (d, 1H), 8.29 (d, 1H), 7.46-7.67 (m, 7H), 6.90 (s, 1H), 6.47 (br s, 1H), 4.26 (d, 1H), 3.89
    (d, 1H), 3.20 (dd, 2H), 1.79 (s, 6H), 1.01 (m, 1H), 0.55 (m, 2H), 0.25 (m, 2H).
    44 *
    45 δ 8.82 (d, 1H), 8.52 (d, 1H), 8.34 (d, 1H), 7.20-7.69 (m, 11H), 6.98 (br s, 1H), 4.61 (d, 1H), 4.32
    (d, 2H), 4.26 (d, 1H), 3.89 (d, 1H).
    46 δ 9.35 (br s, 1H), 8.87 (d, 1H), 8.34 (d, 1H), 7.44-7.71 (m, 11H), 7.35 (br s, 1H), 4.56 (d, 2H),
    4.25 (d, 1H), 3.89 (d, 1H).
    47 *
    48 δ 8.83 (d, 1H), 8.33 (d, 1H), 7.46-7.68 (m, 7H), 6.96 (br s, 1H), 6.57 (br s, 1H), 4.26 (d, 1H), 4.23
    (d, 2H), 3.90 (d, 1H), 3.53 (q, 2H), 2.67 (t, 2H), 2.11 (s, 3H).
    49 δ 8.82 (d, 1H), 8.33 (d, 1H), 7.70 (s, 2H), 7.60-7.68 (m, 3H), 7.48 (d, 1H), 6.97 (br s, 1H), 6.57
    (br s, 1H), 4.26 (d, 1H), 4.22 (d, 2H), 3.89 (d, 1H), 3.52 (q, 2H), 2.66 (t, 2H), 2.11 (s, 3H).
    50 (CD3C(═O)CD3) δ 8.91 (d, 1H), 8.49 (d, 1H), 7.63-7.88 (m, 8H), 7.41 (br s, 1H), 4.60 (d, 1H),
    4.48 (d, 1H), 2.76 (m, 1H), 0.67 (m, 2H), 0.49 (m, 2H).
    51 δ 8.83 (d, 1H), 8.30 (d, 1H), 7.46-7.66 (m, 7H), 7.12 (t, 1H), 6.25 (d, 1H), 4.25 (d, 1H), 4.18 (d,
    2H), 3.89 (d, 1H), 3.79 (m, 1H), 1.91 (m, 2H), 1.70 (m, 2H), 1.60 (m, 1H), 1.12-1.38 (m, 5H).
    52 δ 8.83 (d, 1H), 8.29 (d, 1H), 7.45-7.65 (m, 7H), 7.13 (t, 1H), 6.40 (d, 1H), 4.25 (d, 1H), 4.21 (m,
    1H), 4.19 (d, 2H), 3.88 (d, 1H), 1.97 (m, 2H), 1.57-1.68 (m, 4H), 1.43 (m, 2H).
    53 δ 8.82 (d, 1H), 8.24 (d, 1H), 7.42-7.66 (m, 7H), 6.99 (br t, 1H), 6.73 (br s, 1H), 4.76 (m, 1H), 4.24
    (d, 1H), 3.88 (d, 1H), 2.76 (m, 1H), 1.53 (d, 3H), 0.77 (m, 2H), 0.53 (m, 2H).
    54 (CD3C(═O)CD3) δ 8.92 (d, 1H), 8.50 (d, 1H), 8.06 (br s, 2H), 7.62-7.902 (m, 7H), 7.42 (br s,
    1H), 4.65 (d, 1H), 4.49 (d, 1H), 4.08 (d, 2H), 2.76 (m, 1H), 0.69 (m, 2H), 0.50 (m, 2H).
    55 (CD3C(═O)CD3) δ 8.92 (d, 1H), 8.50 (d, 1H), 8.38 (s, 2H), 8.26 (s, 1H), 7.88 (d, 1H), 7.85 (br s,
    1H), 7.75 (d, 1H), 7.64-7.72 (m, 2H), 7.40 (br s, 1H), 4.74 (d, 1H), 4.65 (d, 1H), 4.08 (d, 2H),
    2.76 (m, 1H), 0.69 (m, 2H), 0.50 (m, 2H).
    56 d 8.73-8.91 (m, 1H), 8.21-8.36 (m, 1H), 7.82 (s, 1H), 7.53-7.67 (m, 5H), 7.46 (d, 1H), 7.29-7.41
    (m, 1H), 7.17 (t, 1H), 6.50 (br s, 1H), 4.24 (d, 1H), 4.20 (d, 2H), 3.90 (d, 1H), 3.15 (dd, 2H),
    0.90 1.01 (m, 1H), 0.50 (dt, 2H), 0.20 (dt, 2 H).
    57 δ 8.83 (d, 1H), 8.32 (d, 1H), 7.82 (s, 1H), 7.53-7.68 (m, 5H), 7.48 (d, 1H), 7.30-7.41 (m, 1H),
    7.04 (br s, 1H), 6.67 (br s, 1H), 4.25 (d, 1H), 4.21 (d, 2H), 3.92 (d, 1H), 3.51 (dt, 2H), 2.65 (t, 2H),
    2.10 (s, 3H).
    58 (CD3OD) δ 8.79-8.87 (m, 1H), 8.34-8.40 (m, 1H), 7.57-7.77 (m, 7H), 7.38-7.45 (m, 1H), 4.46
    (d, 1H), 4.18 (d, 2H), 4.17 (d, 1H).
    59 δ 8.79 (d, 1H), 8.48 (d, 1H) 8.28-8.33 (m, 1H), 7.48-7.68 (m, 8H), 7.44 (d, 1H), 7.29-7.35 (m,
    1H), 7.14-7.26 (m, 3H), 4.56 (d, 2H), 4.22-4.31 (m, 3H), 3.90 (d, 1H).
    60 δ 8.81 (d, 1H), 8.24-8.31 (m, 1H), 7.48-7.64 (m, 6H), 7.44 (d, 1H), 7.28-7.37 (m, 2H), 6.68 (t,
    1H), 4.26 (d, 1H), 4.20 (d, 2H), 3.90 (d, 1H), 3.13 (dd, 2H), 0.87-1.00 (m, 1H), 0.48 (dt, 2H), 0.18
    (dt, 2H).
    61 δ 8.83 (d, 1H), 8.25-8.42 (m, 1H), 7.47-7.77 (m, 6H), 7.32 (d, 1H), 6.95 (br s, 1H), 6.57 (br s,
    1H), 4.28 (d, 1H), 4.22 (d, 2H), 3.92 (d, 1H), 3.46-3.59 (m, 2H), 2.67 (d, 2H), 2.11 (s, 3H).
    62 δ 8.84 (d, 1H), 8.39 and 8.33 (2 d, 1H), 7.68-7.62 (m, 3H), 7.51 (d, 1H), 7.23 (d, 2H), 6.99 and
    6.82 (2 br s, 1H), 6.91 (t, 1H), 6.09 and 5.82 (2 br s, 1H), 4.52 and 4.16 (2 d, 2H), 4.27 (d, 1H),
    3.89 (d, 1H), 2.77 and 2.68 (2 m, 1H), 0.83 (m, 2H), 0.71 and 0.58 (2 m 2H).
    63 δ 8.85 (d, 1H), 8.38 and 8.33 (2 d, 1H), 7.68-7.61 (m, 3H), 7.54-7.40 (m, 4H), 7.15 (t, 1H), 6.99
    and 6.83 (2 t, 1H), 6.13 and 5.82 (2 br s, 1H), 4.52 and 4.16 (2 d, 2H), 4.27 (d, 1H), 3.93 (d, 1H),
    2.77 and 2.63 (2 m, 1H), 0.83 (m, 2H), 0.71 and 0.58 (2 m 2H).
    64 δ 8.82 (m, 1H), 8.23 (m, 1H), 8.14 (s, 2H), 8.00 (s, 1H), 7.40-7.66 (m, 4H), 7.08 (t, 1H), 6.81 (br
    s, 1H), 4.78 (m, 1H), 4.34 (d, 1H), 3.92 (d, 1H), 2.76 (m, 1H), 1.53 (d, 3H), 0.77 (m, 2H), 0.53 (m,
    2H).
    65 δ 8.81 (d, 1H), 8.25 (d, 1H), 8.14 (s, 2H), 8.00 (s, 1H), 7.63 (m, 2H), 7.52 (d, 1H), 7.44 (dd, 1H),
    6.95 (m, 1H), 6.44 (br s, 1H), 5.65 (br s, 1H), 4.85 (m, 1H), 4.35 (d, 1H), 3.93 (d, 1H), 1.57 (d,
    3H).
    66 δ 8.82 (d, 1H), 8.27 (d, 1H), 8.14 (s, 2H), 8.00 (s, 1H), 7.42-7.66 (m, 4H), 7.02 (br s, 1H), 6.55
    (br s, 1H), 4.81 (m, 1H), 4.35 (d, 1H), 3.93 (d, 1H), 3.16 (m, 2H), 1.56 (d, 3H), 0.98 (m, 1H), 0.50
    (m, 2H), 0.21 (m, 2H).
    70 δ 8.83 (d, 1H), 8.31 (d, 1H), 8.13 (s, 2H), 7.99 (s, 1H), 7.68-7.61 (m, 3H), 7.49 (m, 1H), 6.85 (br
    s, 1H), 5.99 (br s, 1H), 5.59 (br s, 1H), 4.37 (d, 1H), 4.25 (d, 2H), 3.92 (d, 1H).
    71 δ 8.85 (d, 1H), 8.34 (d, 1H), 8.14 (s, 2H), 8.00 (s, 1H), 7.69-7.61 (m, 3H), 7.52 (d, 1H), 6.93 (br t,
    1H), 6.15 (br t, 1H), 4.38 (d, 1H), 4.22 (d, 2H), 3.95 (d, 1H), 3.19 (dd, 1H), 0.99 (m, 1H), 0.55 (m,
    2H), 0.23 (m, 2H).
    72 δ 8.82 (d, 1H), 8.24 (d, 1H), 7.87 (s, 1H), 7.82 (s, 1H), 7.72 (s, 1H), 7.62 (m, 2H), 7.50 (d, 1H),
    7.43 (d, 1H), 7.00 (br t, 1H), 6.73 (br s, 1H), 4.76 (m, 1H), 4.29 (d, 1H), 3.90 (d, 1H), 2.76 (m,
    1H), 0.77 (m, 2H), 0.53 (m, 2H).
    73 δ 8.81 (d, 1H), 8.25 (d, 1H), 7.87 (s, 1H), 7.82 (s, 1H), 7.72 (s, 1H), 7.41-7.65 (m, 4H), 7.08 (br t,
    1H), 6.67 (br s, 1H), 4.83 (m, 1H), 4.29 (d, 1H), 3.90 (d, 1H), 3.14 (m, 2H), 1.56 (d, 3H), 0.95 (m,
    1H), 0.48 (m, 2H), 0.20 (m, 2H).
    74 δ 8.78 (d, 1H), 8.20 (d, 1H), 7.86 (s, 1H), 7.81 (s, 1H), 7.72 (s, 1H), 7.59 (m, 2H), 7.45 (d, 1H),
    7.38 (d, 1H), 7.07 (m, 1H), 6.61 (br s, 1H), 5.80 (s, br. 1H), 4.84 (m, 1H), 4.27 (dd, 1H), 3.88 (dd,
    1H), 1.54 (d, 3H).
    80 δ 8.81 (d, 1H), 8.24 (d, 1H), 8.13 (s, 2H), 7.99 (s, 1H), 7.43-7.67 (m, 4H), 6.94 (m, 1H), 6.80 (m,
    1H), 4.82 (m, 1H), 4.35 (d, 1H), 3.93 (d, 1H), 3.62 (m, 1H), 3.20 (m, 1H), 1.84 (m, 1H), 1.56 (dd,
    3H), 1.43 (m, 1H), 1.13 (m, 1H).
    81 δ 8.77-8.88 (m, 1H), 8.25-8.36 (m, 1H), 7.53-7.70 (m, 4H), 7.47 (d, 1H), 7.45 (br s, 1H), 7.34 (s,
    1H), 7.13 (t, 1H), 6.44 (br s, 1H), 4.27 (d, 1H), 4.21 (d, 2H), 3.89 (d, 1H), 3.16 (dd, 2H), 0.89-
    1.02 (m, 1H), 0.51 (dt, 2H), 0.21 (dt, 2H).
    82 (CD3OD) δ 8.78-8.87 (m, 1H), 8.31-8.40 (m, 1H), 7.76 (s, 1H), 7.56-7.73 (m, 5H), 7.50 (s, 1H),
    4.45 (d, 1H), 4.19 (d, 1H), 4.05 (s, 2H), 2.65-2.75 (m, 1H), 0.70-0.78 (m, 2H), 0.50-0.58 (m,
    2H).
    83 δ 8.73 (d, 1H), 8.15 (d, 1H), 8.01 (s, 1H), 7.85 (m, 2H), 7.22-7.57 (m, 5H), 6.80 (br s, 1H), 6.03
    (br s, 1H), 4.82 (m, 1H), 4.23 (m, 1H), 3.85 (m, 1H), 1.50 (d, 3H).
    84 δ 8.80 (d, 1H), 8.26 (d, 1H), 7.49-7.66 (m, 3H), 7.40 (d, 1H), 7.36 (t, 1H), 7.31 (s, 1H), 7.16-
    7.23 (m, 1H), 7.03 (t, 1H), 6.72 (t, 1H), 4.42 (q, 2H), 4.14-4.26 (m, 3H), 3.88 (d, 1H), 3.12 (dd,
    2H), 0.86-0.99 (m, 1H), 0.42-0.51 (m, 2H), 0.13-0.21 (m, 2H).
    85 δ 8.77-8.85 (m, 1H), 8.22-8.29 (m, 1H), 7.52-7.67 (m, 3H), 7.43 (d, 1H), 7.22-7.29 (m, 1H),
    7.20 (s, 1H), 7.03 (t, 1H), 6.76-6.85 (m, 1H), 4.42 (q, 3H), 4.23 (d, 1H), 4.14 (d, 2H), 3.89 (d,
    1H), 2.72 (dt, 1H), 0.71-0.79 (m, 2H) 0.48-0.55 (m, 2H).
    86 δ 8.80 (d, 1H), 8.23 (d, 1H), 7.87 (s, 1H), 7.81 (s, 1H), 7.72 (s, 1H), 7.60 (m, 2H), 7.49 (d, 1H),
    7.42 (d, 1H), 6.97 (br d, 1H), 6.49 (br s, 1H), 5.76 (br s, 1H), 4.77 (q, 1H), 4.28 (dd, 1H), 3.90 (d,
    1H), 2.05 (m, 1H), 1.84 (m, 1H), 1.06 (t, 3H).
    87 δ 8.79 (d, 1H), 8.23 (d, 1H), 7.87 (s, 1H), 7.81 (s, 1H), 7.72 (s, 1H), 7.60 (m, 2H), 7.50 (d, 1H),
    7.41 (dd, 1H), 6.99 (br d, 1H), 6.51 (br s, 1H), 5.86 (br s, 1H), 4.70 (dd, 1H), 4.27 (dd, 1H), 3.88
    (d, 1H), 2.23 (m, 1H), 1.10 (d, 3H), 1.06 (d, 3H).
    89 δ 8.86 (m, 1H), 8.38 (m, 1H), 7.24-7.70 (m, 8H), 4.35 (br s, 2H), 4.28 (d, 1H), 3.92 (d, 1H), 3.61
    (m, 2H), 3.43 (m, 2H), 1.59-1.72 (m, 6H).
    90 δ 8.85 (d, 1H), 8.36 (d, 1H), 7.46-7.68 (m, 7H), 7.04 (m, 1H), 4.27 (m, 2H), 3.75-3.93 (m, 4H),
    2.36-2.57 (m, 2H).
    91 δ 8.84 (d, 1H), 8.36 (d, 1H), 7.46-7.68 (m, 7H), 7.04 (br s, 1H), 4.82 (m, 1H), 4.49 (dd, 1H), 4.27
    (d, 2H), 3.90 (d, 1H), 3.65 (m, 2H), 2.05-2.31 (m, 4H).
    92 (CD3C(O)CD3) δ 9.00 (m, 1H), 8.03-8.10 (m, 2H), 7.75-8.0 (m, 4H), 7.60-7.73 (m, 2H), 7.54
    (d, 1H), 4.65 (d, 1H), 4.48 (d, 1H), 3.9-4.05 (m, 2H), 3.45 (m, 2H), 3.1-3.4 (m, 4H), 2.95-3.1 (m,
    2H), 1.28 (m, 3H).
    93 *
    94 *
    95 *
    96 *
    97 δ 8.88 and 8.86 (2 d, 1H), 8.20 (br s, 1H), 7.67 (m, 2H), 7.57-7.45 (m, 5H), 4.82 (dd, 1H), 4.28
    and 4.27 (2 d, 1H), 3.91 (d, 1H), 3.87 (s, 3H), 3.30 (m, 1H), 3.17 (m, 1H), 2.37, (m, 1H), 2.11 (m,
    1H), 1.97 (m, 1H), 1.88 (m, 1H).
    98 δ 8.88 and 8.86 (2 d, 1H), 8.20 (br s, 1H), 7.67 (m, 2H), 7.57-7.45 (m, 5H), 4.82 (dd, 1H), 4.28
    and 4.27 (2 d, 1H), 3.91 (d, 1H), 3.87 (s, 3H), 3.30 (m, 1H), 3.17 (m, 1H), 2.37, (m, 1H), 2.11 (m,
    1H), 1.97 (m, 1H), 1.88 (m, 1H).
    99 δ 8.89 (d, 1H), 8.06 (br s, 1H), 7.70-7.62 (m, 2H), 7.58-7.42 (m, 5H), 4.89 (dd, 1H), 4.8 (br s,
    1H), 4.27 and 4.26 (2 d, 1H), 3.91 (d, 1H), 3.27 (m, 1H), 3.18 (m, 1H), 2.34, (m, 2H), 1.99 (m,
    1H), 1.88 (m, 1H).
    100 δ 8.89 (d, 1H), 8.06 (br s, 1H), 7.70-7.62 (m, 2H), 7.58-7.42 (m, 5H), 4.89 (dd, 1H), 4.3 (br s,
    1H), 4.27 and 4.26 (2 d, 1H), 3.91 (d, 1H), 3.27 (m, 1H), 3.18 (m, 1H), 2.34, (m, 2H), 1.99 (m,
    1H), 1.88 (m, 1H).
    101 δ 8.89 (d, 1H), 7.86 (d, 1H), 7.80 (t, 1H), 7.71-7.62 (m, 2H), 7.56 (m, 3H), 7.46-7.43 (m, 2H),
    4.94 (dd, 1H), 4.28 and 4.27 (2 d, 1H), 4.13 (m, 1H), 3.93 (m, 1H), 3.91 (d, 1H), 3.21 (m, 1H),
    3.13 (m, 1H), 2.61, (m, 1H), 2.05 (m, 2H), 1.86 (m, 1H).
    102 δ 8.89 (d, 1H), 7.86 (d, 1H), 7.80 (t, 1H), 7.71-7.62 (m, 2H), 7.56 (m, 3H), 7.46-7.43 (m, 2H),
    4.94 (dd, 1H), 4.28 and 4.27 (2 d, 1H), 4.13 (m, 1H), 3.93 (m, 1H), 3.91 (d, 1H), 3.21 (m, 1H),
    3.13 (m, 1H), 2.61, (m, 1H), 2.05 (m, 2H), 1.86 (m, 1H).
    103 δ 8.89 (d, 1H), 7.94 (d, 1H), 7.70-7.63 (m, 2H), 7.57-7.54 (m, 3H), 7.48-7.45 (m, 2H), 7.03 (br s,
    1H), 4.82 (dd, 1H), 4.29 and 4.28 (2 d, 1H), 3.91 (d, 1H), 3.24 (m, 1H), 3.10 (m, 1H), 2.92 (d,
    3H), 2.48, (m, 1H), 2.06 (m, 2H), 1.82 (m, 1H).
    104 δ 8.89 (d, 1H), 7.94 (d, 1H), 7.70-7.63 (m, 2H), 7.57-7.54 (m, 3H), 7.48-7.45 (m, 2H), 7.02 (br s,
    1H), 4.82 (dd, 1H), 4.29 and 4.28 (2 d, 1H), 3.91 (d, 1H), 3.24 (m, 1H), 3.10 (m, 1H), 2.92 (d,
    3H), 2.48, (m, 1H), 2.06 (m, 2H), 1.82 (m, 1H).
    105 δ 8.89 (d, 1H), 7.94 (d, 1H), 7.70-7.62 (m, 2H), 7.57-7.54 (m, 3H), 7.48-7.45 (m, 2H), 7.01 (br s,
    1H), 4.82 (dd, 1H), 4.28 and 4.27 (2 d, 1H), 3.91 (d, 1H), 3.40 (m, 2H), 3.23 (m, 1H), 3.10 (m,
    1H), 2.51, (m, 1H), 2.06 (m, 2H), 1.82 (m, 1H), 1.23 (t, 3H).
    106 δ 8.89 (d, 1H), 7.94 (d, 1H), 7.70-7.62 (m, 2H), 7.57-7.54 (m, 3H), 7.48-7.45 (m, 2H), 7.01 (br s,
    1H), 4.82 (dd, 1H), 4.28 and 4.27 (2 d, 1H), 3.91 (d, 1H), 3.40 (m, 2H), 3.23 (m, 1H), 3.10 (m,
    1H), 2.51, (m, 1H), 2.06 (m, 2H), 1.82 (m, 1H), 1.23 (t, 3H).
    107 δ 8.66 (br t, 1H), 8.62 (d, 1H), 8.18 (d, 1H), 7.87 (d, 1H), 7.70 (dt, 1H), 7.22-7.55 (m, 7H), 4.90
    (d, 2H), 4.24 (d, 1H), 3.86 (d, 1H).
    108 δ 8.60 (d, 1H), 7.70-7.85 (m, 5H), 7.57 (d, 2H), 7.50 (d, 1H), 7.43 (t, 1H), 7.36 (d, 1H), 7.25 (dd,
    1H), 4.82 (d, 2H), 4.43 (d, 1H), 4.03 (d, 1H).
    109 δ 8.48 (d, 1H), 7.68 (t, 1H), 7.52 (s, 2H), 7.46 (s, 1H), 7.18-7.38 (m, 6H), 7.10 (s, 1H), 4.82 (d,
    2H), 4.14 (d, 1H), 3.84 (d, 1H), 3.76 (s, 3H).
    110 δ 11.36 (s, 1H), 8.55 (s, 1H), 8.12 (s, 2H), 8.00 (s, 1H), 7.58 (d, 1H), 7.43 (d, 1H), 6.32 (t, 1H),
    4.39 (d, 1H), 3.94 (d, 1H), 3.41 (m, 2H), 1.14 (m, 1H), 0.62 (m, 2H), 0.34 (m, 2H).
    111 δ 7.45-7.54 (m, 4H), 7.14-7.19 (m, 3H), 7.02 (d, 1H), 4.06-4.19 (m, 3H), 3.86-3.91 (m, 1H),
    3.82 & 3.77 (s, 3H), 3.27 (m, 1H), 2.98 (m, 1H), 2.71 & 2.69 (s, 3H).
    * See synthesis example for 1H NMR data.
    a 1H NMR data are in ppm downfield from tetramethylsilane. Couplings are designated by (s)—singlet, (d)—doublet, (t)—triplet, (q)—quartet, (dd)—doublet of doublets, (dt)—doublet of triplets, (br)—broad peaks, (m)—multiplet.
    • Biological Examples of the Invention
  • The following Tests demonstrate the control efficacy of compounds of this invention on specific pests. “Control efficacy” represents inhibition of invertebrate pest development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species. See Index Tables A-G for compound descriptions.
    • Test A
  • For evaluating control of diamondback moth (Plutella xylostella) the test unit consisted of a small open container with a 12-14-day-old radish plant inside. This was pre-infested with about 50 neonate larvae that were dispensed into the test unit via corn-cob grits using a bazooka inoculator. The larvae moved onto the test plant after being dispensed into the test unit.
  • Test compounds were formulated using a solution containing 10% acetone, 90% water and 300 ppm X-77™ Spreader Lo-Foam Formula non-ionic surfactant containing alkylarylpolyoxyethylene, free fatty acids, glycols and isopropanol (Loveland Industries, Inc. Greeley, Colo., USA). The formulated compounds were applied in 1 mL of liquid through a SUJ2 atomizer nozzle with ⅛ JJ custom body (Spraying Systems Co. Wheaton, Ill., USA) positioned 1.27 cm (0.5 inches) above the top of each test unit. All experimental compounds in these tests were sprayed at 50 ppm, and the test was replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 h and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 25° C. and 70% relative humidity. Plant feeding damage was then visually assessed based on foliage consumed and a pest mortality rating was also counted and calculated for each test unit.
  • Of the compounds of Formula 1 tested the following provided very good to excellent levels of control efficacy (20% or less feeding damage or 80% or more mortality): 3, 4, 5, 6, 7, 8, 10, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 31, 32, 33, 34, 35, 37, 38, 39, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 59, 60, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 89, 90, 91, 92, 93, 94, 97, 98, 99, 102, 103, 104, 105, 106 and 111.
    • Test B
  • For evaluating control of fall armyworm (Spodoptera frugiperda) the test unit consisted of a small open container with a 4-5-day-old corn (maize) plant inside. This was pre-infested (using a core sampler) with 10-15 1-day-old larvae on a piece of insect diet. Test compounds were formulated and sprayed at 50 ppm as described for Test A and replicated three times. After spraying, the test units were maintained in a growth chamber and then the control efficacy was rated for each test unit as described for Test A.
  • Of the compounds of Formula 1 tested the following provided very good to excellent levels of control efficacy (20% or less feeding damage or 80% or more mortality): 4, 14, 15, 16, 17, 18, 19, 20, 21, 22, 27, 31, 32, 33, 38, 44, 47, 49, 50, 51, 52, 53, 54, 55, 56, 60, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 90, 91, 93, 94, 102, 104 and 111.
    • Test C
  • For evaluating control of potato leafhopper (Empoasca fabae) through contact and/or systemic means, the test unit consisted of a small open container with a 5-6 day old Soleil bean plant (primary leaves emerged) inside. White sand was added to the top of the soil and one of the primary leaves was excised prior to application. Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 or 50 ppm as noted, and the test was replicated three times. After spraying, the test units were allowed to dry for 1 hour before they were post-infested with 5 potato leafhoppers (18- to 21-day old adults). A black, screened cap was placed on the top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. The control efficacy of each test unit was then visually assessed by the insect mortality.
  • Of the compounds of Formula 1 tested at 250 ppm, the following provided very good to excellent levels of control efficacy (80% or more mortality): 3, 4, 5, 6, 14, 19, 21, 22, 27, 31, 32, 43, 44, 45, 47, 48, 49, 50, 53, 54, 55, 60, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 90, 91, 93, 94, 103, 104 and 106.
  • Of the compounds of Formula 1 tested at 50 ppm, the following provided very good to excellent levels of control efficacy (80% or more mortality): 4, 5, 6, 14, 22, 27, 31, 32, 39, 43, 44, 45, 48, 49, 50, 53, 54, 55, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 81, 82, 83, 86, 87, 90, 91, 93, 94, 103, 104 and 106.
    • Test D
  • For evaluating control of corn planthopper (Peregrinus maidis) through contact and/or systemic means, the test unit consisted of a small open container with a 3-4-day-old maize plant (spike) inside. White sand was added to the top of the soil prior to application. Test compounds were formulated and sprayed at 250 ppm and replicated three times as described for Test A. After spraying, the test units were allowed to dry for 1 h before they were post-infested with 10-20 corn planthoppers (18- to 20-day-old nymphs) by sprinkling them onto the sand with a salt shaker. A black, screened cap was placed on the top of the cylinder. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. Each test unit was then visually assessed for insect mortality.
  • Of the compounds tested, the following resulted in at least 80% mortality: 27, 53, 72, 74, 78, 83, 86 and 91.
    • Test E
  • For evaluating control of the western flower thrips (Frankliniella occidentalis) through contact and/or systemic means, the test unit consisted of a small open container with a 5-7 day old Soleil Bean plant inside. Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 or 50 ppm as noted, and the test was replicated three times. After spraying, the test units were allowed to dry for 1 hour and then 22-27 adult thrips were added to each unit and then a black, screened cap was placed on top. The test units were held for 6 days at 25° C. and 45-55% relative humidity. A mortality rating was assessed along with a plant damage rating for each test unit.
  • Of the compounds of Formula 1 tested at 250 ppm, the following provided very good to excellent levels of control efficacy (20% or less feeding damage or 80% or more mortality): 3, 4, 6, 8, 22, 26, 31, 33, 43, 44, 45, 47, 48, 49, 50, 53, 55, 64, 66, 67, 68, 72, 73, 74, 76, 78, 79, 80, 89, 90, 93, 94, 98, 104 and 106.
  • Of the compounds of Formula 1 tested at 50 ppm, the following provided very good to excellent levels of control efficacy (20% or less feeding damage or 80% or more mortality): 3, 4, 6, 22, 43, 44, 47, 50, 53, 55, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 76, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 90, 93, 94, 104 and 106.
    • Test F
  • For evaluating control of green peach aphid (Myzus persicae) through contact and/or systemic means, the test unit consisted of a small open container with a 12-15-day-old radish plant inside. This was pre-infested by placing on a leaf of the test plant 30-40 aphids on a piece of leaf excised from a culture plant (cut-leaf method). The larvae moved onto the test plant as the leaf piece desiccated. After pre-infestation, the soil of the test unit was covered with a layer of sand.
  • Test compounds were formulated and sprayed as described for Test A. All experimental compounds in these tests were sprayed at 250 ppm, and the test was replicated three times. After spraying of the formulated test compound, each test unit was allowed to dry for 1 h and then a black, screened cap was placed on top. The test units were held for 6 days in a growth chamber at 19-21° C. and 50-70% relative humidity. Each test unit was then visually assessed for insect mortality.
  • Of the compounds of Formula 1 tested, the following resulted in at least 80% mortality: 4, 27, 38, 43, 44, 47, 50, 51, 53, 55, 65, 66, 67, 69, 71, 72, 73, 74, 76, 78, 79, 80, 81, 82, 83, 86, 87, 90 and 93.
    • Test G
  • For evaluating control of cotton melon aphid (Aphis gossypii) through contact and/or systemic means, the test unit consisted of a small open container with a 6-7-day-old cotton plant inside. This was pre-infested with 30-40 insects on a piece of leaf according to the cut-leaf method described for Test F, and the soil of the test unit was covered with a layer of sand.
  • Test compounds were formulated and sprayed at 250 ppm and the test was replicated three times. After spraying, the test units were maintained in a growth chamber and then visually rated assessed for insect mortality.
  • Of the compounds tested, the following resulted in at least 80% mortality: 27, 53, 65, 71, 72, 74, 78, 82 and 83.
    • Test H
  • For evaluating control of silverleaf whitefly (Bemisia tabaci), the test unit consisted of a 14-21-day-old cotton plant grown in Redi-earth® media (Scotts Co.) with at least two true leaves infested with 2nd and 3rd instar nymphs on the underside of the leaves.
  • Test compounds were formulated in no more than 2 mL of acetone and then diluted with water to 25-30 mL. The formulated compounds were applied using a flat fan air-assisted nozzle (Spraying Systems 122440) at 10 psi (69 kPa). Plants were sprayed to run-off on a turntable sprayer (patent publication EP-1110617-A1). All experimental compounds in this screen were sprayed at 250 ppm and replicated three times. After spraying of the test compound, the test units were held for 6 days in a growth chamber at 50-60% relative humidity and 28° C. daytime and 24° C. nighttime temperature. Then the leaves were removed and then dead and live nymphs were counted to calculate percent mortality.
  • Of the compounds of Formula 1 tested, the following resulted in at least 80% mortality: 5, 27, 39, 73, 76, 86 and 91.
    • Test I
  • For evaluating control of the cat flea (Ctenocephalides felis), a CD-1® mouse (about 30 g, male, obtained from Charles River Laboratories, Wilmington, Mass.) was orally dosed with a test compound in an amount of 10 mg/kg solubilized in propylene glycol/glycerol formal (60:40). Two hours after oral administration of the test compound, approximately 8 to 16 adult fleas were applied to each mouse. The fleas were then evaluated for mortality 48 hours after flea application to the mouse.
  • Of the compounds of Formula 1 tested, the following compounds caused 50% or more mortality: 4, 21, 22, 43, 44, 47, 50, 54, 55, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 93 and 107.
    • Test J
  • For evaluating control of the cat flea (Ctenocephalides felis Bouche), a test compound was solubilized in acetone/water (75:25) to provide a final test concentration of 500 ppm. Then 20 μL of the 500 ppm solution was applied to filter paper in the bottom of a tube. The tube is allowed to dry for 3 hours. Then approximately 10 adult fleas were added to the tube and the tube was capped. The fleas were evaluated for mortality 48 hours later.
  • Of the compounds of Formula 1 tested, the following compounds caused 50% or more mortality: 1, 3, 4, 43, 44, 47, 49, 50, 52, 65, 89 and 90.
    • Test K
  • For evaluating control of the relapsing fever tick (Ornithodoros turicata), a test compound was solubilized in propylene glycol/glycerol formal (60:40) and then diluted in bovine blood to provide a final test concentration of 30 ppm. The treated blood was placed in a tube, and the top of the tube was covered with a membrane. Approximately 5 O. turicata nymphs were placed on the membrane and allowed to feed on the treated blood until fully engorged. The ticks were then evaluated for mortality 48 hours later.
  • Of the compounds of Formula 1 tested, the following compounds caused 50% or more mortality: 43, 44, 45, 47 and 48.

Claims (8)

What is claimed is:
1. A compound selected from Formula 1, N-oxides and salts thereof,
Figure US20150098928A9-20150409-C00132
wherein
A is a 6-membered aromatic ring containing carbon atoms and 0-3 nitrogen atoms as ring members, said ring optionally substituted with 1-5 substituents independently selected from R2;
Q is
Figure US20150098928A9-20150409-C00133
Y1—Y2—Y3 is —CH═CH—S—, —CH═CH—O—, —CH═CH—NH—, —CH═N—NH—, —S—CH═CH—, —O—CH═CH—, —NH—CH═CH— or —NH—N═CH—;
Y4 is CR4 or N;
Z1 is
Figure US20150098928A9-20150409-C00134
Z2 is
Figure US20150098928A9-20150409-C00135
each W1, W2, W3, W4, W5 and W6 is independently O or S;
L1 is C2-C6 alkylene optionally substituted with one or more substituents independently selected from R22;
R1 is C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R21;
each R2 is independently halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
each R3 and R4 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
R5 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R22; or C(═O)R23, CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32 or Q1;
R6 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R33; or C(═O)R23CO2R24, C(═O)NR25R26 or Q1; or
R5 and R6 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24, C(═O)NR25R26, CN and NO2;
R7 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl;
R8 is C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C18 alkylcycloalkyl or C4-C18 cycloalkylalkyl, each substituted with one or more substituents independently selected from R34 and optionally substituted with one or more substituents independently selected from R35; or
R7 and R8 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24 and C(═O)NR25R26;
each R9 and R18 is independently H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35;
R10 is C1-C12 alkyl substituted with one or more R35; or CN, SCN, S(═O)uR37, SO2NR37R38, N═CR38R39, N═CR38OR39, NR37C(═O)R38, NR37C(═O)OR38, SiR41R42R43, CO2R36, C(═O)R36, C(═O)NR37R38, C(═S)SR39, C(═S)OR39, C(═S)R38, C(═S)NR37R38, P(═O)(OR39)2 or P(═S)(OR39)2; provided that when R9 is H or an unsubstituted group of C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, then R10 is CN, SCN, S(═O)uR37, SO2NR37R38, N═CR38R39, N═CR38OR39, SiR41R42R43, CO2R36, C(═O)R36, C(═O)NR37R38, C(═S)SR39, C(═S)OR39, C(═S)R38, C(═S)NR37R38, P(═O)(OR39)2 or P(═S)(OR39)2;
R11 is H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R23, CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38, SO2NR37R38, NR37C(═O)R38, NR37SO2R29 or Q1;
R12 is H; or C1-C12 alkyl, C3-C7 cycloalkyl, C4-C12 alkylcycloalkyl, C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
R13 is H; or C1-C12 alkyl, C3-C7 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R36, C(═O)OR37, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38 or Q1; or
R12 and R13 are taken together with the carbon atom to which they are attached to form a carbocyclic ring containing as ring members from 3 to 6 carbon atoms, said ring optionally substituted with one or more substituents independently selected from R35;
R14 and R15 are independently H; or C1-C12 alkyl, C2-C12 alkenyl, C2-C12 alkynyl, C3-C12 cycloalkyl, C4-C12 alkylcycloalkyl or C4-C12 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R23, CO2R24, C(═O)NR25R26, OR27, SR28, S(═O)R29, SO2R30, NR31R32, C(═S)SR37, C(═S)OR37, C(═S)R37, C(═S)NR37R38, SO2NR37R38, NR37C(═O)R38, NR37SO2R29 or Q1; or
R14 and R15 are taken together with the nitrogen atom to which they are attached to form a ring containing as ring members in addition to the attaching nitrogen atom from 2 to 6 carbon atoms and optionally one additional ring member selected from the group consisting of O, N and S(═O)u, said ring optionally substituted with 1 to 4 substituents independently selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, C(═O)R23, CO2R24, C(═O)NR25R26, CN and NO2; provided that R14 and R15 are other than C1-C6 alkyl or C1-C6 haloalkyl when R11 is H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl;
each R16 and R17 is independently C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35; or
R16 and R17 are taken together with the sulfur atom to which they are attached to form a ring containing as ring members in addition to the attaching sulfur atom from 3 to 6 carbon atoms, said ring optionally substituted with one or more substituents independently selected from R35;
R19 is C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35;
R20 is H; or C1-C6 alkyl optionally substituted with one or more substituents independently selected from R35; or CN, C(═O)R24, CO2R24 or NO2;
R21 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2;
each R22, R33 and R35 is independently H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN, NO2, SCN, C(═O)R37, CO2R37, C(═S)SR37, C(═S)OR37, C(═S)R37, C(—O)NR37R38, C(═S)NR37R38, SO2NR37R38, NR37R38, SiR41R42R43 or Q1;
each R23, R25, R26, R27, R28, R31 and R32 is independently H; or C1-C18 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C9 cycloalkyl, C4-C10 alkylcycloalkyl or C4-C10 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
each R24, R29 and R30 is independently H; or C1-C18 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C9 cycloalkyl, C4-C10 alkylcycloalkyl or C4-C10 cycloalkylalkyl, each optionally substituted with one or more substituents independently selected from R35; or Q1;
R34 is OR36, OC(═O)R37, OC(═O)NR37R38, OCO2R37, OSO2R39, SH, SR36, S(═O)R36, SO2R36, SO2NR37R38, NR36R37, N═CR37R40, N═CR40OR37, NR37C(═O)R38, SCN, SiR41R42R43, CO2H, CO2R46, C(═O)R46, C(═S)SR40, C(═S)OR40, C(═O)SR40, C(═S)R37, C(═S)NR37R38, P(═O)(OR37)2 or P(═S)(OR37)2;
R36 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each substituted with one or more substituents independently selected from halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44 and C(═O)NR44R45;
each R37 and R38 is independently H; or Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each optionally substituted with one of more substituents independently selected from the group consisting of halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44, C(═O)NR44R45 and Q1;
R39 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each optionally substituted with one or more substituents independently selected from the group consisting of halogen, CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44, C(═O)NR44R45 and Q1;
R40 is H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl, C2-C7 alkoxycarbonyl or a phenyl ring, each optionally substituted with one of more substituents independently selected from the group consisting of halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, CN and NO2;
each R41, R42 and R43 is independently C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl or a phenyl ring, each optionally substituted with one of more substituents selected from the group consisting of halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 alkylsulfinyl, C1-C6 alkylsulfonyl, CN and NO2;
each R44 and R45 is independently H; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl or C4-C7 cycloalkylalkyl, each optionally substituted with one of more substituents selected from R35; or Q1;
R46 is Q1; or C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C4-C7 alkylcycloalkyl, C4-C7 cycloalkylalkyl, C2-C7 alkylcarbonyl or C2-C7 alkoxycarbonyl, each substituted with one or more substituents selected from CN, NO2, OR44, SR44, S(═O)R44, SO2R44, CO2R44 and C(═O)NR44R45;
each Q1 is a 3- to 10-membered ring or 7- to 10-membered bicyclic ring system containing as ring members from 2 to 10 carbon atoms and from 0 to 5 heteroatoms selected from the group consisting of carbon, sulfur and nitrogen atoms, of which up to two of the carbon or sulfur atoms are present as C(═O), S(═O) or SO2, said ring or ring system optionally substituted with one or more substituents independently selected from R2;
m is an integer from 0 to 5;
n is an integer from 0 to 4;
q is 0 or 1; and
u is 0, 1 or 2.
2. A compound of claim 1 wherein:
Q is Q-A;
Z1 is Z1-1;
A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN; and
R1 is C1-C3 haloalkyl.
3. A compound of claim 1 wherein:
Q is Q-B;
Z2 is Z2-3;
A is a phenyl ring substituted with 1 to 3 substituents independently selected from the group consisting of halogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 haloalkoxy and CN;
R1 is C1-C3 haloalkyl;
R11 is H;
R12 is H or C1-C3 alkyl;
R13 is H or C1-C3 alkyl;
R14 is C1-C6 alkyl, C3-C6 cycloalkyl or C4-C7 alkylcycloalkyl optionally substituted with one or more substituents independently selected from R35;
R35 is H, halogen, C1-C6 alkoxy, C1-C6 haloalkoxy, C1-C6 alkylthio, C1-C6 haloalkylthio, C1-C6 alkylsulfinyl, C1-C6 haloalkylsulfinyl, C1-C6 alkylsulfonyl, C1-C6 haloalkylsulfonyl, CN or NO2; and
Y4 is CH.
4. A compound of claim 3 wherein:
A is a phenyl ring substituted with 2 substituents independently selected from the group consisting of halogen, C1-C2 haloalkyl and C1-C2 haloalkoxy;
R1 is CF3;
R12 is H;
R13 is H or CH3;
R14 is cyclopropyl or methylcyclopropyl optionally substituted with one or more substituents independently selected from R35;
R15 is H;
R35 is H or halogen.
5. A composition for controlling an invertebrate pest comprising a compound of claim 1 and at least one additional component selected from the group consisting of surfactants, solid diluents and liquid diluents, said composition optionally further comprising at least one additional biologically active compound or agent.
6. The composition of claim 5 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acephate, acequinocyl, acetamiprid, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, azinphos-methyl, bifenthrin, bifenazate, bistrifluoron, borate, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, carbofuran, cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clofentezin, clothianidin, cyflumetofen, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, flufenerim, flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufenuron, malathion, metaflumizone, metaldehyde, methamidophos, methidathion, methiodicarb, methomyl, methoprene, methoxychlor, metofluthrin, monocrotophos, methoxyfenozide, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyrafluprole, pyrethrin, pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, sulprofos, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad, tralomethrin, triazamate, trichlorfon, triflumuron, Bacillus thuringiensis delta-endotoxins, entomopathogenic bacteria, entomopathogenic viruses and entomopathogenic fungi.
7. The composition of claim 6 wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acetamiprid, acrinathrin, amitraz, avermectin, azadirachtin, bifenthrin, 3-bromo-1-(3-chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-1H-pyrazole-5-carboxamide, buprofezin, cadusafos, carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronil, flonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, fosthiazate, hexaflumuron, hydramethylnon, imidacloprid, indoxacarb, lufenuron, metaflumizone, methiodicarb, methomyl, methoprene, methoxyfenozide, nitenpyram, nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirotetramat, tebufenozide, tetramethrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, triazamate, triflumuron, Bacillus thuringiensis delta-endotoxins, all strains of Bacillus thuringiensis and all strains of Nucleo polyhydrosis viruses.
8. A method for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound of claim 1.
US14/148,410 2007-06-13 2014-01-06 Isoxazoline insecticides Active US9095138B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/148,410 US9095138B2 (en) 2007-06-13 2014-01-06 Isoxazoline insecticides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93449607P 2007-06-13 2007-06-13
PCT/US2008/066381 WO2008154528A2 (en) 2007-06-13 2008-06-10 Isoxazoline insecticides
US60282109A 2009-12-03 2009-12-03
US14/148,410 US9095138B2 (en) 2007-06-13 2014-01-06 Isoxazoline insecticides

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2008/066381 Division WO2008154528A2 (en) 2007-06-13 2008-06-10 Isoxazoline insecticides
US12/602,821 Division US8623875B2 (en) 2007-06-13 2008-06-10 Isoxazoline insecticides

Publications (3)

Publication Number Publication Date
US20140127165A1 US20140127165A1 (en) 2014-05-08
US20150098928A9 true US20150098928A9 (en) 2015-04-09
US9095138B2 US9095138B2 (en) 2015-08-04

Family

ID=39930577

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/602,821 Active 2029-11-09 US8623875B2 (en) 2007-06-13 2008-06-10 Isoxazoline insecticides
US14/148,410 Active US9095138B2 (en) 2007-06-13 2014-01-06 Isoxazoline insecticides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/602,821 Active 2029-11-09 US8623875B2 (en) 2007-06-13 2008-06-10 Isoxazoline insecticides

Country Status (11)

Country Link
US (2) US8623875B2 (en)
EP (1) EP2155701B1 (en)
JP (1) JP5473906B2 (en)
CN (1) CN101815706A (en)
AU (1) AU2008261793A1 (en)
BR (1) BRPI0809770B8 (en)
CA (1) CA2684671A1 (en)
ES (1) ES2445651T3 (en)
HK (1) HK1141531A1 (en)
MX (1) MX2009013469A (en)
WO (1) WO2008154528A2 (en)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1380209E (en) * 2001-04-17 2012-09-27 Nihon Nohyaku Co Ltd Pest control agent composition and method of using the same
EA011764B1 (en) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Isoxazoline-substituted benzamide compound and pesticide
TW200803740A (en) * 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
EP2151437A4 (en) * 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide compound and pest control agent
AU2008261793A1 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
AU2016208330A1 (en) * 2007-06-26 2016-08-11 E. I. Du Pont De Nemours And Company Naphthalene isoxazoline invertebrate pest control agents
AU2013273726B2 (en) * 2007-06-26 2016-04-28 Corteva Agriscience Llc Naphthalene isoxazoline invertebrate pest control agents
TWI430995B (en) * 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
CN105640952A (en) 2007-06-27 2016-06-08 杜邦公司 Animal pest control method
TWI461411B (en) 2007-08-17 2014-11-21 Du Pont Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
WO2009045999A1 (en) * 2007-10-03 2009-04-09 E. I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
TW201444787A (en) 2008-04-09 2014-12-01 Du Pont Method for preparing 3-trifluoromethyl chalcones
WO2010003877A1 (en) 2008-07-09 2010-01-14 Basf Se Pesticidal mixtures comprising isoxazoline compounds ii
EP2306837B2 (en) 2008-07-09 2023-10-25 Basf Se Pesticidal active mixtures comprising isoxazoline compounds i
KR20110044873A (en) * 2008-08-22 2011-05-02 신젠타 파티서페이션즈 아게 Insecticidal compounds
CN102131804B (en) * 2008-08-22 2014-12-03 先正达参股股份有限公司 Insecticidal compounds
CN102143960A (en) 2008-09-04 2011-08-03 先正达参股股份有限公司 Insecticidal compounds
US8377942B2 (en) 2008-12-18 2013-02-19 Novartis Ag Isoxazolines derivatives and their use as pesticide
TW201029997A (en) 2008-12-23 2010-08-16 Basf Se Imine compounds for combating invertebrate pests
CN102325759A (en) 2008-12-23 2012-01-18 巴斯夫欧洲公司 Substituted amidine compounds for combating animal pests
US20110288089A1 (en) * 2009-01-22 2011-11-24 Syngenta Crop Protection Llc Insecticidal compounds
US8859592B2 (en) 2009-01-22 2014-10-14 Syngenta Corp Protection Llc Insecticidal compounds
JP5747440B2 (en) 2009-02-06 2015-07-15 住友化学株式会社 Hydrazide compound and its use for pest control
US20120030841A1 (en) * 2009-04-01 2012-02-02 Basf Se Isoxazoline compounds for combating invertebrate pests
MX2011011079A (en) 2009-04-30 2011-11-04 Basf Se Process for preparing substituted isoxazoline compounds and their precursors.
BRPI1015931A2 (en) 2009-06-22 2015-09-01 Syngenta Participations Ag Insecticide Compounds
TWI487486B (en) 2009-12-01 2015-06-11 Syngenta Participations Ag Insecticidal compounds based on isoxazoline derivatives
WO2011075591A1 (en) * 2009-12-17 2011-06-23 Merial Limited Anti parasitic dihydroazole compounds and compositions comprising same
EP2531493B1 (en) 2010-02-01 2015-07-22 Basf Se Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
JP2011219431A (en) * 2010-04-13 2011-11-04 Bayer Cropscience Ag New aryl nitroalkane derivative
CN103119034B (en) 2010-04-16 2016-08-03 拜耳知识产权有限责任公司 Heterocyclic compound as pest control agent
EP2576523B1 (en) * 2010-05-27 2016-01-13 E. I. du Pont de Nemours and Company Crystalline form of 4-[5 - [3 -chloro-5 -(trifluoromethyl)phenyl] -4,5 -dihydro-5 -(trifluoromethyl)-3 - isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1- naphthalenecarboxamide
DK178277B1 (en) 2010-06-18 2015-10-26 Novartis Tiergesundheit Ag Diaryloxazoline compounds for the control of fish lice
US9085541B2 (en) 2010-06-23 2015-07-21 Basf Se Process for producing imine compounds for combating invertebrate pests
JP6215052B2 (en) 2010-06-28 2017-10-18 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ Heterocyclic compounds as pest control agents
WO2012007426A1 (en) 2010-07-13 2012-01-19 Basf Se Azoline substituted isoxazoline benzamide compounds for combating animal pests
EP2619189B1 (en) 2010-09-24 2020-04-15 Zoetis Services LLC Isoxazoline oximes as antiparasitic agents
US9006447B2 (en) 2010-11-03 2015-04-14 Basf Se Method for preparing substituted isoxazoline compounds and their precursors 4-chloro, 4-bromo- or 4-iodobenzaldehyde oximes
JP2014028758A (en) * 2010-11-19 2014-02-13 Nissan Chem Ind Ltd Agent for controlling parasite and sanitary insect pest
AR086113A1 (en) 2011-04-30 2013-11-20 Abbott Lab ISOXAZOLINS AS THERAPEUTIC AGENTS
WO2012155352A1 (en) * 2011-05-19 2012-11-22 Eli Lilly And Company Dihydroisoxazole compounds, parasiticidal uses and formulations thereof
KR102081036B1 (en) 2011-09-12 2020-02-24 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP2794601B1 (en) 2011-12-23 2019-02-20 Basf Se Isothiazoline compounds for combating invertebrate pests
LT2811998T (en) 2012-02-06 2019-02-25 Merial, Inc. Parasiticidal oral veterinary compositions comprising systemically acting active agents, methods and uses thereof
JO3626B1 (en) 2012-02-23 2020-08-27 Merial Inc Topical compositions comprising fipronil and permethrin and methods of use
EP2833867B2 (en) 2012-04-04 2023-05-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds
CN102675237A (en) * 2012-05-24 2012-09-19 南京工业大学 New 2,4-diphenyloxazoline compounds, and synthesis method and acaricidal activity thereof
CN102805105B (en) * 2012-07-23 2016-05-11 广东中迅农科股份有限公司 A kind of composition pesticide that contains Dipel and Rynaxypyr
LT2922845T (en) 2012-11-20 2018-09-10 Merial, Inc. Anthelmintic compounds and compositions and method of using thereof
CN105451771B (en) 2013-03-15 2020-05-19 阿根塔创新有限公司 Chewable formulation
JP6363702B2 (en) * 2013-06-24 2018-07-25 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ Bicyclyl substituted isothiazoline compounds
BR112015032344A2 (en) * 2013-06-24 2017-07-25 Merial Inc naphthyl- or isoquinolinyl-substituted isothiazoline compounds
PT3063144T (en) 2013-11-01 2021-10-28 Boehringer Ingelheim Animal Health Usa Inc Antiparisitic and pesticidal isoxazoline compounds
BR112016023898A8 (en) 2014-04-17 2021-03-30 Basf Se use of malononitrile compounds to protect animals from parasites
CA2949511A1 (en) 2014-05-19 2015-11-26 Merial, Inc. Anthelmintic compounds
AU2015339096B2 (en) 2014-10-31 2018-08-02 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal composition comprising fipronil
CR20170336A (en) * 2014-12-22 2018-01-30 Basf Se AZOLINA COMPOUNDS REPLACED WITH A CONDENSED RING SYSTEM
UY36570A (en) 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
SG11201708068PA (en) 2015-04-08 2017-10-30 Merial Inc Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
MX2021001566A (en) 2015-05-20 2022-09-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds.
UY37137A (en) 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
HUE056909T2 (en) * 2016-04-06 2022-04-28 Boehringer Ingelheim Animal Health Usa Inc Process for the preparation of enantiomerically enriched isoxazoline compounds - crystalline toluene solvate of (s)-afoxolaner
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
JP2019535655A (en) 2016-10-14 2019-12-12 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド Insecticidal and parasiticidal vinylisoxazoline compounds
JP2020504710A (en) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド Anthelmintic depsipeptide compounds
TW201840542A (en) * 2017-03-22 2018-11-16 瑞士商先正達合夥公司 Pesticidally active cyclopropyl methyl amide derivatives
WO2018192793A1 (en) 2017-04-20 2018-10-25 Basf Se Substituted rhodanine derivatives
ES2944616T3 (en) 2017-08-14 2023-06-22 Boehringer Ingelheim Animal Health Usa Inc Pyrazole-Isoxazoline Compounds Pesticides and Parasiticides
BR112020012018A2 (en) 2017-12-15 2020-11-24 Tarsus Pharmaceuticals, Inc. isoxazoline parasiticide formulations and methods to treat blepharitis
TWI812673B (en) * 2018-02-12 2023-08-21 美商富曼西公司 Naphthalene isoxazoline compounds for controlling invertebrate pests
CN112996788A (en) 2018-07-09 2021-06-18 勃林格殷格翰动物保健美国公司 Anthelmintic heterocyclic compounds
AR115794A1 (en) * 2018-07-18 2021-02-24 Fmc Corp ISOXAZOLINE COMPOUNDS TO CONTROL INVERTEBRATE PESTS
TW202012399A (en) * 2018-09-12 2020-04-01 美商富曼西公司 Isoxazoline compounds for controlling invertebrate pests
CN113260419A (en) 2018-11-20 2021-08-13 勃林格殷格翰动物保健美国公司 Indazolyl cyanoethylamino compounds, compositions thereof, methods of making the same, and methods of using the same
RU2700096C1 (en) * 2018-12-28 2019-09-12 Общество с ограниченной ответственностью "Научно-производственная компания "Оргполимерсинтез" Highly concentrated plant nutrition improver
MX2021011302A (en) 2019-03-19 2022-01-19 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic aza-benzothiophene and aza-benzofuran compounds.
AR119790A1 (en) * 2019-08-29 2022-01-12 Pi Industries Ltd ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS
WO2021242481A1 (en) 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
AU2021278889A1 (en) 2020-05-29 2023-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelmintic heterocyclic compounds
UY39309A (en) 2020-07-02 2021-12-31 Pi Industries Ltd ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS
AR124298A1 (en) 2020-12-11 2023-03-15 Pi Industries Ltd ISOXAZOLINE COMPOUNDS AND THEIR USE AS PEST CONTROL AGENTS
WO2022140728A1 (en) 2020-12-21 2022-06-30 Boehringer Ingelheim Animam Health Usa Inc. Parasiticidal collar comprising isoxazoline compounds
BR112023015168A2 (en) 2021-01-27 2023-10-03 Corteva Agriscience Llc CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH
US20240116854A1 (en) 2021-01-27 2024-04-11 Intervet Inc. Cyclopropylamide compounds against parasites in fish
WO2023037253A1 (en) 2021-09-08 2023-03-16 Pi Industries Ltd Isoxazoline compounds and their use as pest control agents
WO2023156938A1 (en) 2022-02-17 2023-08-24 Boehringer Ingelheim Vetmedica Gmbh Method and system for providing a fluid product mailer
CN114521553B (en) * 2022-02-23 2023-04-25 福建省农业科学院植物保护研究所 Special antifeedant for preventing and controlling insect gall thrips on ficus plants
CN114605324A (en) * 2022-03-28 2022-06-10 山东省联合农药工业有限公司 Isoxazoline substituted benzamide derivative and preparation method and application thereof
CN115960053B (en) * 2023-01-16 2023-07-18 山东诚创蓝海医药科技有限公司 Naphthalene isoxazoline compound and application thereof

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879532A (en) * 1974-01-18 1975-04-22 Shell Oil Co Control by isoxazoles of endoparasitic nematodes
US4129568A (en) * 1977-05-12 1978-12-12 Monsanto Company 2-[3-Aryl-2-isoxazolin-5-yl]benzoates
EP0074069B1 (en) 1981-09-03 1986-01-08 Daikin Kogyo Co., Ltd. Process for preparing chlorotrifluoromethylbenzene
GB8523126D0 (en) 1985-09-19 1985-10-23 Ici Plc Aryl pyridones
DE3534133A1 (en) 1985-09-25 1987-04-02 Kolbenschmidt Ag LOW-MAINTENANCE SLIDING BEARING MATERIAL
US5849736A (en) 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
GB9505651D0 (en) 1995-03-21 1995-05-10 Agrevo Uk Ltd AgrEvo UK Limited
CN1076351C (en) 1996-04-26 2001-12-19 日本曹达株式会社 Novel benzene derivatives substituted by heterocycles and herbicides
CA2206151A1 (en) 1996-06-06 1997-12-06 Rohm And Haas Company Benzyloxy substituted aromatics and their use as fungicides and insecticides
US5932766A (en) 1997-05-30 1999-08-03 Abbott Laboratories Process for the preparation of substituted keto-enamines
GB2351081A (en) 1999-06-18 2000-12-20 Lilly Forschung Gmbh Pharmaceutically active imidazoline compounds and analogues thereof
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE10114597A1 (en) 2001-03-23 2002-10-02 Bayer Cropscience Gmbh Arylisoxazoline derivatives, process for their preparation and their use as pesticides
WO2004018410A1 (en) * 2002-08-26 2004-03-04 Nissan Chemical Industries, Ltd. Substituted benzanilide compound and pest control agent
DE10320782A1 (en) 2003-05-09 2004-11-25 Bayer Cropscience Ag Substituted oxyarenes
JP2005272452A (en) 2004-02-23 2005-10-06 Nissan Chem Ind Ltd Substituted benzanilide compound and pesticide
EA011764B1 (en) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Isoxazoline-substituted benzamide compound and pesticide
JP2007530598A (en) 2004-03-26 2007-11-01 サイトカイン・ファーマサイエンシズ・インコーポレーテッド COMPOUND, COMPOSITION, MAKING PROCESS AND METHOD OF USE FOR INHIBITION OF MACROPHAGE MIGRATION INHIBITOR
US20070186971A1 (en) 2005-01-20 2007-08-16 Nanosolar, Inc. High-efficiency solar cell with insulated vias
JP5051340B2 (en) 2005-06-06 2012-10-17 日産化学工業株式会社 Substituted isoxazoline compounds and pest control agents
MY146795A (en) 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
KR101416521B1 (en) 2005-09-02 2014-07-16 닛산 가가쿠 고교 가부시키 가이샤 Isoxazoline-substituted benzamide compound and harmful organism-controlling agent
JP2007106756A (en) 2005-09-14 2007-04-26 Nissan Chem Ind Ltd Substituted isoxazoline compound and pesticide
TWI266597B (en) * 2005-09-27 2006-11-11 Delta Electronics Inc Electronic apparatus capable of dissipating heat uniformly
KR20080080168A (en) * 2005-12-14 2008-09-02 이 아이 듀폰 디 네모아 앤드 캄파니 Isoxazolines for controlling invertebrate pests
TW200803740A (en) * 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
WO2007074789A1 (en) 2005-12-26 2007-07-05 Nissan Chemical Industries, Ltd. 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
TWI412322B (en) * 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
DE602007006288D1 (en) * 2006-03-10 2010-06-17 Nissan Chemical Ind Ltd SUBSTITUTED ISOXAZOLIN COMPOUND AND PESTICIDES
MX2008013307A (en) 2006-04-20 2008-10-27 Du Pont Pyrazolines for controlling invertebrate pests.
WO2007125984A1 (en) 2006-04-28 2007-11-08 Nihon Nohyaku Co., Ltd. Isoxazoline derivative, pest-controlling agent, and use of the pest-controlling agent
JP2008044880A (en) 2006-08-15 2008-02-28 Bayer Cropscience Ag Insecticidal isooxazolines
EP2151437A4 (en) 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd Isoxazoline-substituted benzamide compound and pest control agent
KR20090130064A (en) 2007-04-10 2009-12-17 바이엘 크롭사이언스 아게 Insecticidal aryl isoxazoline derivatives
AU2008261793A1 (en) 2007-06-13 2008-12-18 E. I. Du Pont De Nemours And Company Isoxazoline insecticides
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
EP2172462A4 (en) 2007-06-27 2010-12-15 Nissan Chemical Ind Ltd Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound
CN105640952A (en) 2007-06-27 2016-06-08 杜邦公司 Animal pest control method
TWI556741B (en) * 2007-08-17 2016-11-11 英特威特國際股份有限公司 Isoxazoline compositions and their use as antiparasitics
TWI461411B (en) 2007-08-17 2014-11-21 Du Pont Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
KR20100064382A (en) 2007-09-10 2010-06-14 닛산 가가쿠 고교 가부시키 가이샤 Substituted isoxazoline compound and pest control agent
WO2009045999A1 (en) 2007-10-03 2009-04-09 E. I. Du Pont De Nemours And Company Naphthalene isoxazoline compounds for control of invertebrate pests
TW201444787A (en) 2008-04-09 2014-12-01 Du Pont Method for preparing 3-trifluoromethyl chalcones

Also Published As

Publication number Publication date
BRPI0809770B8 (en) 2022-12-06
JP5473906B2 (en) 2014-04-16
CN101815706A (en) 2010-08-25
BRPI0809770B1 (en) 2020-02-04
MX2009013469A (en) 2010-01-20
WO2008154528A2 (en) 2008-12-18
US20100179195A1 (en) 2010-07-15
CA2684671A1 (en) 2008-12-18
WO2008154528A3 (en) 2009-03-19
US8623875B2 (en) 2014-01-07
AU2008261793A1 (en) 2008-12-18
JP2010529989A (en) 2010-09-02
US9095138B2 (en) 2015-08-04
EP2155701B1 (en) 2013-12-11
ES2445651T3 (en) 2014-03-04
BRPI0809770A2 (en) 2019-03-19
EP2155701A2 (en) 2010-02-24
US20140127165A1 (en) 2014-05-08
HK1141531A1 (en) 2010-11-12

Similar Documents

Publication Publication Date Title
US9095138B2 (en) Isoxazoline insecticides
EP2158188B1 (en) Naphthalene isoxazoline invertebrate pest control agents
CA2799963C (en) Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4,5 -dihydro-5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [(2,2,2-trifluoroethyl)amino]ethyl] -1-naphthalenecarboxamide
EP2360157B1 (en) 5-aryl isoxazolines for controlling invertebrate pests
WO2012087630A1 (en) Pyridine and pyrimidine compounds for controlling invertebrate
AU2014277839B2 (en) Isoxazoline insecticides
AU2018202270B2 (en) Naphthalene isoxazoline invertebrate pest control agents
AU2014262192A1 (en) Crystalline form of 4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide

Legal Events

Date Code Title Description
AS Assignment

Owner name: E.I. DU PONT DE NEMOURS AND COMPANY, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAHM, GEORGE PHILIP;WAGERLE, TY;XU, MING;SIGNING DATES FROM 20091102 TO 20091110;REEL/FRAME:032505/0096

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

AS Assignment

Owner name: CORTEVA AGRISCIENCE LLC, INDIANA

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:E.I. DU PONT DE NEMOURS AND COMPANY;REEL/FRAME:066507/0548

Effective date: 20240220